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 Abstract 
 
Long relegated to the background by the pre-eminence of magnesium-based, 
stoichiometric Grignard reagents, a distinct chemistry of the heavier alkaline earth 
metals, calcium, strontium and barium, is only now starting to emerge. As similarities 
have been drawn between the large, electropositive, redox-inert and d0 alkaline earth 
Ae2+ dications and the Ln3+ cations of the lanthanide series, a growing group 2-mediated 
catalytic chemistry has developed over the last decade, including polymerisation 
reactions, heterofunctionalisation reactions of multiple bonds and some rare examples 
of dehydrocoupling reactions. Among these catalytic reactions the magnesium- and 
calcium-catalysed intramolecular hydroamination of aminoalkenes has attracted 
particular interest. Mechanistic studies have demonstrated many parallels with the 
lanthanide-mediated catalytic cycle based upon successive σ-bond metathesis and 
insertion steps.  
 
In the first part of this thesis, further investigations into the 
hydroamination/cyclisation reaction have demonstrated the prominent role of the charge 
density of the catalytic group 2 cation (M = Mg, Ca, Sr, Ba), the beneficial influence of 
stabilising spectator ligands, and the importance of the choice of the reactive co-ligand 
for efficient catalyst initiation. Kinetic analyses of reactions monitored by NMR 
spectroscopy have given new insight into activation energies, entropic effects, substrate 
and product inhibition, and kinetic isotope effects, leading to a review of the previously 
suggested lanthanide-mimetic mechanism.  
 
In a second part, this study seeks to address two of the main challenges posed by the 
intramolecular hydroamination reaction in particular, and heavier alkaline earth-
catalysed reactions in general:  
(i) The need to design new monoanionic spectator ligands capable of stabilising 
heteroleptic heavier alkaline earth complexes and preventing deleterious Schlenk-
type ligand redistribution processes in solution; 
(ii) The stabilisation of highly reactive heteroleptic group 2 alkyl functionalities for fast, 
irreversible catalyst initiation and novel reactivity. 
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1 Introduction 
 
1.1 Background 
 
More than a century after Grignard’s seminal work on his eponymous reagents, 
which won him the Nobel Prize in 1912,[1] the organometallic chemistry of the alkaline 
earth metals is still largely dominated by stoichiometric organomagnesium reagents.[2] 
Despite early efforts to obtain the analogous heavier alkaline earth alkyl or aryl 
halides,[3] the extremely air- and moisture-sensitive nature of these thermally unstable 
compounds long prevented the development of a related calcium, strontium or barium 
chemistry. It is therefore remarkable that Westerhausen and co-workers recently 
succeeded in isolating and structurally characterising a whole series of calcium aryl 
halides despite their tendency to decompose through ether cleavage even at 
temperatures below -35 oC.[4, 5] Although more reactive calcium alkyl halide analogues, 
as well as related strontium and barium aryl halides, have yet to be structurally 
characterised, the heavier alkaline earth metals, and especially calcium, have been freed 
from their limitations as “heavy Grignard reagents” by the emergence, over the last 
decade, of a rapidly expanding catalytic group 2 chemistry.  
Upon descending the group, the divalent alkaline earth cations display a striking 88% 
increase in ionic radius from magnesium to barium (six-coordinate radii: Mg2+, 0.72 Å; 
Ca2+, 1.00 Å; Sr2+, 1.18 Å; Ba2+, 1.35 Å)[6] accompanied by a marked decrease in 
electronegativity.[7] As a result metal-ligand bonding becomes increasingly ionic and 
non-directional. Furthermore, with the exception of a handful of outstanding, recent 
examples of subvalent Mg(I) and Ca(I) compounds displaying metal-metal bonds 
stabilised by either bulky ligands or extended pi-systems,[8] the vast majority of 
complexes of the alkaline earth metals are redox inactive and found in their 2+ 
oxidation state, thus achieving a d0 electronic configuration. Consequently comparisons 
have often been made with the properties of lanthanide cations which are generally 
found in their principal 3+ oxidation state. Similarly to the alkaline earth metals, Ln3+ 
complexes are characterised by their d0 configuration, redox inactivity and ionic metal-
ligand bonding resulting from high electropositivity and little polarisability.[9] Moreover, 
the f-orbitals, which remain shielded by the 5s25p6 outer shell electrons, do not 
intervene in complex formation. Parallels have also been drawn between the size of the 
12 
 
Ca2+ dication and the ionic radii of the largest lanthanide cations (six-coordinate radii: 
La3+, 1.03 Å; Nd3+, 0.98 Å; Sm3+, 0.96 Å).[6] Both lanthanide and alkaline earth metal 
cations interact preferentially with hard ligands and exhibit strong oxophilic character. 
As a consequence the same problems initially encountered with the synthesis of 
lanthanide complexes also apply to heavier group 2 compounds; for example, simple 
homoleptic species commonly display low solubility in organic solvents, and kinetic 
instability must be countered by the use of sterically demanding anionic ligands. 
These structurally-based analogies have naturally led to the proposal of similar 
reactivity for lanthanide and alkaline earth complexes. Since the 1980s lanthanide 
complexes of the form L2LnX (L = monoanionic spectator ligand, e.g. cyclopentadienyl; 
X = monoanionic substituent, e.g. alkyl, amide, phosphide, hydride, etc.) have been 
widely used in a variety of catalytic transformations based on two simple mechanistic 
pathways: (a) the σ-bond metathesis or protonolysis of the monoanionic substituent X 
and (b) the insertion of unsaturated bonds into the Ln-X σ-bond (Scheme 1).[10] 
 
Scheme 1. Stoichiometric reactivity of lanthanide complexes: (a) σ-bond metathesis and (b) insertion. 
 
 
 
 
 
Incorporated into catalytic cycles, these two reactions pathways have enabled a vast 
number of synthetic reactions ranging from the inter- and intramolecular 
heterofunctionalisation of carbon-carbon multiple bonds (hydroamination, 
hydrophosphination, hydroalkoxylation, hydrosilylation, hydroboration, etc.) to the 
polymerisation of alkenes.[11] A general catalytic cycle for these lanthanide-mediated 
reactions is presented in Figure 1. Activation of the precatalyst occurs through either 
reversible or irreversible σ-bond metathesis, followed by the rate-determining insertion 
of the unsaturated bond which proceeds via a four-membered cyclic transition state. The 
resulting, highly reactive lanthanide alkyl species is then protonated to liberate the 
functionalised product and regenerate the active catalyst. Highly encumbered ligands 
are of importance for the kinetic stabilisation of the active species in order to avoid 
ligand redistribution towards unreactive homoleptic complexes or dimerisation, both 
leading to a decrease in reactivity. Highly substituted and ansa-bridged 
Ln X
L
L
Y H
L2LnX + YH L2LnY + XH
L2LnX + H2C=CHR
Ln X
L
L
XL2Ln
(a)
(b)
R R
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cyclopentadienyl ligands have proved spectator ligands of choice for many of these 
transformations.[12] In recent years, the focus has shifted towards a wide variety of 
sterically demanding, chiral non-cyclopentadienyl ligands for stereoselective 
catalysis.[13] Reduced access to the metal centre as a consequence of steric hindrance of 
the ligand, however, may cause a decrease in reactivity by impeding the insertion step, 
especially if the unsaturated bond is highly substituted. Catalytic activity is also 
generally inhibited by the presence of Lewis donor solvents, such as THF, which may 
block potential coordination sites for substrate access or, if product and substrate 
present a similar pKa, lead to competitive product coordination and/or reversible 
protonolysis. 
 
Figure 1. General catalytic cycle for the lanthanide-mediated heterofunctionalisation of carbon-carbon 
double bonds. 
 
 
 
  
 
 
 
 
 
Owing to the similarities between lanthanide (III) and heavier group 2 complexes, 
the latter have long been treated as merely “lanthanide mimetic”. Indeed the last decade 
has shown that group 2 complexes of the form LAeX (L = monoanionic spectator ligand, 
e.g. β-diketiminate; X = amide, alkyl, phosphide, oxide, hydride, etc.) undergo σ-bond 
metathesis and insertion reactions identical to those of lanthanide species, and these 
have been successfully incorporated into an ever wider range of catalytic processes, 
often analogous to those encountered in lanthanide chemistry (Figure 2).[14]  
 
L2Ln-X
HX
HY
L2Ln-Y
R
Ln
L
L
Y
R
R
YL2Ln
Y
R
Catalyst initiation:
σ-bond metathesis
Rate-determining step:
insertion of
unsaturated bond
Catalyst regeneration:
protonolysis or
σ-bondmetathesis
HY
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Figure 2. Proposed catalytic cycle for the alkaline earth-mediated heterofunctionalisation of carbon-
carbon double bonds. 
 
 
 
 
 
 
 
 
 
Calcium and its heavier group 2 congeners are also finding a unique place in 
organometallic chemistry due to a number of important factors differentiating them 
from their lanthanide counterparts. The 88% increase in size down the group from Mg2+ 
to Ba2+ contrasts markedly with the 17% range of the lanthanide contraction from La3+ 
to Lu3+. Similarly, Pauling electronegativity decreases by 35% from magnesium to 
barium, whereas only a 15% increase is observed from lanthanum to lutetium. While the 
larger Ae2+ dications display higher polarisability, their increasingly diffuse charge 
induces a decrease in their polarising capacity. As a consequence, despite the many 
parallels that can be drawn especially between magnesium or calcium and the 
lanthanide systems, a much wider scope of largely unexploited reactivity might be 
expected from complexes of the heavier alkaline earth metals. Furthermore, from an 
economical and sustainability point of view, the availability of calcium as the fifth most 
abundant element in the earth’s crust (4.15 weight %)[15] and the relative abundance of 
the other alkaline earth metals compared with the rare earth metals make research into 
this nascent area of chemistry even more desirable. This is best illustrated by the cost 
comparison of alkaline earth versus lanthanide starting materials in Figure 3. Finally, 
with the increasing interest in the production of biocompatible polymers for medicinal 
applications, the use of perfectly biocompatible calcium or magnesium polymerisation 
precatalysts might solve the problem of having to remove potentially toxic trace metals 
from these materials.  
 
LAe-X
HX
HY
LAe-Y
R
LAe Y
R
R
YLAe
Y
R
Catalyst initiation:
σ-bond metathesis
Rate-determining step:
insertion of
unsaturated bond
Catalyst regeneration:
protonolysis or
σ-bondmetathesis
Ae = Mg, Ca, Sr, Ba
HY
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Figure 3. Comparison between the cost of alkaline earth and rare earth starting materials.[16] 
 
 
 
 
 
 
 
 
This introduction aims to provide an overview of the whole extent of heavier alkaline 
earth-mediated catalysis (M = Mg, Ca, Sr, Ba), including polymerisation reactions, 
heterofunctionalisation of multiple bonds and σ-bond coupling reactions with well-
defined homoleptic and heteroleptic group 2 precatalysts. Key stoichiometric σ-bond 
metathesis and insertion reactions will be examined in parallel to provide useful 
mechanistic insight into the catalytic processes. Recent and related advances in organic 
asymmetric Lewis acid-catalysed carbon-carbon bond formation relying on chiral 
alkaline earth alkoxides formed in situ will also be discussed briefly. 
 
 
1.2 Catalysis with group 2 complexes 
 
Whereas heterogeneous alkaline earth oxide and alkoxide catalysts have been studied 
for a few decades and have found various industrial applications, often in combination 
with other metals (Li, Al, etc.),[17] homogeneous catalysis with group 2 complexes is 
still in its infancy. Whether based on homoleptic precatalysts of the form AeX2 (X = 
NR2, OR, R) or on heteroleptic compounds of the form LAeX (X = NR2, OR, R, H) 
where L is a sterically demanding, monoanionic, generally polydentate spectator ligand, 
these catalytic transformations can be broken down into a series of σ-bond metathesis 
(or protonolysis) and insertion steps.   
 
 
 
CaI2         LaI3       SrI2      NdI3      BaI2      SmI3 
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1.2.1 The Schlenk equilibrium: a problem for well-defined single-site 
catalysis.  
 
As homoleptic alkaline earth compounds of the form AeX2 may often be polymeric 
or insoluble in hydrocarbon solvents research has focused on designing sterically 
demanding, lipophilic, monoanionic ligands to stabilise and solubilise group 2 amide, 
alkoxide, alkyl or hydride functionalities in heteroleptic complexes of the form LAeX. 
Due to the weakening of the metal-ligand bonds down the group, however, the larger 
alkaline earth metal centres present an increasing problem of ligand exchange equilibria. 
Similarly to the dynamic behaviour of RMgX Grignard reagents exemplified in the 
Schlenk equilibrium, heteroleptic LAeX complexes tend to irreversibly redistribute 
towards the kinetically stabilised homoleptic AeL2 and AeX2 species (Scheme 2). While 
the former are catalytically inactive, the latter, although potentially reactive, are often 
insoluble or may cause a dramatic change in catalytic activity and selectivity. Such 
Schlenk-type equilibria are especially problematic when dealing with LAeX complexes 
for potentially enantioselective catalysis, where L is a chiral spectator ligand.[18] In most 
cases, while the heteroleptic magnesium and calcium analogues can be readily isolated 
in good purity and show no or little ligand lability in solution up to high temperatures, 
the related strontium and barium complexes, if isolable, are usually found in solution 
equilibrium with the homoleptic species, even at room temperature.[19] Another common 
problem is the dimerisation of heteroleptic species bearing small monoanionic co-
ligands, which may impede catalytic reactions by blocking vacant coordination sites. 
 
Scheme 2. Schlenk-type ligand redistribution equilibria for alkaline earth β-diketiminate amide 
complexes. 
 
 
 
 
 
 
While early research focused on sterically hindering cyclopentadienyl ligands to 
overcome this problem, the resulting half-sandwich calcium amide, acetylide, halide or 
borohydride complexes, although heteroleptic in the solid state, often remained prone to 
Schlenk-type ligand redistribution in solution, and thus exhibited limited use as 
NN
MAr Ar
(THF)n N(SiMe3)2
2 N
N
M
Ar
Ar
N
N
Ar
Ar
Ar = 2,6-iPr2C6H3
M = Mg, n = 0
M = Ca, Sr, Ba, n = 1
Ae = Mg, Ca
Ae = Sr, Ba
+ [M{N(SiMe3)2}2(THF)2]
2 LAeX AeL2 + AeX2
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precatalysts.[20] As the synthesis of heteroleptic strontium or barium metallocenes 
proved rather elusive, more recent attention has shifted towards monoanionic non-
cyclopentadienyl ligands bearing bulky substituents which may be easily tuned for 
steric, electronic, and potentially chiral effects. A landmark in this area was the isolation 
in 2004 by Chisholm and co-workers of the heteroleptic calcium β-diketiminate and 
tris(pyrazolyl)borate complexes 2, 3 and 4 and their application to the ring-opening 
polymerisation of lactides (Figure 4).[21] Since then the β-diketiminate ligand has been 
successfully employed to stabilise a wide variety of heteroleptic magnesium, calcium 
and strontium complexes bearing even small functionalities (F, OH, NH2, CN, H, 
etc.).[22] It is therefore not surprising that heteroleptic amide and hydride complexes 
based on this particular ligand have so far been used in the majority of alkaline earth-
catalysed reactions, together with heteroleptic tris(pyrazolyl)borate, aminotroponiminate 
and triazenide group 2 amide complexes, as well as fluorenyl-supported benzyl 
complexes (Figure 4).  
 
Figure 4. Examples of heteroleptic alkaline earth precatalysts. 
 
 
 
 
 
 
 
 
 
 
 
1.2.2 Polymerisation 
 
Polymerisation of polar monomers 
 
The catalytic synthesis of polymers with either mechanical or medicinal applications, 
such as poly(methyl methacrylate) (PMMA) or poly(lactide) (PLA), requires the 
catalyst to be either entirely removable from the finished product or, if this is not the 
N N
Me3Si
R
R
Ca
Me2N THF
SiMe3H
M
(THF)n X
1 M = Mg, X = Me, n = 0
2 M = Ca, X =N(SiMe3)2, n = 1
N N
N N
N N
HB
tBu
tBu
tBu
Ca X
3 X = N(SiMe3)2,
4 X = O-2,6iPr2C6H3
N
N
M
(THF)2
N(SiMe3)2
5 M = Ca
6 M =Sr
N
N
N
Ca
(THF)2
N(SiMe3)2
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case, at least non-coloured or biocompatible. Biocompatible magnesium and calcium 
catalysts are therefore highly desirable for these transformations. The earliest 
polymerisation studies with homogeneous alkaline earth catalysts date back as far as the 
early 1970s. In 1974, Lindsell and co-workers reported the highly syndiotactic 
polymerisation of MMA with bis(cyclopentadienyl) calcium precatalysts, albeit in very 
poor yield (8%).[23] Although attempts by M. S. Chisholm’s group to reproduce the 
tacticity reported in this early study failed, they introduced the use of more soluble 
[(Cp*)2Ca(THF)2] precatalysts to obtain high yields of essentially atactic PMMA.
[24] 
Later studies by Schumann with similar homoleptic and heteroleptic Mg, Ca, Sr and Ba 
precatalysts allowed fast and near quantitative polymerisation of functionalised 
methacrylate monomers and the formation of block-copolymers.[25] More recently, the 
use of heteroleptic β-diketiminato magnesium enolate dimer 9 by Dove et al. (Scheme 3) 
provided fast, living and highly syndioselective polymerisation of PMMA (rr = 96%).[26] 
 
Scheme 3. Syndioselective polymerisation of MMA. 
 
 
 
 
 
 
Until recently the most efficient catalysts for the polymerisation of cyclic esters such 
as lactide (LA), ε-caprolactone (ε-CL) and trimethylene carbonate (TMC) were based 
upon zinc, as well as other transition and main group metals. Over the last decade, 
however, research has turned increasingly and with great success towards biocompatible 
alkaline earth-based catalysts for these polymerisation reactions. As early as 1996, CaH2 
was reported to promote the copolymerisation of L-LA and poly(ethylene glycol).[27] 
Calcium and magnesium acetylacetonate complexes, as well as dibutylmagnesium were 
also used to catalyse the ring-opening copolymerisation of both L-LA and ε-CL with 
glycolide.[28] The resulting polymers were found to be entirely compatible with brain 
tissue. In 2001 Feijin and Westerhausen investigated the potential of commercially 
available [Ca(OMe)2] as well as alkoxide species generated in situ from more soluble 
[Ca{N(SiMe3)2}2(THF)2], showing the latter to be efficient precatalysts for the living 
polymerisation of both ε-CL and L-LA, without racemisation.[29] The resulting polymers 
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displayed narrow polydispersities, enabling the formation of block-copolymers. Since 
then a growing number of heteroleptic monomeric, dimeric and even trimeric calcium 
amide, alkoxide and magnesium alkyl species, as well as several group 2 complexes 
bearing bis(phenolate) ligands have been tested for the polymerisation and 
copolymerisation of L-LA and ε-CL, as shown in Scheme 4.[30] To date only one 
example of barium-catalysed ring-opening polymerisation of L-LA and ε-CL has been 
reported.[31] For the polymerisation of TMC and its copolymerisation with L-LA, 
Darensbourg studied the use of tridentate and tetradentate Schiff base derivatives of 
calcium and magnesium such as 11.[32]  
 
Scheme 4. Polymerisation of L-lactide and ε-caprolactone with examples of group 2 precatalysts. 
 
Stereocontrolled polymerisation of rac-lactide was first achieved by Chisholm and 
co-workers using the tris(pyrazolyl)borate calcium amide and phenoxide complexes 3 
and 4.[21] Conversions > 90% with a heterotacticity of 90% were obtained in less than 
one minute in THF at room temperature, in the presence of 0.5 mol% of 4 (Scheme 5). 
According to Chisholm et al. this was “probably the most reactive and stereoselective 
catalyst reported to date.” Similarly high heteroselectivity could be obtained with a β-
diketiminato magnesium methoxide catalyst.[33] 
 
Scheme 5. Stereoselective polymerisation of rac-lactide with calcium tris(pyrazolyl)borate complex 4. 
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The Union Carbide catalyst [(NH2)Ca(O
iPr)] has also been shown to promote the 
ring-opening polymerisation of propylene oxide, while 3-(S)-iso-propylmorpholine-2,5-
dione may be polymerised with CaH2 in the presence of poly(ethylene oxide).
[34] 
Although several attempts to design bimetallic calcium and magnesium catalysts for the 
copolymerisation of cyclohexene oxide and CO2 have been described, the only 
successful system was reported by Xiao et al. whose bimetallic magnesium complex, 14, 
proved efficient for this reaction, even at CO2 pressures as low as 1 bar (Scheme 6).
[35] 
 
Scheme 6. Copolymerisation of cyclohexene oxide and CO2 with a bimetallic magnesium catalyst, 14. 
 
 
 
 
 
In all the above-mentioned studies catalyst activities were shown to be dependent on 
the metal centre used, with turnover frequencies always in the order of Ca > Mg > Zn 
when analogues of all three metals were compared.[36] In general, reactions are living, 
first-order in monomer, and do not exhibit any induction period. Catalyst activation is 
usually achieved by σ-bond metathesis (protonolysis) of a group 2 amide or alkyl 
precursor with an alcohol, phenol or enolisable ketone (Scheme 7). This first step is well 
documented in the literature.[26, 37-39]  
 
Scheme 7. Examples of catalyst activation through σ-bond metathesis of a magnesium alkyl and a 
calcium amide precursor with an enolisable ketone and a phenol respectively.[26] 
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mechanism, Mingos and co-workers already reported in the 1990s the stoichiometric 
insertion of carbonyl sulphide and carbon dioxide into the M-O bonds of alkaline earth 
bis(alkoxide) species.[40] More recent attempts by Harder and Roesky to insert carbon 
dioxide into the Ca-O bond of heteroleptic calcium hydroxide dimer 16 resulted in the 
irreversible protonation of the β-diketiminate ligand accompanied by slow precipitation 
of calcium carbonate according to the reaction pathway proposed in Scheme 8.[38]   
 
Scheme 8. Insertion of CO2 into a Ca-O bond, followed by decomposition into [Ca(CO3)2]. 
 
 
Polymerisation of styrene 
 
The polymerisation of alkenes by large group 2 metal centres requires conjugation of 
the alkene monomer. In 2000 Weeber et al. reported the first dibenzylbarium catalyst 
for the polymerisation of styrene.[41] The reaction, however, was neither living nor 
stereoselective, and presented a slow initiation as well as high ligand lability of the 
catalyst, as result of the highly diffuse charge density of the large Ba2+ centre. Efforts by 
Harder and co-workers thereafter focused on more readily manipulated calcium 
initiators based on the chiral bidentate (2-NMe2-α-Me3Si-benzyl) ligand, such as 
complex 17 (Scheme 9).[42]  
 
Scheme 9. Synthesis of heteroleptic benzylcalcium initiators by σ-bond metathesis for the stereoselective 
polymerisation of styrene.  
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Although very active for the living anionic polymerisation reaction, the homoleptic, 
diastereomeric precatalyst 17 produced largely atactic polystyrene due to racemisation 
in solution. The heteroleptic versions 8a-d obtained by σ-bond metathesis between 17 
and a number of heavily substituted fluorenes (Scheme 9), however, allowed the 
production of polymers with up to 94% syndiotacticity in dyads from neat styrene at 20 
oC (Scheme 10).[43] Stereoselectivity was found to increase with the steric bulk of the 
fluorenyl substituents.  
 
Scheme 10. Syndioselective polymerisation of styrene. 
 
 
 
 
In all cases, broad molecular weight distributions, arising from slow catalyst 
initiation, prevented the synthesis of block-copolymers. The reaction mechanism is 
thought to involve pre-coordination of the alkene, as the presence of coordinated THF 
deactivates the precatalyst. Following slow catalyst initiation by σ-bond metathesis of 
the alkene with the benzyl ligand, propagation proceeds via multiple insertions of 
styrene into the metal-alkyl bond. In relation to this, Harder and co-workers have shown 
that the reaction of [Ba(CH2Ph)2(THF)2] with 1,1-diphenylethene yields quantitative 
insertion of the alkene into the Ba-C bonds to form [Ba{C(Ph)2CH2CH2Ph}2(THF)2] 
which was characterised by 1H NMR spectroscopy (Scheme 11).[41] 
 
Scheme 11. Insertion of 1,1-diphenylethene into a barium-benzyl bond. 
 
 
 
 
 
Oligomerisation reactions 
 
A small number of oligomerisation reactions mediated by heavier group 2 complexes 
has been reported. In 2007 Hill and co-workers showed that the dimerisation of a 
variety of aldehydes into esters, also known as Tishchenko reaction, could be catalysed 
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by the simple homoleptic alkaline earth bis(bis(trimethylsilylamide)) complexes (Figure 
5).[44] Catalyst activities were in the order of Ca > Sr > Ba. Given that the reaction 
involves the formal reduction of one aldehyde molecule and the oxidation of another, 
and that group 2 Ae2+ cations are redox inactive, the catalytic process necessarily 
involves a hydride transfer between aldehydes. Quenching of the catalytic reaction with 
benzaldehyde in the early stages showed that catalyst initiation generates a calcium 
alkoxide intermediate with liberation of a benzamide through a Meerwein-Ponndorf-
Verley-type reduction of the aldehyde. This is followed by insertion of the second 
aldehyde equivalent into the metal-alkoxide bond and hydride transfer to another 
equivalent of coordinated aldehyde to regenerate the catalyst and liberate the ester. 
Preliminary results showed the reaction could also be applied to the polymerisation of 
dialdehydes into polyesters. 
 
Figure 5. Tishchenko reaction with homoleptic group 2 amides and proposed mechanism. 
 
 
 
 
 
 
 
 
 
 
 
Harder and co-workers showed that the catalytic trimerisation of phenyl- and 
cyclohexyl isocyanate can be achieved with calcium methandiide complex 18 at room 
temperature (Scheme 12).[45] Thanks to the very slow reaction rate of the cyclohexyl 
substrate, the double insertion intermediate 19, which also proved active as a catalyst, 
could be isolated and crystallographically characterised.  
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Scheme 12. Trimerisation of isocyanates. 
 
More recently Hill and co-workers reported the unexpected catalytic dimerisation of 
3-methoxypropyne into the 2,3,4-hexatriene [MeOCH2CH=C=C=CHCH2OMe] in the 
presence of heteroleptic calcium β-diketiminate and triazenide complexes 2 and 7 
(Scheme 13).[46] Since the dimerisation of terminal alkynes with transition metal and 
lanthanide catalysts most often results in the formation of the more stable enyne 
products,[47] the exclusive production of the substituted hexatriene in this case is quite 
remarkable.  
 
Scheme 13. Dimerisation of 3-methoxypropyne and proposed acetylide-butatriene diyl equilibrium. 
 
 
 
 
 
 
Catalyst initiation via σ-bond metathesis between the terminal alkyne and the 
alkaline earth amide precursor has been well documented in numerous stoichiometric 
reactions yielding both homoleptic and heteroleptic group 2 acetylides (Scheme 14).[48, 
49] The reaction is then thought to proceed via a dimeric µ-(Z)-butatriene diyl bridging 
unit as has been shown to exist with group 3 and 4f elements.[50] Carbon-carbon bond 
formation is further driven by the asymmetric bridging mode and coordination of the 
ether moiety to the highly electropositive calcium centres, which reduces charge 
repulsion between the terminal acetylide carbons (Scheme 13). 
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Scheme 14. Synthesis of homoleptic and heteroleptic group 2 acetylides by σ-bond metathesis. 
 
 
 
 
 
 
 
 
 
1.2.3 Heterofunctionalisation of unsaturated bonds 
 
Intra- and intermolecular hydroamination of unsaturated bonds 
 
Achiral and chiral lanthanide complexes, pioneered by Marks and co-workers in the 
early 1990s, are among the most efficient catalysts for the intramolecular 
hydroamination/cyclisation of aminoalkenes, -alkynes, -dienes and -allenes.[51] In 2005 
Crimmin et al. published the first report of the calcium-mediated intramolecular 
hydroamination of a number of aminoalkenes, based on Chisholm’s β-diketiminato 
calcium amide complex 2. Catalytic activity proved to be comparable to the best of the 
conventional group 3 and lanthanide systems.[52] Reactions proceeded at high rates 
under mild conditions (25-60 oC) with moderate catalyst loadings (10-20 mol%) and 
produced substituted pyrrolidines and piperidines in high yields without apparent ligand 
redistribution to the homoleptic calcium species. Later, a study on an extensive range of 
aminoalkene substrates showed that the ease of cyclisation decreases with ring-size, 
following Baldwin’s guidelines for ring-closure (Scheme 15). While pyrrolidines could 
be obtained at room temperature and with low catalyst loadings (2-10 mol%) in near 
quantitative yields within a few minutes, the formation of piperidines and 
hexahydroazepines required longer periods of time (up to 5.5 days), higher catalyst 
loadings (10-20 mol%) and sometimes prolonged heating at 80 oC. Bulky geminal 
substituents in the β-position of the amine facilitated cyclisation by favouring reactive 
conformations of the insertion transition state (Thorpe-Ingold effect), while internal 
substitution of the alkene moiety significantly hindered the reaction. None of the β-
diketiminate precatalysts could achieve the hydroamination of substrates with internal 
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alkenes under the reported reaction conditions. Whereas prochirality in the β-position of 
the amine did not lead to diastereoselectivity, the α-substituted aminoalkenes 1-amino-
1-methyl-4-pentene and 1-amino-1-phenyl-4-pentene underwent diastereoselective 
hydroamination favouring the trans-geometry of the pyrrolidine with a diastereomeric 
excess of 78% for calcium precatalyst 2. The smaller magnesium metal centre of 
precatalyst 1 afforded significantly higher selectivity (84% diastereomeric excess). 
Similar preference for the trans-conformation of the product had already been observed 
in the case of analogous lanthanide-catalysed hydroamination, with smaller Ln3+ centres 
affording increased diastereoselectivity, induced by a tighter conformation of the 
transition state.[53] Although significantly more active than its magnesium counterpart 1, 
the use of calcium complex 2 was limited by its propensity to deleterious Schlenk-like 
ligand redistribution equilibria at high temperature, alkene isomerisation side reactions 
of 1-amino-5-hexene substrates, and its incapacity to cyclise 1-amino-2,2-diphenyl-6-
heptene into the resulting hexahydroazepine. In contrast, this latter reaction could be 
achieved with magnesium precatalyst 1, albeit very slowly and at high temperature (5.5 
days, 80 oC, 88% yield).[54] 
 
Scheme 15. Intramolecular hydroamination of aminoalkenes with heteroleptic Mg and Ca precatalysts. 
 
 
 
 
 
 
The individual steps of the originally proposed catalytic cycle were investigated with 
a series of stoichiometric reactions. Whereas σ-bond metathesis between complexes 1 or 
2 and a number of secondary and primary amines (Scheme 16A) was shown to be fast 
and irreversible, yielding new isolable group 2 amide species, a stoichiometric reaction 
between calcium amide precatalyst 2 and benzylamine resulted in a quantifiable 
equilibrium, with a ∆Go (298 K) value of -11.4 kJ.mol-1 indicating fast but reversible 
catalyst initiation (Scheme 16B).[55-57] Other, less acidic amines such as tert-butylamine 
and cyclohexylamine were found to displace the adducted THF molecule to form amine 
adducts (Scheme 16C), thus providing a model for pre-coordination of the aminoalkene 
and potential substrate inhibition during catalysis. Kinetic experiments with variable 
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substrate concentrations at constant catalyst concentration also revealed the importance 
of substrate and product inhibition, as had already been demonstrated in analogous 
lanthanide-based reactions.[58] The presence of THF also significantly slowed down 
reaction rates. 
 
Scheme 16. Transamination reactions with group 2 amides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Catalytic hydroamination of deuterated substrates pointed towards a short-lived alkyl 
intermediate resulting from the intramolecular insertion of the terminal alkene into the 
metal-amide bond. These findings resulted in the proposal of two distinct catalytic 
cycles depending on the nature of the precatalyst (Figure 6).[54]  
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Figure 6. Proposed catalytic cycles for the intramolecular hydroamination of aminoalkenes with 
reversible or irreversible catalyst initiation. 
 
  
 
 
 
 
 
 
 
 
 
 
Heteroleptic calcium and strontium amide complexes bearing triazenide and 
aminotroponiminate spectator ligands have also been used in the hydroamination of 
aminoalkenes with similar results, despite their propensity to redistribute to homoleptic 
complexes.[59-61] It is, however, notable that the aminotroponiminate-stabilised calcium 
and strontium species 5 and 6 (Figure 4) reported by Roesky allow the facile cyclisation 
of 1-amino-2,2-dimethyl-5-phenyl-4-pentene and 1-amino-7-phenyl-6-hexyne at room 
temperature (Scheme 17). These are the first examples of group 2-catalysed 
hydroamination of aminoolefins with terminal substituents on the olefin moiety. In all 
cases, the calcium precatalysts produced higher turnover frequencies than their 
strontium counterparts. The tendency for ligand redistribution towards the homoleptic 
species, especially with the larger strontium centre, however, did not allow a more 
quantitative comparison of the effect of ionic radii on the rate of catalysis. Initial 
attempts by Buch et al. to achieve stereocontrolled intramolecular hydroamination by 
using a chiral (S)-(Ph-Box)-supported calcium amide precatalyst have only yielded 
extremely low enantioselectivities (ee < 10%), mainly due to Schlenk-type ligand 
redistribution equilibria leading to a catalytically inactive, homoleptic calcium (S)-(Ph-
Box) complex and achiral [Ca{N(SiMe3)2}2(THF)2].
[18] The latter was also proposed to 
be catalytically active. In 2009, Hultzsch and co-workers reported a chiral 
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exchange by protonation.[62] The most efficient systems to date, based on chiral 
tris(oxazolinyl)borate ligands, are still limited to enantioselectivities of 18% and 36% 
for calcium and magnesium respectively.[63] 
 
Scheme 17. Intramolecular hydroamination of terminally substituted aminoalkenes and -alkynes. 
 
 
 
 
 
 
In 2008 group 2-mediated hydroamination was extended to the catalytic synthesis of 
guanidines and ureas from carbodiimides and isocyanates respectively, using 
heteroleptic calcium complex 2 and the homoleptic [M{N(SiMe3)2}2(THF)n] series (M 
= Ca, Sr, Ba; n = 0, 2) as precatalysts (Scheme 18).[64] In both cases strontium yielded 
significantly higher turnover frequencies than calcium, although this was not 
quantitatively investigated. Catalysis with barium, however, was much slower and 
usually accompanied by the precipitation of insoluble products which, although not 
characterised, were thought to be polymeric and catalytically inactive species.  
 
Scheme 18. Catalytic hydroamination of carbodiimides and isocyanates. 
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active intermediates, demonstrating that catalysis occurs via an amide-carbodiimide or 
amide-isocyanate coordination-insertion mechanism (Scheme 19).  
 
Scheme 19. Insertion of carbodiimides and isocyanates into alkaline earth-amide bonds. 
 
 
 
 
 
 
 
 
 
 
 
In 2009 Barrett et al. reported the first example of intermolecular hydroamination of 
activated alkenes with heavier alkaline earth complexes under mild conditions (5 mol% 
catalyst loading, 60 oC) with excellent anti-Markovnikov regioselectivity (Scheme 
20).[65] This time the homoleptic strontium precatalyst displayed higher catalytic 
activities than its calcium counterpart.  
 
Scheme 20. Intermolecular hydroamination of activated alkenes. 
 
 
 
 
Kinetic data showed that, although the activation energy for strontium was higher 
than for calcium, this was counterbalanced by a significantly less negative value of the 
entropy of activation for strontium, mirroring a much looser four-membered insertion 
transition state, and giving the larger metal cation a clear entropic advantage under the 
reported reaction conditions. A computational study of a model ethene-ammonia system 
catalysed by a simplified alkaline earth β-diketiminato amide complex confirmed 
previous experimental findings from the intramolecular hydroamination of 
R1= Bn, R2 = H
R1 = R2 = -(C5H10)-, -(C4H8)-
R3 = H, Me, OMe, Cl
R3
+ HNR1R2
C6H6, 2-168h,
60 oC
R3
NR1R2cat 5 mol%
63-84%cat = [M{N(SiMe3)2}2]2
M = Ca, Sr
NN
CaAr Ar
THF NR1R2
N
N
Ca
Ar
Ar
NR3
NR3
NR1R2
THF
R1 = R2 = Ph, R3 = Cy
R1 =Ar, R2 = H, R3= iPr, Cy
R1= CH2CH2OMe, R
2 = H, R3= iPr
R3N=C=NR3
C6H6, rt
2 PhNH2
+ 2 RN=C=NR
- 2 HN(SiMe3)2
Ca
THF
R
N
Ph
N
N
Ph
N
R
RHN NHR
toluene, rt
NN
CaAr Ar
THF N(SiMe3)2
AdN=C=O
C6H6, rt N
N
Ca
Ar
Ar
O
N
Ad
N(SiMe3)2
THF
Ar = 2,6-iPr2C6H3
[Ca{N(SiMe3)2}2(THF)2]
R = iPr
THF
31 
 
aminoalkenes, by showing that calcium provided much lower activation barriers than 
magnesium for both the alkene insertion and final protonolysis steps (Figure 7).   
 
Figure 7. Computational study of the intermolecular hydroamination of ethene with ammonia by 
heteroleptic group 2 precatalysts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In relation to this theoretical study, it is notable that Harder and co-workers managed 
to stabilise a small amide functionality by reacting heteroleptic calcium amide 2 with 
NH3(g) under very mild conditions at room temperature under a pressure of 1 bar 
(Scheme 21), a result which augurs well for the potential of group 2-mediated 
intermolecular hydroamination of alkenes with ammonia. 
 
Scheme 21. Synthesis of a heteroleptic calcium amide complex by σ-bond metathesis with ammonia. 
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organolanthanide-catalysed version of this reaction remain limited.[67] Based upon the 
success of the intramolecular hydroamination of aminoalkenes with group 2 precatalysts, 
Hill and co-workers reported in 2007 the use of heteroleptic calcium complex 2 for the 
intermolecular hydrophosphination of unhindered activated alkenes and alkynes with 
diphenylphosphine, with activities comparable to those reported for late transition metal 
catalysts.[68] Addition of the phosphine across the carbon-carbon double bond was both 
regioselective, with a marked preference for the anti-Markovnikov product, and 
stereoselective, with nearly exclusive syn-addition as shown by the (Z) geometry of the 
product resulting from the hydrophosphination of 1,2-diphenylethyne (Scheme 22).  
 
Scheme 22. Intermolecular hydrophosphination of activated alkenes and alkynes. 
 
 
 
 
 
 
 
 
 
Initiation of the precatalyst occurs via σ-bond metathesis to generate the heteroleptic 
calcium diphenylphosphide complex 21, which is itself catalytically active.[68] The 
chemistry of stoichiometric σ-bond metathesis between phosphines and group 2 amides 
has been well established by Westerhausen and co-workers since the 1990s and led to 
the isolation of numerous homoleptic alkaline earth phosphides (Scheme 23).[69] 
 
Scheme 23. Synthesis of homoleptic and heteroleptic alkaline earth phosphides by protonolysis. 
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The active catalyst then undergoes concerted insertion of the alkene or alkyne into 
the calcium-phosphorus bond, which leads to the observed syn-stereoselectivity. In 
accordance with this mechanism, Westerhausen et al. described the stoichiometric 
insertion of one equivalent of diphenylbutadiyne into one of the Mg-P bonds of 
[Mg{P(SiMe3)2}2(THF)4] to yield the heteroleptic insertion product displayed in 
Scheme 24.[70]  
 
 Scheme 24. Insertion of diphenylbutadiyne into an Mg-P bond. 
 
 
 
 
Attempts by Hill and co-workers to use homoleptic [Ca{N(SiMe3)2}2(THF)2] under 
these reaction conditions met with limited success due to formation of homoleptic 
calcium diphosphide species which are highly insoluble in benzene. Later, however, 
Westerhausen reported that homoleptic [Ca(PPh2)2] efficiently catalyses the syn-
addition of diphenylphosphine to both diphenylethyne and diphenylbutadiyne in THF, 
in which the catalyst is soluble (Figure 8).[71] 
 
Figure 8. Hydrophosphination of alkynes using [Ca(PPh2)2] and proposed mechanism. 
 
As for the hydroamination reaction, this reactivity could be extended to other 
unsaturated substrates, such as carbodiimides.[72] Although heteroleptic calcium 
complex 2 was found to catalyse the reaction, the less hindered homoleptic heavier 
group 2 bis(amides) [M{N(SiMe3)2}2(THF)2] (M = Ca, Sr, Ba) and the unsolvated 
[Ca{N(SiMe3)2}2]2 proved more active precatalysts. Although no kinetic studies could 
be undertaken due to extremely fast reaction rates, it appeared that the larger strontium 
and barium metal centres were more efficient than their calcium counterpart. 
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Hydrophosphination of both symmetric and unsymmetric carbodiimides with 
diarylphosphines proceeded at room temperature with low catalyst loadings to give the 
analogous phosphaguanidine in high yield (Figure 9). Hydrophosphination of sterically 
demanding 1,3-di-tert-butylcarbodiimide could not be achieved. Furthermore, 
dicyclohexylphosphine did not react with any of the carbodiimide substrates under the 
reported reaction conditions. In this latter case, the decreased acidity of the 
dialkylphosphine compared to the diarylphosphines was reasoned to prevent catalyst 
initiation. As for the hydroamination of carbodiimides, the reaction proceeds via 
insertion of the carbodiimide into the metal-phosphide bond (Scheme 25). Interestingly, 
addition of one equivalent of phosphine to the isolated calcium phosphaguanidinate 
insertion product 22 did not lead to σ-bond metathesis. Addition of a further equivalent 
of carbodiimide, however, resulted in liberation of the free phosphaguanidine. The 
authors explained this by invoking the Curtin-Hammett principle, arguing that the 
intermediate, 22, and diphenylphosphine are in equilibrium with a small amount of the 
phosphaguanidine and calcium phosphide complex, which in turn reacts readily with the 
carbodiimide to achieve catalytic turnover. A catalytic cycle based on mostly reversible 
processes is outlined in Figure 9. 
 
Figure 9. Hydrophosphination of carbodiimides and proposed mechanism. 
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Following this, Westerhausen also reported that the homoleptic calcium phosphide 
complex [Ca(PPh2)2(THF)4] undergoes insertion with carbodiimides to form a 
homoleptic calcium bis(phosphaguanidinate) species, which in turn displays only very 
limited catalytic activity.[73] 
 
Scheme 25. Stoichiometric synthesis of the calcium phosphaguanidinate insertion intermediate. 
 
 
 
 
 
Intermolecular hydroacetylenation of carbodiimides 
 
In 2009 Hill and co-workers reported the stoichiometric insertion of carbodiimides 
into the calcium-carbon bond of heteroleptic calcium acetylides (Scheme 26).[49] 
 
Scheme 26. Stoichiometric insertion of carbodiimides into a heteroleptic calcium acetylide complex. 
 
 
 
 
 
 
 
Based upon the precedent of lanthanide-mediated hydroacetylenation, the authors 
showed in a preliminary experiment that 5 mol% of calcium complex 2 catalyse the 
hydroacetylenation of 1,3-di-iso-propylcarbodiimide with phenylacetylene at 80 oC over 
a period of 14h (Scheme 27). NMR experiments, however, showed that the β-
diketiminate ligand is protonated by the acetylene under the reaction conditions, making 
it unlikely that either the heteroleptic amide, acetylide or insertion products shown 
above are catalytically active species.  
 
Scheme 27. Catalytic calcium-mediated hydroacetylenation of a carbodiimide. 
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Intermolecular hydrosilylation of unsaturated bonds 
 
In 2006, Buch and Harder described the regioselective hydrosilylation of activated 
alkenes with homoleptic calcium and strontium benzyl precatalysts 17 and 23 under 
mild reaction conditions (0.5-10 mol% catalyst loading, 25-50 oC, 0.1-48h).[74] The 
larger strontium metal centre displayed higher turnover frequencies than its smaller 
calcium counterpart. Despite these dibenzyl species also being active as anionic styrene 
polymerisation initiators, clean conversion to the silylated alkene was observed in each 
case. Regioselectivity could be effectively influenced by the choice of solvent: in apolar 
benzene exclusive formation of the Markovnikov product was observed, whereas in 
polar THF only the anti-Markovnikov product was obtained (Scheme 28). Reactions in 
diethyl ether yielded a mixture of isomers in the presence of the calcium precatalyst, but 
only the terminally silylated product was obtained with strontium. 
 
Scheme 28. Regioselective hydrosilylation of activated alkenes. 
 
 
 
 
 
 
 
 
 
In both polar and apolar solvents catalyst initiation occurs through σ-bond metathesis 
of the dibenzyl precatalyst with the silane to form a transient, highly reactive, 
heteroleptic group 2 hydride intermediate which, although it could not be isolated, is 
thought to form hydride-rich clusters in solution. The successful isolation of heteroleptic 
calcium complex 24 and its magnesium analogue, obtained from the reaction of β-
diketiminato magnesium and calcium complexes 1 and 2 with phenylsilane, as well as 
the synthesis of a hydride-rich Mg4H6 cluster, 25, from a similar reaction of a carbene-
supported magnesium bis(amide), strongly support this mechanism (Scheme 29).[75, 76] 
Commercially available CaH2, however, did not catalyse the hydrosilylation of alkenes, 
even if freshly and finely ground. 
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Scheme 29. Synthesis of magnesium and calcium hydride complexes by σ-bond metathesis with PhSiH3. 
 
 
  
 
 
 
 
 
In the case of apolar solvents, the reaction then proceeds through conventional 
insertion of the alkene into the metal-hydride bond to form the most stable alkyl 
intermediate, which then undergoes σ-bond metathesis with another equivalent of silane 
to reform the metal hydride and the silylated Markovnikov product (Figure 10, (A)). In 
the case of polar solvents, the authors made a case for a catalytic cycle proceeding via a 
charge separated ion pair of the form [LM]+[PhSiH4]
- which then converts into a group 
2 silanide complex (Figure 10, (B)). Due to steric factors alkene insertion into the metal-
silicon bond would therefore yield the anti-Markovnikov product, thus accounting for 
the observed regioisomer. Although this second catalytic cycle provides a justification 
for the influence of the solvent on regioselectivity, evidence for the charge-separated 
ion pair or silanide intermediate in THF, as well as for concomitant H2 release, has yet 
to be reported. Therefore the possibility of a polarity-influenced transition state for the 
σ-bond metathesis between the group 2 alkyl intermediate and the silane in the first 
catalytic cycle can not be discounted.  
 
Figure 10. Proposed catalytic cycles for the hydrosilylation of alkenes in apolar (A) and polar (B) 
solvents. 
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Both the homoleptic dibenzyl calcium complex 17 and the molecular calcium 
hydride complex 24 were also reported to promote the catalytic hydrosilylation of 
ketones.[77] Reactions proceeded under mild conditions (1-5 mol% catalyst loading, 20-
50 oC) and yielded almost exclusively the dialkoxysilane, independent of the initial ratio 
between silane and ketone (Scheme 30). Whereas the stoichiometric insertion of ketones 
into the metal-hydride bond to form calcium alkoxide species 26a-e was always 
accompanied by a substantial amount of enolisation (Scheme 31), enolisation products 
were virtually absent under catalytic conditions, suggesting that silylation of the 
alkoxide species is faster than enolisation.  
 
Scheme 30. Catalytic hydrosilylation of ketones. 
 
 
 
 
 
Since the isolated calcium alkoxide species did not react in turn with phenylsilane, it 
was argued that catalysis does not proceed via a calcium alkoxide intermediate. Rather, 
and although reactions were carried out in apolar benzene, Spielmann and Harder put 
forward a catalytic cycle based entirely upon charge separated ion pairs, with reactions 
occurring exclusively at the hypervalent anionic silicon centres. Nonetheless, since the 
isolated calcium alkoxide compounds 26a-e were found to be active catalysts for the 
reaction, it is possible that, according to the Curtin-Hammett principle, the alkoxide 
species and silane are in equilibrium with a small amount of the free alkoxysilane and 
the calcium hydride complex 24, which in turn reacts readily with excess ketone to 
achieve catalytic turnover.  
 
Scheme 31. Stoichiometric insertion of ketones into the heteroleptic calcium hydride complex 24. 
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Hydrogenation of activated alkenes 
 
Based upon their success at catalysing the hydrosilylation of conjugated alkenes, 
Spielmann and Harder described in 2008 the catalytic hydrogenation of alkenes with 
molecular calcium hydride 24 and the dibenzylcalcium and -strontium complexes 17 
and 23.[78] Reactions proceeded under relatively mild conditions (2.5-5 mol% catalyst 
loading, 20-60 oC, 20 bar H2) and gave the mono-hydrogenated product in moderate to 
high yields (Scheme 32). As for the hydrophosphination and hydrosilylation reactions, 
reactivity was limited to activated alkenes such as 1,1-diphenylethene, styrene, α-
methylstyrene and cyclohexadiene.  
 
Scheme 32. Catalytic hydrogenation of conjugated alkenes. 
 
 
 
 
 
 
 
Side reactions producing dimers or oligomers resulting from single or multiple 
insertion of the alkene substrate into the calcium alkyl intermediate remained limited. 
Again, reactivity could be tuned by the choice of solvent: in polar THF or HMPA the 
reaction with styrene resulted exclusively in polymerisation, whereas in apolar benzene 
the hydrogenation product was obtained in 81-85% yield. In line with the 
organolanthanide-catalysed hydrogenation of alkenes the authors proposed the catalytic 
cycle outlined in Figure 11.  
 
Figure 11. Catalytic cycle for the calcium-mediated hydrogenation of activated alkenes. 
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Stoichiometric reactions between 24 and 1,1-diphenylethene or 1,3-cyclohexadiene 
resulted in clean insertion of the least substituted end of the alkene into the calcium-
hydride bond to form the intermediate calcium diphenylethyl and cyclohexenyl species 
27 and 28 respectively (Scheme 33).[78, 79] Hydrogenation of the latter under 20 bar of 
H2 regenerated the calcium hydride catalyst with liberation of the mono-hydrogenated 
alkene. Further evidence of the σ-bond metathesis process was obtained by saturation of 
a solution of the deuterated version of 24 with H2, leading to fast H/D exchange. 
 
Scheme 33. Stoichiometric insertion of activated alkenes into the Ca-H bond of X. 
 
 
1.2.4 Lewis acid-catalysed carbon-carbon bond formation 
 
In recent years the use of alkaline earth complexes as Lewis acid catalysts in 
synthetic Org. Chem. has increased dramatically. Usually prepared in situ over 
molecular sieves from readily available homoleptic metal alkoxides or amides and a 
variety of asymmetric ligands, these catalytic systems have attracted much interest 
owing to their reduced cost compared with more traditional transition metal catalysts, 
their biocompatibility, and their efficiency at catalysing a large array of asymmetric 
nucleophilic addition reactions with excellent yields and high enantio- or 
diastereoselectivity.  
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catalyst loading, 0.5-12h, 65-95% yield) (Scheme 34). A variety of functional groups, 
among which halides, hydroxides, ethers, furans and thiophenes, both present on the 
alkene and on the arene substrates, were tolerated under the mild reaction conditions 
employed. In contrast to the vast majority of alkaline earth-catalysed 
heterofunctionalisation reactions mentioned in this introduction, hydroarylation 
exclusively yielded the Markovnikov products, thus hinting at significant mechanistic 
differences. Although no mechanism was proposed by the authors, the presence of 
Bu4NPF6 proved critical for catalytic turnover to occur, suggesting the formation of a 
more reactive charge-separated [Ca(NTf2)]
+PF6
- species. Moreover, reactions proceeded 
in dichloromethane without the exclusion of moisture or air, and were even inhibited 
under strictly anhydrous conditions, which led the authors to propose that a carbinol 
intermediate might be involved, although the latter could not be detected. 
 
Scheme 34. Calcium Lewis acid-catalysed hydroarylation of alkenes. 
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from [Ba(OiPr)2] and an excess of an (R)-2-hydroxy-2'-methoxy-l,l'-binaphthyl ligand 
precursor. Enantiomeric excesses remained moderate, ranging from 50 to 70%.[81] In 
2001 Noyori and co-workers reported a more enantioselective system for the same 
reaction, prepared in situ from [Ca{N(SiMe3)2}2(THF)2], KSCN and an excess of (S,S)-
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cat 2.5 mol%
CH2Cl2, rt, 0.5-12h
Ph
R
R1 = H, Me, Ph; R2 = H, Me
R1 = R2 = -(CH2)4-
Ar = Ph, 2-F-Ph, 4-Cl-Ph, 3-OH-4-OMe-Ph
Ar
R1
65-95%
+
MeO OMeR2
MeO
OMe
R
n
R = H, (CH2)2OAc
n = 1, 2
cat 5 mol%
CH2Cl2, rt, 2-6h
+
MeO OMe
R
MeO
OMe
n
89-92%
cat =
[Ca(NTf2)2 + Bu4NPF6]
42 
 
(66-91%). CSI-MS provided insight into the oligomeric nature of the catalyst, which 
was otherwise not characterised. The reaction of 3-(benzyloxy)-2,2-dimethylpropanal 
with acetophenone allowed the synthesis of the aldol (R) product, which is an 
intermediate in the synthesis of epothilone A, a chemotherapeutic drug, in 79% yield 
and 91% enantiomeric excess, thus paving the way for the application of these chiral 
alkaline earth catalyst systems in the synthesis of pharmaceutical and natural organic 
products. More recently, Yamaguchi et al. also described an (S)-BINOL/[Ba(OiPr)2] 
system for the asymmetric aldol/retro-aldol reaction of β-γ-unsaturated esters with 
aldehydes leading to high selectivity for the (E)-α-adduct and enantiomeric excesses of 
up to 99% (Scheme 35).[83] The analogous lanthanide-based systems did not catalyse the 
reaction, showing once more that alkaline earth catalysts can not simply be considered 
as lanthanide-mimetic.  
 
Scheme 35. Asymmetric calcium- and barium-mediated aldol reactions. 
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and co-workers extended this work by using a chiral bis(sulfonamide) ligand precursor 
with [Sr{N(SiMe3)2}2]2 for the enantioselective Michael addition of di-iso-
propylmalonate to a series of cyclic and acyclic chalcones.[86] After optimisation of the 
reaction conditions, high yields (>81%) and excellent selectivity (ee>90%) were 
achieved at room temperature within a few hours (Scheme 36). The analogous 
asymmetric 1,4-addition of malonates and β-ketoesters to nitroalkenes was successfully 
catalysed by a [Ca{O(4-OMe-C6H4)}2]/[anti-5,4-diphenyl-PyBox] system (1:2.2 ratio) 
with good yields (>73%) and moderate to excellent enantioselectivities (65-96%), both 
for the formation of tertiary and quaternary carbon stereocentres.[87] 
 
Scheme 36. Asymmetric strontium-catalysed Michael addition. 
 
Other alkaline earth-catalysed 1,4-addition reactions include the addition of α-amino 
acid esters to α,β-unsaturated carbonyl substrates developed by Kobayashi and co-
workers using a calcium catalyst prepared in situ from a chiral Ph-Box ligand and 
[Ca(OiPr)2]. Chiral glutamic acid derivatives were obtained in high yields under mild 
reaction conditions with enantiomeric excesses above 78% (Scheme 37).[88] The 
analogous magnesium system was catalytically inactive, while strontium and barium 
afforded much poorer enantioselectivities, likely due to their larger coordination sphere 
and looser transition states. NMR studies suggested that the catalyst was a monomeric 
calcium alkoxide complex supported by the chiral anionic ligand.   
 
Scheme 37. Highly selective calcium-catalysed synthesis of chiral glutamic acid derivatives. 
 
During the course of these studies the authors discovered that crotonate derivatives, 
instead of yielding the expected 1,4-addition product, underwent a [2+3] cycloaddition 
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process with the α-amino acid to yield highly enantiomerically and diastereomerically 
pure substituted pyrrolidines containing four stereocentres (Scheme 38). A whole range 
of α-amino acids including glycine, alanine, methionine, leucine and serine derivatives 
were successfully used. The reaction between crotonate derivatives and α-substituted α-
amino acid esters yielded pyrrolidines containing contiguous, chiral, tertiary and 
quaternary carbon centres in good yields (41-98%) with excellent selectivity (ee>85%) 
despite longer reaction times. Such high stereoselectivity in the direct formation of 
highly sterically hindered chiral carbon centres is an achievement which places this 
calcium catalyst system among the very best in asymmetric [2+3] cycloaddition. 
Kobayashi and co-workers successfully applied this reactivity to the synthesis of chiral 
pyrrolidine cores for hepatitis-C virus RNA-dependent polymerase inhibitors in 83% 
yield and 85-88% enantiomeric excess.  
 
Scheme 38. Highly diastereo- and enantioselective calcium-mediated [2+3] cycloaddition reactions. 
 
Mechanistic investigation of both the 1,4-addition and [2+3] cycloaddition processes 
led the authors to propose the catalytic cycle outlined in Figure 12. Catalyst initiation 
occurs via reversible σ-bond metathesis of the calcium alkoxide precatalyst with the α-
amino acid ester, followed by 1,4-addition to the α,β-unsaturated carbonyl substrate. 
The reaction then either proceeds towards protonolysis and liberation of the 1,4-addition 
product or intramolecular cyclisation and protonolysis to liberate the chiral pyrrolidine.  
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Figure 12. Proposed catalytic cycles for the 1,4-addition and [2+3] cycloaddition of α,β-unsaturated 
carbonyl substrates to α-amino acid esters. 
 
 
Asymmetric addition of esters and imidates to imines (Mannich-type reactions) 
 
In 2010, Kobayashi and co-workers also reported that the enantioselective Mannich 
reaction of dibenzylmalonate with aromatic N-Boc imines using a [Ca(OiPr)2]/[PyBox] 
system (1:1.5 ratio) afforded the resulting amines in excellent yields, with moderate to 
good selectivity (54-77% ee) within 2 hours at -20 oC.[89] Other Mannich reactions 
reported by the same group include the highly diastereoselective addition of N-Boc 
amides to N-diphenylphosphinoyl imines accompanied by Boc migration in the 
presence of a [Ba(OtBu)2]/[2’-methoxybiphenyl-2-ol] system.
[90] The related reaction of 
sulfonylimidates with aromatic and aliphatic N-Boc imines yielded interesting results: in 
the presence of a simple [Mg(OtBu)2] catalyst in DMF without addition of ligand, 
excellent yields (>80%) and anti-diastereoselectivity (>80%) were achieved, whereas 
with a [Sr{N(SiMe3)2}2(THF)2]/[PyBox] system and a less polar solvent like THF, 
similarly excellent yields and syn-selectivity (>84%) were obtained (Scheme 39).[91] In 
2007 Yamaguchi et al. described a similar Mannich-type reaction between β,γ-
unsaturated esters and N-diphenylphosphinoyl imines, catalysed by a [Ba{O(4-MeO-
C6H4)}2]/[(S)-biaryldiol] system with high selectivity for the α,β-unsaturated α-adduct 
and good enantioselectivity (77-80%).[92] In all cases, catalyst initiation was thought to 
proceed through σ-bond metathesis between the metal alkoxide functionality and the 
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carbonyl substrate, followed by insertion of the imine and formation of the carbon-
carbon bond. 
 
Scheme 39. Diastereoselective reaction of sulfonylimidates with N-Boc imines. 
 
1.2.5 Catalytic dehydrocoupling of σ-bonds 
 
The catalytic dehydrogenative coupling of σ-bonds remains a challenging type of 
reaction and to date, only a very limited number of examples have been reported in 
alkaline earth chemistry. In 2007 Buch and Harder described the dehydrocoupling of 
terminal alkynes and amines with silanes by the azametallacyclopropane complex 
[(Ph2C-NPh)Ca(hmpa)3], 29, at room temperature (Scheme 40). Within the limited 
substrate scope examined, calcium precatalyst 29 displayed catalytic activity and 
selectivity similar to its Yb(II) analogue.[93]  
 
Scheme 40. Calcium-mediated dehydrogenative silylation of amines and acetylenes. 
 
 
 
 
 
 
 
 
 
Contrary to the above-mentioned polymerisation and heterofunctionalisation 
reactions, the catalytic cycle does not involve any insertion step of an unsaturated bond. 
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Initiation occurs via σ-bond metathesis between the alkyl moiety of the ligand and the 
substrate to form either the calcium amide or acetylide catalyst, which in turn reacts 
with the silane to form an ill-defined calcium hydride intermediate and liberate the 
coupled silylated product. Further σ-bond metathesis with another equivalent of amine 
or acetylene regenerates the active species with quantitative release of H2 (Figure 13). 
 
Figure 13. Proposed catalytic cycles for the dehydrogenative silylation of amines and acetylenes. 
 
 
 
 
 
 
In 2009, Harder and co-workers also described the formation of the 
bis(anilino)borane [HB{NH(2,6-iPr2C6H3)}2] catalysed by magnesium β-diketiminate 
complex 30 in the presence of the aniline borane [H3B.H2N(2,6-
iPr2C6H3)] (Figure 
14).[94] A heteroleptic magnesium borohydride complex was identified as a catalytically 
active intermediate, and the BH3 by-product was observed in the 
1H NMR spectrum in 
the form of B2H6. The active catalyst, a β-diketiminate-supported magnesium 
amidoborane was readily isolated from the σ-bond metathesis of the related magnesium 
hydride complex with the aniline borane. In view of these observations, the authors 
proposed the two potential catalytic cycles outlined in Figure 14, both based on an 
intermediate [LMg(NHAr-BH2-NHAr-BH3)] species, which either decomposes through 
β-hydride elimination to form the bis(anilino)borane and a magnesium hydride, or 
through a 1,3-hydride shift to release the product and form a magnesium borohydride 
intermediate.  
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Figure 14. Possible catalytic cycles for the catalytic dehydrocoupling of [H3B.H2N(2,6-
iPr2C6H3)]. 
 
 
 
 
 
 
 
 
Stoichiometric σ-bond metathesis reactions between β-diketiminate-supported 
calcium and magnesium amides or hydrides with H3B.NH2R (R = H, Me, 
iPr, 2,6-
iPr2C6H3) by the same authors led to the isolation of a number of heteroleptic 
amidoborane complexes. These thermally decompose either into borylamide complexes 
(R = 2,6-iPr2C6H3) or into dimers, such as 31a-c, bearing the dianionic ligand [RN-BH-
NR-BH2]
2- (R = H, Me, iPr), in both cases with loss of H2 (Scheme 41).
[94, 95] 
Homoleptic and heteroleptic magnesium complexes bearing the monoanionic [NMe2-
BH2-NMe2-BH3]
- ligand were also recently isolated by Liptrot et al. from the reaction of 
[Mg{CH(SiMe3)2}2(THF)2] and magnesium complex 1 with four and two equivalents of 
Me2NH.BH3 respectively.
[96] 
 
Scheme 41. Stoichiometric σ-bond metathesis reactions of group 2 complexes with amine boranes, 
demonstrating dehydrogenative B-N coupling. 
 
In the same work the authors also reported the selective catalytic dehydrocoupling of 
Me2NH.BH3 to the cyclic [(H2BNMe2)2] dimer with homoleptic alkyl precatalysts of the 
form [M{CH(SiMe3)2}2(THF)2] (M = Mg, Ca), as well as magnesium and calcium β-
diketiminate compounds 1 and 2.[96] Monitoring of the reaction with the homoleptic 
magnesium precatalyst by 11B NMR over 72 hours at 60 oC provided evidence of two 
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amidoborane intermediates which were identified as [Mg{N(Me2)BH3}2] and 32 
(Scheme 41), as well as of the formation of the minor β-hydride elimination by-product 
HB(NMe2)2. The much slower reaction with calcium precatalyst 2 also allowed the 
observation as small amounts of Me2N=BH2 and heteroleptic calcium hydride complex 
24 as potential intermediates, leading the authors to propose the catalytic cycle outlined 
in Figure 15. The difference in catalytic activity between the magnesium and calcium 
precatalysts was explained by the higher polarising capacity of the smaller magnesium 
centre to effect the insertion and the hydride elimination steps. 
 
Figure 15. Proposed catalytic cycle for the catalytic dehydrocoupling of H3B.NHMe2 into cyclic 
[(H2BNMe2)2]. 
 
Despite these results only being preliminary, they will hopefully provide an 
important stepping stone for extending the catalytic reactivity of group 2 complexes 
towards more challenging dehydrocoupling reactions in the future.  
 
 
1.3 Scope of this thesis 
 
Chapter 2 of this thesis seeks to deepen our current mechanistic understanding of the 
alkaline earth-catalysed intramolecular hydroamination of aminoalkenes, with a 
particular focus on the predominant influence of group 2 cation charge density and 
polarisation, as well as on intrinsic differences with analogous lanthanide reactivity. As 
a result of these kinetic and mechanistic studies, it became apparent that ligand design 
was required to overcome two of the major problems commonly presented by alkaline 
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earth organometallics: the Schlenk equilibrium and the stabilisation of highly reactive 
group 2 alkyl species. The use of bis- and tris(carbene)borate ligands (Chapter 3) 
evidenced the stereoelectronic influence of the monoanionic spectator ligand on 
complex stability and catalytic activity, while also stressing the need for more robust 
C,H,N,O-based ligands. Finally, Chapter 4 describes how the unique dearomatisation 
properties of alkaline earth dialkyls may be harnessed to design new and stable 
heteroleptic group 2 alkyl complexes presenting unprecedented catalytic activity.  
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2 Hydroamination of aminoalkenes with group 2 
precatalysts: influence of cation charge density and 
choice of ligands 
 
 
2.1 Introduction 
 
Amines and their derivatives play an important role in many industrial products, such 
as drugs, cosmetics, pesticides, polymers, dyes, antioxidants, stabilisers, and many 
more.[97] Current industrial processes for the synthesis of amines are mainly based on 
the metal-catalysed condensation of ammonia with alkyl halides or alcohols, which in 
turn are obtained from olefins.[98] The direct hydroamination of olefins thus represents 
an attractive, more cost-effective and atom-efficient alternative. Although the direct 
addition of amines to unsaturated bonds is thermodynamically achievable in terms of 
free energy (∆Go ≈ -17 kJ.mol-1), the reaction presents a very high activation barrier due 
to the repulsion between the electron-rich pi-system of the unsaturated substrate and the 
lone pair of the nucleophilic amine.[99] Additionally, the highly negative entropy of the 
process favours the reactants at high temperature. The use of catalysts to overcome 
these barriers is, therefore, indispensable.  
Over the last thirty years a wide variety of homogeneous catalysts has been 
developed for the intramolecular hydroamination/cyclisation of aminoolefins into N-
heterocyclic products, based on metals spanning the whole of the periodic table: alkali 
metal bases,[100-104] early transition metals,[105] such as scandium,[106, 107] yttrium,[107-109] 
titanium and zirconium,[109-117] late transition metals such as rhenium,[118] iron,[119] 
ruthenium,[120] rhodium and iridium,[121, 122] palladium,[123, 124] platinum,[124, 125] 
copper,[126] silver and gold,[127] zinc,[128, 129] as well as lanthanide[51, 53, 60, 130-135] and 
actinide derivatives.[136, 137]  
Since alkaline earth Ae2+ species are d0 and redox-inactive, only d0 metal-catalysed 
intramolecular hydroamination reactions based on a single catalyst oxidation state will 
be presented herein. In all these cases, the 5-, 6- or 7-membered N-heterocyclic products 
arise from exocyclic addition of the olefin (Figure 16).  
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2.1.1 Lithium-catalysed intramolecular hydroamination 
 
Figure 16. Scope and regioselectivity of d0 metal-catalysed intramolecular hydroamination/cyclisation  
 
 
 
 
 
 
 
 
 
 
 
 
 
The first example of intramolecular hydroamination of aminoalkenes in the presence 
of catalytic amounts of n-BuLi was reported in 1992 by Fujita et al.[100] Since then 
lithium bases of the form [LnLiX] (L = neutral ligand, X = monoanionic, reactive 
ligand) have been successfully used for the intramolecular hydroamination of 
unactivated alkenes, conjugated enynes and cyclohexa-2,5-dienes into five- and six-
membered heterocycles, as well as bicyclic products.[101-104] Chiral diamidobinaphthyl 
and bisoxazoline ligands have been developed to achieve enantioselectivities of up to 
91% ee.[103] In most cases, alkene isomerisation by-products were observed, but at 
higher temperatures these disappeared in favour of the N-heterocyclic products. 
Although no in-depth mechanistic studies have been carried out, reactions are thought to 
proceed via deprotonation of the amine moiety to form the catalytically active lithium 
amide species, followed by alkene insertion into the Li-N bond, formation of a transient 
lithium alkyl complex, and finally protonolysis with a second equivalent of substrate to 
regenerate the active species and liberate the cyclised product. It is noteworthy, 
however, that the stoichiometric reaction between n-BuLi and 1-amino-4-pentene 
yielded quantitative formation of the lithiated amidoalkene which, even after prolonged 
heating at reflux, did not undergo intramolecular hydroamination.[104] Rather, the 
addition of small amounts (10-20 mol%) of di-iso-propylamine was necessary to 
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achieve full cyclisation. It is therefore likely that coordinated amines play an important 
role in the charge stabilisation of the polarised alkene moiety during the transition state, 
thus suggesting a concerted insertion-protonation pathway (vide infra). 
 
2.1.2 Lanthanide-catalysed intramolecular hydroamination 
 
The highly efficient organolanthanide-mediated intramolecular hydroamination of 
aminoalkenes, -alkynes, -allenes, and -dienes pioneered by Marks and co-workers in the 
1990s is probably one of the most-studied catalytic transformations.[130] In-depth kinetic 
and mechanistic experimental studies have established the catalytic cycle outlined in 
Figure 17.[53, 132] Catalyst activation occurs via σ-bond metathesis between the alkyl or 
amide co-ligand of the [L2LnX] lanthanide precatalyst (L = monoanionic spectator 
ligand; X = reactive monoanionic ligand) and the amine moiety of the substrate, 
followed by polarisation of the unsaturated carbon-carbon bond, insertion of the latter 
into the Ln-N bond to form a transient alkyl species, and finally protonolysis by another 
equivalent of the substrate, leading to regeneration of the active catalyst and liberation 
of the N-heterocyclic product.  
 
Figure 17. Catalytic cycle for the hydroamination/cyclisation of aminoalkenes by organolanthanide 
precatalysts. 
 
 
 
 
 
 
 
 
 
 
 
Kinetic studies showed that the reaction follows the rate law rate = 
k[substrate]0[catalyst]1 and is subject to substrate inhibition. The reaction rate can be 
tuned by the judicious choice of both the electronic and steric properties of the spectator 
ligands and the size of the lanthanide metal centre, as rates markedly decrease down the 
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series (La > Sm > Lu)[53] in correlation with the general trend of lanthanide-based olefin 
insertion reactions.[10] Furthermore, deuterium-labelling experiments and kinetic studies, 
yielding mild activation enthalpies (∆H‡ ~ 50 kJ.mol-1) and highly negative activation 
entropies (∆S‡ ~ -100 J.mol-1.K-1), are all in agreement with the existence of a highly 
organised transition state leading to rate-determining olefin insertion.[53] High kinetic 
isotope effects have also suggested that neutral adducted aminoolefins play a role in the 
stabilisation of negative charge build-up on the polarised olefin moiety during the 
transition state.[53] First centred on cyclopentadienyl-based organolanthanide 
precatalysts, this field has rapidly expanded towards the use of chiral non-
cyclopentadienyl dianionic ligands for the enantioselective hydroamination of 
aminoolefins with some examples shown in Figure 18.[131, 135] In recent years, a number 
of computational studies on the hydroamination/cyclisation of aminoalkenes, -alkynes, -
allenes and -dienes with trivalent lanthanide catalysts have been carried out, confirming 
the experimental findings.[138] Similar studies for the actinide-catalysed hydroamination 
of aminoolefins suggest an analogous mechanism, based on σ-bond metathesis and 
insertion into the actinide-amide bond.[139]  
 
Figure 18. Examples of chiral cyclopentadienyl and non-cyclopentadienyl precatalysts for the lanthanide-
mediated hydroamination/cyclisation of aminoalkenes. 
 
 
2.1.3 Group 4-catalysed intramolecular hydroamination 
 
While at first limited to the cyclisation of aminoalkynes and -allenes,[110, 111] group 4-
mediated intramolecular hydroamination has been expanding in recent years to the 
enantioselective cyclisation of unactivated aminoalkenes.[112, 115] Cationic group 4 
complexes of the form [L2MX]
+[A]- and neutral complexes of the form [L3MX] bearing 
a single monoanionic substituent capable of undergoing protonolysis (L = monoanionic 
spectator ligand; X = reactive monoanionic ligand; A- = counteranion) have been shown 
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to catalyse hydroamination/cyclisation reactions in a manner similar to lanthanide 
complexes, albeit at much slower rates than their rare earth counterparts.[112, 113, 137] In 
contrast, neutral titanium(IV) and zirconium(IV) complexes of the form [L2MX2] have 
also demonstrated the capacity to form M=N imido bonds with the amine moiety of the 
substrate, and undergo subsequent [2+2] cycloaddition of the olefin residue with the 
M=N bond to complete ring closure.[110] In this particular mechanism, displayed in 
Figure 19, [L2MX2] first reacts with two molecules of substrate to yield an inactive 
[L2M(NHR)2] bis(amide) species which, in a reversible rate-determining process, is 
activated by N-H proton abstraction, elimination of RNH2 and formation of the metal 
imido species. The latter can then undergo an M=N/C=C [2+2] cycloaddition followed 
by protonolysis of the resultant azametallacycle with another two equivalents of 
substrate, liberation of the N-heterocyclic product and regeneration of the active catalyst. 
The [2+2] cycloaddition process has been argued to be thermodynamically unfavourable, 
and in many cases a σ-bond metathesis/insertion process can not be discounted, as was 
demonstrated by Tobisch in a computational study on the cyclisation of 
aminoallenes.[140] In some cases, however, in which the steric crowding about the 
catalytic centre should in theory prevent alkene polarisation and insertion due to a lack 
of vacant coordination sites, catalysis rates have been seen to increase dramatically with 
steric crowding, an observation only compatible with the imido mechanism.[116]  
 
Figure 19. Catalytic imido cycle for the hydroamination/cyclisation of aminoalkenes by neutral group 4 
precatalysts. 
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In general it seems that the preference for the amido/alkene insertion or the 
imido/alkene [2+2] cycloaddition route heavily depends not only on the availability of 
two protonolysable sites for M=N bond formation, but also the nature of the spectator 
ligand, the presence of free coordination sites and the substrate used, as secondary 
amines also prevent M=N bond formation.[117]  
 
2.1.4 Group 2-mediated intramolecular hydroamination 
 
As already outlined in the introduction to this thesis, mechanistic studies on the 
hydroamination/cyclisation of substituted aminoalkenes into pyrrolidines, piperidines 
and hexahydroazepines with β-diketiminate magnesium and calcium precatalysts 1 and 
2 have confirmed a lanthanide-type catalytic cycle based upon σ-bond metathesis and 
rate-limiting insertion steps, with either reversible (2) or irreversible catalyst initiation 
(1), depending on the acidity of the reactive monoanionic substituent (Figure 6). While 
the larger calcium metal centre of complex 2 was found, in all cases, to provide the 
fastest turnover rates, magnesium precatalyst 1 proved more selective for the 
hydroamination/cyclisation of 6- and 7-membered rings.[54] In other comparative 
intramolecular hydroamination studies using calcium and strontium triazenide and 
aminotroponiminate precatalysts (Figure 4), the strontium derivatives proved to be more 
sluggish that their calcium counterparts.[60, 61] Later studies upon the intermolecular 
hydroamination of activated alkenes with homoleptic group 2 bis(amide) precatalysts 
[M{N(SiMe3)2}2] (M = Mg, Ca, Sr, Ba), however, found strontium to be significantly 
superior to calcium, while magnesium and barium, although catalytically active, 
provided extremely slow turnover frequencies.[65] A computational study suggested that 
the interplay between the ability of the group 2 metal-amide bond to polarise the C=C 
alkene bond and the polarisability of the alkaline earth dication dictates the height of the 
activation barrier towards the alkene insertion step. Kinetic analyses also revealed that 
the strontium precatalyst benefits from a considerable entropic advantage arising from a 
less constrained insertion transition state, which results in superior catalytic activity 
despite a higher activation barrier towards the insertion. It thus became apparent that the 
catalytic reactivity of group 2 metal centres is not only dependent on cation size but also 
on more subtle charge density variations. The following study, therefore, seeks to base 
previous qualitative observations on the alkaline earth-catalysed intramolecular 
hydroamination of aminoalkenes on a more quantitative level, in an unprecedented 
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comparison of complexes spanning the whole group 2 series from magnesium to barium, 
assessing the influence of the nature of the metal centre as well as of the various ligands 
and co-ligands employed.  
 
 
2.2 Selection of homoleptic and heteroleptic precatalysts 
 
It had been previously shown that catalytic turnover is inhibited by Lewis bases such 
as THF, substrate or product binding to the metal centre, thus creating coordinative 
saturation.[54] It was therefore of interest to compare hydroamination with calcium 
precatalyst 2 and its recently reported unsolvated analogue 
[{ArNC(Me)CHC(Me)NAr}Ca{N(SiMe3)2}], 33, (Ar = 2,6-di-iso-propylphenyl) which, 
although only three-coordinate, proved stable towards ligand redistribution equilibria in 
solution.[21, 36, 141] Due to contamination with the homoleptic and catalytically inactive 
complex [{ArNC(Me)CHC(Me)NAr}2Sr(THF)] during synthesis and in solution, the 
analogous heteroleptic strontium species 34 was at first deemed unsuitable for catalysis. 
However, if the two-step route designed by Sarish et al. was used in place of the usual 
one-pot synthesis,[39] the heteroleptic strontium compound 34 could be isolated in 
satisfactory purity and yield (Scheme 42). A preliminary test with 1-amino-2,2-
diphenyl-4-pentene at 5 mol% catalyst loading showed that 34 was efficient at 
catalysing the hydroamination/cyclisation process at temperatures up to 60 oC and over 
periods up to several days without any apparent redistribution towards the homoleptic 
complex detectable in the 1H NMR spectra.  
 
Scheme 42. Synthesis of heteroleptic β-diketiminate supported magnesium, calcium and strontium 
precatalysts. 
N N
ArAr
CaI2 + 2 [KN(SiMe3)2]
H
high vacuum, 10h
40 oC
N N
ArAr Ca
Et2O N(SiMe3)2
N N
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+
1) [KN(SiMe3)2], toluene, rt, 2h
2) MeMgBr, rt, 4h
THF, rt, 18h
Et2O, rt, 18h
N N
ArAr Sr
THF N(SiMe3)2
2 [KN(SiMe3)2]
N N
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N N
ArAr Ca
THF N(SiMe3)2
1) THF, rt, 5h
2) SrI2, rt, 18h
1
2
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Ar = 2,6-iPr2C6H3
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Initial attempts to effect the hydroamination/cyclisation of the linear and 
unsubstituted aminoalkene 1-amino-4-pentene with the homoleptic calcium amide 
[Ca{N(SiMe3)2}2]2 had resulted in failure, even at high catalyst loading and 
temperature.[52] Subsequent assessment of the ability of [Ca{N(SiMe3)2}2]2 to cyclise 1-
amino-2,2-diphenyl-4-pentene, however, proved highly successful. For this reason the 
complete series of readily available homoleptic amides [M{N(SiMe3)2}2]2 (M = Mg 35a, 
Ca 35b, Sr 35c, Ba 35d),[142] along with their THF-solvated counterparts 
[M{N(SiMe3)2}2(THF)2] (M = Mg 36a, Ca 36b, Sr 36c, Ba 36d),
[143] were included in 
this comparative and mechanistic study on the hydroamination/cyclisation reaction 
(Scheme 43). In addition the recently reported group 2 dialkyls 
[M{CH(SiMe3)2}2(THF)2] (M = Mg 37a, Ca 37b, Sr 37c, Ba 37d), whose reactivity has 
yet to be fully investigated, were also included in this study.[144]  
 
Scheme 43. Synthesis of homoleptic alkaline earth amide and alkyl precatalysts. 
 
 
 
 
 
 
 
The magnesium dialkyl [Mg{CH(SiMe3)2}2(THF)2] 37d was synthesised in an 
manner analogous to that of the previously reported calcium, strontium and barium 
dialkyls (Scheme 43). Regarding the synthesis of compounds 37a-d it was found that 
the use of glass-coated stirrer bars instead of the usual PTFE stirrer bars greatly 
improved purity and yields as both the potassium and heavier alkaline earth alkyls (Ca, 
Sr, Ba) may react with PTFE, yielding impure compounds. Storage of a hexane solution 
of 37a at -30 oC yielded a crop of colourless crystals suitable for X-ray diffraction. The 
result of this experiment is presented in Figure 20. The compound crystallises as a 
pseudo-tetrahedral bis(THF) adduct with C2 symmetry around the magnesium centre. 
The Mg-C distance of 2.1882(15) Å is significantly longer than the ones in the related 
solvent-free, polymeric [Mg{CH(SiMe3)2}2]n [2.117(4) and 2.105(4) Å],
[145] the diethyl 
ether-solvated monomer [Mg{CH(SiMe3)2}2(OEt)] [2.141(2) Å]
[146] or the solvent-free 
two-coordinate tris(trimethylsilyl)methyl derivative [Mg{C(SiMe3)3}2] [2.116(2) Å].
[147] 
MI2 + 2 [KN(SiMe3)2]
M = Ca, Sr, Ba
MI2 + 2 [KCH(SiMe3)2]
THF, rt, 18h
glass-coated
stirrer bar
M = Mg, Ca, Sr, Ba
[M{CH(SiMe3)2}2(THF)2]
MgBu2 + 2 HN(SiMe3)2
THF, rt, 18h
1) Et2O, rt, 18h
[M{N(SiMe3)2}2(THF)2]
[M{N(SiMe3)2}2]2
35a-d
36a-d
37a-d
2) high vacuum,
40 oC, 8h
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Attempts to prepare the analogous series of unsolvated group 2 dialkyl compounds 
[M{CH(SiMe3)2}2] (M = Mg, Ca, Sr, Ba) following a similar procedure in diethyl ether 
instead of THF repeatedly failed due to ether cleavage side reactions. 
 
Figure 20. ORTEP representation of compound 37a. Thermal ellipsoids drawn at 30% probability. H 
atoms removed for clarity. Selected bond lengths (Å): Mg-C(1) 2.1882(15), Mg-O 2.1043(12). Selected 
angles (o): C(1)-Mg-C(1)’ 137.32(9), C(1)-Mg-O 106.51(5), C(1)-Mg-O’ 104.34(5), O-Mg-O’ 86.07(7). 
 
 
 
 
 
 
 
 
 
2.3 Reaction scope 
 
Hydroamination/cyclisation with magnesium, calcium and strontium precatalyst 
loadings of 2-20 mol% afforded a series of substituted pyrrolidines and piperidines in 
near quantitative yields under relatively mild conditions (25-100 oC). Formation of 
hexahydroazepines was only observed in low to moderate yield at high temperature and 
over extended periods of time with magnesium precatalysts 35a and 36a (Table 1, entry 
20). The structures of the cyclised products were assigned by comparison with literature 
1H NMR data. Comparative results for the reactions performed with the bis(amides) 
35a-c and 36a-c and the dialkyls 37a-c are listed in Table 1. Data related to the β-
diketiminate-stabilised complexes 1, 2, 34 and 35 are provided in Table 2.  
Attempts to catalyse the hydroamination/cyclisation of 1-amino-2,2-diphenyl-4-
pentene with barium precatalysts 35-37d resulted in a maximum of two turnovers and 
was accompanied by the precipitation of insoluble, unidentifiable products. This implies 
that reactivity is limited to a stoichiometric reaction of the substrate with both amide or 
alkyl moieties of the precatalyst. This behaviour is likely the consequence of the very 
large size of the cationic barium centre in which the diffuse charge is not efficient at 
polarising the alkene bond in order to effect the insertion of the C=C bond.  
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A limitation of strontium system 34 became apparent at temperatures above 60 oC, in 
which case catalysis was accompanied by irreversible Schlenk-like ligand redistribution 
towards the homoleptic species, as observed by 1H NMR spectroscopy. The dialkyl 
systems 37a-c also showed serious limitations at temperatures above 40 oC or over 
periods of time exceeding 30 hours at room temperature. Under such conditions these 
precatalysts underwent irreversible degradation into insoluble, and as yet unidentified, 
catalytically inactive species. As a result, compounds 37a-c could only be used for the 
cyclisation of a very limited number of substrates. Monitoring of C6D6 solutions of 37a-
c in the absence of substrate over a week showed that these alkyl species tend to 
decompose over time, even at room temperature, into CH2(SiMe3)2 and unidentified 
insoluble species, the degradation rate increasing dramatically down the group.  
In all cases, calcium precatalysts 35-37b displayed higher catalytic activities than 
their strontium analogues 35-37c, which in turn proved far more reactive than the 
magnesium species 35-37a. Previous comparison between calcium complex 2 and the 
related magnesium compound 1 had already shown 2 to be the more active species.[54] It 
was proposed that the increase in ionic radius from 0.72 Ǻ for Mg2+ to 1.00 Ǻ for Ca2+ 
(in six-coordinate complexes) provides higher coordinative unsaturation at the calcium 
centre, and thus improved access towards substrate binding and alkene pre-coordination. 
A similar trend can be found in the lanthanide series where turnover frequency 
markedly decreases with the ionic radius of the metal centre.[53] An extrapolation of this 
rationale to strontium, with a six-coordinate Sr2+ radius of 1.16 Ǻ, would therefore 
provide the expectation of even higher turnover frequencies than calcium. Previous 
qualitative comparison of calcium and strontium systems for the 
hydroamination/cyclisation of aminoalkenes, however, had shown than strontium 
triazenide and aminotroponiminate precatalysts are less active than their calcium 
counterparts.[60, 61] Similarly, among the precatalysts studied here, the strontium systems 
were less active than their calcium counterparts, both in qualitative and quantitative 
analyses.  
As expected, the coordinative unsaturation of the calcium centre in complex 33 
afforded a substantial increase in catalytic activity when compared to the THF-solvated 
complex 2. The unsolvated bis(amide) complexes 35a-c, however, displayed lower 
turnover frequencies than their THF-solvated analogues 36a-c, except in the case of 
substrates bearing secondary amine functionalities in which catalytic activity was 
reversed (Table 1, entries 22-28). 
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Table 1. Scope of intramolecular hydroamination of aminoalkenes with precatalysts 35-37. 
Entry Substrate Product Catalyst (mol %) Time / h T / 
o
C NMR yield / %
a 
    35 36 37  35 36 37 
1 
NH2
 NH
Me
 
a-c (10 mol%)  48  100  0  
2 a (10 mol %) 5 d 4 d 16 80 60 75 2b 
3 b (2 mol %) 6 5 16 60 >99 
4 
 
NH2
 
 
NH
Me
Me
Me  
c (2 mol %) 10 8 16 60 97-99 
5 a (10 mol %) 48 42 16 25 95 97 2b 
6 b (2 mol %) 1 0.75 0.25 25 93-99 
7 
NH2
 
NH
Me
 
c (2 mol %) 24 8 0.25 25 96-98 
8 a (2 mol %) 6 5 0.25 25 98-99 
9 b (2 mol %) 0.25 0.25 0.1 25 98-99 
10 
 
NH2
Ph Ph
 
 
 
NH
Me
Ph
Ph  
c (2 mol %) 24 8 0.25 25 96-98 
11 a (10 mol %) 62 36 4d 25 99 99 2b 
12 b (10 mol %) 24 16 15 d 25 96 99 58c 
13 
NH2
Ph Ph
 
NH
Me
Ph
Ph
Me
 
c (10 mol %) 66 66 10 d 60 27c 48c 47c 
14 b (20 mol%) 6 d 6 d 6 d 100 0 63 0 
15 
NH2
Ph Ph
 
NH
Ph
Ph
 
c (20 mol%) 6 d 6 d 6 d 100 0 0 0 
16 NH2
Ph Ph
 
NH
i-Pr
Ph
Ph  
a-c 
(20 mol %) 
24 24 24 100 0 0 0 
The following experiments were carried out with 35 and 36 only 35 36  35 36 
17 a (10 mol %) 16 16 60 >99:0d 
18 b (10 mol %) 23 23 60 51:33d 40:54d 
19 
 
NH2
Ph Ph
 
 
 
c (10 mol%) 5d 5d 60 6:33d 9:37d 
20 a (10 mol %) 9 d 9 d 100 19:0d 55:0d 
21 b (20 mol %) 3 d 3 d 80 0:7d 0:21d 
22 
NH2
Ph Ph
 
N
Me
Ph
Ph H +
NH2
Ph Ph
 
c (20 mol%) 2 d 2 d 100 0:4d 0:5d 
23 b (10 mol%) 45 21 25 94 7 
24  - 8 80 - >99 
25 c (10 mol%) 21 45 25 7 92 
26 
H
N Ph
 
N
Me
Ph
 - 18 80 - 98 
27 a (10 mol%) 2 d 2 d 60 43 95 
28 b (10 mol%) 2 d 2 d 25 8e 12e 
29 
H
N
N
Me
 
c (10 mol%) 2 d 2 d 25 <5e 6e 
30 b (2 mol%) - 0.5 25 - >99 
31 
NH2Ph
 
NH
Ph
 
c (2 mol%) - 1.5 25 - >99 
 
a) NMR scale reactions carried out in C6D6 or d8-toluene, yields calculated from an internal TMSS standard. b) Solid 
instantly precipitated out of solution. Only one turnover observed. c) Solid slowly precipitated out of solution until 
catalysis stopped. d) Cyclisation: isomerisation. e) Substrate conversion >99%: the remaining products derive from 
isomerisation and recombination reactions.  
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Table 2. Scope of intramolecular hydroamination with precatalysts 1, 2, 33 and 34.  
 
Entry Substrate Product Catalyst (mol %) Time / h T / 
o
C NMR yield / %
a 
1 2 (10 mol%)
[54]
 21 25 90 
2 33 (10 mol%) 24 60 0 
3 
 
NH2
 
NH
Me
 
34 (10 mol%) 24 60 0 
4 2 (2 mol %)
[54]
 2 25 >95 
5 33 (2 mol%)
[54]
 1.5 25 >99 
6 
 
NH2
 
 
NH
Me
Me
Me  
34 (2 mol %) 30 25 97 
7 1 (5 mol %)
[54]
 2 25 96 
8 2 (2 mol %)
[54]
 0.5 25 98 
9 33 (2 mol %) 0.2 25 97 
10 
NH2
 
NH
Me
 34 (2 mol %) 7 25 98 
11 1 (2 mol %)
[54]
 2 25 99 
12 2 (2 mol %)
[54]
 0.15 25 >99 
13 33 (2 mol %) 0.1 25 >99 
14 
 
NH2
Ph Ph
 
 
NH
Me
Ph
Ph  34 (2 mol %) 0.15 25 >99 
15 1 (5 mol %)
[54]
 0.5 25 86 
16 2 (5 mol %)
[54]
 0.5 25 92 
17 33 (5 mol %) 0.3 25 >99 
18 
 
NH2
Ph Ph
 
NH
Me
Ph
Ph
Me
 34 (5 mol %) 5 25 98 
19 
 
NH2
Ph Ph
 
NH
Ph
Ph
 
1
[54]
, 2
[54]
, 33, 34 
(20 mol %) 
3 d 80 0 
20 1 (10 mol %) 4 25 97:0d 
21 
 
2 (10 mol %) 4 25 83:16d 
22 33 (10 mol %) 4 25 66:15d 
23 
 
NH2
Ph Ph
 
 
 
34 (10 mol %) 48 25 28:62d 
24 1 (20 mol %) 3 d 100 97:0d 
25 2 (20 mol %) 1 d 80 0:20d 
26 33 (20 mol %) 2 d 80 5:25d 
27 
 
NH2
Ph Ph
 
N
Me
Ph
Ph H
+
NH2
Ph Ph
34 (20 mol %) 4 d 60 5:15d 
28 1 (20 mol %)
[54]
 2 d 25 81 
29 2 (20 mol%)
[54]
 2 d 25 >99 
30 33 (10 mol %) 18 25 95 
31 
 
 
NH2
 
 
NH
Me
Me
NH
Me
Me
+
33 86:14
34 88:12
1 92:8
2 89:11
 34 (20 mol %) 2 d 25 90 
32 1 (10 mol %) 2 d 80 95 
33 2 (10 mol %) 8 60 98 
34 33 (10 mol %) 3 25 >99 
35 
H
N Ph
 
N
Me
Ph
34 (10 mol %) 18 25 78 
36 1 (10 mol %) 2 d 60 96 
37 2 (10 mol %) 2 d 25 60e 
38 33 (10 mol %) 18 25 47e 
39 
 
H
N
 
N
Me
 
 34 (10 mol %) 18 25 <5e 
40 NH2Ph
 
NH
Ph
 
2 (2 mol %) 0.15 25 >99 
63 
 
As previously reported for the hydroamination/cyclisation of a range of substrates 
with precatalysts 1 and 2,[54] the rate of catalysis was found to be heavily dependent on 
the substitution pattern of the aminoalkene (Figure 21). Substrates presenting sterically 
demanding geminal substituents in the β-position of the amine moiety gave the highest 
reaction rates at minimal catalyst loading and room temperature (Table 1, entries 5-10; 
Table 2, entries 7-14). These substrates benefit from a favourable Thorpe-Ingold effect: 
the bulkier the geminal substituents (Ph > Cy > Me >>> H), the more constrained the 
conformational freedom of the aminoalkene, which in turn provides a favourable 
conformation for the alkene insertion step. In contrast to the formation of 2-
methylpyrrolidine observed in the presence of calcium precatalyst 2 (Table 2, entry 1)[54] 
cyclisation of the unsubstituted 1-amino-4-pentene substrate was observed with neither 
of the homoleptic precatalysts 35-37 (Table 1, entry 1), nor with the β-diketiminato 
strontium species 34 or the THF-free heteroleptic calcium compound 33, even after 
prolonged heating at 60 oC (Table 2, entries 2-3). These observations suggest that 
substrates which do not intrinsically benefit from a favourable Thorpe-Ingold effect 
require the presence of the sterically constraining β-diketiminate ligand, combined with 
the relatively small calcium metal centre and the added steric demands of the THF co-
ligand in order to induce a propitious conformation for the alkene to approach the metal 
centre and induce the insertion step. 
 
Figure 21. Influence of the substitution pattern of the aminoalkene on catalysis rates. 
 
Alkyl substitution of the alkene moiety induced a significant decrease in the reaction 
rate. Both terminal mono- and disubstitution entirely prevented cyclisation for the β-
diketiminate derivatives 33 and 34 (Table 2, entry 19). Transformation of a terminally 
H
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alkyl-monosubstituted aminoalkene, 1-amino-2,2-diphenyl-4-hexene, into 2-ethyl-4,4-
diphenylpyrrolidine could, however, be achieved with calcium precatalyst 36b (Table 1, 
entry 14) under forcing conditions (100 oC), although the high catalyst loading (20 
mol%) combined with a low yield (63%) militate against a truly catalytic process. 
Although generally more active than the homoleptic bis(amide) compounds, the calcium 
and strontium β-diketiminato species 2, 33 and 34 were observed to undergo 
competitive and irreversible ligand redistribution towards the homoleptic species at such 
high temperatures and, therefore, may be judged as unsuitable for the cyclisation of 
substrates with unactivated internal olefins. This is most likely the consequence of 
electronic factors as the presence of electron-donating alkyl substituents on the alkene 
moiety could destabilise the insertion transition state which involves negative charge 
build-up and partial 2o and 3o alkyl character on the alkene residue. This was confirmed 
by the facile cyclisation of phenyl-substituted 1-amino-2,2-dimethyl-5-phenyl-4-
pentene (Table 1, entries 30-31 and Table 2, entry 40), in which the negative charge on 
the incipient benzylic carbon is stabilised by the phenyl group. Whereas lanthanide 
catalysts have been designed to specifically allow the facile hydroamination of 
aminoalkenes bearing unactivated internal olefins,[134, 135] this is a rare example of 
successful cyclisation of such as substrate by a group 2 complex.[62]  
As has been reported previously,[54] ring formation followed Baldwin’s guidelines, 
with formation of five-membered rings being significantly easier than that of six- or 
seven-membered heterocycles.[148] In all cases higher catalyst loadings, temperatures 
and time periods were necessary to obtain piperidines compared to pyrrolidines. 
Although formation of a seven-membered ring could be observed with the magnesium 
compounds 35a and 36a (Table 1, entry 20), and to a much lesser extent with calcium 
and strontium species 33 and 34 (Table 2, entries 26-27), reaction conditions and the 
formation of alkene-isomerised by-products diminish the viability of this reaction with 
these latter precatalysts. Only β-diketiminate-stabilised magnesium precatalyst 1 
provided a near quantitative route towards formation of hexahydroazepines (88%) after 
prolonged periods of time at 80 oC.[54] 
As previously reported for similar catalysis performed with 2,[54] the cyclisation of 1-
amino-2,2-diphenyl-5-hexene with all calcium and strontium precatalysts in this study 
afforded, next to the cyclised piperidine, the alkene isomerisation by-product trans-1-
amino-2,2-diphenyl-4-hexene, identified by 1H NMR, as the major product (Table 1, 
entries 18-19; Table 2, entries 21-23). The trans geometry was unambiguously assigned 
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by comparison with the independently synthesised trans-1-amino-2,2-diphenyl-4-
hexene. In the case of calcium precatalysts 35b and 36b, a small amount of cyclisation 
of the isomerisation product trans-1-amino-2,2-diphenyl-4-hexene into 2-ethyl-4,4-
diphenylpyrrolidine was observed at temperatures above 60 oC. As was the case with 
magnesium precatalyst 1,[54] no such isomerisation was observed with the bis(amide) 
species 35a and 36a, which contain the smaller and, therefore, more sterically congested 
Mg2+ cation (Table 1, entry 17). 
While alkene isomerisation by-products have not been reported in lanthanide-
catalysed intramolecular hydroamination, they have been observed during the 
cyclisation of N-benzyl-1-amino-4-pentenes and N-benzyl-1-amino-5-hexenes with 
[Ir(COD)Cl]2,
[122] as well as for the hydroamination of a variety of 1-amino-4-pentenes 
catalysed by n-BuLi.[101, 104] It was apparent that the proportion of isomerised by-
product increases with the size of the metal cation, as well as with conformational 
freedom around the metal centre and reaction temperature. These observations can be 
rationalised by taking into consideration the isomerisation mechanism – dependent on 
the conformational freedom of the alkene chain – of the amide resting state laid out in 
Scheme 44. In the first case, insertion of the alkene into the metal-amide bond followed 
by protonolysis leads to liberation of the piperidine. In the second, isomerisation to a 
boat-type conformation may lead to intramolecular proton-transfer to yield an η3-allyl 
complex which, upon protonolysis, liberates either the internally isomerised 
aminoalkene or the substrate.  
 
Scheme 44. Isomerisation versus cyclisation for 1-amino-2,2-diphenyl-5-hexene.  
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Attempts to cyclise 1-amino-2,2-diphenyl-6-heptene with the homoleptic and 
heteroleptic calcium and strontium species 35-36b, 35-36c, 33 and 34 resulted in the 
formation of a small amount of trans-1-amino-2,2-diphenyl-5-heptene as the only 
identifiable product (Table 1, entries 21-22; Table 2, entries 26-27). Further 
isomerisation to 1-amino-2,2-diphenyl-4-heptene or cyclisation of the isomerised chain 
could not be observed under the reaction conditions. Again, no isomerisation occurred 
with the magnesium precatalysts 35a and 36a (Table 1, entry 21). 
Alkene isomerisation by-products were also observed during the reaction of N-allyl-
1-amino-4-pentene with all calcium and strontium precatalysts (Table 1, entries 28-29; 
Table 2, entries 37-39). 1H NMR spectra showed a complex mixture of at least half a 
dozen different products, depending on the nature and concentration of the precatalyst 
and the reaction temperature. The mono-cyclised product N-allyl-2-methylpyrrolidine 
recently reported with 2 could, in all cases, be easily identified,[54] as well as its N-
(trans/cis-1-propenyl)-2-methylpyrrolidine isomers and various isomers of the substrate. 
A scale-up of the reaction to 300 mg of substrate with 10 mol% of 36c at 80 oC over 
three days, and subsequent fractional distillation of the volatile products, allowed 
isolation of further components, among which small amounts of the bi-cyclised product 
already reported for lanthanide-mediated tandem hydroamination/cyclisation, 1-amino-
4-pentene and (E)-N-((E)-2-methylpent-2-enylidene)pent-4-en-1-amine 38 which were 
unambiguously identified by NMR spectroscopy as well as by ESI-MS (Scheme 45).  
 
Scheme 45. Range of products obtained from the attempted hydroamination/cyclisation of N-allyl-1-
amino-4-pentene with calcium and strontium precatalysts 35-36b, 35-36c, 2, 33 and 34. 
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increased with temperature and size of the precatalyst metal centre. It is as yet unclear 
what mechanism might be at work in the formation of this product. Magnesium 
compounds 35-36a and 1 were the only precatalysts to cleanly afford mono-cyclised N-
allyl-2-methylpyrrolidine as the single product (Table 1, entry 27; Table 2, entry 36).  
Another secondary amine substrate, N-benzyl-(1-allylcyclohexyl)methylamine, was 
cleanly converted by all precatalysts into the expected N-heterocyclic product (Table 1, 
23-26; Table 2, entries 32-35). A marked increase in reactivity was observed for the 
THF-free β-diketiminate complex 33 compared to the solvated analogue 2. The reaction 
using 10 mol% of 33 proceeded to completion within 3 hours at room temperature, 
whereas the reaction with 10 mol% of 2 required heating to 60 oC for 8 hours, showing 
that access to the metal centre is essential for the pre-coordination/protonolysis of 
encumbered secondary amines (Table 2, entries 30-31). Contrary to observations for all 
primary amine substrates, the unsolvated bis(amide) species 35a-c presented 
significantly faster catalysis than THF-solvated compounds 36a-c for this substrate 
(Table 1, entries 22-25) . An attempt to explain this inversion of reactivity will be 
provided through the kinetic studies described later (vide infra).  
In the presence of 33 and 34, 2-amino-5-hexene, a substrate possessing two prochiral 
centres, underwent diastereoselective hydroamination/cyclisation, yielding the trans-
pyrrolidine in diastereomeric excess of 72% and 76% for 33 and 34 respectively (Table 
2, entries 27-28). For comparison the calcium and magnesium analogues 1 and 2 
provided a diastereomeric excess of 78% and 84% respectively.[54] Similarly, Roesky 
and co-workers had reported a 60% diastereomeric excess for the same reaction with 
calcium aminotroponiminate precatalyst 5.[59] The relative stoichiometry of the products 
was assigned by integrating two distinct 1H NMR multiplets of the trans (3.15 ppm) 
versus the cis product (2.92 ppm). This confirms the trend that diastereoselectivity 
increases inverse to the size of the group 2 metal centre when using a given ligand set. 
The trans-selectivity can be rationalised by comparing the four isomers of the 7-
membered chair transition state shown in Figure 22. For both the (S) and the (R) 
enantiomers of the substrate, the transition state leading to the cis product is disfavoured 
by a 1,3-diaxial methyl-proton interaction, which may be exacerbated by the additional 
steric crowding and shorter M-N and M-C bond lengths around a smaller metal cation, 
or in the presence of coordinated THF. This leads to the observed trend of decreasing 
diastereomeric excess for 1 > 2 > 34 > 33. Marks and co-workers have reported a 
similar trend in related chemistry utilising the lanthanide series.[53]  
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Figure 22. Qualitative comparison of the transition state energies for the cyclisation of racemic 2-amino-
5-hexene. 
 
These qualitative observations all lead to the conclusion that the group 2-mediated 
hydroamination/cyclisation of aminoalkenes is largely dominated by steric (influence of 
the sterically demanding β-diketiminate ligand and THF co-ligand, Thorpe-Ingold effect, 
ease of ring-formation, substitution of the amine, diastereoselectivity, alkene 
isomerisation side reactions) and electronic effects (substitution of the alkene moiety, 
non-linear effect of the metal centre: Ca > Sr >Mg >>> Ba), the key step seeming to be 
the creation of a favourable conformation for the alkene pre-coordination and insertion 
to take place.  
 
 
 
2.4 Mechanistic analyses  
 
 
2.4.1 Catalyst initiation 
 
As was highlighted previously, reactions involving silylamide precatalysts may 
provide reversible entry into the catalytic cycle due to the comparable acidity of the 
aminoalkene substrate and the protonolysis product, hexamethyldisilazane.[54] The 
stoichiometric reaction of 2 with benzylamine, for example, provided a quantifiable 
dynamic equilibrium between a dimeric heteroleptic calcium benzylamide complex and 
the starting materials, which lay in favour of the benzylamide species at room 
temperature (∆Go (298 K) = -11.4 kJ.mol-1).[56] In contrast, the reaction of 2 with the 
potentially bidentate 2-methoxyethylamine resulted in quantitative formation of the 
heteroleptic calcium primary amide and demonstrated that, under certain conditions, the 
position of the amine/amide equilibrium may be perturbed significantly to one side.[54, 55]  
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In order to further quantify the potentially reversible protonolytic entry into the 
catalytic cycle, similar analyses were performed upon stoichiometric reactions between 
the calcium and strontium complexes 35-36b and 35-36c (0.19 M) and two equivalents 
of the non-cyclisable substrate 1-amino-2,2-diphenyl-5,5-dimethyl-4-pentene. In each 
case variable temperature 1H NMR experiments indicated the establishment of similar 
transamination equilibria for these homoleptic precatalysts. These were followed by 
integrating the bis(trimethylsilyl)amide singlet of the precatalyst against that of the 
protonated hexamethyldisilazane. Examination of the resultant 1H NMR spectra seemed 
to suggest that, despite the presence of two silylamide substituents per alkaline earth 
centre and, thus, two potential catalytic sites, never more than one of these underwent 
amine/amide exchange at a time. Although it is probable that the complexes resulting 
from this amine/amide exchange are dimeric in solution, by analogy with previously 
characterised heteroleptic calcium and magnesium primary amides obtained by 
protonolysis with a primary amine,[54] the exact nuclearity of each of the reactions 
remains uncertain. A variety of equilibria may indeed be envisaged, as depicted in 
Scheme 46. 
 
Scheme 46. Possible transamination equilibria between 35b-c or 36b-c and 1-amino-2,2-diphenyl-5,5-
dimethyl-4-pentene. 
The complexity of these equilibria, which might coexist in solution, and the 
consequent uncertainty over the nuclearity of the various alkaline earth-containing 
components would make a quantitative discussion of these data imprudent. Inspection 
of the temperature-dependent data, however, revealed each reaction to be mildly 
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endothermic (∆Go (298 K) ~ 6 kJ.mol-1) irrespective of the reaction stoichiometry 
employed to deduce the equilibrium constants (Figure 23).  
 
Figure 23. van’t Hoff analyses of equilibria A-C for complexes 35b-c and 36b-c (Scheme 46). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thermodynamic data for each of the equilibria A-C presented in Figure 23 are 
displayed in Table 3. Similarly, for each of the catalytic reactions involving silylamide 
precatalysts presented in Tables 1 and 2, examination of the 1H NMR data suggested 
that the equilibrium lies in favour of the starting materials during catalysis, which makes 
the use of alkyl-based catalysts with irreversible initiation all the more desirable. 
 
Table 3. Thermodynamic data for equilibria A-C (Scheme 46) 
 
 calcium strontium 
 
∆Ho 
(kJ.mol-1) 
∆So 
(J.mol-1.K-1) 
∆Go(298 K) 
(kJ.mol-1) 
∆Ho 
(kJ.mol-1) 
∆So 
(J.mol-1.K-1) 
∆Go(298 K) 
(kJ.mol-1) 
A) 55.9 165 6.8 41.1 122 4.8 
B) 43.5 124 6.4 31.0 85 5.7 
C) 75.0 226 7.6 52.1 154 6.3 
35b 
36b 
36b 
35c 
36c 
36c 
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Addition of a stoichiometric quantity of tert-butylamine or di-iso-propylamine to a 
C6D6 solution of 34 did not lead to any observable reaction, even after prolonged 
heating at 60 oC. Addition of one equivalent of 2,6-di-iso-propylaniline or 
diphenylamine, however, resulted in complete and instantaneous protonolysis of the 
hexamethyldisilazido group, followed by rapid, irreversible and quantitative 
redistribution towards the known homoleptic species 
[{ArNC(Me)CHC(Me)NAr}2Sr(THF)] (Ar = 2,6-di-iso-propylaniline) and ill-defined 
strontium anilido or diphenylamido complexes. The stoichiometric addition of 
benzylamine to 34 at room temperature in C6D6, however, resulted in nearly complete 
conversion (95%) to the heteroleptic strontium benzylamide complex 40. Two further 
species could be characterised in solution as strontium complex 34 (4%) and its 
benzylamine adduct 39 (1%), which persisted as components of a dynamic equilibrium 
with complex 40, as shown in Scheme 47. It has previously been reported that the 
analogous reaction between calcium complex 34 and one equivalent of benzylamine 
results in a similar equilibrium between 34 and a heteroleptic calcium benzylamide 
complex which was isolated and characterised by X-ray crystallography as a dimeric 
species in the solid state.[56] Although no crystals of the strontium benzylamide complex 
suitable for X-ray diffraction analysis could be obtained, variable temperature 1H NMR 
studies upon a d8-toluene solution of the reaction mixture confirmed the existence of a 
dynamic equilibrium between 34, 39 and 40. As was the case in our previous study, 
elevated temperatures favoured both the starting materials and benzylamine adduct 39, 
observed by the distinctive signals of the ligand backbone methine protons. Formation 
of homoleptic [{ArNC(Me)CHC(Me)NAr}2Sr(THF)] was not observed within the 
temperature range (238-368 K) of the experiment. At temperatures below 288 K further 
fluxional processes prevented analysis of the data, but a 1H NMR spectrum recorded at 
238 K revealed two broad and highly shielded signals at -0.07 ppm and -1.19 ppm, 
tentatively attributed to the NH2 resonance of the benzylamine adduct 39 and the NH 
signal of the benzylamide complex 40 respectively. Due to the complexity of these 
equilibria involving three distinct strontium species and the uncertainty about the 
nuclearity of each of them, a quantitative assessment of the variable temperature 1H 
NMR data was not carried out. 
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Scheme 47. Stoichiometric reactions between 34 and various amines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction at room temperature between 34 and the potentially bidentate 
methoxyethylamine resulted in a 75:25 mixture of the amine adduct 41, displaying a 
broad NH2 triplet at -0.09 ppm in the 
1H NMR spectrum, and the amine/amide exchange 
product 42, recognisable by a highly shielded NH resonance at -1.75 ppm. This 
observation contrasts markedly with the previously reported outcome of the analogous 
reaction with calcium compound 2, which resulted in the stoichiometric formation of 
the heteroleptic calcium primary amide species.[55] The formation of a 
methoxyethylamine adduct species as the major component of the strontium-centred 
equilibrium was confirmed through the ambient temperature crystallisation of colourless 
crystals of compound 41 suitable for X-ray diffraction analysis. The result of this 
experiment is illustrated in Figure 24. Selected bond length and angle data are displayed 
in Table 4. The five-coordinate strontium centre adopts a slightly distorted square 
pyramidal geometry (τ = 0.22)[149] with the bis(trimethylsilyl)amide ligand in the axial 
position. The β-diketiminate ligand backbone is planar and, similarly to the parent 
complex, 34, forms a six-membered C3N2Sr ring envelope conformation with the metal 
centre. As a result of the near square pyramidal geometry the distance between the plane 
formed by the ligand framework and the strontium atom increases from 0.724 Å in 34 to 
1.313 Å in 41.[39] A significant increase in the Sr-N bond lengths to both the β-
diketiminate and the silylamide ligands was also observed [Sr-N(1) 2.5742(14); Sr-N(2) 
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2.5424(14); Sr-N(3) 2.4909(14); Sr-O 2.6022(13) Å in 41 compared to Sr-N(1) 
2.554(2); Sr-N(2) 2.514(2); Sr-N(3) 2.446(2); Sr-O 2.536(2) Å in 34].[39] The strontium-
amine bond distance of 2.7113(17) Å, is relatively short in comparison with the range of 
2.743(4) to 2.853(4) Å described by Ruhlandt-Senge and co-workers for strontium-
ethylenediamine interactions,[150] as well as the 2.702(13) to 2.830(2) Å range reported 
by Park et al. for a series of strontium diketonate complexes with polyamine donor 
ligands.[151] A space-filling model of the X-ray crystal structure demonstrates how 
efficiently the three ligands encapsulate the strontium metal centre from all sides 
(Figure 24). 
 
Figure 24. Left: ORTEP representation of compound 41. Thermal ellipsoids drawn at 30% probability. H 
atoms removed for clarity except those bound to N(4). Right: Space-filling model of 41 illustrating the 
total encapsulation of the metal centre.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Selected bond lengths (Å) and angles (o) for compound 41. 
 
Bond lengths (Å) 41 Angles (º) 41 
Sr-N(1) 2.5742(14) N(1)-Sr-N(2) 73.77(4) 
Sr-N(2) 2.5424(14) N(1)-Sr-N(3) 123.62(5) 
Sr-N(3) 2.4909(14) N(2)-Sr-(N3) 121.24(5) 
Sr-N(4) 2.7113(17) N(1)-Sr-O 117.55(4) 
Sr-O 2.6022(13) N(2)-Sr-O 87.96(4) 
N(4)-C(36) 1.465(3) N(3)-Sr-O 117.00(5) 
  N(4)-Sr-O 64.75(5) 
  Sr-N(4)-C(36) 103.97(12) 
  Sr-O-C(37) 118.36(12) 
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Although a general interpretation of these individual transamination equilibria should 
be treated with caution, it is apparent that the mild endo- or exothermicity of catalyst 
initiation is dependent not only upon the identity of the alkaline earth catalytic centre 
but also upon the characteristics of the resultant acid/base pair. Although not rate-
determining, these potentially reversible catalyst initiation equilibria certainly play an 
influential role in any specific catalytic reaction employing an alkaline earth precatalyst 
derived from the conveniently employed hexamethyldisilazide anion. 
 
2.4.2 Kinetic studies 
 
With these considerations in mind, a kinetic study of the cyclisation of (1-
allylcyclohexyl)methylamine with the calcium and strontium precatalysts 2, 33, 34, 35-
36b and 35-36c in C6D6 (determination of order in catalyst, 0.56 M substrate solutions) 
or d8-toluene (Eyring and Arrhenius plots, 0.80 M substrate solutions, 2 mol% catalyst 
loading) was conducted by 1H NMR spectroscopy (Figure 25).  
 
Figure 25. Example of 1H NMR stack plot of the cyclisation of (1-allylcyclohexyl)methylamine with 
calcium and strontium group 2 amide precatalysts.  
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The dialkyl species 37b-c could not be reliably assessed due to the extremely rapid 
conversion of the chosen substrate, which generally resulted in more than 70% 
conversion even before start of the NMR monitoring. Magnesium precatalysts 1 and 35-
36a were not included in this kinetic study either due to their exceedingly low turnover 
frequency at such low catalyst loading. NMR solutions were prepared in the glovebox, 
immediately frozen to 193 K and then thawed directly before transferring them to the 
NMR spectrometer. Conversion to the heterocyclic product was followed by integrating 
substrate and product peaks relative to an internal tetrakis(trimethylsilyl)silane (TMSS) 
standard. Substrate consumption was monitored over three half-lives. Reaction rates 
were derived from plots of ln([substrate]t/[substrate]t=0) versus time. As previously 
determined with 1 and 2,[54] reactions evidenced an apparent first-order decline in 
[substrate] as shown by the example in Figure 26.  
 
Figure 26. Example of variable temperature kinetic analysis: plot of ln([substrate]t/[substrate]t=0) versus 
time (min) at 4 different temperatures for 0.8 M (1-allylcyclohexyl)methylamine and 2 mol% of 34 in d8-
toluene. The slope of each linear set of data points corresponds to the reaction rate constant k (min-1). 
 
 
 
 
 
 
 
 
For each precatalyst, substrate cyclisation was monitored at four to five different 
temperatures. The temperature range of these experiments remained limited to 20 oC, 
outside which the reaction was either to fast or to slow to monitor over three half lives. 
This resulted in relatively high standard errors, especially in the case of activation 
entropies, although comparison with literature data shows that errors of this magnitude 
are by no means uncommon in the determination of ∆S‡ (see Table 5).  
Arrhenius analyses of the data sets thus obtained afforded activation energies (Ea) of 
81.2 (1.4) (36b), 84.7 (5.5) (35b), 86.2 (3.2) (36c) and 93.6 (0.7) kJ.mol-1 (35c) in 
accordance with the qualitative decrease of reaction rate already observed for this series 
of bis(amide) precatalysts, and of 65.5 (1.9) (2), 81.9 (3.5) (33) and 87.9 (2.8) kJ.mol-1 
(34) for the β-diketiminate-stabilised complexes (Figure 27). Surprisingly the activation 
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energy for 33 was significantly higher than for 2 despite the fact that 33 was found, in 
all cases, to provide the fastest turnover.  
 
Figure 27. Top: Arrhenius plot of ln(k) (k = reaction rate, s-1) versus 1/T (T = temperature, K) for calcium 
complexes 35-36b and strontium complexes 35-36c. Bottom: idem for calcium and strontium β-
diketiminate complexes 2, 33 and 34. Activation energies (Ea) were calculated from the slope (Ea/R; R = 
8.314472 J.mol-1.K-1) of each linear set of data points. Data were collected at [(1-
allylcyclohexyl)methylamine] = 0.8 M and 2 mol% catalyst loading in d8-toluene.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eyring analyses (Figure 28) provided activation enthalpies (∆H‡) of a similar 
magnitude (∆H‡ = 78.7 (1.4) (36b), 82.5 (5.5) (35b), 83.5 (3.2) (36c) and 91.0 (0.6) 
kJ.mol-1 (35c) for the bis(amides); ∆H‡ = 63.2 (1.9) (2), 79.6 (3.5) (33) and 85.4 (2.8) 
kJ.mol-1 (34) for the β-diketiminato compounds). While activation entropies (∆S‡) 
displayed only marginal variations across the series of homoleptic precatalysts (∆S‡ = -
41.3 (4.8) (36b), -34.1 (18.8) (35b), -32.8 (9.7) (36c) and -18.2 (2.0) J.mol-1.K-1 (35c)) 
the β-diketiminate-stabilised complexes showed more significant differences, with the 
THF-solvated calcium species 2 providing the most negative value of ∆S‡ (∆S‡ = -78.0 
(7.0) (2), -16.7 (12.8) (33) and -28.9 (9.1) J.mol-1.K-1 (34)). It is proposed that these 
values are a quantitative reflection of the relative organisation of the four-membered 
alkene insertion transition states when assembled about the group 2 metal centres, with 
the smaller calcium cations and the THF-containing species providing a more 
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constrained configuration of the substrate and the catalytic centre. In the case of calcium 
complex 2, the smaller metal centre, the steric demands of the (2,6-di-iso-
propylphenyl)-substituted β-diketiminate ligand and the presence of the, at least initially, 
adducted molecule of THF appear to have a summative effect in enforcing the most 
constrained transition state inferred from the most negative ∆S‡ value.  
 
Figure 28. Top: Eyring plot of ln(kh/kBT) (k = reaction rate constant, s
-1; T = temperature, K; h = 
6.626068*10-34 m2.kg.s-1; kB = 1.3806503*10
-23 m2.kg.s-1.K-1) versus 1/T (K-1) for calcium complexes 35-
35b and strontium complexes 35-36c. Bottom: idem for β-diketiminate-stabilised complexes 2, 33 and 34. 
Activation enthalpies ∆H‡ were calculated from the slope (∆H‡/R) of each linear set of data points, and 
∆S‡ from the intercept (∆S‡/R). Data were collected at [(1-allylcyclohexyl)methylamine] = 0.8 M and 2 
mol% catalyst loading in d8-toluene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At 298 K, the calculated ∆G‡ values reflect the relative reactivity series deduced 
from the qualitative experimental findings (homoleptic amides: ∆G‡ (298 K) = 91.0 
(36b), 92.6 (35b), 93.2 (36c) and 96.4 kJ.mol-1 (35c); β-diketiminato species: ∆G‡ (298 
K) = 86.5 (2), 84.6 (33) and 94.0 kJ.mol-1 (34)). A previous kinetic analysis of the 
hydroamination/cyclisation of 1-amino-4-pentene with the lanthanum precatalyst 
[Cp*2La{CH(SiMe3)2}] by Marks and co-workers provided ∆H
‡ and ∆S‡ values of 53.2 
□ 35b 
♦ 36b 
● 35c 
∆ 36c 
▲ 2 
 ○ 33 
 ◊ 34 
35b 
35c 
36b 
36c 
33 
34 2 
78 
 
kJ.mol-1 and -113.0 J.mol-1.K-1 respectively.[53] Thus, despite a significantly lower 
activation enthalpy than those reported herein, the highly negative activation entropy 
deduced for the lanthanide-centred species results in a free energy of activation of 86.7 
kJ.mol-1, which is comparable to those values obtained for 2 and 33 (Table 5).  
 
Table 5. Comparison of activation parameters for the hydroamination/cyclisation of (1-
allylcyclohexyl)methylamine with 2 mol% of the homoleptic and heteroleptic calcium and strontium 
precatalysts. Standard errors are indicated in parentheses. 
 
Precatalyst ∆H‡ (kJ.mol-1) ∆S‡ (kJ.mol-1) ∆G‡ (298 K) (kJ.mol-1) 
35b 82.5 (5.5)  -34.1 (18.8)  92.6  
35c 91.0 (0.6) -18.2 (2.0) 96.4 
36b 78.7 (1.4) -41.3 (4.8) 91.0 
36c 83.5 (3.2) -32.8 (9.7) 93.2 
2 63.2 (1.9) -78.0 (7.0) 86.5 
33 79.6 (3.5) -16.7 (12.8) 84.6 
34 85.4 (2.8) -28.9 (9.1) 94.0 
[Cp*2LaCH(SiMe3)2]
a 53.2 (5.9) -113.0 (20.9) 86.7 
[Me2SiCp’’2Sm{CH(SiMe3)2}]
b 74.1 (8.8) -103.4 (20.9) 104.9 
 
a- Substrate = 1-amino-4-pentene, 2.8 mol% catalyst.
[53]
 
b- Substrate = 1-amino-2,2-dimethyl-4-hexene, 5 mol% catalyst.
[134]
 
 
The case of the THF-free β-diketiminate-stabilised calcium precatalyst 33 is of 
particular note since the kinetic studies yielded a considerably higher activation 
enthalpy for 33 than for 2. This apparent disadvantage is compensated, however, by a 
significantly less negative ∆S‡ value and a consequential lower ∆G‡ (298 K) value, 
which agrees with the reactivity series deduced from the qualitative findings outlined 
above. This mirrors the results of our recent kinetic study on the intermolecular 
hydroamination of styrene with piperidine catalysed 35b and 35c, in which the higher 
activation enthalpy for strontium was counterbalanced by a tangible entropic advantage, 
leading to an overall lower ∆G‡ (298 K) value for the more active strontium precatalyst, 
in agreement with the qualitative observations.[65] 
It is also apparent that the THF-free homoleptic precatalysts 35a-c are considerably 
less active than their THF-solvated analogues 36a-c, whereas the solvent-free β-
diketiminato calcium complex 33 provided higher turnover frequencies than its THF-
solvated analogue 2. To further inform our understanding of this phenomenon, kinetic 
studies were carried out at constant substrate concentration (0.56 M) and temperature 
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for varying catalyst loadings to determine the order in [catalyst] of each reaction. For 
the β-diketiminate derivatives and the THF-solvated homoleptic species 36b-c, the 
reaction was first-order in [catalyst]. In contrast, a second-order dependence upon 
[catalyst] was deduced for the homoleptic complexes 35b-c (Figure 29). This result is 
consistent with the reduction in activity observed for the THF-free precatalysts at equal 
catalyst loading and most likely indicates a rate-determining process involving two 
catalyst molecules. This latter observation is supported by the fact that these species 
commonly exist as dimers in non-coordinating solvents.[142] At high catalyst 
concentrations (typically > 0.05 M) a deviation from the linear plots was observed in 
most cases, followed by a significant drop in activity for concentrations above 0.1 M. 
This phenomenon may be due to increasing catalyst aggregation in solution at high 
concentrations. In the case of substrates bearing a secondary amine moiety, the steric 
hindrance provided by the second substituent may prevent dimerisation and thus restore 
the otherwise expected order of reactivity, leading to higher turnover rates for the THF-
free homoleptic species. Hydroamination with β-diketiminato precatalysts 33 and 34 
showed a first-order dependence in [catalyst], as had previously been determined for 1 
and 2.[54] 
 
Figure 29. Top left: linear plot of k (min-1), pseudo first-order rate constant, versus [35b]2 (mol2.L-2) 
obtained by varying [35b] at constant concentration of (1-allylcyclohexyl)methylamine (0.56 M). Data 
were collected at 298 K in C6D6. Bottom left: idem with [35c]
2 (mol2.L-2) at 313 K. Top right: idem with 
[36b] (mol.L-1) at 293 K. Bottom right: idem with [36c] (mol.L-1) at 308 K. Data points diverging from 
the linear plot at high catalyst loading may be due to catalyst aggregation in solution. 
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In line with previous findings,[54] the rate of cyclisation of (1-
allylcyclohexyl)methylamine in the presence of homoleptic calcium precatalyst 36b at 
constant concentration (0.02 M in C6D6) was dependent on the initial aminoalkene 
concentration, with turnover frequency decreasing with increasing substrate 
concentration (Figure 30). As had previously been demonstrated in the case of 
lanthanide-mediated hydroamination/cyclisation[53] and by the isolation of the strontium 
amide amine adduct 41 reported earlier in this study, a number of substrate and/or 
product molecules may bind to the metal centre as neutral donor ligands and thus block 
free coordination sites required for the alkene insertion step. A near-linear dependence 
between the pseudo first-order rate constant k and the inverse of the initial substrate 
concentration could be derived from these data sets. 
 
Figure 30. Above: Inhibition kinetics: plot of ln([substrate]t/[substrate]t=0) versus time (min) at 4 different 
initial substrate concentrations at 0.02 M of 36b in C6D6 at 298 K. Below: plot of k (min
-1) versus the 
inverse of the initial substrate concentration (L.mol-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.3 Substrate deuteration 
 
Previous deuterium-labelling experiments with (1-allylcyclohexyl)methylamine-d2 (> 
95% deuteration) showed that deuteration of the cyclised product was limited to the 
exocyclic methyl substituent, and was interpreted as providing evidence for a short-
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lived alkyl intermediate in the catalytic cycle (Figure 31).[54] In order to quantify the 
dependence of the kinetic isotope effect on the nature of the metal centre, diprotio 
(RNH2) and dideuterio (RND2) substrate cyclisation with 2 mol% of the calcium and 
strontium bis(amide) precatalysts 36b and 36c (0.56 M of (1-
allylcyclohexyl)methylamine in C6D6) were monitored by 
1H NMR at 298 K and 318 K 
respectively (Figure 31). The reactions exhibited pseudo first-order kinetics in [substrate] 
and rates of 2.56 h-1 (36b, RNH2), 0.564 h
-1 (36b, RND2), 2.46 h
-1 (36c, RNH2) and 0.72 
h-1 (36b, RND2), yielding high kinetic isotope effects (KIEs) of kH/kD = 4.5 (298 K) and 
3.4 (318 K) for 36b and 36c respectively.  
 
Figure 31. Left: plot of ln([substrate]t/[substrate]t=0) versus time (min) for the cyclisation of (1-
allylcyclohexyl)methylamine (RNH2) and (1-allylcyclohexyl)methylamine-d2 (RND2) with calcium 
precatalyst 36b. Data were collected at 298 K, [substrate]t=0 = 0.8 M and 2 mol% catalyst loading in C6D6. 
Right: idem for strontium precatalyst 36c. The slope of each linear set of data points corresponds to the 
pseudo first-order reaction rate k (h-1). 
 
 
 
 
 
 
 
 
 
 
 
 
Although such large KIEs might be naively interpreted to militate against a rate-
determining alkene insertion step involving no N-H or N-D bond breaking during the 
course of the catalytic turnover, these observations are precedented by kinetic analyses 
of lanthanide-based cyclisations.[53] In these latter cases KIEs of a similar magnitude 
were interpreted as a reflection of the direct involvement of additional amine in the 
coordination sphere of the lanthanide centre during the rate-determining insertion step. 
It therefore appears reasonable to suggest that a similar rationale may be applied to the 
group 2-mediated hydroamination of aminoalkenes reported in this study. Such a model 
is attractive as it views the augmented polarisation of the alkene moiety as a 
ND2
cat 2 mol%
D
N
D
C6D6
cat = [M{N(SiMe3)2}2(THF)2]
M = Ca 36b, Sr 36c
82 
 
consequence of both the polarising effect of the Ae-N bond and the simultaneous 
formation of an initial intramolecular N-H(δ+)···C(δ-)=C interaction, prior to onset of a 
concerted insertion/protonolysis step (Scheme 48), a hypothesis supported by a recent 
publication by Sadow and co-workers showing that an isolated tris(oxazolinyl)borate 
magnesium amidoalkene complex would not undergo alkene insertion unless one 
equivalent of a “dummy” amine was added to the solution, resulting in rapid cyclisation 
of the aminoalkene.[63] In this scenario, both substrate access to the metal centre and 
substrate polarisation, affected by the intrinsic properties (i.e. electropositivity and ionic 
radius) of the individual alkaline earth Ae2+ cation under observation, are key elements 
of the rate-determining insertion step. Computational studies may be of advantage to 
assess the polarising effect of adducted amines and their viability as “proton shuttles” in 
a concerted insertion/protonolysis pathway. 
 
Scheme 48. Possible concerted insertion/protonolysis mechanism accounting for the high observed 
kinetic isotope effects. 
 
 
 
2.4.4 Derivation of a rate law 
 
Previous observations and kinetic analyses led by Hill and co-workers on this subject 
had proposed a mechanism involving both product and substrate inhibition and 
suggested that for the rate-determining insertion to occur, the catalyst must go via an 
amidoalkene intermediate bare of amine adducts.[54] The resulting rate law (Equation 1), 
derived using steady state theory reminiscent of enzyme kinetics, reflected the observed 
first-order dependence of the reaction in [catalyst] as well as substrate and product 
inhibition, but failed to reproduce the observed pseudo first-order decline in [substrate] 
during the course of the reaction or to take into account the effect of non-protic Lewis 
bases such as THF. 
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    (1) 
 
Where:   [cat]0  = total catalyst concentration, 
  [sub]0 = initial substrate concentration, 
ka, kd   = respectively rate of association and dissociation of neutral substrate or product, 
k3        = rate of insertion. 
 
Taking into account the observed high kinetic isotope effects suggestive of a 
concerted insertion/protonolysis mechanism involving an adducted molecule of amine, 
and the presence of THF/amine adduct exchange, a modified mechanism may now be 
envisaged, as shown in Scheme 49. For simplification this model is based upon 
irreversible catalyst initiation. 
 
Scheme 49. Proposed reaction steps for group 2-mediated intramolecular hydroamination catalysis. 
Model based upon fast, irreversible catalyst initiation. I = non protic inhibitor e.g. THF, SH = substrate, 
PH = product. 
 
 
 
 
 
 
 
 
 
In a manner reminiscent of the rules of enzyme kinetics, which are subject to similar 
inhibition equilibria, using the assumptions that the neutral substrate and product have 
equal binding constants to the catalyst (kA ≈ kD) and that the rate of the amine/amide 
exchange is equal in both directions (k-1 ≈ k1), it is possible to derive a relatively simple 
rate law (Equation 2) which reflects all the aspects of the reaction previously described 
in this study and is very similar to the Michaelis-Menten equation commonly used in 
enzyme inhibition kinetics. 
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Under this regime the reaction rate increases with increasing catalyst concentration 
and decreases with increasing initial substrate and THF concentration. From this 
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equation it is also possible to take into account reversible catalyst initiation through the 
addition of a third term in the denominator of the equation, related to the initial catalyst 
concentration and the amine/amide exchange constant between the silylamide co-ligand 
and the substrate or product. While equation 2 is appropriate for systems based upon the 
alkaline earth β-diketiminate and the THF-solvated bis(amide) precatalysts used in this 
study, it accounts neither for the observed second-order dependence in [catalyst] 
observed for the THF-free bis(amide) species 36b and 36c, nor for recent observations 
made by Hultzsch and co-workers on the catalytic intramolecular hydroamination 
activity of a series of magnesium phenoxyamine complexes, in which the cyclisation 
rate of 1-amino-2,2-diphenyl-4-pentene was found to display either a zero-order or 
second-order decline in [substrate].[152] Although no explanation was given for these 
observations, these results highlight the complexity of group 2-catalysed intramolecular 
hydroamination reactions and the limitations of the above-given mechanism, which may 
only apply in specific cases.        
 
 
2.5 Conclusion and future work 
 
 
2.5.1 Mechanistic conclusions 
 
It has become apparent from this study that, in contrast to previous lanthanide-
catalysed intramolecular hydroamination reactions displaying smooth trends across the 
series, the alkaline earth metals exhibit a rather more complex behaviour, marked by 
notable discontinuities arising from the intricate interplay between kinetic and 
thermodynamic factors. Calcium remains the metal of choice for the highest catalysis 
rates while magnesium provides greater selectivity, albeit at the cost of efficiency. After 
focusing primarily on the hydroamination/cyclisation of aminoalkenes further studies 
will be needed to systematically investigate the group 2-mediated intramolecular 
hydroamination of other types of aminoolefins, such as aminoalkynes, aminoallenes and 
aminodienes, and to explore whether similar or different reactivity patterns also apply in 
these closely related systems. Detailed computational studies of each of these reactions 
would provide valuable mechanistic information and help understand the fundamental 
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differences between lanthanides and alkaline earth metals, and among the different 
alkaline earth metals themselves. 
 
 
2.5.2 Limitations of the β-diketiminate ligand framework 
 
This study has also demonstrated that reactivity is greatly influenced by the choice of 
both the ancillary spectator ligand and the reactive amide or alkyl ligand. Although the 
β-diketiminate ligand precursor [ArNC(Me)CHC(Me)NHAr] (Ar = 2,6-di-iso-
propylphenyl) has the advantage of being readily synthesised in a one-step 
procedure,[153] and has provided a useful platform for the first mechanistic studies of the 
magnesium-, calcium- and strontium-mediated intramolecular hydroamination of 
aminoalkenes, allowing the isolation of key intermediates and the acquisition of 
valuable kinetic data, it has also reached its limits in certain ways.  
The problem of ligand lability, in particular, common to these large, electropositive 
elements, is a key issue which needs to be addressed, especially if reactions are to be 
made enantioselective. Indeed, while magnesium complex 1 and its derivatives are 
immune to Schlenk-like ligand redistribution processes in solution, analogues of 
calcium complex 2 bearing less sterically demanding co-ligands often tend to 
redistribute, either over time at room temperature or at high temperature, to the 
homoleptic species.[19] The problem becomes even more acute with strontium complex 
34 whose synthesis is always accompanied by the formation of a non-negligible amount 
(25-40%) of the homoleptic species [{ArNC(Me)CHC(Me)NAr}2Sr(THF)]
[19] which 
may only be separated with difficulty by fractional crystallisation. Even then, isolated 
samples of 34 remained usually contaminated with traces of the homoleptic compound.  
Furthermore, while reactive alkyl ligands provide attractive, irreversible entry into 
the catalytic cycle, independent attempts by Harder and Hill to obtain the benzyl or 
alkyl derivatives of β-diketiminato alkaline earth complexes using the 
[ArNC(Me)CHC(Me)NAr]- ligand systematically resulted in C-H activation of one of 
the methyl groups on the ligand backbone and precipitation of insoluble and 
catalytically inactive material (Scheme 50).[154, 155] The high basicity of alkaline earth 
organometallics needs, therefore, to be taken into account when designing new ligand 
systems for the kinetic stabilisation of heteroleptic group 2 alkyl precatalysts.  
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Scheme 50. C-H activation of β-diketiminate backbone methyl groups by alkaline earth dialkyls 37b-d. 
  
 
 
 
 
 
The issue of the Schlenk equilibrium 
 
One way of preventing deleterious Schlenk-like ligand redistribution processes in 
solution for alkaline earth β-diketiminate complexes may simply be to increase the 
steric demands of the nitrogen-bound substituents. The limits of this approach became 
apparent, however, when trying to substitute the 2,6-di-iso-propylphenyl groups by 2,6-
diphenylmethyl-4-methylphenyl substituents (Scheme 51), using a method reported by 
Berthon-Gelloz et al. for the synthesis of the aniline precursor.[156]  
 
Scheme 51. Synthesis of a (2,6-diphenylmethyl-4-methylphenyl)-substituted β-diketiminate ligand 
precursor.[156] 
 
 
 
 
 
 
 
 
After purification by column chromatography ligand precursor 43 was isolated as 
colourless solid in an 88:12 mixture of the amino-imine and the diimine respectively, as 
indicated by 1H NMR spectroscopy. Recrystallisation from hot chloroform yielded 
crystals of the amino-imine isomer suitable for X-ray diffraction analysis. The result of 
this experiment is illustrated in Figure 32. Selected bond length and angle data are given 
in Table 6. 
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Figure 32. Ortep representation of one of the two molecules in the asymmetric unit of compound 43. 
Thermal ellipsoids drawn at 30% probability. Hydrogens omitted for clarity, except N-H proton. 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Selected bond lengths (Å) and angles (o) for compounds 43 and 44. 
 
 43 44  43 44 
N(1)-C(1) 1.345(5) 1.326(5) C(6)-N(1)-C(1) 124.5(3) 119.4(3) 
C(1)-C(3) 1.383(6) 1.404(6) N(1)-C(1)-C(3) 122.1(3) 122.8(3) 
C(3)-C(4) 1.423(6) 1.403(6) C(1)-C(3)-C(4) 125.8(3) 130.0(4) 
C(4)-N(2) 1.314(5) 1.335(5) C(3)-C(4)-N(2) 121.7(3) 123.5(4) 
N(1)-C(6) 1.423(5) 1.440(5) C(4)-N(2)-C(39) 120.4(3) 118.8(3) 
N(2)-C(39) 1.421(5) 1.448(5) N(1)-Mg-N(2)  90.97(13) 
Mg-N(1)  2.082(3) C(6)-N(1)-Mg  118.6(3) 
Mg-N(2)  2.084(4) C(39)-N(2)-Mg  119.4(3) 
Mg-C(37)  2.131(5)    
Mg-O  2.105(3)    
 
 
While reaction of ligand 43 with one equivalent of dibutylmagnesium in THF at 60 
oC for two hours provided the desired heteroleptic complex, 44, in quantitative yield 
(Scheme 52), attempts to obtain the potassium complex by heating a THF suspension of 
the ligand precursor and potassium hydride at 60 oC for two days failed. Further 
attempts to deprotonate the ligand precursor with [KN(SiMe3)2] equally met with failure.  
 
88 
 
Scheme 52. Synthesis of magnesium β-diketiminate complex 44. 
 
 
 
 
 
 
The reason for this became apparent upon inspecting the results of an X-ray 
diffraction experiment on single crystals of complex 44 obtained from a 10:1 
toluene/THF solution at room temperature over a period a three days. As shown by the 
space-filling model of the structure in Figure 33 the magnesium centre is tightly 
encapsulated by four of the phenyl groups of the bulky side arms so that there is 
virtually no access to the metal centre. The small size of the ligand cavity may indeed 
not be capable of accommodating the increase in ionic radius of the four-coordinate 
metallic cation from Mg2+ (0.57 Å) to K+ (1.37 Å). The complexity of the 13C{1H} 
NMR spectrum, in which all the carbon nuclei of the 2,6-diphenylmethyl-4-
methylphenyl groups appear as inequivalent, clearly demonstrated that the ligand 
conserves its constrained geometry in solution. NMR spectroscopic analysis also 
indicated that the adducted THF molecule was removed upon prolonged drying in vacuo 
of complex 44. Preliminary hydroamination/cyclisation experiments with 1-amino-2,2-
diphenyl-4-pentene indicated that 44 is catalytically active despite reduced substrate 
access to the metal centre. 
 
Figure 33. Left: Ortep representation of compound 44. Thermal ellipsoids drawn at 30% probability. 
Hydrogens omitted for clarity. Right: space-filling model of complex 44. 
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Preliminary efforts to obtain a calcium analogue of 44 by reacting the ligand 
precursor 43 with [Ca{X(SiMe3)2}2(THF)2] (X = N 36b, CH 37b) were also thwarted 
by either the lack of reactivity of 36b towards the ligand precursor, or the tendency of 
37b to deprotonate the benzylic carbon atoms of the nitrogen-bound ligand substituents 
instead of the amine functionality, resulting in the formation of insoluble dark red 
products. Although different synthetic approaches may allow the isolation of a calcium 
analogue of compound 44, substrate access to the calcium metal centre may still be too 
hindered for catalytic activity to occur. It seems essential, therefore, to find the right 
balance between increasing the steric demands of the ligand to prevent Schlenk-type 
redistribution processes from occurring, and sufficient space inside the ligand cavity to 
accommodate and ultimately access the group 2 dication for catalysis to proceed.  
 
Increasing the denticity of the β-diketiminate ligand may be another solution to 
improve the stabilisation of heteroleptic alkaline earth complexes. Similarly to the 
tris[3-(2-methoxy-1,1-dimethyl)pyrazolyl]hydroborate ligand designed by Chisholm 
and co-workers,[157] additional coordination may be provided by replacing one or both 
of the nitrogen substituents on the β-diketiminate framework with flexible N- or O-
donor arms. Only few examples of magnesium and calcium complexes of this type have 
been reported in recent years (Figure 34) and the field remains open to extend this 
chemistry to the heavier alkaline earth metals and their application to homogeneous 
catalysis.[158] 
 
Figure 34. Examples of heteroleptic alkaline earth complexes of tridentate and tetradentate monoanionic 
β-diketiminate ligands. 
 
The issue of ligand C-H activation 
 
Rather than increasing the size of the β-diketiminate nitrogen-bound substituents, 
another option may be to augment the steric demands of the 2,4-dimethyl substituents 
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on the β-diketiminate backbone, which in turn would cause the nitrogen-bound 
substituents to move closer to the metal centre through the effects of steric repulsion. 
El-Kaderi et al. have shown that replacing the methyl groups with tert-butyl groups in 
the ligand precursor [ArNC(tBu)CH2C(
tBu)NAr] (Ar = 2,6-di-iso-propylphenyl) not 
only allows the isolation of heteroleptic β-diketiminate calcium and strontium iodide 
complexes but also of the analogous barium iodide complex, which could not be 
stabilised with the conventional methyl-substituted β-diketiminate ligand.[159] Replacing 
the methyl functionalities with tert-butyl or phenyl groups may also address a second 
complication, that of C-H activation of the β-diketiminate backbone methyl substituents 
(Scheme 50).[154, 155] A potential synthetic route towards stable β-diketiminate calcium 
and strontium alkyl complexes is outlined in Scheme 53. 
 
Scheme 53. Proposed synthetic route towards stable β-diketiminate calcium and strontium alkyl 
complexes. 
 
 
 
 
 
 
 
Chiral β-diketiminates and related ligands 
 
Ultimately, further work may involve designing new chiral β-diketiminate-type 
ligand precursors in order to obtain enantiopure heteroleptic alkaline earth complexes 
for the enantioselective hydroamination/cyclisation of aminoalkenes. To date, the only 
examples in this area remains the attempt by Harder and co-workers to use a chiral (S)-
(Ph-Box)-stabilised calcium amide precatalyst,[18] and by Hultzsch and co-workers 
using an amidobinaphthyl magnesium precatalyst,[129] which both resulted in rather poor 
enantioselectivity (ee < 14%) due to deleterious Schlenk-type ligand redistribution 
processes during the course of catalysis. More recently Sadow and co-workers obtained 
enantioselectivities up to 36% with a chiral tris(oxazolinyl)borate magnesium 
precatalyst while the calcium analogue only provided 18% ee.[63] It is possible that other, 
more sterically demanding oxazoline-containing ligands may prove capable of 
preventing ligand redistribution (Figure 35C). Although enantiopure β-diketiminate 
ligands bearing 2-phenylethyl substituents (Figure 35A) have been successfully 
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employed to stabilise copper, zinc and zirconium complexes,[160] they did not provide 
sufficient steric protection against ligand redistribution for the larger calcium metal 
centre.[18] Furthermore, due to the attested reactivity of group 2 alkyls towards benzylic 
protons, any ligand bearing benzyl substituents would certainly be unsuitable for the 
stabilisation of alkaline earth alkyl functionalities. A potential β-diketiminate ligand 
candidate capable of providing sufficient protection against Schlenk equilibria and CH-
activation is presented in Figure 35B but remains to be synthesised. IAN-amines, 
derived from isoquinolines and aminonaphthalenes, may provide another class of 
related ligands which could be tuned for these purposes (Figure 35D).  
 
Figure 35. Examples of chiral β-diketiminate ligands and related chiral bis(oxazoline) and IAN-amine 
ligands. 
 
 
Although there still remains some scope for the development of new β-diketiminate-
derived ligands for alkaline earth precatalysts, it also remains important to design new, 
more adaptable monoanionic ligands to solve both the problem of the Schlenk 
equilibrium and the issue of the stabilisation of highly reactive group 2 alkyl moieties. 
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3 Bis- and tris(carbene)borate ligands for the kinetic 
stabilisation of alkaline earth complexes 
 
 
3.1 Introduction 
 
 
3.1.1 Importance of N-heterocyclic carbene complexes 
 
Since the report of the first transition metal carbene complexes by Öfele[161] and 
Wanzlick in the 1960s,[162] and Lappert’s studies on late transition metal carbene 
complexes during the following decade,[163] the area of N-heterocyclic carbene (NHC) 
organometallic chemistry has expanded dramatically following the isolation by 
Arduengo et al. of the first stable free carbene in 1991.[164] First used in catalysis by 
Herrmann and co-workers in 1995,[165] NHC complexes have found numerous catalytic 
applications and the area has been regularly reviewed in recent years.[166, 167] The major 
significance of these ligands was recognised by the award of the 2005 Nobel Prize for 
the development of Grubbs’ second generation catalysts for olefin metathesis.[168, 169] 
Recent developments in organocatalysis have also demonstrated the use of NHCs as 
metal-free catalysts in their own right.[170] Although at first considered to be simple 
phosphine-mimics due to their mainly σ-donating character,[171] NHC complexes are 
generally more thermally stable than their phosphine-based counterparts, due to stronger 
metal-ligand interactions.[166, 172, 173] Numerous comparative catalytic studies have 
proven the superiority of NHC-stabilised catalysts over their phosphine analogues,[174] 
especially in ruthenium-catalysed olefin metathesis reactions,[168] and palladium-
catalysed coupling reactions.[175] Studies showed that the least basic NHCs are still 10 
pKb units more basic than the most basic phosphine, P
tBu3.
[176] The ease of preparation 
of saturated or unsaturated NHCs of different ring sizes bearing a wide variety of 
nitrogen-bound substituents allows for fine-tuning of the stereoelectronic properties of 
these ligands (Figure 36).[173, 177] It is thought that NHC stabilisation mainly occurs 
through donation from the adjacent nitrogen lone pairs into the vacant pi-orbital of the 
carbene centre, and a certain degree of aromaticity.[178] Structural and computational 
analyses have also shown evidence for a non-negligible amount of pi-back-bonding from 
the metal centre to the carbene ligand, particularly in group 11 and uranium 
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complexes,[179] while DFT studies upon unusually stable 14-electron rhodium and 
iridium complexes supported by tert-butyl-substituted NHC ligands even suggested the 
possibility of pi-donation from the carbene fragment into the vacant d orbitals of the 
metal centre.[180] Other studies upon the variation of metal-carbene bond strengths also 
suggest that bonding is essentially controlled by electrostatic factors.[181]  
 
Figure 36. Examples of N-heterocyclic carbene ligands. 
 
 
 
 
 
 
 
3.1.2 NHC complexes of rare earth and alkaline earth metals 
 
Whereas late transition metal NHC complexes have been studied extensively, examples 
of s-block and f-block carbene complexes remain relatively rare. A recent review by 
Arnold and Casely details the whole extent of group 3, lanthanide and actinide 
complexes bearing NHC ligands, as well as their reactivity.[182] The first lanthanide 
NHC complexes, [{C5Me4Et}2Sm{C(NRCMe)2)] (R = Me, 
iPr) were reported in 1994 
by Schumann et al. and obtained by reacting [{C5Me4Et}2Sm(THF)] with the free 
carbene.[183] In the same year, Arduengo et al. used a similar method to synthesise 
[(Cp*)2Yb(NHC)n] (n = 1, 2) and tris(diketonate) europium and yttrium NHC 
complexes.[184] Computational studies have shown that the strength of the NHC-
lanthanide bond owes mainly to the σ-donating power of the carbene fragment, although 
in some cases pi-back-bonding from amide co-ligands within the metal coordination 
sphere has been observed.[185, 186] The problem of ligand lability commonly encountered 
in these complexes was overcome by developing NHC ligands tethered to anionic 
amido or alkoxo functionalities which strongly bind to hard, electropositive metal 
centres.[187] Among the few catalytic applications of rare earth metal carbene complexes, 
the amido-functionalised NHC yttrium bis(amide) complex 45 was reported for the 
ring-opening polymerisation of rac-lactide, yielding highly heterotactic polymers with 
low polydispersity,[188] while the indenyl-tethered NHC yttrium complex 46 was found 
to be active for the catalytic 3,4-selective living polymerisation of isoprene (Figure 
37).[189, 190] More recently, Lv et al. reported the cis-1,4-selective version of the same 
N N
R R
N N
R R
N N N N
R R R R
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reaction using the CCC-pincer bis(NHC) rare earth dibromide complexes 47a-e (Figure 
37).[191] Whether the carbene ligand remains bound to the metal centre during these 
catalytic reactions remains unclear. 
 
Figure 37. Rare earth NHC polymerisation precatalysts. 
 
 
 
 
 
 
 
 
While a number of NHC complexes of the alkali metals have been synthesised and 
characterised,[189, 192] only a handful of examples of alkaline earth NHC complexes has 
been reported to date. In 1993, Arduengo et al. reported the first dialkyl magnesium 
carbene adducts obtained from the direct reaction of diethylmagnesium with 
[:C(NRCH)2] (R = mesityl, adamantyl).
[193] Two years later a beryllium dichloride 
complex was reported to form a stable adduct with 1,3-dimethylimidazolin-2-
ylidene.[194] The alkaline earth metallocene compounds [(Cp*)2M{C(NMeCMe)2}] (M 
= Ca 48, Sr 49, Ba 50) synthesised by Arduengo and co-workers in 1998,[195] and the 
related NHC complexes of group 2 metallocenes (M = Mg, Ca, Sr, Ba) described by 
Schuman et al. in 2001,[196] remained for nearly a decade the only examples of NHC 
adducts of the heavier alkaline earth elements (Figure 38). Only recently has the 
synthesis of simple NHC adducts of heavier alkaline earth bis(amides) been described 
by Hill and co-workers.[197] The compounds [{(HCNAr)2C}M{N(SiMe3)2}2] were 
obtained either by reacting the imidazolium chloride (Ar = mesityl; M = Ca 51, Sr 52, 
Ba 53) or the free carbene (Ar = 2,6-di-iso-propylphenyl; M = Ca 54) with the 
corresponding homoleptic group 2 amides [M{N(SiMe3)2}2]2. Although characteristic 
low-field 13C{1H} NMR carbene resonances between 193 and 199 ppm, and 
multinuclear NMR experiments suggested that, in solution, the NHC ligand stays bound 
to the metal centre on the NMR time scale, these complexes underwent ligand 
dissociation in the presence of protic substrates or harder Lewis bases, making them 
unstable under catalytically relevant conditions. Arnold and co-workers have also 
reported a variety of magnesium complexes bearing amide- or alkoxide-functionalised 
NHC ligands, of which 55 and 56 were successfully used as precatalysts for the ring-
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opening polymerisation of rac-lactide with activities superior to the analogous zinc 
catalysts, yielding polymers of modest heterotacticity.[181, 198, 199] Furthermore, carbene 
ligands have been used to stabilise a hydride-rich Mg4H6 cluster, 25, which displays the 
highest hydride to magnesium ratio described to date (Scheme 29).[76] 
 
Figure 38. Examples of group 2 NHC complexes. 
 
 
 
 
 
 
 
 
 
3.1.3 Monoanionic poly(carbene)borate “scorpionate” ligands  
 
Since the description of the first tris(pyrazolyl)borate ligand by Trofimenko in 
1966,[200] an ever-growing variety of scorpionate ligands has been reported and the area 
has been reviewed several times.[201] Variation of the substituents borne by the pyrazolyl 
residues and the boron bridgehead atom allows for steric and, to a lesser degree, 
electronic tuning of the original tris(pyrazolyl)borate ligand. The term “scorpionate”, 
introduced by Trofimenko in 1999,[202] now applies to a class of ligands bearing three 
donor fragments tethered by a monoanionic bridge, in which two of the donor groups 
act as “claws” while the third one arches over to “sting” the metal centre. Recent years 
have focused on replacing the pyrazolyl fragments by stronger donors, such as 
thioimidazolyl, selenoimidazolyl, phosphine or NHC donors, thus offering a wider 
range of steric and electronic tuning.[203]  
Bearing in mind the tendency of heteroleptic β-diketiminate calcium complexes with 
small monoanionic co-ligands to undergo Schlenk-type ligand redistribution to the 
homoleptic species [{ArNC(Me)CHC(Me)NAr}2Ca] (Ar = 2,6-di-iso-propylphenyl) 
Chisholm and co-workers developed a series of kinetically stable calcium 
tris(pyrazolyl)borate complexes for the catalytic polymerisation of rac-lactide, of which 
two examples, complexes 3 and 4 are displayed in Figure 39.[21, 36] Despite the high 
kinetic stability of these species, even when coordinated to small aryloxide 
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functionalities, a certain degree of lability of the pyrazolyl fragments and rapid ligand 
exchange in solution were observed in some cases.[204] It was hoped that the more 
strongly donating poly(carbene)borate ligands might provide enhanced kinetic stability 
for the heavier group 2 elements and avoid detrimental ligand lability.  
First reported by Fehlhammer in 1996,[205] the use of tris(carbene)borate ligands in 
both transition metal and main group chemistry has remained relatively limited.[206-209] 
Studies on the νN=O IR frequencies of various tris(carbene)borate nickel nitrosyl 
complexes have shown that this class of ligand is by far the most strongly σ-donating of 
the scorpionates.[209] Furthermore it seems that, in contrast to monodentate NHC ligands, 
the electronic properties of tris(carbene)borates may be tuned by varying the nitrogen-
bound substituents on the carbene fragments. Modification of the substitution on the 
boron bridgehead atom, however, had little influence on the νN=O IR shifts.
[209] The only 
example of an alkaline earth metal complex bearing a tris(carbene)borate ligand is the 
magnesium complex 57 [{HB(ImtBu)3}MgBr] which was obtained from the reaction of 
the boronium salt precursor [HB(ImtBu)3]Br2 with three equivalents of [MeMgBr] and 
used by Smith and co-workers as an intermediate in the synthesis of the analogous iron 
(II) complex.[207] More recently lithium and nickel complexes of the bidentate 
[H2B(Im
tBu)2]
- ligand have been reported by Nieto et al.[210]  
 
Figure 39. Examples of alkaline earth scorpionate complexes. 
 
 
 
 
 
 
 
 
3.2 Synthetic, structural and catalytic studies of calcium and 
strontium bis(imidazolin-2-ylidene-1-yl)borate complexes.
[211]
 
 
 
3.2.1 Synthesis of ligand precursors 
 
The ligand precursor boronium salt [H2B(Im
tBu)2]I, compound 58, was synthesised 
by adapting the procedure recently described by Nieto et al. by refluxing two 
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equivalents of tert-butylimidazole with Me3N.BH2I in chlorobenzene (b.p. 131 
oC),[210] 
which had already been used by the same authors for the synthesis of the related 
tridentate ligand precursor [HB(ImtBu)3]Br2,
[207] rather than the lower boiling solvent 
toluene (b.p. 110.6 oC) (Scheme 54). The analogous bromide salt, compound 59, and the 
respective [H2B(ImMes)2]X analogues (X = I, 60; Br, 61) were obtained following the 
same method and isolated as colourless crystalline solids after recrystallisation from 
water (58), dichloromethane (59), or chloroform (60 and 61). In general, the use of the 
iodoborane instead of the bromoborane precursor afforded much shorter reaction times 
(3-5h instead of 10-15h) and better yields. 
 
Scheme 54. Synthesis of dihydro-bis(imidazole)boronium bromide and iodide ligand precursors 58-61. 
 
 
 
 
Compound 58 provided 1H and 13C{1H} NMR chemical shift data in concordance 
with those quoted recently by Smith and co-workers.[210] All four ligand precursors 
displayed characteristic 1H NMR low field resonances around 9.5 ppm corresponding to 
the imidazole H-2 proton as well as a distinctive triplet between -6.10 and -9.90 ppm in 
the proton-coupled 11B NMR spectra. The B-H bonds were indentified in the IR 
spectrum as a broad band around 2440 cm-1 correlating with the findings of Smith and 
co-workers for the related tridentate ligand.[207] The structures of compounds 58 and 60 
are illustrated in Figure 40. Selected bond length and angle data are provided in Table 7. 
Although showing some internal variation, the B-N distances within the cationic units 
of 58 [1.545(8), 1.568(8) Å] and 60 [1.567(2) Å] are within the range of distances 
observed in the previously reported boronium cations, [(tBuNH2)(1-
methylimidazole)BH2]
+ [1.557(4) Å] and [(Me3N)(1-methylimidazole)BH2]
+ [1.555(3), 
1.604(3) Å].[212] Mesityl compound 60 displays Cs symmetry and a slightly smaller N-
B-N bite angle than its tert-butyl analogue [N(1)-B-N(1)’ 107.38(18)o 60; N(1)-B-N(3) 
109.0(5)o 58]. The imidazolium rings in both compounds remain planar, forming a ca. 
106o angle with the mesityl substituents in ligand precursor 60.  
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Figure 40. Ortep representations of compounds 58 (left) and 60 (right). Thermal ellipsoids drawn at 30% 
probability. C(2) and C(3) inverted in 60 for the sake of comparison.  
 
Table 7. Selected bond lengths (Å) and angles (o) for ligand precursors 58 and 60. 
 
Bond lengths (Å) 58 60a Angles (o) 58 60a 
B-N(1) 1.545(8) 1.567(2) N(1)-B-N(3) 109.0(5) 107.38(18)d 
B-N(3) 1.568(8) - B-N(1)-C(1) 126.5(5) 125.51(16) 
N(1)-C(1) 1.343(7) 1.3267(19) B-N(3)-C(8) 125.5(5) - 
N(3)-C(8) 1.332(7) - C(1)-N(1)-C(3) 106.3(5) 107.58(13) 
N(1)-C(3) 1.383(7) 1.379(2) C(8)-N(3)-C(9) 107.3(5) - 
N(3)-C(9) 1.382(7) - C(1)-N(2)-C(2) 107.7(5) 107.67(13) 
C(1)-N(2) 1.336(7) 1.3376(19) C(8)-N(4)-C(10) 107.2(5) - 
C(8)-N(4) 1.344(7) - N(1)-C(1)-N(2) 110.4(5) 109.68(13) 
N(2)-C(2) 1.382(7) 1.378(2) N(3)-C(8)-N(4) 110.1(5) - 
N(4)-C(10) 1.382(7) - B-N(1)-C(3)e 127.2(5) 126.91(16) 
C(2)-C(3) 1.354(8) 1.348(2) B-N(3)-C(9) 127.1(5) - 
C(9)-C(10) 1.356(8) - - - - 
B-H(1A) 1.10(6) 1.14(3)b - - - 
B-H(1B) 1.07(7) 1.11(3)c - - - 
a- Symmetry transformations used to generate equivalent atoms: x, -y+½ , z 
b- B(1)-H(1)  c-        B(1)-H(2)  d-      N(1)-B(1)-N(1)’        
 
 
3.2.2 Synthesis of calcium and strontium bis(carbene)borate complexes 
 
Following a “one pot” procedure similar to the one used in the synthesis of calcium 
β-diketiminate complex 2,[21, 36] addition of THF at low temperature to a solid mixture 
of three equivalents of [KN(SiMe3)2], one equivalent of the ligand precursor (58 or 59) 
and either CaI2 or SrI2 provided after extraction into hexane the desired heteroleptic 
complexes 62 and 63 (Scheme 55). The analogous reactions employing BaI2 as the 
alkaline earth starting material did not yield any tractable products: NMR analysis of the 
crude solids obtained after extraction and drying in vacuo showed a complex mixture of 
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products, among which the presence of free tert-butylimidazole was indicative of the 
fragmentation of the ligand precursors during the reactions (vide infra). Storage of 
concentrated solutions of 62 and 63 at -20 oC for extended periods allowed the isolation 
of both compounds as colourless crystalline solids in moderate to good yields (50-70%). 
Both yield and purity of the products were improved by using the iodide ligand 
precursor 58 rather than the bromide 59, which may be due to the lesser solubility of the 
reaction-driving KI salt metathesis by-product in hydrocarbon solvents compared with 
KBr. 
 
Scheme 55. “One-pot” synthesis of heavier alkaline earth bis(carbene)borate amides 62 and 63. 
 
 
 
 
 
The 1H and 13C{1H} NMR data were consistent with the expected structures. The 
BH2 
1H NMR resonances appeared as broad signals at ca. 4.3 ppm. Integration of the 
THF multiplets indicated one coordinated THF molecule for calcium complex 62 and 
two for strontium complex 63. The 11B{1H} NMR resonance was broadened and shifted 
slightly downfield compared with that of the free ligand precursors. Particularly 
diagnostic were the signals ascribed to the metal-coordinated C-2 carbenoid centres of 
the borate ligands which appeared at 195.0 ppm (62) and 201.5 ppm (63) in the 
respective 13C{1H} NMR spectra. This correlates well with previous observations of a 
series of alkaline earth bis(amides) with neutral NHC ligands, compounds 51-54 (Figure 
38), in which it was noted that the smaller and more Lewis acidic metal centres induced 
a higher upfield shift (∆δ13C) in the resonance of the C-2 centre from that of the free 
carbene.[213] Examination of these, related alkaline earth tris(imidazolin-2-ylidene-1-
yl)borate complexes described in this work (vide infra) and other relevant literature data 
listed in Table 8 reveal that the nature of the Lewis basic carbene σ-donors is apparently 
not perturbed by incorporation into the bidentate monoanionic borate ligand.  
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Table 8. Comparison of M-Ccarbene bond lengths and δ13C NMR data for calcium, strontium and barium 
NHC complexes. 
 
Compound M-Ccarbene (Å) 
δ13C C-2 carbene 
centre (ppm) 
Reference 
62 - 195.0 This work 
64 2.583(3), 2.646(4) 195.0 This work 
66 - 196.0 This work 
67 2.562(13), 2.562(14) - This work 
73 - 198.5 This work 
76 - 195.5 This work 
76' 2.582(5), 2.510(5), 2.526(4) - This work 
77 2.544(2), 2.564(2), 2.559(2) 199.5 This work 
[{L1}Ca{N(SiMe3)2}2] 51 2.598(2) 193.3 
[213] 
[{L2}Ca{N(SiMe3)2}2] 53 2.6259(2) 195.4 
[213] 
[(Cp*)2Ca{L
3}] 48 2.562(2) 196.2 
[195] 
63 2.739(3), 2.757(4) 201.5 This work 
65 - 198.9 This work 
74 2.749(3), 2.776(3), 2.811(3) 201.6 This work 
74' - 201.5 This work 
78 2.810(3), 2.802(3), 2.805(3) 198.9 This work 
[{L1}Sr{N(SiMe3)2}2] 52 2.731(3) 199.0 
[213] 
[(Cp*)2Sr{L
3}] 49 - 198.2 
[195] 
[(Cp*)2Sr{L
3}2] 2.868(5), 2.854(5) 203.7 
[195] 
75 2.977(3), 2.947(3), 2.978(3) 205.9 This work 
[{L1}Ba{N(SiMe3)2}2] 53 2.915(4) - 
[213] 
[(Cp*)2Ba{L
3}] 50 2.951(3) 203.5 
[195] 
 
L1 = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene; L2 = 1,3-bis(2,6-di-iso-
propylphenyl)imidazol-2-ylidene; L3 = 1,3,4,5-tetramethylimidazol-2-ylidene. 
 
Variable temperature 1H and 13C{1H} NMR studies performed on calcium compound 
62 showed some evidence of fluxional behaviour in solution (Figure 41). Cooling of a 
sample of 62 in d8-toluene revealed a decoalescence of the bis(imidazolin-2-ylidene-1-
yl)borate and bis(trimethylsilyl)amide ligand resonances into a series of singlets of 
equal intensity as the temperature was lowered. Although a splitting of the broad B-H 
resonance around δ1H 4.3 ppm was also observed down to the low temperature limit 
(208 K) of the 1H{11B} NMR spectrum, consistent with the formation of a labile 
agostic-type interaction with the calcium metal centre, this process was ill-defined due 
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to the diastereotopic nature of the BH2 protons and coupling to the 20% quadrupolar 
10B 
nucleus. The fluxional behaviour was therefore best characterised by examination of the 
aromatic protons of the imidazolin-2-ylidene fragments which provided a value of ∆G‡ 
= 48.7 kJ.mol-1 for a coalescence temperature of 238 K (Scheme 56). It is noteworthy 
that the C-2 carbene resonance in the 13C{1H} NMR spectrum also split into two (199.8 
and 198.8 ppm) at the low temperature limit (218 K) of the experiment.  
 
Scheme 56. Proposed isomerisation mechanism of compound 62 in solution.  
 
 
 
 
 
 
Figure 41. Top: variable temperature 1H NMR stack-plot of a d8-toluene solution of 62 taken every 10 K 
from 298 to 198 K. Bottom: 13C{1H} NMR spectrum of 62 at 218 K. 
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In the structure of the homoleptic nickel complex [{H2B(Im
tBu)2}2Ni] recently 
reported by Smith and co-workers the nickel centre displayed a square planar 
coordination geometry while the six-membered BN2C2Ni between the metal and the 
borate ligands adopted a boat conformation, a geometry that was retained in solution at 
room temperature.[210] This bonding situation contrasts with that of the related 
octahedral bis(pyrazolyl)borate complex, [{H2B(
tBuPz)2}2Ni], in which two agostic-
type Ni···H-B bonds completed the coordination sphere of the metal centre (Figure 
42).[214] Similar M···H-B (M = Ca, Sr) interactions were observed in the solid state 
analyses of the group 2 complexes reported herein (vide infra) and are reminiscent of 
the general coordination behaviour of scorpionate bis(pyrazolyl)borate coordination 
complexes.[202] Although alternative processes can not be discounted unequivocally, we 
propose, therefore, that the fluxional solution behaviour observed for compound 62 is a 
consequence of the lability of the metal to ligand interactions typically observed in 
heavier group 2 complexes, and indicative of equilibration of the geometric isomers 
illustrated in Scheme 56. Variable temperature studies performed upon the strontium 
analogue of 62, compound 63, revealed similar, but less well defined, fluxional 
behaviour, most likely as a consequence of the reduced charge density of the larger Sr2+ 
cation.  
 
Figure 42. Left: geometry of the square planar [{H2B(Im
tBu)2}2Ni] complex. Right: geometry of the 
octahedral [{H2B(
tBuPz)2}2Ni] complex displaying Ni···H-B agostic-type interactions. 
 
 
 
 
 
 
 
Crystals of compound 63 suitable for X-ray diffraction analysis were isolated from a 
hexane solution at -20 oC. The results of this experiment are illustrated in Figure 43 and 
selected bond length and angle data are provided in Table 9. Compound 63 adopts a 
distorted pseudo-octahedral coordination geometry in the solid state with a facial O2N 
donor set provided by two molecules of THF, one of which is disordered, and the 
silylamide co-ligand. The other face is occupied by the bis(imidazolin-2-ylidene-1-
yl)borate ligand which adopts a boat conformation and an effective tridentate 
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coordination mode. In this latter case, donation to the strontium cation is provided by 
the two imidazolin-2-ylidene carbene centres and an apparent agostic-type interaction 
with a boron B-H bond. The Sr-Ccarbene distances [2.757(4) - 2.739(3) Å] are comparable 
to that observed within the recently reported three-coordinate neutral carbene adduct 52 
[(NHC)Sr{N(SiMe3)2}2] [2.731(3) Å]
[213] despite the increased coordination number at 
strontium (Table 8). The interaction between the strontium cation and a hydridic 
hydrogen of the BH2 unit [Sr···H(1a), 2.87(3) Å], although long, is within the range 
established [2.59(3)-2.89(3) Å] within several borohydride and phosphinoborane-
substituted carbanionic strontium derivatives.[215, 216] Several attempts to obtain a crystal 
structure of the calcium analogue 62 failed due to the extremely temperature-sensitive 
nature of the crystals.   
 
Figure 43. Ortep representation of compound 63. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens omitted for clarity, except those attached to the boron atom. Sr-H(1A) 
agostic interaction represented as a dashed bond. 
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Table 9. Selected bond lengths (Å) and angles (o) for complexes 63 and 64. 
 
Bond lengths (Å) 63a 64b Angles (o) 63a 64b 
M-C(1) 
Ca-C(7) 
2.757(4) 
- 
2.583(3) 
2.640(4) 
C(1)-M-C(8/4)c 
C(7)-Ca-C(10) 
83.29(11) 
- 
83.74(11) 
85.77(11) 
M-C(8/4)c 
Ca-C(10) 
2.739(3) 
- 
2.646(4) 
2.607(3) 
N(2/1)-B(1)-N(3)c 
N(5)-B(2)-N(7)d 
112.0(3) 
- 
111.0(3) 
111.2(3) 
M-O(1) 
Sr-O(2) 
2.592(3) 
2.606(4) 
2.467(3) 
- 
C(1)-N(2/1)-B(1)c 
C(7)-N(5)-B(2)d 
123.3(3) 
- 
122.7(3) 
122.9(3) 
B(1)-N(2/1)c 
B(2)-N(5)d 
1.555(5) 
- 
1.549(5) 
1.552(5) 
C(8/4)-N(3)-B(1)c 
C(10)-N(7)-B(2)d 
123.0(3) 
- 
124.4(3) 
123.3(3) 
B-N(3) 
B-N(7)d 
1.544(5) 
- 
1.552(6) 
1.546(5) 
N(2/1)-C(1)-Mc 
N(5)-C(7)-Ca 
109.0(2) 
- 
113.3(2) 
106.9(2) 
N(2/1)-C(1)c 
N(5)-C(7)d 
1.367(5) 
- 
1.365(4) 
1.361(5) 
N(3)-C(8/4)-Mc 
N(7)-C(10)-Ca 
109.6(2) 
- 
111.5(2) 
109.7(2) 
N(3)-C(8/4)c 
N(7)-C(10) 
1.371(5) 
- 
1.362(5) 
1.363(4) 
N(1)-C(1)-N(2) 
N(5)-C(7)-N(6)d 
103.6(3) 
- 
104.4(3) 
104.0(3) 
Sr-N(5) 2.510(3) - N(3)-C(8/4)-N(4)c 104.3(3) 104.0(3) 
M···H(1a) 2.87(3) - N(7)-C(10)-N(8)d - 104.5(3) 
B-H(1a) 1.12(3) -    
B-H(1b) 1.14(4) -    
a- M = Sr       b-   M = Ca       c-   (Complex 63/64)      d-   Complex 64 only  
 
In an attempt to synthesise heteroleptic alkaline earth iodide derivatives, two molar 
equivalents of [KN(SiMe3)2] were used instead of three, in reactions similar to the one 
presented in Scheme 55 with the more efficient iodide ligand precursor 58 (Scheme 57). 
Both reactions employing calcium and strontium iodides provided similar results and 
yielded homoleptic species, compounds 64 [{H2B(Im
tBu)2}2Ca(THF)] and 65 
[{H2B(Im
tBu)2}2Sr(THF)2], which are evidently formed due to the reduced steric 
demands of the intended iodide compared with the hexamethyldisilazide co-ligand 
employed in the syntheses of compounds 62 and 63. Although both compounds proved 
to be extremely air-, moisture- and temperature-sensitive, preventing the acquisition of 
accurate microanalytical data, promptly prepared samples analysed by 1H and 13C{1H} 
NMR spectroscopy displayed similar spectral features suggestive of a single borate 
ligand environment. The chemical shifts attributed to the donor-carbon carbene 
resonances [64, δ13C 195.0; 65, 198.9 ppm] also bore close comparison to those 
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observed for the heteroleptic species 62 and 63, indicative of comparable binding modes 
and charge donation (Table 8).  
 
Scheme 57. Synthesis of homoleptic calcium and strontium bis(carbene)borate complexes 64 and 65. 
 
This deduction was confirmed by a further X-ray structural analysis obtained for the 
calcium compound 64. Although crystals of 64 required handling under a cryogenic N2 
stream to prevent decomposition and were weakly diffracting, the structure was 
unambiguous and revealed a similar κ3-CC’H-binding of the borate ligands to that 
observed for 63. The structure of compound 64 is illustrated in Figure 44 and selected 
bond length and angle data are provided in Table 9. The range of calcium-carbon 
distances [2.583(3) - 2.646(4) Å] is similar to that observed within the neutral NHC 
adducts [(NHC)Ca{N(SiMe3)2}2] [51, 2.598(2); 54, 2.6259(2) Å]
[213] and 48 
[(Cp*)2Ca(NHC)] [2.562(2) Å]
[195] listed in Table 8, as well as the range of distances 
reported by Harder and co-workers for several calcium 
bis(iminophosphoranyl)methandiyl derivatives [2.528(2) - 2.805(1) Å].[45, 217] Although 
substantially longer than those observed within the previously reported 
dialkyldihydridoborate [HC{C(Me)CN(2,6-iPr2C6H3)2}Ca(H2BR2)] (R = the anion 
formed from 9-borabicyclo[3.3.1]nonane) [2.17(4) - 2.31(4) Å][218] and the calcium 
tetrahydroborate [(DME)2Ca(BH4)2] [2.35(3) - 2.58(3) Å],
[215] the Ca···H(1b/2a) 
distances within 64 [2.97 - 2.83 Å] again describe a structurally significant interaction 
such that the calcium centre may be depicted as effectively seven-coordinate. As for the 
heteroleptic strontium complex 63, the carbene-calcium vectors are not coplanar with 
the imidazole rings. It is also notable that the chelating framework of the borate ligand 
evidently possesses little flexibility as the N-B-N bond angles display little variation 
across the precursor 58 [109.0(5)o] and the calcium and strontium complexes 64 
[111.0(3), 111.2(3)o] and 63 [112.0(3)o] respectively. The same observation can also be 
made about the other angles and distances within the ligand framework as shown by a 
more comprehensive list of measurements displayed in Table 9. 
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Figure 44. Ortep representation of compound 64. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens omitted for clarity, except those attached to the boron atom. Ca-
H(1a/2a) agostic interactions represented as dashed bonds. 
 
 
 
 
 
 
 
 
 
 
Attempts to elaborate a rational synthesis of these homoleptic species were 
unsuccessful. Although an analogous “one pot” procedure employing four equivalents 
of the silylamide base produced materials with 1H and 13C{1H} NMR spectra 
reminiscent of those of 64 and 65, these materials contained no coordinated THF. 
Rather, additional singlet resonances at δ1H 0.84 (9H), 6.36 (1H) and 7.13 (1H) ppm 
were attributed to coordinated 1-tert-butylimidazole which was evidently produced by 
rupture of the B-N bonds of the ligand precursor during borate anion formation. 
Although no evidence of ligand degradation subsequent to anion formation was 
observed, it appears that such B-N cleavage is a common feature of this ligand class at 
some stage in the deprotonation of, and the necessary charge distribution within, the 
ligand precursors. Similar difficulties also blighted attempts to synthesise analogues of 
compounds 62-65 utilising the N-mesityl substituted precursors, 60 and 61 via the “one 
pot” procedures illustrated in Scheme 55 and Scheme 57. In these cases the reactions 
turned deep crimson in colour, and were shown by NMR analysis of the crude solids to 
contain a complex and intractable mixture of products. This problem was partially 
circumvented through the adoption of an alternative synthetic route, which utilised the 
homoleptic calcium amide [Ca{N(SiMe3)2}2(THF)2], 36b, as both base and source of 
the group 2 metal. Reaction of 1.5 equivalents of 36b with the boronium iodide salt 
precursor compound 60 (Scheme 58) provided the colourless complex 66, which 
provided NMR spectra indicative of the intended heteroleptic formulation. Although the 
13C{1H} NMR carbene resonance of 66 (196.0 ppm) was again similar to that observed 
C7 
N6 
C8 
C9 
N5 
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in compounds 62 and 64, variable temperature 1H NMR studies revealed none of the 
fluxional behaviour attributed to the heteroleptic species described above.  
 
Scheme 58. Synthesis of compound 66. 
 
 
 
 
Whilst compound 66 provided well-formed single crystals at low temperature, 
multiple attempts to acquire X-ray diffraction data were frustrated by the extremely 
rapid decomposition of the material once removed from the chilled mother liquor. A 
data set collected on a more durable crystal from one of these reactions yielded the 
structure of an unanticipated heteroleptic iodide species, compound 67 (Figure 45). 
Although the data set for 67 was very weak and yielded residuals for the structure which 
were unacceptably high (R1 = 0.1107, wR2 = 0.2617), precluding any detailed 
discussion, the connectivity was unambiguous. The borate ligands again adopts a 
tridentate coordination mode, while the presence of the iodide ligands highlights the 
propensity towards redistributative processes of heavier group 2 centres. 
 
Figure 45. Ortep representation of the dimeric compound 67. Thermal ellipsoids drawn at 30% 
probability. Hydrogens omitted for clarity, except those attached to the boron atom. Ca···H(1a) agostic 
interaction represented as a dashed bond. 
 
 
 
 
 
 
 
 
 
Several attempts to obtain analogues of compounds 62-67 less prone to ligand 
redistribution and/or B-N bond cleavage failed. Indeed, refluxing in chlorobenzene of 
Me3N.BH2I with two equivalents of the more sterically demanding 1-(2,6-di-iso-
propylphenyl)imidazole or the potentially bidentate 1-(2-methoxyphenyl)imidazole 
precursors, both prepared according to literature procedures,[219] yielded complex 
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mixtures of boron-containing products out of which the desired boronium salts could 
not be isolated in satisfying purity. Although a chiral version of the ligand precursor 
using 1-((S)-α-phenylethyl)imidazole was prepared, albeit in modest yield, neither the 
“one-pot” salt metathesis-based synthesis used to obtain 62 and 63 nor the reaction with 
1.5 equivalents of [Ca{N(SiMe3)2}2(THF)2] in cold THF yielded any tractable products. 
1H NMR data of the crude hexane extraction mixtures once again provided evidence for 
considerable B-N bond cleavage and presence of the free imidazole precursor. 
 
 
3.2.3 DFT calculations 
 
The nature of the metal to ligand coordination in complexes 62 and 63 was assessed 
by DFT calculations on the model heteroleptic complexes 
[{H2B(NHC)2}M{N(SiH3)2}(OMe2)2] 68 (M = Ca) and 69 (M =Sr) (NHC = 3-
methylimidazol-2-ylidene) using the B3LYP density functional theory and LAN2DZ 
pseudopotentials (and basis set) implemented in Gaussian03.[220] The geometry 
optimisations were performed by selecting an initial geometry based upon that deduced 
for the structure of the heteroleptic strontium complex 63 and, in both cases, were 
confirmed as true minima by independent frequency calculations which did not yield 
any imaginary frequencies. To reduce computational expense the tert-butyl groups of 
the borate ligands were replaced by methyl groups, the methyl groups of the silylamide 
ligands by hydrogen atoms, and the coordinated THF molecules were simplified to two 
molecules of dimethyl ether. The second molecule of coordinated solvent was retained 
within the coordination sphere of the calcium centre of 68 despite the lower 
coordination number determined for the “real case” of compound 62. It was felt that this 
was necessary to take into account the reduced steric demands of the truncated ligands 
and to allow for internal consistency when comparing the two calculated structures. 
Figure 46 illustrates the results of this study. In both cases the calcium and strontium 
contacts to the carbon donors of the κ3-coordinated ligands replicate the distances 
observed within the structures of compounds 63 and 64 respectively, to within ca. 0.02 
Å (see Figure 46 caption). Especially notable was the agreement between the calculated 
M···H-B distances [68, 2.93 Å; 69, 2.87 Å] and the values determined in the X-ray 
studies. The calculated νB-H stretching vibrations for both model compounds (68 2503, 
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2412 cm-1; 69 2499, 2401 cm-1), corresponding to the symmetric and asymmetric 
stretching of both B-H bonds, are somewhat higher than those observed for the 
heteroleptic species 62 (2385, 2252 cm-1) and 63 (2363, 2252 cm-1). However this may 
be ascribed to the decreased reduced mass of the oscillators within the simplified 
models and it is notable that ∆ν, the difference between the stretching vibrations in both 
the real and model compounds, is of a similar magnitude (ca. 100 cm-1) across all four 
sets of data. For both 68 and 69 natural bond orbital (NBO) calculations were 
undertaken and the calculated charges on the Ca2+ (68, +1.83) and Sr2+ (69, +1.86) 
centres were suggestive of essentially ionic bonding. In both cases the donor carbon 
centres bear only a modest negative charge (< -0.03) indicating that they retain the 
essentially pure σ-donor character implicated in the formation of neutral alkaline earth 
carbene adducts such as [(NHC)M{N(SiMe3)2}2], 51-54.
[213] Although the majority of 
the anionic charge of the ligands is borne by the boron-bound imidazolin-2-ylidenyl 
nitrogen centres (ca. -0.63), the electrostatic nature of the M···H-B interactions is 
indicated by the hydridic nature (ca. -0.11 for the “coordinated” hydrogen) of the 
borohydride subunits.  
 
Figure 46. Representations of the optimised (DFT, B3LYP/LAN2DZ) structures of compounds 68 (left) 
and 69 (right). Calculated NBO charges for selected atoms shown in parenthesis. Selected bond lengths 
(Å); 68: Ca-C(avg.) 2.63; Ca-N 2.47; Ca···H-B 2.93; Ca-O(avg.) 2.48. 69: Sr-C(avg.) 2.79; Sr-N 2.55; 
Sr···H-B 2.87; Sr-O(avg.) 2.62. 
 
 
 
 
 
 
 
 
 
3.2.4 Stoichiometric and catalytic reactivity  
 
We have reported previously that neutral NHC ligands readily dissociate from 
alkaline earth cations in solution in the presence of harder (e.g., N- and O-centred) 
donors.[213] This observation is especially relevant to the potential application of group 2 
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complexes in hydroamination catalysis where the reaction conditions are innately 
disposed towards carbene displacement. In order to assess the stability of the 
bis(carbene)borate alkaline earth systems, compounds 62 and 63 were subjected to 
stoichiometric NMR scale reactions with various Brønsted acids. While reaction of 
calcium complex 62 with terminal acetylenes resulted in instantaneous protonation and 
displacement of the ligand, reaction with benzylamine yielded complete consumption of 
the amine and conversion to the heteroleptic calcium benzylamide complex 70 (Scheme 
56), displaying a characteristic broad Ca-NH  1H NMR resonance at -1.25 ppm within 
the first point of analysis. Monitoring of a sample of 70 in solution over a week, 
however, showed gradual protonation and degradation of the bis(carbene)borate ligand 
into free tert-butylimidazole, a process significantly accelerated at higher temperatures, 
which prevented the assessment of a potential amine-amide equilibrium through van’t 
Hoff analysis for comparison with the analogous reaction involving β-diketiminate 
complex 2.[56] Reaction of 62 with 2-methoxyethylamine similarly yielded rapid and 
quantitative conversion to the heteroleptic amine-amide exchange product 71, 
displaying a very broad high-field resonance at δ1H -0.89 ppm (Scheme 59). Again, 
isolation of this compound was prevented by slow protonation of the ligand carbene 
residues in solution over a period of several days. The analogous stoichiometric reaction 
with diphenylamine instantly resulted in partial ligand protonation as well as rapid 
redistribution towards the homoleptic species. Analogous stoichiometric reactions with 
strontium complex 63 led to similar results, albeit with faster ligand redistribution and 
protonation.   
 
Scheme 59. Stoichiometric reactions of calcium complex 62 with primary and secondary amines. 
 
Stoichiometric addition of non-cyclisable 1-amino-2,2-diphenyl-5-methyl-4-hexene 
to a C6D6 solution of calcium and strontium compounds 62 and 63, however, resulted in 
an amine-amide equilibrium significantly in favour of the starting materials. After one 
week at room temperature ligand protonation and redistribution remained limited to less 
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than 5%. Encouraged by this last result, therefore, compounds 62 and 63 were assessed 
for the intramolecular hydroamination of a range of substituted aminoalkenes on an 
NMR scale in C6D6. In all cases, careful inspection of the NMR spectra revealed no 
significant protonation or dissociation of the borate ligand throughout reaction times up 
to a period of one week and temperatures up to 70 oC. The imidazole 1H NMR signals 
and the 13C{1H} carbene resonances remained effectively unaltered and no conclusive 
evidence for Schlenk-type ligand redistribution was observed, except at temperatures 
above 70 oC. 
Examination of the results listed in Table 10 indicated that the amidocalcium 
complex 62 displayed similar activity to that reported for the β-diketiminato calcium 
precatalyst, 2.[54] In common with these previous studies, bulky geminal substituents in 
the β-position of the amine favoured cyclisation due to a Thorpe-Ingold effect (entries 
3-7), while alkyl monosubstitution of the alkene moiety considerably hindered the 
reaction and terminal disubstitution prevented it entirely (entries 8-11). Catalytic 
activity also rapidly diminished with increasing ring-size (5 > 6 > 7; entries 12-16). 
Generally, cyclisation occurred faster, with better conversion, and at lower 
temperature and catalyst loading with the strontium complex 63 than with its calcium 
counterpart. This conflicts with the observations made for heteroleptic calcium and 
strontium β-diketiminate and homoleptic bis(amide) complexes (Tables 1 and 2) as well 
as with previous reports by Datta et al. and Hill and co-workers in which strontium 
aminotroponiminate and triazenide precatalysts were found to be significantly less 
active than their calcium counterparts for the intramolecular hydroamination of 
aminoalkenes.[60, 61] Although detailed kinetic studies would provide a more quantitative 
insight into the inversion of reactivity observed in these preliminary results, qualitative 
comparison of the catalytic activity of tris(imidazolin-2-ylidene-1-yl)borate calcium and 
strontium complexes, in which the strontium complex also displayed significantly 
higher activity, seems to suggest that this phenomenon might be linked to the 
stereoelectronic properties of this specific class of ligand in combination with the 
catalytic strontium centre, rather than being an intrinsic feature of the group 2 element 
selected (vide infra). Despite an apparently positive influence on the catalytic activity of 
calcium and strontium complexes, the anionic [H2B(Im
tBu)2]
- ligand generally provided 
neither advantageous kinetic protection against ligand redistribution compared to the 
more readily accessible β-diketiminate ligand, nor better selectivity or improved scope 
for the intramolecular hydroamination reaction. The following study aims to address the 
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issue of kinetic protection by employing the more sterically demanding, monoanionic 
[HB(ImtBu)3]
- ligand. 
 
Table 10. Scope of intramolecular hydroamination with calcium and strontium bis(carbene)borate 
precatalysts 62 and 63. 
 
Entry Substrate Product Catalyst (mol %) Time / h T / 
o
C NMR yield / %
a 
1 62 (10 mol %) 2 25 >95 
2 
 
NH2
 
 
NH
Me
Me
Me  
63 (5 mol %) 1 25 >95 
3 62 (5 mol %) 0.5 25 30 
4 62 (5 mol %) 0.15 70 >95 
5 
NH2
 
NH
Me
 
63 (5 mol %) 0.15 25 95 
6 62 (5 mol %) 0.3 25 95 
7 
 
NH2
Ph Ph
 
 
NH
Me
Ph
Ph  
63 (5 mol %) 0.15 25 >99 
8 62 (5 mol %) 1 d 25 50 
9 
NH2
Ph Ph
 
NH
Me
Ph
Ph
Me
 
63 (5 mol %) 1 70 >99 
10 62 (5 mol %) 2 d 70 0 
11 
NH2
Ph Ph
 
NH
i-Pr
Ph
Ph  
63 (20 mol %) 3 d 70 0 
12 62 (5 mol %) 1 d 25 55:5b 
13 62 (10 mol %) 6 25 80:6b 
14 
 
NH2
Ph Ph
 
 
 
63 (5 mol %) 4 25 68:20b 
15 62 (10 mol %) 3 d 75 10:65b 
16 
 
NH2
Ph Ph
 
 
N
Me
Ph
Ph H
+
NH2
Ph Ph
 
63 (10 mol %) 2 d 75 12:68b 
 
a- NMR scale reactions carried out in C6D6 or d8-toluene, yields calculated from an internal TMSS standard.  
b- Cyclisation: isomerisation.  
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3.3 Synthetic, structural and catalytic studies of heavier alkaline 
earth tris(imidazolin-2-ylidene-1-yl)borate complexes.
[221]
 
 
 
3.3.1 Synthesis of calcium, strontium and barium tris(carbene)borate 
complexes 
 
The ligand precursor salt 72 [HB(ImtBu)3]Br2 was synthesised following the 
procedure described by Smith and co-workers (Scheme 60)[207] and crystallised from 
dichloromethane. 1H and 13C{1H} NMR chemical shift data were in accordance with 
those reported by Nieto et al., with a characteristic low-field H-2 imidazole proton 
resonance at δ1H 9.85 ppm.
[207] The analogous diiodide salt could not be obtained due to 
complications in attempts to isolate the Me3N.BHI2 precursor. 
 
Scheme 60. Synthesis of [HB(ImtBu)3]Br2 72. 
 
 
 
 
 
Using a “one-pot” procedure similar to that employed in the synthesis of 
bis(carbene)borate complexes 62 and 63, addition of THF at -78 °C to a mixture of four 
equivalents of [KN(SiMe3)2], one equivalent of the ligand precursor 72 and either CaI2, 
SrI2 or BaI2 provided, after extraction into toluene, the desired heteroleptic alkaline 
earth amides 73, 74 and 75 (Scheme 61). Contrary to the previously described group 2 
bis(imidazolin-2-ylidene-1-yl)borate amides, whose coordination sphere is completed 
by THF, NMR and X-ray data of compounds 74 and 75 showed the presence of 1-tert-
butylimidazole adducts arising from fragmentation of the ligand precursor during the 
reaction. Such decomposition had already been observed in the NMR spectra of the 
crude reaction mixtures of the bis(imidazolin-2-ylidene-1-yl)borate compounds. After 
separation from KI and KBr by-products and storage of concentrated toluene solutions 
at -20 °C, complexes 73-75 could, however, be isolated as colourless crystalline, very 
low-melting solids in moderate to good yields (48-88%).  
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Scheme 61. Synthesis of heavier alkaline earth tris(carbene)borate complexes 73-75. 
 
 
 
 
 
 
Repeating the synthesis of 74 without the use of the potentially acidic Celite during 
filtration, and washing of the Schlenk flasks with a basic isopropanol solution of 
potassium hydroxide before drying for one day at 150 ºC, yielded a 60:40 mixture of the 
desired THF adduct 74' and compound 74 respectively, which were separated by 
fractional crystallisation from toluene at -20 oC. Although suitable crystals of compound 
74' could not be prepared for X-ray crystallography, 1H and 13C{1H} NMR data and 
elemental analyses of 74' were in accordance with the expected structure. Analogous 
reaction and filtration conditions for the synthesis of the barium silylamide complex, 
however, did not yield the THF adduct and instead resulted in decomposition of the 
ligand. 1H and 13C{1H} NMR data of 73, 74, 74' and 75 were consistent with the 
expected structures. Particularly diagnostic were the low-field 13C{1H} signals 
attributed to the metal-coordinated C-2 carbene centres of the borate ligand appearing at 
196.2 (73), 201.5 (74), 198.7 (74') and 205.9 ppm (75) respectively. This trend 
correlates well with that observed in the calcium and strontium bis(imidazolin-2-
ylidene-1-yl)borate species 62-66 as well as in the neutral NHC adducts 
[(NHC)M{N(SiMe3)2}2], 51-54,
[213] confirming that the magnitude of the upfield shift 
(∆δ13C) of the C-2 centre from that of the free carbene decreases with the Lewis acidity 
of the group 2 metal (Table 8). As for its bidentate counterpart, it appears that the 
incorporation of the NHC fragments into the tridentate monoanionic borate ligand does 
not affect the behaviour of the C-2 carbene centres as pure σ-donors. Crystals of 
compounds 74 and 75 suitable for X-ray diffraction analysis were obtained from toluene 
solutions at -20 °C. The results of these experiments are illustrated in Figure 47 and 
Figure 48 respectively. Selected bond length and angle data are provided in Table 11 
and Table 12 respectively. Compound 74 adopts a highly distorted square pyramidal 
coordination geometry in the solid state (τ = 0.16)[149] in which the axial position is 
occupied by one of the arms of the ligand. The strontium centre is bound to all three 
carbene carbons of the anionic ligand which is only slightly distorted from C3ν 
4 [K{N(SiMe3)2] + MI2
THF, -78 oC, 18h
73M = Ca, n = 0
74M = Sr, n = 1
75M = Ba, n = 1.5
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N N
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symmetry. The Sr-C distances [2.776(3), 2.811(3) and 2.749(3) Å] are very similar to 
those of the strontium bis(imidazolin-2-ylidene-1-yl)borate silylamide analogue, 63 
[2.757(4) - 2.739(3) Å] and the neutral carbene adduct [(NHC)Sr{N(SiMe3)2}2] [52, 
2.731(3) Å][213] despite the increased coordination number at the strontium centre (Table 
8).  
 
Figure 47. Ortep representation of compound 74. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens removed for clarity, except those attached to the boron atom. 
 
 
 
 
 
 
 
 
 
 
 
Although crystals of compound 75 were extremely temperature-sensitive and had to 
be selected under a cryogenic flow of N2 to avoid melting, the structure was 
unambiguous. The asymmetric unit of compound 75 is composed of two distinct barium 
tris(imidazolin-2-ylidene-1-yl)borate silylamide units solvated by one and two 
imidazole heterocycles respectively (Figure 48). The five-coordinate barium complex 
adopts a distorted square pyramidal coordination geometry (τ = 0.33).[149] Two arms of 
the tris(imidazolin-2-ylidene-1-yl)borate ligand occupy equatorial positions together 
with the silylamide co-ligand and the imidazole adduct while the third arm of the 
scorpionate ligand occupy the axial position. The other six-coordinate barium monomer 
adopts a very distorted pseudo-octahedral geometry instead, with a facial C3 donor set 
provided by the tridentate carbene ligand while the other face is occupied by the 
silylamide co-ligand and the two coordinated imidazole ligands. As observed for the 
strontium analogue 74, the anionic ligand adopts a κ3-coordination mode through all 
three carbene carbons. The Ba-C distances [2.977(3), 2.947(3), 2.978(3), 2.904(3), 
2.934(3) and 2.953(3) Å] are comparable to that of the neutral carbene adducts reported 
by Arduengo [50, 2.951(3) Å][195] and by Hill and co-workers [53, 2.915(4) Å].[213] In 
116 
 
both compounds 74 and 75 the carbene-metal vectors do not lie in the plane of the 
imidazole rings so that the NHC fragments are slightly distorted from the ideal C3ν 
symmetry, most likely due to high crystal packing forces. Similar observations had 
already been made by Arduengo and co-workers for the neutral carbene adducts.[195] 
 
Table 11. Selected bond lengths (Å) for compounds 74, 75, 76', 77 and 78. 
 
 74 75 76' 77 78 
B(1)-N(2) 
B(1)-N(4) 
1.555(3) 
1.554(4) 
1.546(4) 
1.549(4) 
1.547(6) 
1.559(6) 
1.552(3) 
1.554(3) 
1.555(4) 
1.552(4) 
B(1)-N(6) 
B(2)-N(13) 
B(2)-N(15) 
B(2)-N(17) 
1.557(4) 
- 
- 
- 
1.554(4) 
1.555(4) 
1.551(4) 
1.563(4) 
1.546(6) 
- 
- 
- 
1.554(3) 
- 
- 
- 
1.553(4) 
- 
- 
- 
C(1)-N(1) 1.373(3) 1.373(4) 1.364(6) 1.367(3) 1.372(4) 
C(1)-N(2) 1.372(3) 1.372(4) 1.369(6) 1.367(3) 1.378(4) 
C(4)-N(3) 1.374(3) 1.372(4) 1.366(6) 1.368(3) 1.371(4) 
C(4)-N(4) 1.370(3) 1.364(4) 1.364(6) 1.364(3) 1.379(4) 
C(7)-N(5) 1.369(3) 1.370(4) 1.363(6) 1.367(3) 1.368(4) 
C(7)-N(6) 
C(42)-N(12) 
C(42)-N(13) 
C(45)-N(14) 
C(45)-N(15) 
C(48)-N(16) 
C(48)-N(17) 
1.375(3) 
- 
- 
- 
- 
- 
- 
1.365(4) 
1.371(4) 
1.369(4) 
1.364(3) 
1.374(3) 
1.369(3) 
1.366(3) 
1.368(6) 
- 
- 
- 
- 
- 
- 
1.366(3) 
- 
- 
- 
- 
- 
- 
1.367(4) 
- 
- 
- 
- 
- 
- 
B(1)-H(1) - 1.14(3) - 1.13(2) 1.15(3) 
B(2)-H(2) 
Ca-I 
Ca-Br 
Ca-Br’ 
- 
- 
- 
- 
1.14(2) 
- 
- 
- 
- 
3.0490(9) 
- 
- 
- 
- 
2.8930(4) 
2.9040(4) 
- 
- 
- 
- 
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Table 12. Selected angles (o) for compounds 74, 75, 76', 77 and 78. 
 
 74 75 76' 77 78 
N(2)-B(1)-N(4) 110.9(2) 112.6(3) 109.5(4) 112.42(17) 111.6(2) 
N(2)-B(1)-N(6) 113.2(2) 112.9(3) 110.6(4) 111.33(17) 112.4(2) 
N(6)-B(1)-N(4) 
N(13)-B(2)-N(15) 
112.1(2) 
- 
111.3(2) 
113.1(2) 
112.3(4) 
- 
109.57(17) 
- 
112.9(2) 
- 
N(13)-B(2)-N(17) - 112.3(2) - - - 
N(17)-B(2)-N(15) - 110.5(2) - - - 
C(1)-N(2)-B(1) 128.7(2) 129.4(2) 127.2(4) 127.07(17) 128.8(2) 
C(4)-N(4)-B(1) 
C(7)-N(6)-B(1) 
C(42)-N(13)-B(2) 
C(45)-N(15)-B(2) 
C(48)-N(17)-B(2) 
N(1)-C(1)-N(2) 
N(3)-C(4)-N(4) 
N(5)-C(7)-N(6) 
N(12)-C(42)-N(13) 
N(14)-C(45)-N(15) 
N(16)-C(48)-N(17) 
128.5(2) 
128.4(2) 
- 
- 
- 
103.5(2) 
103.9(2) 
103.7(2) 
- 
- 
- 
128.3(2) 
128.6(2) 
128.6(2) 
127.9(2) 
127.3(2) 
103.6(2) 
103.9(2) 
103.8(2) 
103.9(2) 
103.8(2) 
103.9(2) 
125.4(4) 
126.0(4) 
- 
- 
- 
104.4(4) 
104.0(4) 
104.4(4) 
- 
- 
- 
127.26(17) 
126.67(17) 
- 
- 
- 
104.24(17) 
104.50(17) 
104.11(17) 
- 
- 
- 
128.7(2) 
127.9(2) 
- 
- 
- 
103.8(2) 
103.5(2) 
103.9(2) 
- 
- 
- 
 
Figure 48. Ortep representation of the asymmetric unit of compound 75. Thermal ellipsoids drawn at 
30% probability. Tert-butyl methyl groups and hydrogens removed for clarity, except those attached to 
the boron atoms. 
 
 
 
 
 
 
 
 
 
The synthesis of the heteroleptic calcium iodide derivative followed a similar 
reaction scheme employing three rather than four equivalents of [KN(SiMe3)2] and 
yielded monomeric compound 76 [{HB(ImtBu)3}CaI(N-Im
tBu)] and compound 76' 
[{HB(ImtBu)3}CaI(THF)] in a 9:1 mixture (Scheme 62). Fractional crystallisation from 
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toluene allowed the isolation of crystals of the THF adduct 76' after two days at -20 oC 
and of the imidazole adduct 76 after another two days at -20 oC. Although suitable for 
an X-ray crystallographic analysis, quantities of 76' did not allow the collection of 
NMR spectra or elemental analysis. Repeated attempts to isolate larger amounts of the 
complex for these purposes failed. Conversely, although complex 76 was repeatedly 
obtained in good yield (68%) and purity, no crystals suitable for X-ray diffraction 
analysis could be isolated. Elemental analysis as well as 1H and 13C{1H} NMR spectra 
were, however, in accordance with the expected structure containing a single borate 
ligand environment and a coordinated tert-butylimidazole fragment. 
 
Scheme 62. Synthesis of compounds 76 and 76'. 
 
 
 
 
 
 
 
 
The 13C{1H} chemical shift of the carbene carbon in 76 at 195.5 ppm was slightly 
further downfield than that observed for the silylamide analogue 73 at 198.5 ppm, and 
compares well with the carbene shifts in calcium bis(imidazolin-2-ylidene-1-yl)borate 
compounds described earlier in this thesis (Table 8). X-ray structural studies of 
compound 76' confirmed a similar κ3-binding mode of the borate ligand to that 
observed in compounds 74 and 75.* The results of this experiment are illustrated in 
Figure 49 and selected bond length and angle data are provided in Table 11 and Table 
12 respectively. The complex presents a highly distorted square pyramidal geometry (τ 
= 0.39)[149] in which the third arm of the scorpionate ligand occupies the axial position. 
The Ca-I distance [3.0490(9) Ǻ] is slightly shorter than the range of bond lengths 
reported by Westerhausen for a series of arylcalcium iodides [3.178(3) - 3.306(1) Ǻ][4, 5] 
or for the aminotroponiminate complex [{(iPr)ATI}CaI(THF)3] reported by Roesky and 
co-workers [3.1365(8) Ǻ].[222] The Ca-C distances [2.582(5), 2.510(5) and 2.526(4) Ǻ] 
are similar to those of the neutral calcium carbene adducts [(NHC)Ca{N(SiMe3)2}2] 
                                                 
* The structure of complex 76' was determined by Dr Peter B. Hitchcock, University of Sussex. 
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[51, 2.598(2) Å; 54, 2.6285(16) Å)],[213] the homoleptic bis(carbene)borate species 65 
[2.583(3), 2.646(4) Ǻ] described earlier (Table 8), as well as the range of calcium-
carbene carbon distances described in the bis(iminophosphoranyl)-methandiyl calcium 
complexes [2.528(2) - 2.805(1) Å][45, 217] reported by Harder and co-workers. 
 
Figure 49. Ortep representation of compound 76'. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens removed for clarity, except that attached to the boron atom. 
 
 
 
 
 
 
 
 
 
 
To obtain the calcium tris(imidazolin-2-ylidene-1-yl)borate bromide, 1.5 equivalents 
of the homoleptic silylamide species [Ca{N(SiMe3)2}2(THF)2] and one equivalent of 
ligand precursor 72 were combined in THF at low temperature (Scheme 63). Extraction 
into toluene followed by concentration of the solution and two days at -20 ºC afforded 
compound 77 as a colourless solid in good purity and yield (69%). 1H and 13C{1H} 
NMR data were in agreement with the expected calcium bromide species. The 
characteristic 13C{1H} NMR shift for the carbene carbon at 199.4 ppm is the furthest 
downfield of all calcium NHC derivatives described so far (Table 8).  
 
Scheme 63. Synthesis of compounds 77 and 78. 
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X-ray structural analysis of the crystals showed that the compound crystallises as a 
dimer with bridging bromides. The result of this experiment is shown in Figure 50 and 
selected bond length and angle data are provided in Table 11 and Table 12 respectively. 
As in compounds 74, 75 and 76', the calcium centre adopts a highly distorted square 
pyramidal geometry (τ = 0.39).[149] Ca-Br distances [2.8930(4) - 2.9040(4) Ǻ] are 
similar to those in the phenylcalcium bromide complex [2.8899(8) Ǻ] reported by 
Westerhausen and co-workers and the simple complex [CaBr2(THF)4] [2.8425(3) Ǻ].
[4, 
223] The calcium-carbene carbon bond lengths [2.544(2), 2.564(2) and 2.559(2) Ǻ] are 
similar to those in the mononuclear calcium iodide complex 76' described above.  
 
Figure 50. Ortep representation of compound 77. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens removed for clarity, except those attached to the boron atoms. 
 
 
 
 
 
 
 
 
 
 
An analogous synthesis using the homoleptic strontium silylamide 
[Sr{N(SiMe3)2}2(THF)2] provided the homoleptic species 78 [{HB(Im
tBu)3}2Sr] in 54% 
yield based on the initial amount of the ligand precursor (Scheme 63). Among by-
products, free imidazole and compound 74 could be identified in the 1H NMR spectrum 
of the crude extraction solids. 1H and 13C{1H} NMR data of 78 displayed similar 
features to those of related complexes mentioned above, suggesting a single borate 
ligand environment. The downfield 13C{1H} chemical shift of the donor-carbon carbene 
resonances at 201.6 ppm was very similar to that of the heteroleptic strontium 
silylamide species 74. Fine needle-like crystals suitable for X-ray diffraction analysis 
confirmed the homoleptic nature of this complex, which is evidently a result of the 
lesser steric demands of the bromide ligand compared to the bulky 
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bis(trimethylsilyl)amide co-ligand of compound 74, combined with the larger ionic 
radius of strontium compared to the calcium centre of compound 77 (Figure 51).  
 
Figure 51. Ortep representation of compound 78. Thermal ellipsoids drawn at 30% probability. Tert-
butyl methyl groups and hydrogens removed for clarity, except those attached to the boron atoms. 
 
 
 
 
 
 
 
 
 
Repeated attempts to synthesise the strontium iodide analogue of compounds 76 and 
76’ also failed and gave complex mixtures of free 1-tert-butylimidazole, compound 74, 
and the homoleptic species 78. After consideration of these results, no attempts were 
made to synthesise an analogous barium halide species. The structure of 78 is displayed 
in Figure 51 and selected bond length and angle data are provided in Table 11 and Table 
12 respectively. The complex adopts an octahedral geometry with equatorial angles of 
103.87(9)º and 76.13(9)º and crystallographically imposed C3v symmetry around the 
(BSrB) axis. In this case, contrary to all previously described structures, the imidazole 
rings are perfectly co-planar with the Sr-C bonds. The two C3ν-symmetric ligands adopt 
a staggered conformation leading to an overall D3d symmetry of the complex. The Sr-C 
distances [2.810(3), 2.802(3) and 2.805(3) Ǻ] can be considered identical and are 
similar to those in compound 74. Over the whole series of compounds described in this 
study, the geometry of the ligand varies only slightly, with N-B-N angles ranging from 
109.5(4)º to 113.2(2)º, showing the relative rigidity of the tris(imidazolin-2-ylidene-1-
yl)borate ligand even in the presence of large metal cations such as Sr2+ or Ba2+. A 
similar observation had already been made for the calcium and strontium 
bis(imidazolin-2-ylidene-1-yl)borate compounds described earlier. 
Attempts to synthesise mesityl-substituted analogues of compounds 73-78 either by 
the “one pot” salt metathesis procedure or with the homoleptic alkaline earth 
bis(trimethylsilyl)amides usually led to the reaction mixture turning crimson upon 
reaching room temperature, a potential sign of deprotonation of the mesityl methyl 
122 
 
substituents and formation of benzylic species. 1H NMR spectra of the crude extraction 
mixtures proved too complex to decipher. In the case of the reaction between the ligand 
precursor [HB(ImMes)3]Br2, four equivalents of [KN(SiMe3)2] and one equivalent of 
SrI2, however, colourless crystals of complex 79 suitable for X-ray diffraction studies 
could be isolated. The result of this experiment is illustrated in Figure 52. Although the 
structure could be refined to a satisfactory degree (R1 = 0.0600 and wR2 = 0.1244) and 
there can be no doubt as to the presence of the κ3-coordinated mesityl-substituted 
tris(imidazolin-2-ylidene-1-yl)borate ligand, refinement of the diffraction data also 
suggested the potential presence of a superoxide O2
- bridging unit with the oxygen 
atoms disordered over three position in a 0.75:0.75:0.50 ratio. The positioning of the 
oxygen atoms and the O-O bond distances of 1.181(7) Å and 1.346(8) Å, however, do 
not fit the average structure of bridging superoxides. Since there was insufficient 
crystalline material to acquire elemental analysis data and repeated attempts to 
reproduce this result failed, the nature of this bridging unit remains unclear.   
 
Figure 52. Ortep representation of compound 79. Thermal ellipsoids drawn at 30% probability. Mesityl 
methyl groups and hydrogens removed for clarity, except those attached to the boron atoms. 
 
 
 
  
 
 
 
 
 
 
Further attempts to use the more sterically demanding 2,6-di-iso-propylphenyl-
substituted and the chiral (S)-α-phenylethyl-substituted versions of ligand precursor 72 
also met with serious problems of ligand degradation and redistribution during synthesis, 
preventing the isolation of any compounds of interest. Furthermore, replacing the 
hydrogen on the boron bridgehead with a phenyl substituent promoted a significant 
increase in ligand cleavage reactions during attempted syntheses. 
 
123 
 
3.3.2 Hydroamination studies 
 
Attempted intramolecular hydroamination with 73 and 74 was much less efficient 
than with their bidentate counterparts 62 and 63. For aminoalkenes requiring high 
cyclisation temperatures yields did not exceed 20% due to complete protonation and 
decomposition of the tris(imidazolin-2-ylidene-1-yl)borate ligands into free tert-
butylimidazole fragments, leading to solutions turning first yellow then brown within 
hours at temperature above 50 oC. This process was easily detected by the appearance of 
a tert-butyl 1H NMR singlet at 0.98 ppm in d8-toluene and disappearance of the 
equivalent ligand signal around 1.3-1.4 ppm. A slight amount of ligand decomposition 
(5-20%) was also observed at lower temperatures but did not prevent catalysis. Heating 
of d8-toluene solutions of 73, 74 and 75 at 80 
oC over a period of six days, however, did 
neither result in any visible decomposition nor in ligand redistribution towards the 
homoleptic species. The presence of a protic substrate seems, therefore, required to 
degrade the ligand by protonation of the carbene fragments, a process which inevitably 
competes with the amine-amide exchange of the catalytic insertion step. Similar 
decomposition and the formation of intractable products were also observed in the 
presence of one equivalent of other protic substrates such as diphenylamine or 
phenylacetylene.  
The low conversion rates for the intramolecular hydroamination reactions, especially 
for calcium catalyst 73, could be due to the high kinetic activation barrier of the 
insertion step of the catalytic cycle, as the metal centre is tightly encapsulated by the 
ligand and access for substrate pre-coordination is blocked by the highly sterically 
demanding hexamethyldisilazide co-ligand. Although the larger ionic radius of 
strontium in 74 allows better access for pre-coordination of both the amine and the 
alkene moiety to the catalytic metal centre, the steric demands of the tridentate carbene 
ligand noticeably hinder the insertion step compared with the previously mentioned 
bidentate carbene analogue 63. Despite these limitations strontium complex 74 was 
significantly more active than its calcium counterpart 73 as is apparent from the limited 
results displayed in Table 13. These observations are consistent with earlier findings for 
bis(imidazolin-2-ylidene-1-yl)borate complexes 62 and 63 but contrast with those for 
calcium and strontium β-diketiminate complexes 2 and 34, homoleptic complexes 35b-c, 
36b-c and 37b-c, and previous reports for calcium and strontium aminotroponiminate 
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and triazenide complexes.[60, 61] As suggested earlier with regard to the catalytic activity 
of bis(carbene)borate complexes 62 and 63, this inversion of reactivity might reflect the 
intrinsic stereoelectronic effects of the highly σ-donating ligand on the catalytic alkaline 
earth metal centre. Barium complex 75 showed little activity even with 1-amino-2,2-
diphenyl-4-pentene and heating at 50 oC for seven days. At 5 mol% catalyst loading the 
amount of cyclised product indicated a single turnover most likely achieved before the 
catalyst was entirely dismantled by protonation and B-N bond cleavage. 
 
Table 13. Scope of intramolecular hydroamination with calcium and strontium tris(carbene)borate 
precatalysts 73 and 74. Experiments were performed at 5 mol% catalyst loading in C6D6. 
 
Entry Substrate Product Catalyst Time / h T / 
o
C NMR yield / %
a 
1 73 3 d 45 11 
2 NH2
 
NH
Me
 
74 24 25 86 
3 73 4 d 45 85 
4 
 
NH2
Ph Ph
 
 
NH
Me
Ph
Ph  
74 1.8 25 97 
 
 
3.4 Limitations of the (carbene)borate systems and further work 
 
As evidenced by this study the synthesis of alkaline earth bis- and tris(carbene)borate 
complexes seems to invariably involve a certain amount of ligand decomposition by B-
N bond cleavage. As shown in the synthesis of compounds 74' and 76', even 
precautions such as washing all glassware with a base solution and avoiding filtration 
through potentially acidic Celite only leads to various proportions of (THF) and 
imidazole adduct mixtures. In virtually all reactions crystallisation and selection of 
crystals were made particularly difficult due to the presence of oily non-coordinated 1-
tert-butylimidazole in the toluene solution. Coordination-induced B-N bond cleavage of 
tris(pyrazolyl)borate ligands has been previously observed.[202] For example, Harding et 
al. isolated [Co(TpPh2)(O2CMe)(Hpz
Ph2)] containing a coordinated pyrazole ligand 
resulting from B-N bond cleavage induced by the Lewis acidic Cu(II) centre,[224] while 
Hamon and co-workers have described the formation of [trans-FeCl2(
tBu-pzH)4] as the 
only isolable product from the attempted synthesis of an iron tris(pyrazolyl)borate 
125 
 
complex.[225] Similarly, partial decomposition has also been observed during the 
synthesis of lanthanum and neodymium tris(pyrazolyl)borate complexes by Domingos 
et al. who suggested this propensity towards decomposition was a result of B-N bond 
elongation and twisting of the pyrazole fragments caused by the polarisation of the large 
Lewis acidic metal cation.[226]  
The synthesis of compound 73 yielded crystals of a by-product which was 
structurally characterised as the homoleptic compound 80 [Ca{N(SiMe3)2}2(N-Im
tBu)2] 
(Figure 53, left). 1H and 13C{1H} NMR shifts of complex 80 allowed its identification in 
the crude mixtures of 76 and 77, as well as the analogous strontium and barium species 
in the crude mixtures of 74, 75 and 78. A possible indication as to the fate of the boron 
backbone in such ligand cleavage reactions was provided by the unexpected structure of 
the single isolable compound of the attempted synthesis of the diphenyl-substituted 
analogue of 62, [{Ph2B(Im
tBu)2}Ca{N(SiMe3)2}(THF)]. X-ray diffraction analysis of 
compound 81 revealed the dimeric boron NHC complex displayed in Figure 53 (right), 
containing a single imidazolin-2-ylidene-1-yl arm coordinated to a second boron centre. 
As suggested by the reaction conditions in the synthesis of compounds 74' and 76', 
which did not completely avoid B-N bond cleavage, residual acid traces on the 
glassware are only partly responsible for the decomposition mechanism of the ligand. It 
is likely, therefore, that other factors, such as the necessary redistribution of charge 
within the ligand framework during deprotonation, are implicated in the degradative 
pathways.  
It thus seems clear that the fragility of both bis- and tris(imidazolin-2-ylidene-1-
yl)borate ligands towards B-N bond cleavage reactions makes them rather unsuitable for 
the stabilisation of heavier alkaline earth metal centres. The resulting isolable 
heteroleptic complexes, although presenting greater kinetic stability than previously 
reported β-diketiminate, triazenide or aminotroponiminate complexes, are much more 
prone to ligand protonation in the presence of protic substrates, limiting their catalytic 
applications. Moreover, all attempts to obtain heteroleptic alkaline earth alkyl 
complexes stabilised by these ligand systems were thwarted by total degradation of the 
ligand precursors in the presence of either [K{CH(SiMe3)2}2] or 
[M{CH(SiMe3)2}2(THF)2] (M = Ca, Sr, Ba) used during the synthesis, even if reactions 
were carried out at low temperature. The challenge of a straightforward synthesis of 
kinetically stable heteroleptic heavier alkaline earth alkyl complexes thus remains and 
will certainly require the use of more robust ligands. 
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Figure 53. Ortep representations of ligand decomposition by-products 80 and 81. Thermal ellipsoids 
drawn at 30% probability. Hydrogens omitted for clarity. 
 
The problem of the fragility of the B-N bonds in the presence of alkaline earth bases 
may easily be overcome by using other types of monoanionic scorpionate carbene 
ligands in which the bridgehead element is, for example, a carbon atom, as well as other 
monoanionic pincer-type carbene ligands based on C, H, N and O such as those 
presented in Figure 54.[187, 191, 198, 227] These ligand systems, other than being more stable 
towards ligand decomposition and providing a larger scope for the tuning of 
stereoelectronic properties, could also provide access to the more desirable heteroleptic 
alkaline earth alkyl complexes. 
 
Figure 54. Examples of monoanionic scorpionate and CCC or CNC pincer-type bis(carbene) ligands. 
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4 Towards stable heteroleptic group 2 alkyl precatalysts 
 
 
4.1 Deprotonation and dearomatisation of a bis(imino)pyridine 
ligand with group 2 dialkyls
[228]
 
 
 
4.1.1 Introduction 
 
In the search for post-metallocene catalysts,[229] transition metal complexes stabilised 
by the versatile 2,6-bis(imino)pyridine ligands have received much attention during the 
past decade since the independent discovery in 1998 by Brookhart and Gibson of the 
exceptional ethylene polymerisation activity of bis(arylimino)pyridine iron and cobalt 
(II) complexes activated with MAO.[230] Much of the research has focused on the use of 
these complexes and their derivatives for both homogeneous[231] and heterogeneous 
oligomerisation, polymerisation and copolymerisation reactions.[232] A number of 
theoretical studies have been carried out on this subject to investigate the oxidation state 
of the redox active metal centre during these transformations.[233] Further catalytic 
applications include the epoxidation of cyclohexene,[234] the cyclopropanation of 
styrene,[235] hydrogenation and hydrosilylation reactions,[236] the [2pi +2pi] cycloaddition 
of 1,6-dienes and the reductive cyclisation of 1,6-enynes and -diynes.[237] Modification 
of the original bis(arylimino)pyridine ligand has given rise to a wealth of related 
coordination compounds which can be easily tuned for their stereoelectronic 
properties.[238]  
In many reactions the bis(imino)pyridine ligand was found to be non-innocent. The 
methyl-substituted ligand [2,6-{ArN=C(CH3)}2C5H3N] (Ar = 2,6-di-iso-propylphenyl), 
82, in particular, has been observed to possess a remarkable capacity to function either 
as a passive ancillary ligand or to undergo anionisation via either hydrogen abstraction 
at one or both of the methyl groups attached to the imine carbon atoms[239, 240] or 
through direct alkylation.[241-245] In this latter case alkylation may occur not only at the 
carbon of the imine function but also at the C2 and, less commonly, the N1 and C4 
positions of a dearomatised pyridine ring, as shown by the examples of the reactivity of 
magnesium dialkyls[242] and aluminium trialkyls[243] towards 82 in Scheme 64. The only 
example of alkylation in the C3 position is that of a vanadium (I) dialkyl complex 
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reported by Gambarotta and co-workers.[244] Dearomatisation reactions are usually 
accompanied by a radical colour change of the reaction mixtures from colourless to 
intense red, green, blue or purple. 
 
Scheme 64. Alkylation pattern of bis(imino)pyridine ligand 82 with aluminium and magnesium alkyls.  
 
 
4.1.2 NMR spectroscopic study of the reactions between 37a-d and 82 
 
Encouraged by the results of the reaction of MgR2 (R = Me, Et, 
iPr) with 82 and 
related ligand precursors (Scheme 64A),[242] NMR scale reactions were carried out 
between 82 and the series of group 2 dialkyls [M{CH(SiMe3)2}2(THF)2] (M = Mg 37a; 
Ca 37b; Sr 37c; Ba 37d) in the hope of obtaining analogous heteroleptic group 2 alkyl 
species. Addition of magnesium dialkyl 37a to a C6D6 solution of 82 caused the 
instantaneous formation of an orange solution, which, from the simplicity of its 1H 
NMR spectrum, was inferred to contain a C2-symmetric bis(imino)pyridine adduct of 
the dialkyl species as the only magnesium-containing compound. Monitoring of this 
solution heated at 60 oC by 1H NMR spectroscopy for 24 hours indicated conversion of 
this species to a single product, compound 86a, the result of deprotonation of both of 
the methyl groups attached to the imine functionalities of the bis(imino)pyridine unit. In 
contrast to the analogous reactivity observed with calcium, strontium and barium 
dialkyls 37b-d (vide infra), the only identifiable intermediate species during the course 
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of this reaction was the monodeprotonated species, compound 85a, and the reaction 
mixture remained red-brown in colour throughout the reaction (Scheme 65).  
 
Scheme 65. Double deprotonation of 82 with group 2 dialkyls 37a-d, and intermediate monodeprotonated 
and dearomatised species. 
 
This latter observation contrasts markedly with analogous reactions performed with 
the heavier alkaline earth compounds 37b-d. Combination of the relevant metal dialkyl 
with 82 in C6D6 provided, in each case, the instantaneous formation of a deep blue 
solution. Analysis of the calcium- and strontium-based reactions by 1H NMR 
spectroscopy revealed the presence of singly deprotonated species analogous to 85a, 
compounds 85b and 85c, which appeared as 20-40% of the total bis(imino)pyridine-
derived species in solution at the first point of analysis (Scheme 65). Further monitoring 
of both these reactions at 298 K indicated that 85b and 85c were consumed during the 
course of the continued reactions over periods of 12 hours and 1.5 hours respectively. 
The signals in the 1H NMR spectra attributed to compounds 85b and 85c appeared in 
both reactions alongside two further isomeric species which were identified as the 
dearomatised metal alkyl compounds 83b and 84b (calcium), and 83c and 84c 
(strontium) formed by migration of a single alkyl residue to either the C3 or C4 positions 
of the pyridine ring (Scheme 65). In contrast to these observations, the reaction with the 
barium dialkyl 37d provided no evidence for any singly deprotonated species. Rather, 
the respective C3- and C4-dearomatised species, 83d and 84d, were observed as the only 
intermediate products throughout the course of reaction (Scheme 65). Although the C3-
dearomatised compounds 84b, 84c and 84d were present in excess (ca. 2:1 - 3:1 ratios) 
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during the course of the respective reactions, continued NMR monitoring indicated 
progressive consumption of all intermediate species accompanied by a gradual fading of 
the blue colour of the solutions into green-brown over several hours (Ca, 36 hours; Sr, 2 
hours; Ba, 8 hours). At this point the NMR spectra for all three reactions were 
reminiscent of that obtained for the synthesis of compound 86a and indicated a 
stoichiometric formation of calcium, strontium and barium complexes 86b, 86c and 86d, 
containing an identical pyridine-based ene-diamido ligand. An annotated 1H NMR 
spectrum obtained from the reaction performed with the strontium dialkyl at a lower (ca. 
0.04 M) concentration is provided in Figure 55 and illustrates the clean formation of 
each of the intermediate species, 83c, 84c and 85c, identified by combining 1H, 13C, 
COSY, HMQC and HMBC NMR techniques.  
For all intermediates the 1H NMR upfield singlet of the M-CH(SiMe3)2 alkyl ligand 
was identified by integration against the other characteristic signals of the compounds. 
The symmetric C4-alkylated intermediates 83b-d presented a characteristic doublet 
integrating for two protons at ca. 5 ppm, coupled to a less distinctive (1H) multiplet at 
ca. 4.7 ppm. COSY experiments revealed coupling of the latter to an upfield proton 
signal at ca. 0.3 ppm assigned to the -CH(SiMe3)2 alkyl substituent. Although the shifts 
of the proton doublet in the meta-position of the dearomatised pyridine ring are similar 
to those (4.87-5.10 ppm) of C4-alkylated and -hydrogenated products observed in the 
reaction of 82 with various aluminium alkyls (Scheme 64),[243] the para-proton shifts of 
the latter are significantly higher upfield (3.52-3.81 ppm), possibly a reflection of the 
more covalent nature of the aluminium to ligand bonding.  
The asymmetric C3-alkylated intermediates 84b-d were characterised by three 
distinct pyridine proton resonances in a 1:1:1 ratio: a doublet at ca. 6.3 ppm, coupled to 
a doublet of doublets at ca. 5.3 ppm, itself coupled to a broad multiplet at ca 4.4 ppm. 
Again, COSY experiments allowed the identification of the -CH(SiMe3)2 C
3-substituent 
at ca. 0.3 ppm. Contrary to the symmetric dearomatised intermediates, 83b-d, the 
methyl resonances were inequivalent and appeared as two distinct singlets at ca. 1.7 and 
1.8 ppm respectively. Given that the only other reported compound bearing a C3-
dearomatised bis(imino)pyridine ligand is a paramagnetic vanadium (I) complex,[244] no 
NMR comparison can be provided. Although imine, N1-, and C2-alkylation are more 
commonly observed, it seems that, in this case, the steric bulk of the -CH(SiMe3)2 alkyl 
substituent combined with that of the 2,6-di-iso-propylphenyl ligand appendages gives 
preference to the less sterically hindered C3 and C4 positions. 
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 Figure 55. Annotated (30 min, rt) 1H NMR spectrum ((a) –2 to 2.5 ppm region; (b) 3.5 to 8.5 ppm 
region) obtained from the reaction of 37c and 82 (0.04 M) illustrating the formation of 86c and each of 
the intermediate species. The numbers in the coloured boxes refer to the assignments indicated for 82 
(yellow), 83c (blue), 84c (green), 85c (orange) and 86c (red). 
(a) 
(b) 
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The monodeprotonated (imino-amido)pyridine intermediates 85a-c displayed three 
distinct (1H) pyridine resonances in a 1:1:1 ratio reflecting the asymmetric nature of the 
complexes. HMBC NMR experiments identified the doublet at ca. 7.8 ppm as the 
proton in the meta position of the pyridine backbone on the side bearing the methyl 
substituent and the other doublet at ca. 6.9 ppm as the proton in the meta position on the 
deprotonated side. Compared with the ligand and the final doubly deprotonated products 
86a-c, the shift of the proton in the para position of the pyridine backbone was barely 
affected. Two (1H) singlets in a 1:1 ratio at ca. 3.9 and 4.5 ppm respectively were 
attributed to the methylene resonances, while a singlet at ca. 1.7 ppm integrating for 
three protons corresponded to the intact methyl substituent. These shifts were essentially 
comparable to those observed for an analogous lithium complex.[245]  
The symmetric ene-diamido complexes 86a-d were characterised by two sharp 
methylene singlets at ca. 3.6 and 4.5 ppm, as well as a downfield doublet at ca. 7.6 ppm 
corresponding to the protons in the meta position of the pyridine ring. As the protons in 
the para position were overlapping with the multiplet of the aromatic substituents their 
chemical shifts (ca. 7.1 ppm) were identified by COSY NMR experiments. Again, these 
shifts are closely comparable to those observed in related lanthanide complexes bearing 
the same doubly deprotonated ligand.[240]  
Comparison of these chemical shifts for the different alkaline earth intermediates and 
products did not yield any smooth trends in descending the group from magnesium to 
barium, as shown by the summary of 1H NMR shifts in Figure 56. Most shifts are fairly 
similar across the series of calcium, strontium and barium analogues, with the exception 
of the highly upfield M-CH(SiMe3)2 singlets which are strongly influenced by the 
proximity of the metal centre, although again without obvious trend. It is, however, 
noteworthy that the Mg-CH(SiMe3)2 singlet at -1.57 ppm in intermediate 85a is 0.25 
ppm further downfield than in its calcium counterpart 85b, reflecting the reduced ionic 
character of the metal to ligand binding in the magnesium complexes.  
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Figure 56. 
1H NMR shifts (ppm, C6D6, 298 K, 300 MHz) of intermediates and products 83-86 of the 
reaction outlined in Scheme 65. The symbols in front of the shifts represent: M = ○ Mg, ● Ca, □ Sr, ■ Ba. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3 Structural studies of doubly deprotonated products 
 
Compounds 86a-d were isolated as yellow, orange, bright red and dark red crystals 
respectively, which were suitable for X-ray diffraction analyses. The magnesium and 
calcium derivatives 86a and 86b were found to be mononuclear and isostructural, and to 
contain a five-coordinate metal centre comprising the tridentate N3-ene-diamido ligand 
and two molecules of THF. The structures of compounds 86a and 86b are illustrated in 
Figure 57. Selected bond length and angle data are listed in Table 14. In contrast, and 
although compounds 86c and 86d were found to crystallise with only a single molecule 
of coordinated THF, the coordination number of the strontium and barium centres was 
maintained through an additional intermolecular methylene to metal centre interaction 
such that the compounds assembled into isostructural six-fold symmetric cyclic arrays. 
The intermolecular M···CH2 contacts between the alkaline earth centres and the 
methylene unit of the adjacent molecule within compounds 86c and 86d [Sr···C(14’) 
2.942(3); Ba···C(14’) 3.142(8) Å] are significantly longer than either of the M···CH2 
contacts within the recently reported products resulting from β-diketiminate methyl 
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4.69
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0.30
0.28
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4.34
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6.22
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deprotonation [Sr···CH2 2.759(3), 2.815(3); Ba···CH2 2.966(2), 3.001(2) Å].
[155] The 
structure of a single molecule of 86c and the hexameric unit of compound 86d are 
illustrated in Figure 58. Selected bond length and angle data for compounds 86c and 
86d are provided in Table 14. 
 
Figure 57. Ortep representations of compounds 86a (left) and 86b (right). Thermal ellipsoids drawn at 
30% probability. Hydrogens omitted for clarity, except for methylene protons. 
 
 
 
 
 
 
 
 
 
 
 
All four complexes adopt a distorted square pyramidal coordination geometry (86a, τ 
= 0.37; 86b, τ = 0.55; 86c, τ = 0.15; 86d, τ = 0.08).[149] Unlike other compounds bearing 
the same ene-diamido ligand in which the pyridine ring, the two ene-amido functions 
and the metal centre are more or less coplanar, the ligand in all four alkaline earth 
complexes is distorted from its usual planarity, displaying an angle ranging from 9.3o 
(86d) to 22.5o (86b) between the plane of the pyridine backbone and those of the ene-
amido functionalities. Furthermore, the metal centre is situated at a distance of 0.645-
1.220 Å above the pyridine plane, the distance increasing with the size of the alkaline 
earth cation. The deprotonation of the two former methyl groups within 82 is apparent 
from the values of the C-C distances [1.354(10) Å to 1.381(5) Å] as expected for a 
conjugated double bond, while the short C-N single bond distances [1.341(4) Å to 
1.376(3) Å] indicate some degree of delocalisation over the ene-amido system. 
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Figure 58. Ortep representations of a single molecule of strontium complex 86c (left) and the hexameric 
unit of barium compound 86d (right). Thermal ellipsoids drawn at 30% probability. Hydrogens omitted 
for clarity, except for methylene protons. Ba···CH2 interactions in 86d represented as dashed bonds. 
 
 
 
 
 
 
 
 
 
 
 
Table 14. Selected bond lengths and angles in complexes 86a-d. 
 
 86aa 86bb 86cc 86dd 
M-N(1) 2.1096(18) 2.321(2) 2.524(3) 2.642(6) 
M-N(2) 2.0739(17) 2.3718(18) 2.538(3) 2.725(6) 
M-N(3) 2.1190(18) 2.334(2) 2.456(3) 2.573(7) 
M-O(1) 2.0977(17) 2.3612(18) 2.495(2) 2.684(6) 
M-O(2) 2.0804(16) 2.3432(17) - - 
N(1)-C(13) 1.376(3) 1.368(3) 1.341(4) 1.343(9) 
N(3)-C(20) 1.344(3) 1.376(3) 1.365(4) 1.362(10) 
C(13)-C(14) 1.357(3) 1.358(3) 1.381(5) 1.354(10) 
C(20)-C(21) 1.363(3) 1.357(3) 1.360(5) 1.371(12) 
C(13)-C(15) 1.491(3) 1.493(3) 1.514(4) 1.516(10) 
C(20)-C(19) 1.487(3) 1.499(3) 1.493(5) 1.481(11) 
C(15)-N(2) 1.339(3) 1.344(3) 1.353(4) 1.346(9) 
C(19)-N(2) 1.344(3) 1.346(3) 1.348(4) 1.346(9) 
M-C(14)’ - - 2.942(3) 3.142(8) 
N(1)-M-N(3) 146.34(7) 133.94(7) 120.21(9) 113.4(2) 
C(13)-N(1)-M 116.77(13) 121.23(15) 122.0(2) 124.4(5) 
C(20)-N(3)-M 117.89(13) 119.98(14) 120.4(2) 123.5(5) 
N(1)-C(13)-C(15) 112.65(17) 112.98(19) 113.7(3) 113.2(6) 
N(3)-C(20)-C(19) 113.94(17) 113.68(19) 113.9(3) 113.7(7) 
C(15)-N(2)-C(19) 122.80(17) 122.11(18) 121.3(3) 121.5(6) 
a- M = Mg b-   M = Ca c-   M = Sr d-   M = Ba 
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4.1.4 Kinetic analysis  
 
Kinetic data relating to the relative abilities of heavier group 2 organometallic 
compounds to participate in even apparently simple deprotonation chemistries are, to 
date, non-existent. We undertook, therefore, to place our understanding of the course of 
the reactions to produce compounds 86a-d on a more quantitative foundation. The 
appearance and decay of each intermediate identified in Scheme 65 as well as the 
consumption of the ligand precursor 82 and the production of the final doubly 
deprotonated products 86a-d were readily monitored by 1H NMR spectroscopy and 
evidenced some rather complex metal-dependent behaviour. From experiments 
undertaken at 298 K and with 0.10 M concentrations of the reagents in C6D6, it was 
apparent that although the barium dialkyl provided the most rapid, effectively 
instantaneous, consumption of the ligand precursor (Figure 59a) this did not translate to 
the most facile formation of the final doubly deprotonated product. In addition, the 
failure to observe a barium-centred analogue of the singly deprotonated complexes, 
85a-c, indicated that the dearomatised intermediate species 83d and 84d possess 
enhanced stability for this heaviest and most electropositive member of the group 2 
series. This observation was further borne out by direct monitoring of the total 
concentration of the two dearomatised species for each metal (Figure 59b). Although 
the appearance and decline of each of these species could not be fitted to any simple rate 
dependence, it may be deduced that the subsequent proposed intermediate, a singly 
deprotonated barium complex analogous to 85b and 85c, is consumed immediately to 
form the ultimate reaction product, compound 86d. It thus seems that the ability of 
alkaline earth metal alkyls to effect the second deprotonation of the monodeprotonated 
intermediates increases with the size and electropositivity of the metal cation (Figure 
59c). 
Monitoring of the consumption of the ligand precursor in reactions with the calcium 
and strontium dialkyls 37b and 37c provided an apparent first-order dependence upon 
both [ligand] and [37b or 37c] such that -d[82]/dt = k[82][ 37b or 37c] and gave k = 
0.0713 mol-1.min-1 for the calcium dialkyl 37b and k = 0.468 mol-1.min-1 for the 
strontium dialkyl 37c (Figure 60). From this data it is further apparent that the reactivity 
series of the metal dialkyl towards an initial reaction with the ligand precursor varies in 
the order Ba > Sr > Ca, which may be a simple reflection of the increasing Ae2+ radii 
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and access to the metal centre on descending the group. Conversely, the rate of 
formation of the final reaction products, 86b-d (Figure 61), is then a more complex 
interplay of the stability of the various dearomatised and monodeprotonated 
intermediate species that varies in the order Sr > Ba > Ca. 
 
Figure 59. (a) Disappearance of 82 in reaction with 37b (green), 37c (red) and 37d (blue) (Ba >> Sr > 
Ca). (b) Total concentration of dearomatised intermediates 83b + 84b (green), 83c + 84c (red), 83d + 84d 
(blue). (c) Formation and consumption of the singly deprotonated intermediate species, 85b (green) and 
85c (red) during the reaction of 37b and 37c with 82 (apparent stability Ca > Sr >>>> Ba). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 60. Overall apparent second-order reaction of 82 with 37b (green) and 37c (red). 
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This study shows once again that the reactivity of group 2 metals is more complex 
than simply size-dependent. Consequently, the activation barriers towards the individual 
molecular steps encountered in the construction of a typical catalytic cycle will also 
show a more nuanced dependence upon the identity of the alkaline earth cation. 
 
Figure 61. Formation of the final (ene-diamido)pyridine complexes 86b (green), 86c (red) and 86d (blue). 
 
 
 
 
 
 
 
 
 
 
4.1.5 Attempt at “trapping” the dearomatised group 2 alkyl intermediates 
 
Treatment of the calcium complex 86b with two equivalents of methyl iodide and 
subsequent heating at 60 oC quantitatively afforded the ethyl-substituted 
bis(imino)pyridine ligand 87 (Scheme 66) which was isolated by extraction with 
dichloromethane and recrystallisation from hot methanol. 
 
Scheme 66. Synthesis of the ethyl-substituted bis(imino)pyridine 87. 
 
 
 
 
 
It was expected that the reaction between ligand precursor 87 and group 2 dialkyls 
37b-d might enable the ‘trapping’ of the alkylated dearomatised analogues of 83c-d and 
84c-d since the protons of the ethyl substituents are considerably less acidic and prone 
to deprotonation than those of the methyl-substituted ligand precursor 82. The reaction 
between calcium dialkyl 37b and 87 in C6D6, however, did not lead to the formation of 
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a deep blue solution as had been observed with 37b and 82, rather the solution turned 
orange, and the simplicity of the 1H NMR data suggested the formation of a 
bis(imino)pyridine adduct of the calcium dialkyl similar to the one observed upon 
addition of the magnesium dialkyl 37a to ligand precursor 82 (Scheme 67). Only small 
amounts (<5%) of the expected dearomatised species were observed. Prolonged heating 
of this solution at 60 oC did not result in increased alkylation/dearomatisation of the 
ligand. Instead the solution turned dark red over a period of one week. Monitoring of 
the reaction by 1H NMR spectroscopy showed slow consumption of the 
bis(imino)pyridine adduct and protonation of the alkyl co-ligands into CH2(SiMe3)2. 
Although this suggested deprotonation of the ligand, increased broadening of the signals 
prevented the unambiguous identification of the calcium complex formed.  
 
Scheme 67. Reaction of calcium and strontium dialkyls 37b and 37c with ligand precursor 87. 
 
 
 
 
 
 
 
 
 
 
In contrast, the reaction between the strontium dialkyl 37c and 87 in C6D6 instantly 
resulted in complete solubilisation of the ligand precursor and the formation of a deep 
blue solution reminiscent of those obtained in previous reactions with 82. 1H NMR data 
at the first point of analysis showed complete conversion of the starting materials into 
the desired C4- and C3-alkylated products 88 and 89 in a 1:2 ratio (Scheme 67). 
Attempts to isolate these compounds, however, were marred by the slow deprotonation 
of both ethyl methylene fragments over a period of two days at room temperature to 
yield the ene-diamido strontium complex 91. Cooling of a d8-toluene solution of the 
reaction mixture to -30 oC did not prevent deprotonation, which reached completion 
after a period of eight days. Monitoring of the slow disappearance of both dearomatised 
intermediates, however, demonstrated that the deprotonation process proceeds in the 
N
Et
N
Et
N
Ar Ar
N
Et
N
Et
N
Ar Ar
Ca
CH(SiMe3)2(Me3Si)2HC
37b, C6D6, rt
N
Et
N
Et
N
SrAr Ar
CH(SiMe3)2
CH(SiMe3)2
N
Et
N
Et
N
SrAr Ar
CH(SiMe3)2
CH(SiMe3)2
+
THF THF
1:2
87
88 89
N
NN
SrAr Ar
THFTHF
91
48h, rt
37c, C6D6, rt
fast
Ar = 2,6-iPr2C6H3
140 
 
order proposed in Scheme 65, first via the dearomatised intermediates, which are then 
converted into the monodeprotonated and finally the doubly deprotonated species 
(Figure 62). Indeed, the decay of 88 and 89 in the 1H NMR is accompanied at first by a 
slow increase in concentration of the monodeprotonated intermediate 90, analogous to 
85c, suggesting conversion of 88 and 89 into 90 (Figure 63). Furthermore, while the C3-
alkylated intermediate 89 is consumed from the start of the reaction, the concentration 
of the C4-alkylated intermediate 88 only starts to decrease after an induction period of 
about 10 hours. Although no definite reaction mechanism can be inferred from these 
observations it seems reasonable to suggest that deprotonation probably occurs via an 
intramolecular pathway in which the alkyl substituent of the dearomatised pyridine 
backbone attacks one of the methylene protons of the ethyl substituent, the process 
being likely driven by the re-aromatisation of the pyridine ring. The closer proximity of 
the alkyl fragment to the ethyl substituent in the C3-alkylated complex 89 would then 
explain the faster deprotonation rate obtained with this intermediate. It remains as yet 
unclear whether intermediate 88 must first be converted into 89 to achieve 
deprotonation.  
 
Figure 62. 
1H NMR stack plot monitoring the reaction of 37c with 87 in C6D6 at 25 
oC (▲ 88, ♦ 89, ■ 90, 
● 91). 
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Figure 63. Variation of the concentration of compounds 88-91 in solution over a period of 48 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.6 Conclusion and further work 
 
Although the reaction of group 2 dialkyls 37a-d with methyl- and ethyl-substituted 
bis(imino)pyridine ligand precursors did not yield the desired heteroleptic alkaline earth 
alkyl complexes, this study has demonstrated the unprecedented capacity of these 
dialkyl species to dearomatise a pyridine ligand backbone and, for the first time, 
allowed the identification by NMR spectroscopy of C3-alkylated versions of this class of 
ligand. While 1H NMR kinetic studies have allowed some insight into a potential 
mechanism of these complex reactions, these results are only preliminary. 
Computational studies upon the stability of the various dearomatised and 
monodeprotonated intermediates, as well as of possible reaction pathways, would be of 
great interest and would provide a deeper understanding of the significant variations 
observed in the reactivity of the different alkaline earth metal cations involved in these 
reactions. Additionally, the use of a phenyl-substituted bis(imino)pyridine ligand 
precursor,[246] entirely immune to deprotonation, may enable the isolation of the desired 
heteroleptic alkaline earth alkyl species bearing either C3- or C4-alkylated ligands 
(Scheme 68A). CNC pyridine-bridged bis(carbene) ligands[186, 247] may also allow this 
dearomatisation chemistry to be combined with the σ-donating properties of N-
heterocyclic carbenes studied earlier in this work and could provide regioselective 
alkylation of the para position of the pyridine backbone (Scheme 68B).  
 
88 
89 
90 
91 
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Scheme 68. Suggested reactions with other pyridine-centred ligand precursors which may provide access 
to heteroleptic alkaline earth alkyl species bearing dearomatised ligands. 
 
In view of making alkaline earth-catalysed reactions enantioselective, the use of the 
readily accessible chiral pyridine-2,6-bis(oxazoline) (PyBox) ligands, which have 
already proven their use in enantioselective transition metal catalysis,[248] may also be 
envisaged in combination with these group 2 dialkyls precursors, as proposed in 
Scheme 69. It is indeed noteworthy that the dearomatised calcium, strontium and 
barium alkyl intermediates 83b-d, 84b-d, 88 and 89 described in this section did not 
seem to show any sign of the Schlenk-type ligand redistribution processes which 
commonly prevent efficient enantioselective group 2-mediated catalysis. 
 
Scheme 69. Suggested route towards chiral PyBox derivatives of heteroleptic alkaline earth alkyl species. 
 
 
 
 
 
 
 
Beyond bis(imino)pyridine ligands, this novel alkylation/dearomatisation reactivity 
may also apply to other types of bis(imine) ligands bearing aromatic backbones, thus 
enlarging the scope of available monoanionic ligands for the stabilisation of highly 
reactive, heteroleptic heavier alkaline earth alkyl complexes. 
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4.2 Selective dearomatisation of a BIAN ligand with group 2 dialkyls 
 
 
4.2.1 Introduction 
 
In the catalogue of readily available diimine ligands, bis(imino)acenaphthene (BIAN) 
ligands (Figure 64) have gained some prominence over the last 2 decades. Although 
first reported in the 1960s,[249] the use of this class of ligand only became popular in the 
late 1990s.  
 
Figure 64. BIAN ligand precursors.  
 
 
 
 
The ability of neutral BIAN ligands to act as strong and rigid chelators for metals in 
a variety of oxidation states has given rise to a rich transition metal coordination and 
catalytic chemistry.[250, 251] In particular, Elsevier and co-workers have reported the use 
of palladium and platinum aryl-BIAN complexes for catalytic C-C bond formation, 
hydrogenation and hydrosilylation reactions,[252] while Brookhart[253] and Coates[254] 
have demonstrated the efficiency of cationic nickel(II), palladium(II) and platinum(II) 
aryl-BIAN precatalysts in the polymerisation of olefins. Due to the presence of the 
naphthalene backbone, BIAN ligands may also act as electron acceptors in the presence 
of strongly reducing metals. For example the addition of one, two, three or four 
equivalents of elemental sodium to dipp-BIAN (dipp = 2,6-di-iso-propylphenyl) 
respectively yielded the mono-, di-, tri- and tetra-anion salts [{dipp-BIAN}n-
{Nan(S)m}
n+] (n = 1, m = 0; n = 2, (S)m = (Et2O)3; n = 3, (S)m = (Et2O)2; n = 4, (S)m = 
(THF)4).
[255] This chemistry, extended to group 1,[256-258] group 2,[258-263] several p-block 
metals[263, 264] and, more recently, f-block elements,[261, 265] has been extensively 
explored, especially by the group of Fedushkin.  
The reaction between magnesium, calcium, strontium or barium metal and dipp-
BIAN in THF or DME invariably led to the isolation of alkaline earth complexes of the 
di-anion [dipp-BIAN]2-. The magnesium species [{dipp-BIAN}Mg(THF)3], 92, has 
been shown to act as a reducing agent for non-enolisable ketones via single electron 
N NR R
R = aryl or alkyl
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transfer to form the corresponding alcoholate magnesium radical-anion complex.[266] 
Complex 92 was also oxidised by halogenated tin, copper, mercury or silicon reagents 
to the radical-anion magnesium halide [{dipp-BIAN}MgX(S)n] (X = Cl, Br, (S)n = 
(THF)2; X = I, (S)n = DME) (Scheme 70).
[267] Furthermore, compound 92 and its 
strontium and barium analogues may deprotonate acidic substrates such as enolisable 
ketones,[268] phenylacetylene[269] or α-acidic nitriles[270] to give the corresponding 
enolate, acetylide or keteniminate group 2 complexes of the protonated monoanionic 
amine-amido ligand [dipp-BIAN(H)]-. Alkylation of the imine carbon of the BIAN 
ligand has also been observed in several cases. For example the reaction between 92 and 
ethyl halides resulted in the formation of a racemic imine-amido magnesium halide 
species through ethylation of the carbon adjacent to the amide functionality (Scheme 
70).[271] The mechanism proposed by the authors for the formation of these compounds 
involves a single electron transfer from 92 to the ethyl halide, yielding the intermediate 
radical-anion magnesium halide and Et•, followed by radical attack of Et• to form the 
ethylated magnesium halide complex. A similar alkyl transfer has also been observed in 
the reaction between n-BuLi or MR3 (M = Al, R = 
iBu; M = Ga, R = Et; M = In, R = Me) 
and dipp-BIAN in non-coordinating solvents, leading to the formation of a imine-amido 
complex bearing an alkyl substituent on the carbon adjacent to the amide 
functionality.[272, 273]  
 
Scheme 70. Versatile reactivity of the BIAN magnesium complex 92. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following study describes the facile synthesis of a series of NMR-active alkaline 
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ligand naphthalene backbone and their application to the intramolecular hydroamination 
of aminoalkenes. 
 
 
4.2.2 Synthetic and structural study of group 1 and group 2 C
5
-alkylated 
dearomatised BIAN compounds 
 
Addition of [KCH(SiMe3)2] to a suspension of dipp-BIAN in C6D6 caused instant 
solubilisation of the ligand precursor, accompanied by a rapid colour change from 
bright orange to dark green (Scheme 71). 1H NMR data indicated complete 
consumption of both starting materials and the formation of a single alkylated 
dearomatised potassium species, 93, characterised by six distinct multiplets in the 
region from 4.4 to 6.5 ppm. A COSY NMR experiment identified the alkylation of the 
acenaphthene backbone as having occurred in the C5 position (Scheme 71), which was 
confirmed by a subsequent X-ray diffraction analysis. As a consequence of the chiral 
centre thus formed, the two magnetically inequivalent (Si(CH3)3) groups appear as two 
separate (9H) singlets at 0.18 and 0.04 ppm respectively. The asymmetry of the 
monoalkylated ligand is reflected by a splitting of the iso-propyl methine and methyl 
resonances, both in the 1H and 13C{1H} NMR spectra.  
 
Scheme 71. Synthesis of potassium dimer 93. 
 
Recrystallisation at room temperature in toluene afforded dark green crystals of 
compound 93 suitable for X-ray diffraction. The result of this experiment is displayed in 
Figure 65, and selected bond length and angle data are listed in Table 15 and Table 16 
respectively. This is, to our knowledge, the first example of alkylation/dearomatisation 
of the naphthalene backbone in a BIAN ligand.  
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Figure 65. Ortep representation of compound 93. Thermal ellipsoids drawn at 30% probability. 
Hydrogens omitted except for those attached to chiral centre C(31). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15. Selected bond lengths (Å) for compounds 93, 99, 100 and 101. 
 
 93a 99 100b 101a 
M-N(1) 2.694(3)  2.571(4) 2.702(4) 
M-N(2) 2.703(3)  2.372(5) 2.762(4) 
N(1)-C(25) 1.281(4) 1.263(4) 1.287(7) 1.267(5) 
N(2)-C(36) 1.335(4) 1.283(5) 1.355(7) 1.318(5) 
C(25)-C(36) 1.518(4) 1.513(5) 1.489(8) 1.521(6) 
C(25)-C(26) 1.496(4) 1.489(5) 1.494(8) 1.489(6) 
C(34)-C(36) 1.393(4) 1.487(5) 1.418(8) 1.415(6) 
C(30)-C(31) 1.533(5) 1.523(5) 1.519(9) 1.524(6) 
C(31)-C(32) 1.517(5) 1.563(5) 1.510(9) 1.514(7) 
C(32)-C(33) 1.351(5) 1.501(5) 1.344(8) 1.390(6) 
C(32)-C(32’)  1.557(6)   
M-C(13) 3.243(3)   3.150(4)c 
M-C(14) 3.133(3)   3.321(5)d 
M-C(18) 3.096(4)   3.169(4)e 
M-C(19) 3.142(4)   2.974(4)f 
M-C(20) 3.223(4)    
M-C(21) 3.289(3)    
M-centroid 2.866(4)   2.884(5) 
 a- M = K b- M = Ca c- K’-C(30)    d- K’-C(33)    
 e- K’-C(34)    f- K’-C(35)      
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Similarly to the related potassium complex containing the radical-anion [dipp-
BIAN]-• ligand, compound 93 crystallises as a dimer in which the coordination 
environment about both potassium centres is provided by one of the η6-aryl substituents 
of the second molecule of 93, and the bidentate imine-amido dearomatised BIAN 
ligand.[257] The K-centroid and K-K’ distances of 2.866(4) and 4.5657(17) Å 
respectively are shorter than those in [{dipp-BIAN}K] [K-centroid 2.904; K-K’ 4.619 
Å].[257] Despite the asymmetry of the ligand framework the potassium-imine and 
potassium-amide K-N distances of 2.694(3) and 2.703(3) Å can be considered identical 
and within the range of those observed in [{dipp-BIAN}K].[257] Whereas the 
N(1)=C(25) bond length of 1.281(4) Å falls within the range of N=C bonds lengths of 
the ligand precursor [1.250(6) and 1.295(6) Å][257] the N(2)-C(36) bond of the amido 
fragment shows substantial elongation to 1.335(4) Å, although the distance is still short 
for a formal N-C single bond. While the ethanediylidyne C(25)-C(36) bridge remain 
unaffected by the charge redistribution [93, 1.518(4); dipp-BIAN 1.526(3) Å] the C(36)-
C(34) distance is considerably shortened compared to that in the ligand precursor [93 
1.518(4); dipp-BIAN 1.505(5) Å].[257] The dearomatised naphthalene ligand backbone is 
only slightly distorted from its original planar geometry. The C-C bond lengths and 
angles of the aromatic C6H3 ring [1.374(5) – 1.410(5) Å; 116.6(3) – 122.3(3)
o] remain 
within the range of those of the ligand precursor, whereas the dearomatised C6H3 ring is 
distorted due to the presence of the sp3 C(31) carbon centre [C(30)-C(31) 1.533(5); 
C(31)-C(32) 1.517(5) Å; C(30)-C(31)-C(32) 111.6(3)o]. The four-coordinate C(31) 
stereocentre is pseudo-tetrahedral [C(32)-C(31)-C(37) 111.3(3)o; C(32)-C(31)-C(30) 
111.6(3)o; C(30)-C(31)-C(37) 113.4(3)o].  
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Table 16. Selected angles (o) for compounds 93, 99, 100 and 101. 
 
 93a 99 100b 101a 
N(1)-M-N(2) 63.52(8)  70.08(15) 61.95(11) 
M-N(1)-C(1) 121.28(19)  132.0(3) 118.7(3) 
M-N(2)-C(13) 126.18(18)  130.7(3) 123.0(3) 
M-N(1)-C(25) 118.2(2)  109.7(3) 119.7(3) 
M-N(2)-C(36) 117.4(2)  114.8(3) 118.2(3) 
N(1)-C(25)-C(36) 121.7(3) 122.0(3) 121.5(5) 119.0(4) 
N(2)-C(36)-C(25) 119.0(3) 121.3(3) 120.1(5) 121.0(4) 
C(30)-C(31)-C(32) 111.6(3) 114.4(3) 111.8(5) 109.6(4) 
C(30)-C(31)-C(37) 113.4(3) 114.7(3) 113.6(5) 110.5(4) 
C(32)-C(31)-C(37) 111.3(3) 110.1(3) 111.8(5) 109.7(4) 
C(31)-C(32)-C(33)  117.9(3)   
C(33)-C(32)-C(32’)  109.9(2)   
C(31)-C(32)-C(32’)  110.7(4)   
N(1)-M-N(3)   169.65(14)  
N(1)-M-N(4)   115.92(15)  
N(2)-M-N(3)   115.99(15)  
N(2)-M-N(4)   117.49(16)  
N(1)-M-O(1)   84.08(14)  
N(2)-M-O(1)   123.06(16)  
N(3)-M-O(1)   85.57(14)  
N(4)-M-O(1)   119.42(16)  
a- M = K b- M = Ca 
 
Similarly, addition of [M{CH(SiMe3)2}2(THF)2] (M = Ca 37b, Sr 37c) to a 
suspension of dipp-BIAN in C6D6 resulted in instant solubilisation of the starting 
materials and a rapid colour change to dark green. The analogous reaction with 
[Mg{CH(SiMe3)2}2(THF)2] required 24 hours heating at 60 
oC to yield the same result 
(Scheme 72). In all three cases 1H NMR spectra were reminiscent of that of 93, showing 
clean formation of the heteroleptic alkaline earth organometallic species 94, 95 and 96, 
with the additional (18H) and (1H) singlets of the metal-bound monoanionic 
[CH(SiMe3)2]
- co-ligand at ca. 0.3 ppm and -1.7 ppm respectively. Figure 66 shows the 
annotated 1H NMR spectrum of the calcium complex 95 synthesised in toluene. 
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Scheme 72. Synthesis of magnesium, calcium and strontium compounds 94, 95 and 96. 
 
 
 
 
 
 
 
 
Figure 66. Annotated 1H NMR spectrum of the dearomatised calcium complex 95. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although the analogous reaction with the barium dialkyl 37d also led to an instant 
colour change to dark green, 1H NMR data at the first point of analysis showed the 
formation of three distinct dearomatised species, among which the heteroleptic barium 
alkyl complex 97 (50-70% yield) was identified by the characteristic upfield Ba-
CH(SiMe3)2 proton shift at -1.73 ppm (Scheme 73). A subsequent independent synthesis 
of the homoleptic barium complex 98 from the reaction between two equivalents of the 
potassium complex 93 and barium iodide (vide infra) enabled the identification of the 
second component of the reaction mixture as complex 98, present in 25-40% yield.  
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Scheme 73. Reaction of the barium dialkyl 37d with dipp-BIAN. 
 
 
 
 
 
 
 
 
 
 
Crystallisation of this reaction mixture from a 1:2 toluene/hexane solution at -30 oC 
over several days also provided orange crystals suitable for X-ray diffraction, which 
yielded the surprising structure of compound 99, composed of two C5-alkylated 
dearomatised BIAN ligands coupled at the C4 position. The result of this experiment is 
displayed in Figure 67. Selected bond length and angle data are provided in Table 15 
and Table 16 respectively. Compound 99 crystallises as a single (4R, 4’R, 5S, 5’S) 
enantiomer (absolute structure parameter = 0.03(15)) in the chiral space group P 31 2 1. 
As in the ligand precursor, both N-C bond lengths [1.263(4), 1.283(5) Å] are indicative 
of imine bonds. The presence of the two pseudo-tetrahedral sp3 carbon centres, C(31) 
[C(30)-C(31)-C(32) 114.4(3)o; C(30)-C(31)-C(37) 114.7(3)o; C(32)-C(31)-C(37) 
110.1(3)o] and C(32) [C(31)-C(32)-C(33) 117.9(3)o; C(33)-C(32)-C(32’) 109.9(2)o; 
C(31)-C(32)-C(32’) 110.7(4)o], induces a significant distortion of the alkylated C6H3 
ring of the ligand backbone, accompanied by an increase in the C-C bond lengths 
[C(30)-C(31) 1.523(5); C(31)-C(32) 1.563(5); C(31)-C(32) 1.501(5) Å]. Although the 
mechanism of formation of 99 remains unclear, it may be explained by taking into 
account the well-known ability of the BIAN ligand to act as electron acceptor. Two-
electron oxidation of the alkylated ligand to form the coupled product 99 may thus be 
accompanied by two-electron reduction of one equivalent of either the dipp-BIAN 
ligand precursor or the alkylated/dearomatised ligand. Efforts are currently under way 
to rationalise the synthesis of compound 99.  
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Figure 67. Ortep representation of compound 99. Thermal ellipsoids drawn at 30% probability. Iso-
propyl methyl groups and hydrogens omitted except for those attached to the chiral centres C(31) and 
C(32). 
 
 
 
 
  
 
 
 
 
 
 
 
Multiple attempts to obtain crystals of the alkaline earth organometallic complexes 
94-97 suitable for X-ray analyses were thwarted by the extreme solubility of these 
compounds even after months of storage at -30 oC in minimal amounts of hydrocarbon 
solvents such as hexane or pentane. NMR data and elemental analyses of the crude 
magnesium, calcium and strontium products, however, left no doubt as to their 
formulation. Attempts to recover the alkylated amino-imine ligand by controlled 
hydrolysis of the organometallic complexes initially led to a colour change from green 
to purple, followed by a gradual change towards dark red over a period of several hours. 
1H NMR data and later recrystallisation of the crude product from toluene showed 
quantitative conversion to the re-aromatised dipp-BIAN ligand precursor with 
formation of the alkane CH2(SiMe3)2. Although the mechanism of this reaction remains 
to be elucidated it is possible that the extreme stability of the aromatic BIAN ligand 
may be the driving force of this de-alkylation process.  
The kinetic stability of the heteroleptic complexes 94, 95 and 96 was assessed by 
heating a d8-toluene solution of these compounds at 80 
oC for a week. Apart from a 
slight amount of protonolysis of the alkyl ligand into the alkane CH2(SiMe3)2 in the 
cases of 95 and 96 (< 5%), possibly due to reaction with the solvent, the 1H NMR 
spectra remained virtually unchanged, suggesting an absence of Schlenk-type ligand 
redistribution processes. Addition of two equivalents of the ligand precursor to one 
equivalent of the magnesium, calcium or strontium dialkyl species in d8-toluene did not 
yield the expected homoleptic complexes at room temperature. Rather, the heteroleptic 
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complexes 94, 95 and 96 were formed while the excess ligand remained unreacted. 
Heating of these mixtures at 90 oC over a period of several days did not result in 
reaction with the second equivalent of ligand. Instead, partial protonation of the alkyl 
co-ligand and a substantial decrease in the methyl signal of the toluene solvent peak 
were observed, suggesting deprotonation of the solvent had occurred. In contrast, the 
analogous reaction with the barium dialkyl, 37d, in d8-toluene led to the complete 
solubilisation of both equivalents of ligand within ten minutes at room temperature 
(Scheme 74). 1H NMR data showed complete consumption of the ligand precursor and 
37d, concomitant with the clean formation of a single dearomatised species identified 
as the homoleptic barium compound 98 by comparison with the NMR data obtained 
from the independent synthesis of 98 from the potassium complex 93 and barium 
iodide. Although the 1H NMR spectrum of 98 remained relatively simple, the 
complexity of the 13C{1H} spectrum indicated that the 2,6-di-iso-propylphenyl groups 
are no longer equivalent due to the conformational restriction induced by the steric 
crowding about the barium metal centre. 
 
Scheme 74. Independent syntheses of the homoleptic barium complex 98. 
 
Stoichiometric NMR scale reactions of calcium complex 95 with protic substrates 
such as hexamethyldisilazane, diphenylamine or diphenylphosphine in C6D6 resulted in 
immediate protonolysis of the alkyl co-ligand, as observed in the 1H NMR spectra by 
the disappearance of the up-field Ca-CH(SiMe3)2 singlet at -1.72 ppm and the 
appearance of the characteristic alkane resonance at -0.2 ppm (Scheme 75). Given the 
comparable steric demands of the bis(trimethylsilyl)amide and 
bis(trimethylsilyl)methanide co-ligands, the resulting heteroleptic calcium 
bis(trimethylsilyl)amide complex evidenced solution stability similar to complex 95. In 
contrast, monitoring by 1H NMR spectroscopy of the heteroleptic calcium complexes 
bearing the less sterically demanding diphenylamide and diphenylphosphide co-ligands 
under the same conditions suggested slow Schlenk-type ligand redistribution towards 
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the homoleptic calcium species 100 characterised by the broadening and shifting of the 
dearomatised ligand backbone and iso-propyl resonances, accompanied by precipitation 
of insoluble colourless products tentatively attributed to homoleptic calcium amide and 
phosphide species (Scheme 75) which are known to be insoluble in non-coordinating 
hydrocarbon solvents.[274] An independent synthesis of complex 100 by the reaction 
between two equivalents of potassium complex 93 and calcium iodide in THF 
confirmed the nature of the complex formed.  
 
Scheme 75. Stoichiometric reactivity of calcium complex 95 with protic substrates. 
 
 
 
 
 
 
 
 
Crystals of compound 100 suitable for X-ray diffraction analysis were isolated from 
the reaction of 95 with diphenylphosphine after storage in a 4:1 toluene-THF mixture at 
-30 oC for several weeks. The result of this experiment is displayed in Figure 68. 
Selected bond length and angle data are listed in Table 15 and Table 16 respectively. 
Contrary to the homoleptic calcium β-diketiminate complex [{HC(CMeNAr}2}2Ca] (Ar 
= 2,6-di-iso-propylphenyl),[275] but similarly to the homoleptic complex of the radical-
anion [{dipp-BIAN}2Ca(THF)],
[260] compound 100 crystallises as a mono-THF adduct. 
The five-coordinate calcium centre presents a highly distorted trigonal bipyramidal 
geometry (τ = 0.78)[149] with both imine nitrogen atoms in axial positions. The mean 
planes formed by the two almost planar ligand backbones form an angle of 82.8o. While 
in the case of complex 93 the KN2C2 ring remains planar, the presence of the large 
calcium centre in 100 causes a slight distortion in the CaN2C2 rings. The N(1)-Ca-N(2) 
and N(3)-Ca-N(4) bite angles of the two alkylated BIAN ligands [70.08(15) and 
69.66(15)o respectively] are notably smaller than the N-Ca-N angles observed in 
calcium complexes supported by a doubly reduced BIAN ligand [75.76(7) – 
78.5(2)o][259] or the homoleptic complex of the radical-anion [{dipp-BIAN}2Ca(THF)] 
[73.58(9) o].[260] The Ca-Nimine distances of 2.571(4) and 2.573(5) Å are substantially 
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longer than the Ca-Namide bonds of 2.372(5) and 2.353(5) Å, reflecting the stronger 
bonding between the metal centre and the anionic amide moiety of the ligand. As for the 
potassium complex 93 the N(2)-C(36) and N(4)-C(79) bond lengths of the amide 
residues [1.355(7) and 1.347(7) Å] are significantly longer than the N(1)=C(25) and 
N(3)=C(68) bond lengths of the imine moieties [1.287(7) and 1.279(7)Å], while the 
ethanediylidyne bridges are slightly shorter in 100 than in 93 [100 1.489(8) and 
1.509(8) Å; 93 1.518(4) Å]. As previously observed for compound 93, the 
dearomatisation of the alkylated C6H3 rings only induces a slight distortion from 
planarity despite the presence of the sp3 C(31) and C(74) carbon centres indicated by 
the elongated C-C bond lengths [C(30)-C(31) 1.519(9); C(31)-C(32) 1.510(9); C(73)-
C(74) 1.521(8); C(74)-C(75) 1.499(8) Å] and the pseudo-tetrahedral angles [C(32)-
C(31)-C(30) 111.8(5); C(32)-C(31)-C(37) 111.8(5); C(30)-C(31)-C(37) 113.6(5); 
C(75)-C(74)-C(73) 111.4(5); C(75)-C(74)-C(80) 111.9(5); C(73)-C(74)-C(80) 
114.8(5)o]. 
 
 
Figure 68. Ortep representation of compound 100. Thermal ellipsoids drawn at 30% probability. Iso-
propyl methyl groups and hydrogens omitted except for those attached to the chiral centres C(31) and 
C(74). 
 
 
 
 
 
 
 
 
 
 
 
 
An interesting insight into the possible mechanism of formation of these 
alkylated/dearomatised BIAN complexes came from the result of the reaction between 
the potassium benzyl complex [K{CH(SiMe3)(2-NMe2-C6H4)}] and dipp-BIAN in 
toluene (Scheme 76). As for the analogous reaction with [KCH(SiMe3)2] the reaction 
mixture instantly turned dark green. 1H NMR data indicated the formation of complex 
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101 as a mixture of two diastereomeric dearomatised potassium complexes alkylated in 
the C5 position of the acenaphthene backbone in an 88:12 mixture.  
 
Scheme 76. Synthesis of the potassium hexamer 101. 
 
 
 
 
 
 
Crystallisation from this solution after one day at room temperature yielded green 
crystals of compound 101 suitable for X-ray diffraction analysis. The result of this 
experiment is illustrated in Figure 69. Selected bond length and angle data are listed in 
Table 15 and Table 16 respectively. Compound 101 crystallises as a single (R,S) + (S,R) 
diastereomer which, according to crystalline yield (~80%), was identified as the major 
diastereomer observed in the 1H NMR spectrum. Each potassium centre is coordinated 
to the imine and amide functionalities of the dearomatised BIAN ligand and completes 
its coordination sphere by an η4 interaction with the conjugated system of the alkylated 
C6H3 ring of the ligand backbone, with a K-centroid distance of 2.884(5) Å. Contrary to 
potassium complex 93 the K-N bond lengths in 101 reflect the asymmetry of the 
alkylated amido-imine ligand [K-Nimine 2.762(4); K-Namide 2.702(4) Å]. The pi-
interaction between the potassium centres and the ligand backbone causes a strong 
distortion of the latter from planarity in both the aromatic and the alkylated C6H3 rings 
of the naphthalene fragment. Although calculations would be required to support this 
hypothesis, it seems possible that alkylation of the ligand occurs via pre-coordination of 
the relevant metal alkyl complex to the aromatic naphthalene backbone in these cyclic 
arrays, followed by alkyl transfer by insertion.  
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Figure 69. Ortep representation of compound 101. Ellipsoids drawn at 30% probability. Left: two-
molecule view of the complex. Iso-propyl methyl groups and hydrogens omitted except for those attached 
to the chiral centres C(31) and C(37). Right: hexameric unit of complex 101. Hydrogens omitted for 
clarity except for those attached to the chiral centres C(31) and C(37). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.3 Computational study of alkylation regioselectivity 
 
Preliminary DFT calculations were undertaken to investigate the regioselectivity of 
this BIAN alkylation process on the model complexes [{Cn-iPr-(tBu-BIAN)}Ca(iPr)] (n 
= 3, 102; 4, 103; 5, 104) using B3LYP density functional theory and a 6-31G basis set 
implemented in Gaussian03.[220] Independent frequency calculations confirmed the 
optimised geometries as true minima. To reduce computational expense, the bulky 2,6-
di-iso-propylphenyl groups were replaced by less demanding tert-butyl groups thought 
to best reflect the steric demands of these substituents, while the silicon atoms and 
methyl groups of the CH(SiMe3)2 fragments were replaced by carbon and hydrogen 
atoms respectively. Although NMR and elemental analysis data confirmed the presence 
of two adducted THF molecules on the parent complex 95, their presence was deemed 
unnecessary in an assessment of alkylation regioselectivity. Figure 70 illustrates the 
results of this study in the form of an energy diagram. 
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Figure 70. Energy diagram of the optimised (DFT, B3LYP/6-31G) structures of compounds (a) 102, (b) 103 and (c) 
104.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The C5-alkylated isomer 104 was calculated to be the most stable product with the 
C3- and C4-alkylated isomers 30.2 kJ.mol-1 and 121.8 kJ.mol-1 higher in energy 
respectively. The observed regioselectivity may arise from both electronic stabilisation 
and minimisation of the steric repulsion between the alkyl substituent on the 
naphthalene backbone and the nitrogen-bound substituents. The bond lengths and 
angles calculated in 104 show good agreement with those obtained experimentally from 
the crystal structure of the homoleptic calcium complex 100 (compare Tables 15 and 16 
and Figure 71, caption), except for the Ca-N bond lengths which are considerably 
longer in compound 100 (avg. 2.73 Å) compared to the model complex 104 (avg. 2.53 
Å). This is most likely due to the lower coordination number employed for complex 104. 
The shorter Ca-N(2) bond length [2.48 Å] compared to Ca-N(1) [2.57 Å] in 104, 
however, confirms the asymmetric nature of the bonding between the alkaline earth 
dication and the alkylated amido-imine ligand. The calculated Ca-C(50) bond length of 
2.57 Å between the calcium centre and the alkyl co-ligand is slightly longer than that in 
the calcium dialkyl precursor [2.4930(18) Å],[144] which can be explained by the 
difference in polarity arising from the replacement of the silicon atoms with carbon 
atoms. Molecular orbital (MO) analysis showed that the LUMO (Figure 71b) is 
delocalised over the conjugated pi-system of the ligand, while the HOMO remains 
localised on the side of the ligand which underwent dearomatisation and on the amido 
functionality (Figure 71c). The HOMO-1 (Figure 71d) encompasses the σ-antibonding 
30.2 kJ.mol-1 
121.8 kJ.mol-1 
(a) 
(b) 
(c) 
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between the metal centre and the ligands. Natural Bond Orbital (NBO) calculations 
were undertaken and the calculated charges (Ca +1.12, N(1) -0.68, N(2) -0.79, C(50) -
0.44) were indicative of essentially ionic bonding. 
 
Figure 71. (a) Optimised (DFT, B3LYP/6-31G) structure of compound 104. Selected bond lengths (Å): Ca-
C(50) 2.57, Ca-N(1) 2.48, Ca-N(2), 2.38, N(1)-C(25) 1.31, N(2)-C(36) 1.35, C(25)-C(36) 1.56, C(25)-
C(26) 1.50, C(34)-C(36) 1.41, C(30)-C(31) 1.52, C(31)-C(32) 1.51, C(32)-C(33) 1.36. Selected angles (o): 
N(1)-Ca-N(2) 70.58, Ca-N(1)-C(25) 114.50, Ca-N(2)-C(36) 117.86, N(1)-C(25)-C(36) 119.65, N(2)-
C(36)-C(25) 116.55, C(30)-C(31)-C(32) 111.13, C(30)-C(31)-C(37) 112.44, C(32)-C(31)-C(37) 111.75. 
(b) LUMO of 104. (c) HOMO of 104. (d) HOMO-1 of 104. 
 
 
 
4.2.4 Preliminary scope of intramolecular hydroamination  
 
Calcium complex 95 was assessed for the intramolecular hydroamination of a wide 
range of substituted aminoalkenes on an NMR scale in C6D6 or d8-toluene. In all cases 
careful inspection of the 1H NMR data showed no change suggestive of ligand 
redistribution in the characteristic shifts of the dearomatised ligand backbone 
throughout the reaction times.  
C30 
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C37 
C32 
C33 
C34 C36 
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C25 Ca 
N1 
C35 
C26 
C50 
(a) (b) 
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Table 17. Scope of hydroamination/cyclisation with magnesium and calcium precatalysts 94 and 95. 
 
Entry Substrate Product Catalyst (mol %) Time / h T / 
o
C NMR yield / %
a 
1 
 
NH2
 
 
NH
Me
Me
Me  
95, 2 mol % 1 25 95 
2 
NH2
 
NH
Me
 
95, 1 mol % 0.3 25 99 
3 
 
NH2
Ph Ph
 
 
 
NH
Me
Ph
Ph  
95, 0.5 mol % 0.25 25 >99 
4 NH2
Ph Ph
 
NH
Me
Ph
Ph
Me
 
95, 2 mol % 1 25 98 
5 NH2
Ph Ph
 
NH
Ph
Ph
 
95, 5 mol % 5 25 95 
6 NH2
Ph Ph
 
NH
i-Pr
Ph
Ph  
95, 5 mol % 24 110 0 
7 
 
NH2
Ph Ph
 
 
 
95, 2 mol % 1 25 85:11b 
8 
 
 
9 
NH2
Ph Ph
 
N
Me
Ph
Ph H
+
NH2
Ph Ph
 
94, 20 mol % 
 
 
95, 20 mol% 
24 
 
 
48 
80 
 
 
90 
95:0
b, c
 
 
 
0:21
b
 
10 
H
N Ph
 
N
Me
Ph
95, 5 mol % 3.5d 60 92 
11 
H
N
 
 
N
Me
 
95, 5 mol % 3.5d 60 22d 
12 
 
NH2
 
  
95, 5 mol % 18 60 24 
a- NMR yields were measured against TMSS as an internal standard in C6D6 or d8-toluene. 
b- Cyclisation: isomerisation. 
c- Yield after hydrolysis. 
d- Substrate conversion >99%: the remaining products derive from recombination and isomerisation reactions. 
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Complete disappearance of the distinctive up-field alkyl singlet at ca. -1.7 ppm 
within the first point of analysis was indicative of rapid and irreversible catalyst 
initiation. Comparison of the results listed in Table 17 with previous intramolecular 
hydroamination experiments carried out with the THF-free calcium β-diketiminate 
complex 33 (Table 2) indicated that cyclisation with 95 generally occurred faster, and at 
lower temperature and catalyst loading, with the exception of more hindered α-
substituted or secondary aminoalkenes (Table 17, entries 10-12). Especially remarkable 
was the fast cyclisation of 1-amino-2,2-diphenyl-4-hexene at room temperature (entry 5) 
as shown by the 1H NMR stack plot displayed in Figure 72. The only other calcium 
precatalyst to have achieved this reaction, [Ca{N(SiMe3)2}2(THF)2] (Table 2, entry 14), 
required forcing conditions and gave much lower yields (20 mol%, 100 oC, 6 days, 63% 
yield).  
 
Figure 72. 
1H NMR stack plot from the room temperature intramolecular hydroamination of 1-amino-
2,2-diphenyl-4-hexene (♦  characteristic signals of the dearomatised ligand backbone).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The terminally disubstituted aminoalkene 1-amino-2,2-diphenyl-5-methyl-4-hexene, 
however, did not undergo cyclisation under the forcing reaction conditions employed 
(Table 17, entry 6). Similarly to all other calcium precatalysts studied thus far 95 did not 
allow the cyclisation of 1-amino-2,2-diphenyl-6-heptene (entry 9). The same reaction 
17% conversion       20 min 
85% conversion       3h 
92% conversion       4h 
♦    ♦       ♦     ♦        ♦ 
♦    ♦       ♦     ♦        ♦ 
♦    ♦              ♦        ♦ 
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performed with the magnesium analogue 94, however, yielded surprisingly swift 
conversion of this substrate to the hexahydroazepine product (94: 20 mol%, 24h, 80 oC, 
95% yield; compared to 1: 20 mol%, 3 days, 100 oC, 97% yield). The important 
increase in reactivity for aminoalkenes bearing a primary amine moiety can clearly be 
attributed to the fast and irreversible initiation of the calcium precatalyst while the 
dramatic decrease in reactivity for substrates with secondary amine moieties may arise 
from the steric hindrance of the two, at least initially, adducted THF molecules, a 
phenomenon that had already been observed in the comparison between 33 and its THF-
solvated analogue 2 (Table 2, entries 29, 33 and 37). This same steric hindrance, 
however, seemed to have a positive influence on the diastereoselectivity of the 
cyclisation of 2-amino-5-hexene which favoured the trans-2,5-dimethylpyrrolidine 
product in 91% diastereomeric excess, albeit in very low yield (Table 17, entry 12).  
 
 
4.2.5 Conclusion and future work 
 
While providing fast and irreversible catalyst initiation, calcium complex 95 is also 
the first calcium precatalyst to efficiently effect the cyclisation of a terminally alkyl-
substituted aminoalkene at room temperature in near quantitative yield. In comparison, 
lanthanide alkyl precatalysts generally require high temperatures (125o) to achieve the 
cyclisation of aminoalkenes with unactivated internal olefin moieties,[134, 135] while 
magnesium phenoxyamine precatalysts (20 mol%) reported by Hultzsch and co-workers 
performed the cyclisation of 1-amino-2,2-diphenyl-4-hexene at 150 oC with only 
moderate yields (47-69%).[152] New group 2 alkyl precatalysts are yet to be designed to 
accomplish the hydroamination of terminally disubstituted aminoalkenes. Although 
only preliminary, these results show promising potential for this new series of alkaline 
earth precatalysts, the first one to provide facile access to highly reactive analogous 
heteroleptic magnesium, calcium and strontium alkyl species, the full scope of whose 
catalytic reactivity has yet to be investigated.  
Although the heteroleptic magnesium, calcium and strontium complexes 94-96 
themselves show no tendency towards ligand lability in solution or during 
intramolecular hydroamination catalysis, the introduction of smaller anionic co-ligands 
seems to inevitably induce irreversible Schlenk-type ligand redistribution processes. In 
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order to avoid these undesirable processes further work may involve introducing more 
sterically demanding nitrogen-bound substituents onto the BIAN ligand framework. 
Although complexes 94-96 present a chiral centre in the C5 position of the ligand 
backbone, they form as racemic mixtures. Besides, the chiral centre is too far removed 
from the coordination sphere of the metal centre to have much influence upon 
enantioselectivity during catalysis. The introduction of chiral nitrogen-bound 
substituents onto the BIAN framework would therefore be necessary in order to develop 
potentially enantioselective alkaline earth precatalysts based upon dearomatised BIAN 
ligands. A new synthetic route to chiral anilines developed by Coates and co-workers, 
for example, has enabled the synthesis of the first chiral aryl-BIAN ligands (Figure 
73A), which have been successfully used in stereoselective nickel-catalysed 
polymerisation reactions.[254, 276] The presence of benzylic protons on these ligands, 
however, could make them unsuitable for reactions with highly basic alkaline earth 
dialkyls. The difficulty of synthesising chiral alkyl-BIAN ligands was only recently 
overcome by Hagar et al. by using chiral cyclopropylamine precursors (Figure 73B) 
which prevent the decomposition by isomerisation usually observed in alkyl-BIAN 
ligands bearing non-cyclic alkyl substituents.[277] Alternatively, asymmetric amido-
imine ligands obtained by alkylation in the C1 position of dipp-BIAN by group 13 
trialkyls may also present suitable candidates, as Fedushkin and co-workers reported 
that both [{C1-Et-(dipp-BIAN)}Ga(Et)2] and [{C
1-Me-(dipp-BIAN)}In(Me)2] 
crystallise as separate isomers, of which the free ligands may be recovered by controlled 
hydrolysis of the complexes (Figure 73C).[273]  
 
Figure 73. Extent of currently available chiral BIAN or BIAN-derived ligands. 
 
Beyond BIAN ligands, this novel alkylation/dearomatisation chemistry with alkaline 
earth dialkyl and dibenzyl species may well apply to other neutral ligand precursors 
with conjugated pi-systems. Kiplinger and co-workers, for example, have already 
described the dearomatisation of terpyridine ligands by lutetium trialkyls.[278] More 
N N
Ar
Ar
Ar
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N N
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H
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R
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recently, Kaneko et al. also reported the monoalkylation and dialkylation of Ar-DAB 
ligands (Ar = 2,6-dimethylphenyl, 2,6-di-iso-propylphenyl) by rare earth 
[M{CH2(SiMe3)}3(THF)2] (M = Sc, Y) complexes to form the amido-imine and 
diamido complexes respectively.[107] Other potential candidates may include bipyridine- 
or phenanthroline-based ligands. 
 
Scheme 77. Dearomatisation of pyridine by a homoleptic calcium allyl complex and a heteroleptic 
magnesium alkyl complex in the presence of phenylsilane. 
 
 
 
 
 
  
 
 
Recent reports by Okuda and co-workers on the alkylation and C-H activation of 
pyridines with a calcium bis(allyl) complex (Scheme 77A),[279] and by Hill et al. on the 
dearomatisation of pyridine with a β-diketiminate-supported magnesium hydride 
complex (Scheme 77B),[280] also open the possibility of heterocycle coupling which has 
been recently reported by Diaconescu and co-workers using group 3 and lanthanide 
benzyl complexes (Scheme 78).  
 
Scheme 78. Pyridine coupling and dearomatisation at group 3 centres. 
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5 General conclusions and perspectives 
 
Although the breakthrough in the development of a well-defined chemistry of the 
heavier alkaline earth elements originated in similarities with the equally ionic, redox 
inactive lanthanide (III) d0 complexes, and a common reactivity pattern based upon σ-
bond metathesis and insertion reaction, it is becoming more and more apparent that, 
rather than simply being lanthanide-mimetic, alkaline earth organometallics have a 
distinct chemistry of their own. Contrary to the linear trends displayed across the series 
of lanthanide elements, only marked by slight variations in electropositivity and size, 
the stark differences in ionic radii, and consequently charge density, across the alkaline 
earth group from magnesium to barium (Figure 74) also lead to marked differences in 
reactivity, not only between group 2 and f-elements, but also between the group 2 
elements themselves.  
 
Figure 74. Average charge density trends derived from the 6-coordinate ionic radii of the alkaline earth 
(II) and lanthanide (III) cations.[6] 
 
 
 
 
 
 
 
 
 
 
These discrepancies are particularly highlighted by the study of the alkaline earth-
mediated intramolecular hydroamination reaction. Instead of a smooth increase in 
catalytic activity from magnesium to barium, as observed in the lanthanide series from 
the smallest (lutetium) to the largest (lanthanum) metal centre, catalytic activity 
increases dramatically from magnesium to calcium, drops again for strontium, and 
becomes quasi inexistent for barium, a trend which may be explained by the complex 
interaction between entropic effects, such as substrate access to the catalytic metal 
centre or the dimerisation of key intermediate species, and charge density effects, such 
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as the polarising capacity of the individual group 2 metal centre. Moreover, the 
observation of a rate law displaying a first-order decline in [substrate], rather than the 
zero-order dependence observed in lanthanide-mediated hydroamination/cyclisation 
reactions, also hints at intrinsic mechanistic differences which will require further 
computational investigations.  
 
The search for monoanionic ligands capable of stabilising heteroleptic alkaline earth 
complexes bearing highly reactive alkyl functionalities has led to the discovery of a new 
dearomatisation/alkylation reactivity providing easy access to the desired group 2 
precatalysts. Further work will be required to design new chiral alkaline earth 
precatalysts based upon this chemistry and to improve kinetic stability against 
detrimental ligand redistribution processes in solution, especially for the larger group 2 
cations.  
 
While the potential of the alkaline earth elements has long been underestimated, the 
last decade has seen a dramatic increase in the number and variety of group 2-catalysed 
reactions. The now readily available alkaline earth hydride, alkyl, benzyl and allyl 
species offer new possibilities for stoichiometric and catalytic reactivity. As this 
chemistry is still in its infancy, years to come could see a surge in new group 2-
mediated heterofunctionalisation reactions (e.g. hydroboration, hydroalkoxylation, 
hydrothiolation, but also aminoboration, silylboration etc. of unsaturated bonds), 
functionalisation reactions of aromatic heterocycles, as well as a plethora of more 
challenging group 2-catalysed dehydrocoupling reactions to form new element-element 
σ-bonds (e.g. N-P, P-Si, O-Si, Si-Si, perhaps even C-C bonds) as suggested in Figure 75.  
 
Figure 75. Potential catalytic cycles envisaged for new alkaline earth-mediated heterofunctionalisation 
and dehydrocoupling reactions. 
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6  Experimental 
 
 
6.1 General experimental procedures 
 
All reactions dealing with air- and moisture sensitive compounds were carried out 
under argon atmosphere using standard Schlenk line and glovebox techniques in an 
MBraun Labmaster glovebox at O2, H2O < 0.1 ppm. NMR experiments using air-
sensitive compounds were conducted in Youngs tap NMR tubes prepared and sealed in 
a glovebox under argon. For kinetic analysis samples were frozen to -196 oC 
immediately after preparation and defrosted before transfer into the NMR machine. 
Except if stated otherwise, all NMR data was acquired on a Bruker 300 UltrashieldTM 
for 1H (300 MHz), 13C{1H} (75.48 MHz) and 11B (96.25 MHz) spectra at room 
temperature, or on a Bruker 400 UltrashieldTM for variable temperature, kinetics and 2D 
experiments (1H at 400 MHz and 13C at 100 MHz). Except if stated otherwise all NMR 
data was acquired at 298 K. 1H/13C NMR spectra were referenced using residual solvent 
resonances. Infrared analyses of air-sensitive organometallics were conducted using 
KBr plates pressed under an argon atmosphere, organic compounds were analysed as 
KBr discs or dichloromethane films. Melting points were determined in sealed 
capillaries. Elemental analyses of all moisture- and air-sensitive compounds were 
performed by Stephen Boyer of London Metropolitan Enterprises. X-ray diffraction 
data was collected at 150 K on a single crystal FR590 Nonius KappaCCD 
diffractometer, equipped with Oxford Cryosystems, using graphite-monochromated Mo 
Kα radiation (λ =0.71073 Å), by Dr G. Kociok-Köhn, Dr D. MacDougall or the author 
at the University of Bath. Data was processed using Nonius Software.[281] Crystal 
parameters and details on data collection, solution and refinement of all the complexes 
are presented in the supplementary data section. Structure solution, followed by full-
matrix least-squares refinement, was performed using the WINGX-1.70 suite of 
programs throughout.[282] 
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6.2 Solvents and reagents 
 
 
Glassware, Celite and molecular sieves were dried for 24 hours in an oven at 150 °C 
prior to use. 
 
Solvents: Solvents for air- and moisture-sensitive reactions were provided by an 
Innovative Technology Solvent Purification System. Hexane, toluene and benzene were 
used as collected whereas THF and diethyl ether were first dried by distillation over 
sodium-benzophenone ketyl. All solvents were stored under argon over molecular 
sieves activated at 150 oC in vacuo. C6D6, d8-THF and d8-toluene were purchased from 
Fluorochem and dried over molten potassium prior to vacuum transfer into a sealed 
ampoule and storage in the glovebox under argon.  
 
Inorganic reagents: (Tetrakis(trimethylsilyl))silane (TMSS) was purchased from Goss 
Scientific Instruments Ltd. and used as received. MgI2, CaI2, SrI2 and BaI2 were 
purchased from Sigma-Aldrich and used as received. Solid potassium 
hexamethyldisilazane was either purchased from Sigma-Aldrich and used as received or 
synthesised from stirring hexamethyldisilazane with an excess of potassium hydride in 
toluene at room temperature for 24 hours. 2.5M n-Bu-Li in hexanes and LiAlH4 were 
purchased from Fisher Scientific and used as received. 
 
Amines: All bromo- and chloroalkenes, nitriles and amines were purchased from 
Sigma-Aldrich and used as received. After drying over CaH2 all aminoalkenes were 
distilled in vacuo and either vacuum transferred into sealed ampoules or freeze-dried 
prior to transfer into the glovebox. 
 
Ligand precursors: 1-(tert-butyl)imidazole,[208] 1-mesitylimidazole,[219] the β-
diketiminate ligand precursor [(Dipp)NC(Me)CHC(CMe)NH(Dipp)] (Dipp = 2,6-di-iso-
propylphenyl),[153] 2,6-diphenylmethyl-p-toluidine,[156] the halogenated boranes 
Me3N.BH2I,
[283] Me3N.BH2Br, Me3N.BHBr2 (variation of the procedure reported for 
Me3N.BBr3)
[284] and Ph2BBr,
[285] the tridentate carbene ligand precursors 
[HB(ImtBu)3]Br2 and [HB(ImMes)3]Br2,
[207] the bis(imino)pyridine ligand precursor 
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[2,6-{(Dipp)NCMe}2(C5H3N)]
[286] and [Dipp-BIAN][251] were all synthesised using 
literature procedures.  
Organometallics: The homoleptic group 2 amides and alkyls [M{N(SiMe3)2}2] (M = 
Mg 35a, Ca 35b, Sr 35c, Ba 35d)[142] [M{N(SiMe3)2}2(THF)2] (M = Mg 36a, Ca 36b, 
Sr 36c, Ba 36d)[143] and [M{CH(SiMe3)2}2(THF)2] (M = Mg 37a, Ca 37b, Sr 37c, Ba 
37d)[144] were synthesised using literature procedures. 
 
 
6.3 Equations 
 
Van’t Hoff analyses of equilibria 
( ))ln)( To KRTTG −=∆  
ooo STHTG ∆−∆=∆ )(  
R = molar gas constant (1.9858775 cal.mol-1.K-1) 
∆Go = Gibbs free energy (J.mol-1) 
∆Ho = free enthalpy (J.mol-1) 
∆So = free entropy (J.mol-1.K-1) 
KT = equilibrium constant 
T = temperature (K) 
 
Activation energies of NMR fluxional processes 
2
o
f
v
k
∆
=
pi
 
∆G‡(T) = -RTc ln(kf) 
∆νo = maximum peak to peak separation (s
-1) 
∆G‡ = Gibbs free energy of activation (J.mol-1) 
Tc = coalescence temperature (K) 
kf = rate of exchange (s
-1) 
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A
M
C
B
D
E
Arrhenius equation  
B
RT
E
k aT +−=)ln(  
Ea = activation energy in (J.mol-1) 
kT = reaction rate (s
-1) 
B = constant 
Eyring equation 
 
 
∆G‡(T) = ∆H‡ - T∆S‡ 
h = Planck constant (6.626068*10-34 m2.kg.s-1) 
kB = Boltzmann constant (1.3806503*10
-23 m2.kg.s-1.K-1) 
∆H‡ = enthalpy of activation in (J.mol-1) 
∆S‡ = entropy of activation in (J.mol-1.K-1) 
 
Degree of trigonality of 5-coordinate metal centres
[149]
 
60
αβ
τ
−
=  
A = axial ligand 
β = largest basal angle (B-M-D) 
α = second largest basal angle (C-M-E) 
Perfect spare pyramidal geometry: τ = 0 
Perfect trigonal bipyramidal geometry: τ = 1 
 
 
6.4 Hydroamination scope methodology (Tables 1 & 2) 
 
 
In a glovebox, C6D6 or d8-toluene solutions of each aminoalkene (~ 1.0 M) 
were prepared. For each reaction, 2-20 mol% of the catalyst precusor under study 
were added into 0.5 mL of aminoalkene solution in a Youngs tap NMR tube and 
immediately transferred to the 250 MHz NMR spectrometer. The reaction was 
then regularly monitored by 1H NMR until maximum conversion was reached. 
R
S
RT
H
Tk
hk
B
T
±± ∆
+
∆
−=)ln(
‡ ‡ 
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6.5 Kinetic hydroamination studies 
 
 
6.5.1 General procedure  
 
In a glovebox, d8-toluene solutions of the precatalysts at 0.016 M (Eyring and 
Arrhenius analyses) and 0.0112 M (deuteration studies) were prepared with 
tetrakis(trimethylsilyl)silane (TMSS) at 0.16 M as a reference. For each reaction 
diprotio or dideuterio (1-allylcyclohexyl)methylamine (61mg, 71 µL, 0.4 mmol for 
Eyring and Arrhenius analyses; 43 mg, 50 µL, 0.28 mmol for deuteration studies) were 
pipetted into 0.5 mL of catalyst solution and transferred to a Youngs tap NMR tube. The 
tube was sealed, removed from the glovebox, immediately frozen with liquid nitrogen 
and thawed just prior to loading into the NMR spectrometer. 1H NMR spectra were 
recorded at regular intervals. Substrate consumption was monitored by integration of the 
internal methane proton of the alkene moiety. Concentrations were calculated over 3 
half-lives using TMSS as an internal standard. Data was normalised against the initial 
substrate concentration [substrate]t=0 so that:  
 
 
 
 
Reaction rates were derived from the plot of ln(Ct) versus time by using linear 
trendlines generated by Microsoft Excel software. To obtain Arrhenius and Eyring plots, 
kinetic analyses were conducted at 4-5 different temperatures, each separated by 
approximately 5 K. Temperature calibration of the NMR spectrometer was carried out 
at a gas flow of 535 L.h-1 using 80% ethylene glycol in methanol and waiting 15 
minutes for temperature equilibration. Thus the following equations were obtained: 
 
Cooling power 5%:  Treal = 1.3568 Tdisplayed - 104.7 
Absence of cooling:   Treal = 1.1293 Tdisplayed - 38.6 
 
For later reactions using precatalyst 34 a new calibration gave:  
 
Cooling power 5%: Treal = 1.345 Tdisplayed - 101.6 
 
0][
][
=
=
t
t
t
substrate
substrate
C
171 
 
For the determination of the order in catalyst, a C6D6 solution of the aminoalkene 
(0.56 M) with an internal TMSS standard at 0.16 M was prepared. For each reaction an 
approximate amount of precatalyst (2 mg, 4 mg, 6 mg, etc.) was then added to 0.5 mL 
of the substrate solution and the procedure outlined above repeated. The exact 
concentration of the precatalyst was measured by integration of the 
hexamethyldisilazide signal against the internal TMSS standard.   
 
 
6.5.2 Calculation of standard errors for Eyring plots
[287]
 
 
Standard errors σ(∆H‡) and σ(∆S‡) were calculated using the least squares 
method for linear regression outlined below (see e.g. the website 
http://mathworld.wolfram.com/LeastSquaresFitting.html): 
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The variance of x (σ2x) and y (σ
2
y) and the covariance of x and y (cov(x,y)) are 
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The standard errors σ(∆H‡) and σ(∆S‡) are calculated as follows: 
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6.5.3 Derivation of hydroamination rate law 
 
 
 
 
 
 
 
 
 
PH = product  SH = substrate  I = non-protic inhibitor e.g. THF 
 
])[]([ MSSHMSPHkrate +=  
 
Condition: rapid pre-equilibria. 
A) ]][[]][[ IMPSHkSHMPIk da =  
B) ]][[]][[ IMSPHkPHMSIk da =  
C) ]][[]][[ IMSSHkSHMSIk da =  
D) ]][[]][[ IMPPHkPHMPIk da =  
E) ]][[]][[ SHMPPHkPHMPSHk AD =  
F) ]][[]][[ SHMSPHkPHMSSHk AD =  
G) ][][ 11 MSPHkMPSHk −=  
 
Total catalyst concentration:  
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• PH and SH probably have similar binding constants as adducts to the catalyst: 
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• substrate and product amine/amide exchange is roughly equal in both directions 
 KE ≈ 1  
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6.6 Study of the intramolecular hydroamination of aminoalkenes 
 
 
6.6.1 Synthesis of alkaline earth precatalysts 
 
Synthesis of [{(Dipp)NC(Me)CHC(Me)N(Dipp)}Ca{N(SiMe3)2}(THF)] (2)
[36]
 
 
 
 
 
Ligand precursor [(Dipp)NC(Me)CHC(Me)NH(Dipp)] (Dipp = 2,6-di-iso-propylphenyl) 
(3.00 g, 7.17 mmol), calcium iodide (2.11 g, 7.17 mmol) and [KN(SiMe3)2] (2.86 g, 
14.3 mmol) were stirred over night in a sealed Schlenk flask in 60 mL of THF under 
argon. The solvent was removed in vacuo and the crude product was extracted with 100 
mL of hexane. The mixture was stirred for another hour prior to canula filtration away 
from insoluble KI and concentration until incipient crystallisation. A large crop of 
colourless crystals was obtained after 1 day at -20 oC (3.4 g, 4.9 mmol, 69%). 1H NMR 
ppm (C6D6): 7.14-7.20 (m, 6H, Ar-H), 4.85 (s, 1H, H-2), 3.40 (m, 4H, THF), 3.24 (sept, 
4H, iPr-CHMe2, 
3
J = 6.9 Hz), 1.69 (s, 6H, H-3), 1.36 (d, 12H, iPr-CH3, 
3
J = 6.9 Hz), 
1.26 (d, 12H, iPr-CH3, 
3
J = 6.9 Hz), 1.15 (m, 4H, THF), 0.17 (s, 18H, Si(CH3)3). 
13C{1H} 
NMR ppm (C6D6): 166.5 (C-1), 147.4 (i-Ar-C), 141.5 (o-Ar-C), 124.7 (p-Ar-C), 124.1 
(m-Ar-C), 94.2 (C-2), 69.3 (THF), 28.5 (iPr-CHMe2), 25.5 + 24.9 (
iPr-CH3), 25.3 (THF), 
25.0 (C-3), 6.0 (Si(CH3)3). 
N N
Dipp Dipp
1
23
Ca
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Synthesis of [{(Dipp)NC(Me)CHC(Me)N(Dipp)}Ca{N(SiMe3)2}] (33)
[21, 36, 141]
 
 
 
 
 
Same procedure as above in Et2O instead of THF: ligand precursor (1.00 g, 2.39 mmol), 
calcium iodide (0.70 g, 2.39 mmol) and [KN(SiMe3)2] (0.95 g, 4.78 mmol). The isolated 
ether adduct was dried at 40 oC in vacuo for a day to remove the ether. Subsequent 
recrystallisation in hexane at -20 oC yielded colourless crystals (0.92 g, 1.5 mmol, 62%). 
1H NMR ppm (C6D6): 7.13-7.18 (m, 6H, Ar-H), 4.77 (s, 1H, H-2), 3.12 (sept, 4H, 
iPr-
CHMe2, 
3
J = 6.9 Hz), 1.69 (s, 6H, H-3), 1.36 (d, 12H, iPr-CH3, 
3
J = 6.9 Hz), 1.22 (d, 
12H, iPr-CH3, 
3
J = 6.9 Hz), 0.05 (s, 18H, Si(CH3)3). 
13C{1H} NMR ppm (C6D6): 166.9 
(C-1), 145.3 (i-Ar-C), 141.1 (o-Ar-C), 125.2 (p-Ar-C), 124.3 (m-Ar-C), 91.9 (C-2), 29.9 
(iPr-CHMe2), 25.4 + 24.4 (
iPr-CH3), 24.7 (C-3), 5.1 (Si(CH3)3). 
 
Synthesis of [{(Dipp)NC(Me)CHC(Me)N(Dipp)}Sr{N(SiMe3)2}(THF)]
[39]
 
 
 
 
 
Ligand precursor [(Dipp)NC(Me)CHC(Me)NH(Dipp)] (1.00 g, 2.39 mmol) and 
[KN(SiMe3)2] (1.00 g, 4.77 mmol) were stirred for 5 hours in a sealed Schlenk flask in 
30 mL of THF under argon. The solution was added via canula to a second Schlenk 
flask containing a slurry of strontium iodide (0.81 g, 2.39 mmol) in 50 mL of THF. The 
solution was stirred at room temperature overnight under argon. The solvent was 
removed in vacuo and the crude product extracted with 100 mL of hexane. The mixture 
was stirred for another hour and allowed to settle prior to canula filtration away from 
insoluble KI and removal of the solvent. Subsequent recrystallisation in 3 mL of toluene 
at -20 oC yielded a crop of yellow crystals (1.04 g, 1.4 mmol, 59%). 1H NMR ppm 
(C6D6): 7.09-7.16 (m, 6H, Ar-H), 4.78 (s, 1H, H-2), 3.31 (m, 4H, THF), 3.18 (sept, 4H, 
iPr-CHMe2, 
3
J = 6.9 Hz), 1.69 (s, 6H, H-3), 1.32 (d, 12H, iPr-CH3, 
3
J = 6.9 Hz), 1.24 (d, 
12H, iPr-CH3, 
3
J = 6.9 Hz), 1.09 (m, 4H, THF), 0.15 (s, 18H, Si(CH3)3). 
13C{1H} NMR 
ppm (C6D6): 165.1 (C-1), 147.4 (i-Ar-C), 141.0 (o-Ar-C), 124.3 (p-Ar-C), 124.1 (m-Ar-
N N
Dipp Dipp
1
23
Sr
THF N(SiMe3)2
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C), 92.6 (C-2), 69.0 (THF), 28.5 (iPr-CHMe2), 25.5 + 25.1 (
iPr-CH3), 24.9 (THF), 24.5 
(C-3), 5.9 (Si(CH3)3). 
 
Synthesis of [Mg{CH(SiMe3)2}2(THF)2] (37a) 
 
THF (30 mL), precooled to -78 oC, was added to a solid mixture of MgI2 (0.70 g, 2.52 
mmol) and [K{CH(SiMe3)2}] (1.0 g, 5.04 mmol). The reaction mixture was allowed to 
warm to room temperature and stirred for 10 hours, at which point all volatiles were 
removed in vacuo to leave a colourless solid. Extraction into hexane, filtration, 
concentration of the filtrate and storage at -30 oC provided compound 37d as a 
colourless crystalline solid (0.60 g, 41%). 1H NMR ppm (C6D6): 3.49 (8H, m, THF), 
1.18 (8H, m, THF), 0.30 (36H, s, CH(SiMe3)2), -1.54 (2H, s, CH(SiMe3)2). Anal. Calc. 
for C22H54MgO2Si4 (487.3): C, 54.22; H, 11.17%. Found: C, 54.09; H, 11.07%.  
 
6.6.2 Substrates and products of hydroamination studies 
 
Synthesis of aminoalkenes: General Procedure
[54]
 
 
[LiN(SiMe3)2] was generated in situ by addition of a 2.5 M solution of n-BuLi in 
hexanes to a THF solution of hexamethyldisilazane at -78 ºC under argon. After 30 
minutes one equivalent of the nitrile was added via syringe. The yellow solution was 
stirred at -78 ºC for 30 minutes. One equivalent of the bromo- or chloroalkene was then 
added via syringe and the mixture stirred at room temperature overnight. The solution 
was quenched with 150 mL of water at 0 ºC and the organic phase extracted with 3 
times 100 mL of Et2O and dried over MgSO4. The solvent was removed in vacuo 
yielding the crude substituted nitrile as a yellow oil. The crude oil was added via syringe 
to a suspension of 2.2 equivalents of LiAlH4 in Et2O at 0 ºC under argon. After reflux 
N
R1
R1
1) 1.1 eq. LiN(SiMe3)2
THF, -78 oC, 30 min
R3
R4
R2
X
THF, -78 oC to rt, 18h
2)
R3
R4
R2
N
R1R1 2.2 eq. LiAlH4
Et2O, ref lux 3h R3
R4
R2
NH2
R1R1
n = 1; R1 = Me, (CH2)5; R
2 = R3 = R4 = H
R1 = Ph; R2 = Me; R3 = R4 = H
R3 = Me; R2 = R4 = H
R2 = H; R3 = R4 = Me
n = 2, 3; R1 = Ph; R2 = R3 = R4 = H
X = Br, Cl
n n
n
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for 3 hours the solution was slowly quenched at -78 ºC with a 95:5 THF/water mixture. 
The solid inorganic residues were filtered on a Büchner funnel and washed with 3 x 100 
mL of Et2O. The filtrates were washed with 200 mL of water, dried over MgSO4 and the 
solvent removed in vacuo, affording a light yellow oil which was either distilled at room 
pressure or in vacuo. The pure aminoalkene was dried for 3 hours over CaH2 before 
being either redistilled or vacuum-transferred into a dry ampoule to be used in the glove 
box.  
 
Synthesis of 1-amino-2,2-diphenyl-4-pentene 
 
 
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), diphenylacetonitrile (5.00 g, 25.9 mmol), allyl bromide (2.25 mL, 25.9 mmol), 
LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled in vacuo as a 
colourless oil (4.00 g, 16.8 mmol, 65%), b.p. 170 ºC at 0.2 mbar. 1H NMR ppm (CDCl3, 
250 MHz) of the crude nitrile: 7.18-7.31 (m, 10H, Ph-H), 5.60 (ddt, 1H, H-4, 3J = 7.0 
Hz, 3Jcis = 10.1 Hz, 
3
Jtrans = 17.1 Hz), 5.10 (dq, 1H, H-5trans, 
2
J = 1.4 Hz, 3Jtrans = 17.1 
Hz, 4J = 1.4 Hz), 5.07 (dq, 1H, H-5cis, 
2
J = 1.4 Hz, 3Jcis = 10.1 Hz, 
4
J = 1.4 Hz), 3.02 (d, 
2H, H-3, 3J = 7.0 Hz). 1H NMR ppm (CDCl3) of the aminoalkene: 7.10-7.27 (m, 10H, 
Ph-H), 5.34 (ddt, 1H, H-4, 3J = 7.0 Hz, 3Jcis = 10.0 Hz, 
3
Jtrans = 17.1 Hz), 4.98 (ddt, 1H, 
H-5trans, 
2
J = 2.3 Hz, 3Jtrans = 17.1 Hz, 
4
J = 1.3 Hz), 4.94 (md, 1H, H-5cis, 
3
Jcis = 10.0 Hz), 
3.28 (s, 2H, H-1), 2.88 (dd, 2H, H-3, 3J = 7.0 Hz, 4J = 1.3 Hz), 0.94 (broad s, 2H, NH2). 
13C{1H} NMR ppm (CDCl3): 146.6 (i-Ph-C), 135.0 (C-4), 128.5 (m-Ph-C), 128.2 (o-Ph-
C), 126.5 (p-Ph-C), 118.1 (C-5), 51.8 (C-2), 49.0 (C-1), 41.5 (C-3). 
 
Synthesis of 1-amino-2,2-diphenyl-4-methyl-4-pentene 
 
 
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), diphenylacetonitrile (5.00 g, 25.9 mmol), 3-chloro-2-methyl-1-propene (2.6 mL, 
25.9 mmol), LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled in 
vacuo as a colourless oil (4.31 g, 17.1 mmol, 66%), b.p. 170 ºC at 0.3 mbar. 1H NMR 
ppm (CDCl3, 250 MHz) of the crude nitrile: 7.18-7.33 (m, 10H, Ph-H), 4.82 (s, 1H, H-
5trans), 4.66 (s, 1H, H-5cis), 3.02 (s, 2H, H-3), 1.41 (s, 3H, H-6). 
1H NMR ppm (CDCl3) 
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of the aminoalkene: 7.06-7.20 (m, 10H, Ph-H), 4.72 (dd, 1H, H-5trans, 
2
J = 2.2 Hz, 4J = 
1.5 Hz), 4.50 (s, 1H, H-5cis), 3.14 (s, 2H, H-2), 2.83 (s, 2H, H-3), 0.98 (s, 3H, H-6), 0.83 
(broad s, 2H, NH2). 
13C{1H} NMR ppm (CDCl3): 145.9 (i-Ph-C), 141.8 (C-4), 127.3 
(m-Ph-C), 126.8 (o-Ph-C), 125.0 (p-Ph-C), 114.2 (C-5), 50.2 (C-2), 46.8 (C-1), 43.0 (C-
3), 23.3 (C-6). 
 
Synthesis of trans-1-amino-2,2-diphenyl-4-hexene 
 
 
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), diphenylacetonitrile (5.00 g, 25.9 mmol), 3-bromo-1-propene (2.24 mL, 25.9 
mmol), LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled in vacuo 
as a colourless oil (2.35 g, 9.35 mmol, 36 %), b.p. 180 ºC at 0.4 mbar. 1H NMR ppm 
(CDCl3) of the aminoalkene: 7.14-7.27 (m, 10H, Ph-H); 5.44 (dq, 1H, H-5, 
3
J = 6.3 Hz, 
3
Jtrans = 21.5 Hz), 4.98-5.11 (m, 1H, H-4), 3.30 (s, 2H, H-1), 2.85 (d, 2H, H-3, 
3
J = 7.3 
Hz), 1.56 (d, 3H, H-6, 3J = 6.3 Hz), 0.99 (broad s, 2H, NH2). 
13C{1H} NMR (CDCl3):  
146.4 (i-Ph-C), 128.1 (C-4), 128.0 (m-Ph-C), 127.7 (o-Ph-C), 126.4 (p-Ph-C), 125.6 (C-
5), 51.5 (C-2), 48.4 (C-1), 39.8 (C-3), 17.8 (C-6). 
 
Synthesis of 1-amino-5-methyl-2,2-diphenyl-4-hexene 
 
 
 
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), diphenylacetonitrile (5.00 g, 25.9 mmol), 3-bromo-1,1-dimethyl-1-propene (3.0 
mL, 25.9 mmol), LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled 
in vacuo as a colourless oil (4.50 g, 16.8 mmol, 65%), b.p. 150ºC at 0.2 mbar. 1H NMR 
ppm (CDCl3) of the aminoalkene: 7.10-7.26 (m, 10H, Ph-H), 4.78 (dt, 1H, H-4, 
3
J = 7.1 
Hz, 4Jtrans = 1.1
 Hz), 3.24 (s, 2H, H-1), 2.77 (d, 2H, H-3, 3J = 7.1 Hz), 1.53 (d, 3H, H-7, 
4
Jtrans = 1.1 Hz), 1.42 (s, 3H, H-6), 0.95 (broad s, 2H, NH2). 
13C{1H} NMR ppm 
(CDCl3): 145.4 (i-Ph-C), 133.0 (C-4), 126.9 (m-Ph-C), 126.6 (o-Ph-C), 126.6 (p-Ph-C), 
118.8 (C-5), 51.2 (C-2), 48.1 (C-1), 34.2 (C-3), 24.9 (C-7), 16.8 (C-6).  
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Synthesis of 1-amino-2,2-diphenyl-5-hexene 
 
 
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), diphenylacetonitrile (5.00 g, 25.9 mmol), 4-bromo-1-butene (2.7 mL, 25.9 
mmol), LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled in vacuo 
as a colourless oil (4.01 g, 16.1 mmol, 62%), b.p. 150 ºC at 0.3 mbar. 1H NMR ppm 
(CDCl3, 250 MHz) of the crude nitrile: 7.27-7.44 (m, 10H, Ph-H), 5.83 (ddt, 1H, H-5, 
3
J 
= 6.4 Hz, 3Jcis = 10.2 Hz, 
3
Jtrans = 16.7 Hz), 5.06 (dq, 1H, H-6trans, 
2
J = 1.6 Hz, 3Jtrans = 
16.7 Hz, 4J = 1.6 Hz), 5.02 (dq, 1H, H-6cis, 
2
J = 1.6 Hz, 3Jcis = 10.2 Hz, 
4
J = 1.6 Hz), 
2.46-2.52 (m, 2H, H-4), 2.16-2.25 (m, 2H, H-3). 1H NMR ppm (CDCl3) of the 
aminoalkene: 7.07-7.22 (m, 10H, Ph-H), 5.68 (ddt, 1H, H-5, 3J 6.5 = Hz, 3Jcis = 10.2 Hz, 
3
Jtrans = 16.8 Hz), 4.86 (dq, 1H, H-6trans, 
2
J = 1.6 Hz, 3Jtrans = 16.8 Hz, 
4
J = 1.6 Hz), 4.81 
(md, 1H, H-6cis, 
3
Jcis = 10.2 Hz), 3.24 (s, 2H, H-1), 2.08-2.13 (m, 2H, H-4), 1.62-1.70 
(m, 2H, H-3), 0.84 (broad s, 2H, NH2). 
13C{1H} NMR ppm (CDCl3): 146.7 (i-Ph-C), 
139.2 (C-5), 128.7 (m-Ph-C), 128.5 (o-Ph-C), 126.5 (p-Ph-C), 114.8 (C-6), 52.2 (C-2), 
49.5 (C-1), 36.2 (C-4), 29.0 (C-3).  
 
Synthesis of 1-amino-2,2-diphenyl-6-heptene.  
 
 
HN(SiMe3)2 (3.00 g, 18.6 mmol), 2.5 M solution of n-BuLi in hexanes (7.5 mL, 18.6 
mmol), diphenylacetonitrile (3.27 g, 16.9 mmol), 5-bromo-1-pentene (2.0 mL, 16.9 
mmol), LiAlH4 (1.41 g, 37.2 mmol). The resulting aminoalkene was distilled in vacuo 
as a colourless oil (2.14 g, 8.1 mmol, 48%), b.p. 150 ºC at 0.2 mbar. 1H NMR ppm 
(CDCl3, 250 MHz) of the crude nitrile: 7.15-7.31 (m, 10H, Ph-H), 5.64 (ddt, 1H, H-6, 
3
J 
= 6.7 Hz, 3Jcis = 10.2 Hz, 
3
Jtrans = 16.9 Hz), 4.91 (dq, 1H, H-7trans, 
2
J = 1.6 Hz, 3Jtrans = 
16.9 Hz, 4J = 1.6 Hz), 5.07 (md, 1H, H-7cis, 
3
Jcis = 10.1 Hz), 2.69 (td, 2H, H-5, 
3
J = 6.7 
Hz, 3J = 4.5 Hz), 2.02 (apparent q, 2H, H-3, 3J = 7.1 Hz), 1.44 (apparent tq, 2H, H-4, 3J 
= 4.5 Hz). 1H NMR ppm (CDCl3) of the aminoalkene: 7.12-7.29 (m, 10H, Ph-H), 5.68 
(ddt, 1H, H-6, 3J = 6.7 Hz, 3Jcis = 10.2 Hz, 
3
Jtrans = 16.9 Hz), 4.92 (dq, 1H, H-7trans, 
2
J = 
1.6 Hz, 3Jtrans = 16.9 Hz, 
4
J = 1.6 Hz), 4.88 (md, 1H, H-7cis, 
3
Jcis = 10.0 Hz), 3.29 (s, 2H, 
H-1), 2.07 (dt, 2H, H-5, 3J = 6.7 Hz, 3J = 4.5 Hz), 1.98 (apparent q, 2H, H-3, 3J = 4.5 
Hz), 1.08 (apparent tq, 2H, H-4, 3J = 4.5 Hz), 0.86 (broad s, 2H, NH2). 
13C{1H} NMR 
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ppm (CDCl3): 147.0 (i-Ph-C), 139.0 (C-6), 128.7 (m-Ph-C), 128.4 (o-Ph-C), 126.4 (p-
Ph-C), 115.1 (C-7), 52.2 (C-2), 49.5 (C-1), 36.3 (C-5), 34.6 (C-3), 23.8 (C-4) . 
 
Synthesis of 1-amino-2,2-dimethyl-4-pentene 
 
 
HN(SiMe3)2 (3.93 g, 24.4 mmol), 2.5 M solution of n-BuLi in hexanes (9.8 mL, 24.4 
mmol), isobutyronitrile (2.0 mL, 22.3 mmol), allyl bromide (1.9 mL, 22.3 mmol), 
LiAlH4 (2.11 g, 55.7 mmol). The resulting aminoalkene was distilled at room pressure 
as a colourless oil (1.40 g, 12.5 mmol, 56%), b.p. 130 ºC. 1H NMR ppm (CDCl3, 250 
MHz) of the crude nitrile: 5.75 (ddt, 1H, H-4, 3J = 7.3 Hz, 3Jcis = 10.3 Hz, 
3
Jtrans = 16.9 
Hz), 5.10 (md, 1H, H-5cis, 
3
Jcis = 10.3 Hz), 5.07 (dq, 1H, H-5trans, 
2
J = 1.5 Hz, 3Jcis = 
16.9 Hz, 4J = 1.5 Hz), 2.16 (md, 2H, H-3, 3J = 7.3 Hz), 1.22 (s, 6H, H-6). 1H NMR ppm 
(CDCl3) of the aminoalkene: 5.67 (ddt, 1H, H-4, 
3
J = 7.5 Hz, 3Jcis = 11.7 Hz, 
3
Jtrans = 
16.0 Hz), 4.91 (md, 1H, H-5cis, 
3
Jcis = 11.7 Hz), 4.89 (md, 1H, H-5trans, 
3
Jtrans = 16.0 Hz), 
2.31 (s, 2H, H-1), 2.88 (md, 2H, H-3, 3J = 7.5 Hz), 1.69 (broad s, 2H, NH2), 0.72 (s, 6H, 
H-6). 13C{1H} NMR ppm (CDCl3): 133.8 (C-4), 115.6 (C-5), 51.2 (C-2), 42.6 (C-1), 
33.5 (C-3), 23.2 (C-6). 
 
Synthesis of (1-allylcyclohexyl)methylamine 
 
 
  
HN(SiMe3)2 (4.59 g, 28.5 mmol), 2.5 M solution of n-BuLi in hexanes (11.4 mL, 28.5 
mmol), cyclohexanecarbonitrile (3.0 mL, 25.9 mmol), allyl bromide (2.3 mL, 25.9 
mmol), LiAlH4 (2.16 g, 56.9 mmol). The resulting aminoalkene was distilled in vacuo 
as a colourless oil (2.51 g, 16.3 mmol, 63%), b.p. 75 ºC at 0.3 mbar. 1H NMR ppm 
(CDCl3, 298 K, 250 MHz) of the crude nitrile: 5.88 (ddt, 1H, H-4, 
3
J = 7.4 Hz, 3Jcis = 
10.3 Hz, 3Jtrans = 16.8 Hz), 5.19 (md, 1H, H-5cis, 
3
Jcis = 10.3 Hz), 5.16 (dq, 1H, H-5trans, 
2
J = 1.5 Hz, 3Jcis = 16.8 Hz, 
4
J = 1.5 Hz), 2.16 (md, 2H, H-3, 3J = 7.4 Hz), 1.90-1.98 (m, 
2H, Cy-H), 1.51-1.79 (m, 6H, Cy-H), 1.18-1.27 (m, 2H, Cy-H). 1H NMR ppm (CDCl3) 
of the aminoalkene: 5.75 (ddt, 1H, H-4, 3J = 7.5 Hz, 3Jcis = 10.8 Hz, 
3
Jtrans = 16.4 Hz), 
5.00 (md, 1H, H-5cis, 
3
Jcis = 10.8 Hz), 4.99 (md, 1H, H-5trans, 
3
Jtrans = 16.8 Hz), 2.46 (s, 
2H, H-1), 2.01 (md, 2H, H-3, 3J = 7.5 Hz), 1.98-1.39 (m, 10H, Cy-H), 1.13 (broad s, 2H, 
NH23
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NH2). 
13C{1H} NMR ppm (CDCl3): 135.4 (C-4), 117.2 (C-5), 49.2 (i-Cy-C), 40.2 (C-1), 
37.7 (o-Cy-C), 33.6 (C-3), 26.8 (m-Cy-C), 22.1 (p-Cy-C). 
 
Synthesis of (1-allylcyclohexyl)methylamine-d2 
 
 
 
(1-allylcyclohexyl)methylamine (1 g, 6.53 mmol) was stirred in a 1:1 mixture of 
methanol-d/D2O under argon for a week. After extraction with Et2O and drying over 
MgSO4 the solvent was removed in vacuo. The resulting crude oil was distilled in 
vacuo yielding a colourless oil (0.89 g, 5.75 mmol, 88%), b.p. 75 oC at 0.3 mbar. 
 
Synthesis of 2-amino-5-hexene 
 
5-hexene-2-one (5 mL, 43.3 mmol), hydroxylamine hydrochloride (9.02 g, 130 mmol) 
and sodium acetate (10.66 g, 130 mmol) were dissolved in 500 mL of water and 20 mL 
of Et2O. The mixture was refluxed for 40h, then extracted into CH2Cl2. The organic 
phase was dried over MgSO4 and solvent removed in vacuo. The crude oil was further 
distilled in vacuo (43 oC, 8.10-2 mbar) to yield the oxime as a colourless oil (4.81 g, 4.25 
mmol, 98%). Both the (E) and the (Z) isomer could be identified in the NMR in a 60:40 
ratio respectively. 1H NMR ppm (CDCl3): 8.93 (broad s, 1H, OH), 5.74-5.90 (m, 1H, H-
5), 5.07 (apparent qd, 0.4H, (Z)-H-6trans, 
2
J = 4J = 1.7 Hz, 3Jtrans = 17.1 Hz,), 5.04 (md, 
0.6H, (E)-H-6trans 
3
Jtrans = 17.1 Hz,), 4.99 (md, 1H, H-6cis,
 3
Jcis = 10.1 Hz), 2.47 (m, 0.8H, 
(Z)-H-3), 2.24-2.31 (m, 3.2H, (E)-H-3 + H-4), 1.89 (s, 1.8H, (E)-H-1), 1.87 (s, 1.2H, 
(Z)-H-1). 13C{1H} NMR ppm (CDCl3): 158.3 + 157.9 (C-2), 137.4 + 137.2 (C-5), 115.3 
+ 115.2 (C-6), 35.2 ((E)-C-4), 30.3 ((E)-C-3), 29.4 ((Z)-C-4), 27.9 ((Z)-C-3), 19.9 ((Z)-
C-1), 13.5 ((E)-C-1). 5-hexene-2-one oxime (5.76 g, 50.9 mmol) was syringed into a 
Schlenk flask containing a slurry of LiAlH4 (3.86 g, 101.8 mmol, 2.2 eq.) at 0 
oC. The 
suspension was refluxed for 2h and allowed to cool to 0 oC before careful quenching 
with water and 5 mL of a 50% aqueous NaOH solution. The resulting suspension was 
O 3 eq. HONH3Cl
3 eq. NaOAc
Et2O/H2O 5:100
ref lux 40h
N
OH
NH21) Et2O, 2.2 eq. LiAlH4, 0
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3) H2O, NaOHaq, 2h, 0
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filtered and the solid washed with 3 x 10 mL Et2O. The ether was distilled away from 
the filtrate. Atmospheric distillation at 100 oC yielded the amine as a colourless oil (1.20 
g, 12.1 mmol, 24%). 1H NMR ppm (CDCl3): 5.82 (tdd, 1H, H-5, 
3
J = 6.7 Hz, 3Jcis = 10.1 
Hz, 3Jtrans = 17.2 Hz), 5.03 (ddd, 1H, H-6trans, 
2
J = 2.1 Hz, 3Jtrans = 17.2 Hz, 
4
J = 1.7 Hz), 
4.95 (tdd, 1H, H-6cis,
 2
J = 2.1 Hz, 3Jcis = 10.1 Hz, 
4
J = 1.2 Hz), 2.90 (apparent sext, 1H, 
H-2, 3J = 6.5 Hz), 2.10 (m, 1H, H-4), 1.41 (m, 1H, H-3), 1.25 (broad s, 2H, NH2), 1.07 
(d, 3H, H-1, 3J = 6.2 Hz). 13C{1H} NMR ppm (C6D6): 139.5 (C-5), 115.9 (C-6), 47.8 
(C-2), 41.0 (C-3), 28.7 (C-4), 23.9 (C-1). 
 
Synthesis of 6-amino-1-pentene 
 
 
 
 
 
5-bromo-1-pentene (2 mL, 16.9 mmol) and potassium phtalimide (3.13g, 16.9 mmol) 
were stirred in 30 mL of DMF at 60 oC for 2 days. After filtration, addition of a 1:1 
mixture of water and saturated sodium chloride solution, extraction with diethyl ether, 
drying over MgSO4 and evaporation of all solvent under high vacuum a yellow oil was 
obtained. After 30 minutes at -20 oC, 6-phtalimide-1-pentene crystallised as an off-
white solid (2.77 g, 12.9 mmol, 76%). 1H NMR ppm (CDCl3): 7.70 (dd, 2H, Ph-H, 
3
J = 
5.5 Hz, 4J = 3.0 Hz), 7.59 (dd, 2H, Ph-H, 3J = 5.5 Hz, 4J = 3.0 Hz), 5.60 (tdd, 1H, H-2, 
3
J = 7.3 Hz, 3Jcis = 10.4 Hz, 
3
Jtrans = 16.7 Hz), 4.92 (ddd, 1H, H-1trans, 
2
J = 1.7 Hz, 3Jtrans 
= 16.7 Hz, 4J = 1.7 Hz), 4.84 (ddd, 1H, H-1cis,
 2
J = 1.7 Hz, 3Jcis = 10.4 Hz, 
4
J = 4.8 Hz), 
3.56 (t, 2H, H-5, 3J = 7.3 Hz), 1.97 (m, 2H, H-3), 1.66 (m, 2H, H-4). 13C{1H} NMR 
ppm (CDCl3): 168.0 (C=O), 137.0 (C-4), 133.6 (Ph-C), 131.8 (Ph-C), 122.8 (Ph-C), 
114.9 (C-5), 37.2 (C-1), 30.6 (C-3), 27.3 (C-2). 6-phthalimide1-pentene (2.77g, 12.9 
mmol) and hydrazine monohydrate (0.66 g, 32.3 mmol) were refluxed in ethanol for 
24h. HCl 36% in water (15 mL) was added dropwise and the mixture refluxed for 
another 2h. After filtration, the solvent was removed from the filtrate to yield the 
hydrochloride salt as a crystalline solid. The crude solid was dissolved in water, basified 
with NaOH and extracted with Et2O. Distillation of the ether at atmospheric pressure 
yielded 6-amino-1-pentene as a crude yellow oil which was distilled at atmospheric 
pressure at 100 oC (220 mg, 2.58 mmol, 20 %). 1H NMR ppm (CDCl3): 5.80 (ddd, 1H, 
NK
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H-4, 3J = 6.9 Hz, 3Jcis = 12.1 Hz, 
3
Jtrans  = 17.2 Hz), 5.01 (d, 1H, 
3
Jtrans  = 17.2 Hz), 4.95 
(d, 1H, 3Jcis = 12.1 Hz), 2.70 (t, 2H, H-1, 
3
J = 7.0 Hz), 2.13 (dt, 2H, H-3, 3J = 7.2, 6.8, 
Hz), 1.54 (tt, 2H, H-2, 3J = 7.2, 7.0 Hz), 1.20 (s, 2H, NH). 13C{1H} NMR (C6D6): 139.2 
(C-4), 114.9 (C-5), 42.0 (C-1), 33.6 (C-3), 29.8 (C-2). 
 
Synthesis of N-allyl-6-amino-1-pentene 
 
 
5-bromo-1-pentene (1.25 mL, 10.5 mmol) and an excess of allylamine (3 mL, 39.9 
mmol) was stirred in a sealed ampoule under argon at 60 oC for 4 days. After addition of 
water, extraction with diethyl ether, drying over magnesium sulphate and evaporation of 
the solvent and the excess allylamine, the crude product was dried over CaH2 and 
vacuum transferred into a sealed ampoule, affording a colourless oil (0.89 g, 7.11 mmol, 
68%).1H NMR ppm (CDCl3): 5.73-5.98 (m, 2H, H-2/7), 5.09 (md, 1H, H-1/8trans, 
3
Jtrans 
= 17.5 Hz), 5.00 (md, 1H, H-1/8cis,
3
Jcis = 10.2 Hz), 4.94 (md, 1H, H-1/8trans, 
3
Jtrans = 
17.2 Hz), 4.88 (md, 1H, H-1/8cis,
3
Jcis = 10.0 Hz), 3.24 (dt, 2H, H-6, 
3
J = 6.0 Hz, 4J = 1.3 
Hz), 2.62 (t, 2H, H-5, 3J = 7.2 Hz), 2.00 (m, 2H, H-3), 1.52 (m, 2H, H-4), 1.26 (broad s, 
1H, NH). 13C{1H} NMR ppm (CDCl3): 138.4 (C-2/7), 137.0 (C-2/7), 115.6 (C-1/8), 
114.5 (C-1/8), 52.4 (C-6), 48.8 (C-5), 31.5 (C-3), 29.2 (C-4).  
 
Synthesis of N-benzyl-(1-allylcyclohexyl)methylamine 
 
 
 
(1-allylcyclohexyl)methylamine (1 g, 6.53 mmol) and a slight excess of benzaldehyde 
(0.77 g, 7.26 mmol) were stirred at room temperature for 5h. An excess of NaBH4 (0.41 
g, 10.8 mmol) was added and the mixture stirred overnight. After treating with water 
and 20 mL of a 1M aqueous solution of NaOH the reaction mixture was extracted twice 
with CH2Cl2, the combined organic fractions dried over MgSO4 and the solvent 
removed in vacuo. Distillation in vacuo yielded the desired aminoalkene as a colourless 
oil (1.08 g, 4.44 mmol, 68 %). 1H NMR ppm (CDCl3): 7.19-7.32 (m, 5H, Ph-H), 5.79 
(tdd, 1H, H-4, 3J = 7.6, 3Jcis = 10.0, 
3
Jtrans = 16.9 Hz), 4.95-5.02 (m, 2H, H-5), 3.77 (s, 
2H, H-6), 2.41 (s, 2H, H-1), 2.11-2.13 (m, 2H, H-3), 1.28-1.41 (m, 10H, Cy-H), 1.13 
(broad s, 1H, NH). 13C{1H} NMR ppm (CDCl3): 141.3 (i-Ph-C), 135.6 (C-4), 128.6 (m-
neat, 60 oC, 4dBr
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Ph-C), 128.2 (o-Ph-C), 126.9 (p-Ph-C), 116.9 (C-5), 56.1 (C-6), 55.1 (C-1), 40.9 (C-3), 
36.9 (Cy-C), 34.2 (C-2), 26.8 (Cy-C), 21.8 (Cy-C). 
 
 
6.6.3 Synthesis of cyclised amines: General Procedure 
 
All NMR spectra of cyclised amines were recorded from in situ NMR scale catalytic 
hydroamination/cyclisation reactions of the corresponding aminoalkene with the most 
appropriate group 2 catalyst.  
 
Synthesis of 2-methyl-4,4-dimethylpyrrolidine 
 
 
 
1H NMR ppm (C6D6): 3.08 (m, 1H, H-2), 2.62 (dd, 1H, H-5, 
2
J = 10.0 Hz, 3J = 5.4 Hz), 
2.47 (dd, 1H, H-5, 2J = 10.0, 3J = 7.4 Hz), 1.48 (dd, 1H, H-3, 2J = 12.2 Hz, 3J = 6.7 Hz), 
1.74 (broad s, 1H, NH), 1.04 (d, 3H, H-6, 3J = 6.2 Hz), 0.97 + 0.92 (two s, 3H each, H-
7), 0.94 (m, 1H, H-3). 13C{1H} NMR ppm (C6D6): 56.8 (C-5), 55.0 (C-2), 47.1 (C-3), 
39.3 (C-4), 27.2 (C-7), 18.8 (C-6).  
 
Synthesis of 2-methyl-4,4-diphenylpyrrolidine 
 
 
 
1H NMR ppm (C6D6): 6.96-7.20 (m, 10H, Ph-H), 3.50 + 3.42 (two d, 1H each, H-5, 
2
J = 
11.1 Hz), 3.18 (m, 1H, H-2), 2.39 (ddd, 1H, H-3, 2J = 12.6 Hz, 3J = 6.8 Hz, 4J = 0.8 Hz), 
1.82 (dd, 1H, H-3, 2J = 12.6 Hz, 3J = 8.5 Hz), 1.40 (broad s, 1H, NH), 0.99 (d, 3H, H-6, 
3
J = 6.4 Hz). 13C{1H} NMR ppm (C6D6): 148.4 + 147.9 (i-Ph-C), 128.6 + 128.5 (m-Ph-
C), 127.5 + 127.4 (o-Ph-C), 126.2 + 126.1 (p-Ph-C), 58.7 (C-5), 57.3 (C-4), 53.5 (C-2), 
47.4 (C-3), 22.5 (C-6).  
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Synthesis of 2-methyl-4,4-cyclohexylpyrrolidine 
 
 
 
 
1H NMR ppm (C6D6): 3.01 (m, 1H, H-2), 2.75 (dd, 1H, H-5, 
2
J = 10.4 Hz, 3J = 4.9 Hz), 
2.52 (dd, 1H, H-5, 2J = 10.4 Hz, 3J = 7.8 Hz), 1.55 (dd, 1H, H-3, 2J = 12.4 Hz, 3J = 6.7 
Hz), 1.23-1.37 (m, 10H, Cy-H), 1.17 (broad s, 1H, NH), 1.05 (d, 3H, H-6, 3J = 6.2 Hz), 
0.87 (dd, 1H, H-3, 2J = 12.4 Hz, 3J = 9.0 Hz) . 13C{1H} NMR ppm (C6D6): 59.8 (C-5), 
54.3 (C-2), 47.9 (C-3), 44.0 (C-4), 39.0 (Cy-C), 37.6(Cy-C), 26.5 (Cy-C), 24.3 (Cy-C), 
24.1 (Cy-C), 22.0 (C-6).  
 
Synthesis of N-benzyl-2-methyl-4,4-cyclohexylpyrrolidine 
 
 
 
1H NMR ppm (d8-tol): 7.30 (d, 2H, o-Ph-H, 
3
J = 7.3 Hz), 7.16 (t, 2H, m-Ph-H, 3J = 7.3 
Hz), 7.07 (d, 1H, p-Ph-H, 3J = 7.3 Hz), 3.90 (d, 1H, H-7, 2J = 13.5 Hz) 2.90 (d, 1H, H-7, 
2
J = 13.5 Hz) , 2.76 (d, 1H, H-5, 2J = 9.1 Hz), 2.35 (m, 1H, H-2), 1.73 (d, 1H, H-5, 2J = 
9.1 Hz), 1.61 (dd, 1H, H-3, 2J = 12.2 Hz, 3J = 7.2 Hz), 1.21-1.35 (m, 10H, Cy-H), 1.20 
(dd, 1H, H-3, 2J = 12.2 Hz, 3J = 9.0 Hz), 1.06 (d, 3H, H-6, 3J = 5.8 Hz) . 13C{1H} NMR 
ppm (d8-tol): 140.9 (i-Ph-C), 128.6 (o-Ph-C), 128.3 (m-Ph-C), 126.7 (p-Ph-C), 59.4 (C-
5), 58.3 (C-4), 39.5 (C-2), 38.6 (C-7), 26.4 (C-3), 25.1 (Cy-C), 24.0 (Cy-C), 23.7 (Cy-
C), 19.7 (C-6).  
 
Synthesis of 2,2-dimethyl-4,4-diphenylpyrrolidine 
 
 
 
1H NMR ppm (C6D6): 6.96-7.22 (m, 10H, Ph), 3.53 (d, 2H, H-5, 
3
J = 7.7 Hz), 2.34 (s, 
2H, H-3), 1.28 (t, 1H, NH, 3J = 7.7 Hz), 1.03 (s, 6H, H-6). 13C{1H} NMR ppm (C6D6): 
148.6 (i-Ph-C), 128.5 (m-Ph-C), 127.5 (o-Ph-C), 126.0 (p-Ph-C), 59.2 (C-5), 58.3 (C-4), 
58.0 (C-2), 52.7 (C-3), 31.0 (C-6).  
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Synthesis of 2-ethyl-4,4-diphenylpyrrolidine 
 
 
 
1H NMR ppm (C6D6): 6.98-7.19 (m, 10H, Ph-H), 3.47 (ddd, 1H, H-5, 
2
J = 10.9 Hz, 3J = 
6.3 Hz, 4J = 1.4 Hz), 3.26 (dd, 1H, H-5, 2J = 10.9 Hz, 3J = 8.7 Hz), 2.93 (m, 1H, H-2), 
2.48 (ddd, 1H, H-3, 2J = 12.4 Hz, 3J = 6.5 Hz, 4J = 1.4 Hz), 1.82 (dd, 1H, H-3, 2J = 12.4 
Hz, 3J = 9.1 Hz), 1.60 (broad s, 1H, NH), 1.46 (qm, 2H, H-6, 3J = 7.4 Hz), 0.85 (t, 3H, 
H-7, 3J = 7.4 Hz). 13C{1H} NMR ppm (C6D6): 148.7 (i-Ph-C), 129.8 (m-Ph-C), 127.5 
(o-Ph-C), 126.2 (p-Ph-C), 59.6 (C-2), 58.3 (C-5), 56.9 (C-4), 45.5 (C-3), 17.9 (C-6), 
11.7 (C-7).  
 
Synthesis of 2-methyl-5,5-diphenylpiperidine 
 
 
 
1H NMR ppm (C6D6): 7.44 (dm, 2H, p-Ph-H), 6.99-7.22 (m, 8H, o/m-Ph-H), 3.77 (dt, 
1H, H-6, 2J = 12.9 Hz, 3J = 3.0 Hz), 2.92 (dd, 1H, H-6, 2J = 12.9 Hz, 3J = 6.7 Hz), 2.54 
(dtq, 1H, H-2, 3J = 2.6 Hz, 3J = 6.3 Hz, 3J = 6.4 Hz), 2.47 (dq, 1H, H-4, 2J = 13.1 Hz, 3J 
= 3.2 Hz), 2.07 (dt, 1H, H-4, 2J = 13.1 Hz, 3J = 3.4 Hz), 1.40 (dq, 1H, H-3, 2J = 13.0 Hz, 
3
J = 3.0 Hz), 1.06-1.19 (ddt, 1H, H-3, 2J = 13.0 Hz, 3J = 11.0 Hz, 3J = 3.2 Hz), 0.94 
(broad s, 1H, NH), 0.91 (d, 3H, H-7, 3J = 6.3 Hz). 13C{1H} NMR ppm (C6D6): 149.8 (i-
Ph-C), 129.2 (m-Ph-C), 128.6 (o-Ph-C), 127.0 (p-Ph-C), 56.7 (C-6), 52.5 (C-2), 45.6 
(C-5), 36.2 (C-4), 31.4 (C-3), 22.6 (C-7).  
 
Synthesis of 2-methyl-6,6-diphenylhexahydroazepine 
 
 
 
1H NMR ppm (d8-tol): 7.41 (dm, 2H, p-Ph), 7.10-7.28 (m, 8H, o/m-Ph), 3.81 (dd, 1H, 
H-7, 2J = 14.5 Hz, 3J = 7.2 Hz), 2.91 (dd, 1H, H-7, 2J = 14.5 Hz, 3J = 2.7 Hz), 2.58 (m, 
1H, H-6), 2.55 (dd, 1H, H-5, 2J = 14.4 Hz, 3J = 8.0 Hz), 2.17-2.26 (m, 1H, H-3), 1.66-
1.74 (m, 1H, H-5), 1.46-1.54 (m, 1H, H-4), 0.22-1.32 (m, 2H, H-3 + H-4), 1.10 (broad s, 
1H, NH), 1.04 (d, 3H, H-8, 3J = 6.3 Hz. 13C{1H} NMR ppm (d8-tol): 151.9 + 149.2 (i-
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Ph-C), 128.3 + 128.1 (m-Ph-C), 128.0 (o-Ph-C), 125.9 + 125.6 (p-Ph-C), 59.8 (C-1), 
57.9 (C-2), 52.4 (C-6), 40.9 (C-5), 40.0 (C-3), 23.7 (C-4), 23.6 (C-8).  
 
Synthesis of 1-allyl-2-methylpyrrolidine 
 
 
 
1H NMR ppm (C6D6): 5.93 (dddd, 1H, H-8, 
3
Jtrans = 17.2 Hz, 
3
J cis = 10.2 Hz, 
3
J = 7.6 
Hz, 3J = 4.8 Hz), 5.15 (ddt, 1H, H-9trans, 
2
J = 2.0 Hz, 3Jtrans = 17.2 Hz, 
4
J = 1.8 Hz), 4.99 
(ddt, 1H, H-9cis, 
2
J = 2.0 Hz, 3Jcis = 10.2 Hz, 
4
J = 0.9 Hz), 3.40 (ddt, 1H, H-7, 2J = 13.5 
Hz, 3J = 4.8 Hz, 4J = 1.8 Hz), 3.06 (m, 1H, H-1), 2.59 (ddt, H-7, 2J = 13.5 Hz, 3J = 7.6 
Hz, 4J = 0.9 Hz), 2.16 (m, 1H, H-2), 1.99 (m, 1H, H-5), 1.68-1.79 (m, 1H, H-3), 1.56-
1.68 (m, 1H, H-4), 1.39-1.52 (m, 1H, H-4), 1.22-1.39 (m, 1H, H-3), 1.02 (d, 3H, H-6, 3J 
= 6.0 Hz). 13C{1H} NMR ppm (C6D6): 137.7 (C-8), 115.7 (C-9), 59.5 (C-2), 57.2 (C-7), 
54.3 (C-5), 33.4 (C-3), 22.1 (C-4), 19.5 (C-6). 
 
 
Synthesis of N-(2-methylpent-2-enylidene)pent-4-en-1-amine 
 
 
1H NMR ppm (CDCl3): 8.32 (s, 0.09H, H-7cis), 7.77 (s, 0.09H, H-7trans), 5.82 (m, 1H, H-
5), (dm, 1H, H-10, 3J = Hz) 4.98 (dm, 1H, H-6trans, 
3
Jtrans = 17.5 Hz), 4.95 (dm, 1H, H-
6cis, 
3
Jcis = 10.3 Hz), 3.50 + 3.46 (two aparent t, 0.18H + 1.82H, H-2, 
3
J = 6.9 Hz), 2.29 
+ 2.24 (two apparent quint., 0.18H + 1.82H, H-11, 3J = 7.5 Hz), 2.07 (apparent q, 2H, 
H-4, 3J = 6.6 Hz), 1.87 (s, 0.27H, H-9cis), 1.83 (s, 2.73H, H-9trans), 1.71 (apparent quint., 
2H, H-3, 3J = 6.8 Hz), 1.04 + 1.03 (two t, 2.73H + 0.27H, H-12, 3J = 7.5 Hz). 13C{1H} 
NMR ppm (CDCl3): 165.8 (C-7), 143.2 (C-10), 138.5 (C-5), 135.2 (C-8), 114.6 (C-6), 
60.6 (C-2), 31.4 (C-4), 30.14 (C-3), 21.7 (C-11), 13.5 (C-12), 11.4 (C-9). ESI-MS: [M-
H]+ = 166.16.  
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Synthesis of 2,5-dimethylpyrrolidine 
 
 
 
1H NMR ppm (C6D6) trans: 3.09-3.22 (m, 2H, H-2/5), 1.63-1.82 (m, 2H, H-3/4), 1.04-
1.15 (m, 2H, H-3/4), 0.99 (d, 6H, H-6/7), 0.87 (broad s, 1H, NH); cis: 2.87-2.99 (m, 2H, 
H-2/5), 1.63-1.82 (m, 2H, H-3/4), 1.04-1.15 (m, 2H, H-3/4), 1.00 (d, 6H, H-6/7), 0.87 
(broad s, 1H, NH). 13C{1H} NMR ppm (C6D6) trans: 53.4 (C-2/5), 35.1 (C-3/4), 22.7 
(C-6/7); cis: 54.9 (C-2/5), 33.9 (C-3/4), 22.1 (C-6/7).  
 
 
6.6.4 Stoichiometric reactions 
 
 
 
 
 
2-methoxyethylamine (5.9 µL, 67.8 µmol) was added to 0.5 mL of C6D6 solution of 34 
(50 mg, 67.8 µmol) at room temperature. A 1H NMR spectrum recorded after 25 
minutes at room temperature showed a 70:25:5 mixture of 41, a potentially dimeric 
strontium methoxyethylamide complex 42 and the known homoleptic complex 
[{ArNC(Me)CHC(Me)NAr}2Sr(THF)]. 
 
Synthesis of [{ArNC(Me)CHC(Me)Ar}Sr{N(SiMe3)2}{H2N(CH2)2OMe}] (41) 
 
 
 
 
1H NMR ppm (C6D6): 7.02-7.11 (m, 6H, Ar-H), 4.89 (s, 1H, H-4), 3.55 (m, 7H, THF + 
H-6), 3.36 (broad sept, 4H, iPr-CH), 2.33 (broad t, 2H, H-5, 3J = 4.4 Hz), 1.76 (broad t, 
2H, H-3, 3J = 4.4 Hz), 1.70 (s, 6H, H-2), 1.27 (broad d, 24H, iPr-CH3), 0.32 (s, 18H, 
Si(CH3)3), -0.07 (broad t, 2H, NH2). 
13C NMR ppm (d8-tol): 159.8 (C-1), 151.3 (i-Ar-C), 
139.5 (o-Ar-C), 123.2 (m-Ar-C), 120.6 (p-Ar-C), 91.0 (C-3), 73.1 (C-5), 57.8 (C-6), 
41.3 (C-4), 27.6 (iPr-CH), 24.5 (iPr-CH3), 24.0 (C-2), 1.3 (Si(CH3)3). Anal. calc. for 
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C38H88N4OSi2Sr (760.9): C, 61.61; H, 9.25; N, 7.56%. Found: C, 61.68; H, 9.29; N, 
7.47%. 
 
Identification of the amine/amide exchange product 42  
 
 
 
 
1H NMR ppm (C6D6): 7.02-7.11 (m, 6H, Ar-H), 4.74 (s, 1H, H-3), 3.55 (m, 7H, THF + 
H-6), 3.23 (sept, 4H, iPr-CH, 3J = 6.8 Hz), 2.79 (broad s, 2H, H-5), 2.67 (broad s, 2H, 
H-4), 2.08 (s, 6H, H-2), 1.22 + 1.11 (two d, 12H each, iPr-CH3, 
3
J = 6.8 Hz), 0.09 (s, 
18H, HN(SiMe3)2), -1.75 (broad s, 1H, NH). 
 
 
6.6.5 Reactions with the bulky β-diketiminate ligand 43 
 
Synthesis of ligand precursor 43 
 
 
 
 
2,4-pentanedione (1.37 g, 13.6 mmol) and 2,6-diphenylmethyl-p-toluidine (12 g, 27.3 
mmol) were refluxed with p-toluenesulfonic acid (5.19 g, 27.3 mmol) in toluene under 
Dean-Stark conditions for five days. Upon cooling of the resulting brown mixture a 
cream-coloured solid precipitated, which was filtered, neutralised with 500 mL of a 5% 
aqueous NaOH solution and extracted into 800 mL of CH2Cl2. After drying over 
MgSO4 the solvent was removed in vacuo yielding an off-white solid which was 
purified by flash chromatography with a 50:50 hexane/THF mixture. Crystallisation 
from hot chloroform afforded compound 43 as colourless needles (6.70 g, 7.11 mmol, 
52%). 1H NMR ppm (CDCl3), amino-imine 43A (88%): 12.11 (s, 1H, NH), 7.26-7.28 
(m, 16H, Ph-H), 7.00-7.05 (m, 24H, Ph-H), 6.85 (s, 4H, H-6), 5.95 (s, 4H, H-8), 4.18 (s, 
1H, H-2), 2.24 (s, 6H, H-9), 0.25 (s, 6H, H-3); diimine 43B (12%): 7.08-7.23 (m, 40H, 
Ph-H), 6.69 (s, 4H, H-6), 5.42 (s, 4H, H-8), 3.07 (s, 2H, H-2), 2.17 (s, 6H, H-9), 0.56 (s, 
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6H, H-3). 13C{1H} NMR ppm (CDCl3), amino-imine 43A: 164.0 (C-1), 144.8 (C-4), 
142.3 (i-Ph-C), 138.6 (C-7), 133.4 (C-5), 130.0 (m-Ph-C), 129.4 (m-Ph-C), 128.2 (o-Ph-
C), 128.0 (o-Ph-C), 126.1 (C-6), 125.8 (p-Ph-C), 94.8 (C-2), 52.1 (C-8), 21.5 (C-3), 
19.5 (C-9); diimine 43B: 164.0 (C-1), 144.0 (C-4), 141.2 (i-Ph-C), 138.6 (C-7), 132.5 
(C-5), 129.9 (m-Ph-C), 129.3 (m-Ph-C), 128.3 (o-Ph-C), 127.9 (o-Ph-C), 126.1 (C-6), 
125.9 (p-Ph-C), 77.0 (C-2), 51.5 (C-8), 21.5 (C-3), 19.5 (C-9). ESI-MS: [M-H]+ = 
944.48. Anal. calc. for C71H62N2 (943.3): C, 90.41; H, 6.63; N, 2.97%. Found: C, 90.36; 
H, 6.58; N, 2.94%. 
 
Synthesis of ligand magnesium complex 44 
 
 
 
 
MgBu2 (0.318 mL of a 1 M solution in heptane, 0.318 mmol) and ligand precursor 43 
(300 mg, 0.318 mmol) were heated in THF at 60 oC for 2 hours. The solvent was 
removed in vacuo and the crude product recrystallised at room temperature from a 10:1 
toluene/THF mixture to yield pale yellow crystals (270 mg, 0.246 mmol, 77%). 1H 
NMR ppm (C6D6): 7.40 (dd, 16H, Ph-H, 
3
J = 6.8, 5.4 Hz), 7.23 (s, 4H, H-6), 7.16-7.21 
(m, 20H, Ph-H), 7.10 (t, 4H, Ph-H, 3J = 7.3 Hz), 7.00 (t, 4H, Ph-H, 3J = 7.3 Hz), 5.95 (s, 
4H, H-8), 4.67 (s, 1H, H-2), 3.74 (m, 4H, THF), 1.96 (s, 6H, H-9), 1.41-1.46 (m, 8H, 
THF + Bu-(CH2)2), 1.09 (t, 3H, Bu-CH3, 
3
J = 6.7 Hz), 1.03 (s, 6H, H-2), -0.43-(-0.38) 
(m, 2H, Mg-CH2). 
13C{1H} NMR ppm (C6D6): 171.0 (C-1), 145.1 (C-4), 144.5 (i-Ph-C), 
143.2 (i-Ph-C), 134.0 (C-7), 130.4 (m-Ph-C), 130.2 (C-5), 129.9 (m-Ph-C), 128.9 (m-
Ph-C), 128.7 (m-Ph-C), 128.5 (C-6), 128.3 (o-Ph-C), 128.1 (o-Ph-C), 128.0 (o-Ph-C), 
127.9 (o-Ph-C), 126.9 (p-Ph-C), 126.7 (p-Ph-C), 96.2 (C-2), 52.8 (C-8), 32.0 + 31.9 
(Bu-(CH2)2), 23.3 (C-3), 21.4 (THF), 21.2 (C-9), 14.2 (Bu-CH3), 6.5 (Mg-CH2). Anal. 
calc. for C79H78MgN2O (1095.8): C, 86.59; H, 7.17; N, 2.56%. Found: C, 86.62, H, 7.09, 
N 2.52%. 
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6.7 Synthesis and characterisation of bis(carbene)borate compounds 
 
 
6.7.1 Synthesis of dihydro-bis(imidazole)boronium salts: General Procedure 
 
Two equivalents of the imidazole and one equivalent of Me3N.BH2X (X = Br, I) were 
refluxed in 20 mL of dry chlorobenzene at 133 °C under argon for 3-5 hours (X = I) or 
10-15 hours (X = Br). Upon cooling to room temperature a white precipitate formed. 
After removal of the solvent in vacuo, the crude white solid was recrystallised and dried 
in vacuo for several hours before transfer into the glove box. 
 
Synthesis of [H2B(Im
t
Bu)2]I (58) 
 
 
 
1-(tert-butyl)imidazole (6.00 g, 48.32 mmol) and Me3NB.H2I (4.80 g, 24.16 mmol). 
Recrystallised from water as a colourless solid (7.72 g, 19.89 mmol, 82%), mp 135°C. 
1H NMR ppm (CDCl3): 9.21 (s, 1H, H-2), 7.16 (d, 1H, H-5, 
3
J 1.8 Hz), 7.12 (d, 1H, H-4, 
3
J 1.8 Hz), 1.70 (s, 9H, CH3), BH2 signal broadened into baseline. 
13C{1H} NMR ppm 
(CDCl3): 138.3 (C-2), 130.0 (C-5), 126.0 (C-4), 59.2 (C(CH3)3), 30.9 (CH3). 
11B NMR 
ppm (CDCl3): -7.60 (broad s, BH2). IR (Nujol): νB-H 2434 cm
-1, br. Anal. Calc. for 
C14H26BIN4 (388.1): C, 43.33; H, 6.75; N, 14.44%. Found: C, 43.0; H, 6.70; N, 14.0%. 
 
Synthesis of [H2B(Im
t
Bu)2]Br (59) 
 
 
 
1-(tert-butyl)imidazole (2.00 g, 16.11 mmol) and Me3N.BH2Br (1.25 g, 8.05 mmol). 
Recrystallised from CH2Cl2 as a colourless solid (2.92 g, 8.2 mmol, 100%), mp 110°C. 
1H NMR ppm (CDCl3): 9.49 (t, 1H, H-2, 
4
J = 1.5 Hz), 7.15 (t, 1H, H-5, 3J = 1.5 Hz), 
7.08 (t, 1H, H-4, 3J = 1.5 Hz), 1.70 (s, 9H, CH3), BH2 signal broadened into baseline. 
13C{1H} NMR ppm (CDCl3): 130.1 (C-2), 129.0 (C-5), 126.0 (C-4), 59.0 (C(CH3)3), 
30.8 (CH3). 
11B NMR ppm (CDCl3): -9.09 (broad s, BH2). IR (Nujol): νB-H 2434 cm
-1, br. 
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Anal. Calc. for C14H26BBrN4 (340.1): C, 49.2; H, 7.53; N 16.67%. Found: C, 49.30; H, 
7.68; N, 16.43%. 
 
Synthesis of [H2B(ImMes)2]I (60) 
 
 
 
1-mesitylimidazole (2.00 g, 10.74 mmol) and Me3N.BH2I (1.07 g, 5.37 mmol). 
Recrystallised from CHCl3 as a colourless solid (2.35 g, 4.56 mmol, 85%), mp 172°C. 
1H NMR ppm (CDCl3): 9.20 (s, 1H, H-2), 7.60 (s, 1H, H-5), 7.05 (s, 1H, H-4), 6.98 (s, 
2H, m-Mes-H), 2.33 (s, 3H, p-CH3), 2.04 (s, 6H, o-CH3), BH2 signal broadened into 
baseline. 13C{1H} NMR ppm (CDCl3): 141.1 (C-2), 140.2 (i-Mes-C), 134.8 (m-Mes-C), 
130.1 (p-Mes-C), 126.8 (C-5), 123.2 (o-Mes-C), 115.1 (C-4), 21.5 (p-CH3), 18.2 (o-
CH3). 
11B NMR ppm (CDCl3): -6.10 (broad s, BH2). IR (Nujol): νB-H 2444 cm
-1, br. Anal. 
Calc. for C24H30BIN4 (512.2): C, 56.27; H, 5.90; N, 10.94%. Found: C, 56.7; H, 5.89; N, 
10.7%. 
 
Synthesis of [H2B(ImMes)2]Br (61) 
 
 
 
1-mesitylimidazole (2.00 g, 10.74 mmol) and Me3N.BH2Br (0.82 g, 5.37 mmol). 
Crystallised from CHCl3 as a colourless solid (1.30 g, 2.79 mmol, 52%), mp 190-192°C. 
1H NMR ppm (CDCl3): 9.55 (s, 1H, H-2), 7.60 (s, 1H, H-5), 7.00 (s, 1H, H-4), 6.97 (s, 
2H, m-Mes-H), 2.32 (s, 3H, p-CH3), 2.04 (s, 6H, o-CH3), BH2 signal broadened into 
baseline. 13C{1H} NMR ppm (CDCl3): 140.4 (C-2), 140.3 (i-Mes-C), 134.3 (m-Mes-C) , 
129.4 (p-Mes-C), 126.1 (C-5), 122.1 (o-Mes-C), 114.4 (C-4), 20.9 (p-CH3), 17.4 (o-
CH3). 
11B NMR ppm (CDCl3): -7.90 (broad s, BH2). IR (Nujol): νB-H 2441 cm
-1, br. Anal. 
Calc. for C24H30BBrN4 (465.2): C, 61.91; H, 6.50; N, 12.04%. Found: C, 61.7; H, 6.48; 
N, 11.9%. 
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Synthesis of [Ph2B(Im
t
Bu)2]Br 
 
 
 
1-(tert-butyl)imidazole (2.04 g, 16.40 mmol) and diphenylbromoborane (2.00 g, 8.20 
mmol) were weighed out into separate Schlenk flasks and dissolved in toluene. The 
boronium salt instantly precipitated upon addition of the imidazole to the borane via 
canula. The mixture was refluxed at 120 °C for 1 hour, cooled down and the air-stable 
precipitate dried over a Büchner funnel. The crude product was recrystallised from a 
10:1 mixture of CH2Cl2 and Et2O at -20 °C, yielding a colourless solid (2.14 g, 5.82 
mmol, 71%), mp 169-172°C. 1H NMR ppm (CDCl3): 8.20 (s, 2H, H-2), 7.34 (t, 2H, H-5,
 
3
J = 1.8 Hz), 7.17-7.23 (m, 4H, m-Ph-H), 7.19 (s, 2H, H-4), 7.03-7.06 (m, 6H, o/p-Ph-
H), 1.59 (s, 18H, CH3). 
13C{1H} NMR ppm (CDCl3): 140.5 (C-2), 134.7 (C-5), 132.2 (i-
Ph-C), 126.6 (m-Ph-C), 126.0 (p-Ph-C), 124.5 (o-Ph-C), 118.0 (C-4), 57.7 (C(CH3)3), 
28.9 (CH3). 
11B NMR ppm (CDCl3): 1.97 (s, BPh2). 
 
 
6.7.2 Synthesis of bis(imidazolin-2-ylidene-1-yl)borate alkaline earth 
complexes: General Procedure 
 
 
In a glovebox, the appropriate bis(imidazole)boronium salt, calcium- or strontium 
iodide and potassium bis(trimethylsilyl)amide were weighed out at a 1:1:2 or 3 ratio 
into a dry Schlenk flask. 15 mL of dry THF were added under argon at -78 °C. The 
solution was stirred at room temperature overnight. The solvent was removed in vacuo 
and the crude product extracted with hexane. The mixture was stirred for another hour 
prior to canula filtration away from insoluble KI and concentration of the filtrate to 
incipient crystallisation. Crystals were obtained after 3-7 days at -20 ºC. All X-ray 
structures were obtained from crystals selected under a cryogenic flow of nitrogen due 
to their extreme temperature-sensitivity. 
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Synthesis of [{H2B(Im
t
Bu)2}Ca{N(SiMe3)2}(THF)] (62) 
 
 
 
 
a) 59 (2.08 g, 6.12 mmol), calcium iodide (1.79 g, 6.12 mmol) and [KN(SiMe3)] (3.66 g, 
18.38 mmol): pale yellow transparent solid, very air- and temperature-sensitive, oily at 
21 °C, crystallised after 4 days at -16 °C (0.55g, 1.03 mmol, 16.8%). b) 58 (2.00 g, 5.15 
mmol), calcium iodide (1.51 g, 5.15 mmol) and [KN(SiMe3)2] (3.08 g, 15.46 mmol): 
off-white powder (1.55 g, 2.90 mmol, 56%). 1H{11B} NMR ppm (C6D6): 7.23 (d, 1H, 
H-5, 3J = 1.5 Hz), 7.13 (s, 1H, H-5), 6.59 (d, 1H, H-4, 3J = 1.5 Hz), 6.52 (s, 1H, H-4), 
4.31 (broad, 2H, BH2), 3.63 (m, 4H, THF), 1.36 (m, 4H, THF), 1.31 (s, 18H, C(CH3)3), 
0.45 (s, 18H, Si(CH3)3). 
13C{1H} NMR ppm (C6D6):195.0 (C-2), 125.0, (C-5), 114.4 (C-
4), 68.6 (THF), 54.8 (THF), 31.1 (C(CH3)3), 25.0 (C(CH3)3), 2.3 (Si(CH3)3 ). 
11B{1H} 
NMR ppm (C6D6): -5.8 (BH2). In d8-toluene, the imidazol-2-ylidene 
1H and 13C{1H} 
NMR signals split at low temperatures. IR (Nujol): νB-H 2385, 2252 cm
-1. Anal. Calc. for 
C24H52BCaN5OSi2 (533.8): C, 54.00; H, 9.82; N, 13.12%. Found: C, 54.09; H, 9.41; N, 
13.23%. 
 
Synthesis of [{H2B(Im
t
Bu)2}Sr{N(SiMe3)2}(THF)2] (63) 
 
 
 
 
58 (1.00 g, 2.58 mmol), strontium iodide (0.88 g, 2.58 mmol) and [KN(SiMe3)2] (1.54 g, 
7.73 mmol): large crop of colourless crystals after 1 day at -20 ºC (1.85 g, 1.98 mmol, 
76%), mp 137-140 ºC. X-ray crystallography and NMR showed presence of hexane in 
the lattice. 1H{11B} NMR ppm (C6D6): 7.23 (broad s, 2H, H-5), 6.62 (s, 2H, H-4), 4.31 
(broad, 2H, BH2), 3.59 (m, 8H, THF), 1.35 (s, 18H, C(CH3)3), 1.30 (m, 8H, THF), 0.86-
0.94 (m, hex), 0.37 (s, 18H, Si(CH3)3). 
13C{1H} NMR ppm (C6D6): 201.5 (C-2), 126.0 
(C-5), 115.2 (C-4), 69.0 (THF), 55.5 (C(CH3)3), 32.3 (C(CH3)3), 30.3 (hex), 25.8 (THF), 
23.4 (hex), 14.7 (hex), 5.9 (Si(CH3)3). 
11B{1H} NMR ppm (C6D6): -5.71 (BH2). IR 
(Nujol): νB-H 2363, 2252 cm
-1. Anal. Calc. for C29.5H61.5BN5O2Si2Sr (937.8): C, 52.63; 
H, 9.21; N, 10.41%. Found: C, 52.75; H, 9.43; 10.33. 
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Synthesis of [{H2B(Im
t
Bu)2}2Ca(THF)] (64) 
 
 
 
 
 
Redistribution product from the attempted synthesis of [{H2B(Im
tBu)2}CaI(THF)]: 58 
(0.50 g, 1.29 mmol), calcium iodide (0.38 g, 1.29 mmol) and [KN(SiMe3)2] (0.51 g, 
2.58 mmol): colourless crystals after 3 days at -20 ºC (0.20 g, 49% based on CaI2). 
1H{11B} NMR ppm (C6D6): 7.26 (d, 4H, H-5, 
3
J = 1.5 Hz), 6.60 (d, 4H, H-4, 3J = 1.5 
Hz), 4.44 (broad, 2H, BH2), 3.59 (m, 4H, THF), 1.38 (m, 4H, THF), 1.36 (s, 36H, 
C(CH3)3). 
13C{1H} NMR ppm (C6D6): 195.0 (C-2), 124.0 (C-5), 113.3 (C-4), 66.7 
(THF), 53.8 (C(CH3)3), 30.0 (C(CH3)3), 24.3 (THF). 
11B{1H} NMR ppm (C6D6): -5.42 
(BH2). IR (Nujol): νB-H 2363, 2255 cm
-1. 
 
Synthesis of [{H2B(Im
t
Bu)2}2Ca{N-(Im
t
Bu)}] (64’) 
 
 
 
 
 
Result of the rational synthesis of [{H2B(Im
tBu)2}2Ca(THF)]: 58 (0.50 g, 1.29 mmol), 
calcium iodide (0.19 g, 0.64 mmol) and [KN(SiMe3)2] (0.51 g, 2.58 mmol): colourless 
crystals (0.19 g, 0.28 mmol, 44 %). 1H{11B} ppm NMR (C6D6): 7.46 (broad s, 1H, H-7), 
7.38 (d, 4H, H-5, 3J = 1.5 Hz,), 7.13 (s, 1H, H-10), 6.70 (d, 4H, H-4, 3J = 1.5 Hz), 6.36 
(s, 1H, H-9), 4.45 (broad, 2H, BH2), 1.34 (s, 36H, ligand C(CH3)3), 0.84 (9H, s, co-
ligand C(CH3)3). 
13C{1H} NMR ppm (C6D6): 198.0 (C-2), 134.9 (C-7), 126.3 (C-10), 
124.3 (C-4), 114.0 (C-9), 113.0 (C-5), 53.9 (ligand C(CH3)3), 52.7 (co-ligand C(CH3)3), 
29.9 (ligand C(CH3)3), 28.6 (co-ligand C(CH3)3). 
11B{1H} NMR ppm (C6D6): -5.11 
(BH2). 
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Synthesis of [{H2B(Im
t
Bu)2}2Sr(THF)2] (65) 
 
 
 
 
 
Redistribution product of the synthesis of [{H2B(Im
tBu)2}SrI(THF)]: 58 (0.50 g, 1.29 
mmol), strontium iodide (0.44 g, 1.29 mmol) and [KN(SiMe3)2] (0.51 g, 2.58 mmol): 
colourless crystals after 3 days at -20 ºC (0.21 g, 43%). 1H{11B} NMR ppm (C6D6): 
7.29 (d, 4H, H-5, 3J = 1.5 Hz), 6.63 (d, 4H, H-4, 3J = 1.5 Hz), 4.44 (broad, 2H, BH2) 
3.67 (m, 4H, THF), 1.30 (s, 36H, C(CH3)3), 1.30 (m, 4H, THF). 
13C{1H} NMR ppm 
(C6D6): 198.9 (C-2), 124.3 (C-5), 113.1 (C-4), 67.2 (THF), 53.7 (C(CH3)3), 30.0 
(C(CH3)3), 24.2 (THF). 
11B{1H} NMR ppm (C6D6): -5.64 (BH2). 
 
Synthesis of [{H2B(ImMes)2}Ca{N(TMS)2}(THF)] (66) 
 
 
 
 
60 (0.50 g, 0.98 mmol) and 36b (0.74 g, 1.46 mmol) were stirred in cold THF overnight. 
Extraction with hexane yielded a light pink powder (0.14 g, 0.49 mmol, 50 %). 1H{11B} 
NMR ppm (C6D6): 7.21 (d, 2H, H-5, 
3J = 1.5 Hz), 6.77 (s, 4H, m-Mes-H), 6.27 (d, 2H, 
H-4, 3J = 1.5 Hz), 4.41 (broad, 2H, BH2), 3.52 (m, 4H, THF), 2.12 (s, 6H, p-CH3), 1.93 
(s, 12H, o-CH3), 1.14 (m, 4H, THF), 0.12 (s, 18H, TMS). 
13C{1H} NMR ppm (C6D6): 
196.0 (C-2), 137.1 (i-Mes-C), 136.2 (p-Mes-C), 135.0 (o-Mes-C), 128.2 (m-Mes-C), 
123.6 (C-5), 117.7 (C-4), 67.6 (THF), 23.7 (THF), 19.6 (p-CH3), 16.4 (o-CH3), 3.9 
(Si(CH3)3). 
11B{1H} NMR ppm (C6D6): -5.87 (BH2). 
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Synthesis of [Ph2B(Im
t
Bu)]2 (81) 
 
 
 
 
Only isolable product of the reaction of [Ph2B(Im
tBu)2Br] and [Ca{N(SiMe3)2}2(THF)2] 
in 1:1.5 ratio at -78 ºC in THF. Reaction mixture turned brown at room temperature and 
yielded [Ph2B(Im
tBu)]2 as colourless crystals from toluene after 10 days at -20 ºC. 
1H{11B} NMR ppm (C6D6): 7.59 (dd, 4H, o-Ph-H, 
3
J = 8.1 Hz, 4J = 1.5 Hz), 7.19-7.29 
(m, 6H, m/p-Ph-H), 6.91 (d, 1H, H-5, 3J = 1.8 Hz), 6.45 (d, 1H, H-4, 3J = 1.8 Hz), 0.74 
(s, 9H, C(CH3)3). 
13C{1H} NMR ppm (d8-tol): 182.9 (C-2), 136.6 (i-Ph-C), 129.7 (o-Ph-
C), 128.9 (p-Ph-C), 127.8 (m-Ph-C), 126.0 (C-5), 124.3 (C-4), 59.2 (C(CH3)3), 31.7 
(C(CH3)3). 
11B{1H} NMR ppm (d8-tol): -2.53 (BPh2). Anal. Calc. for C38H42B2N4 
(576.4): C, 79.18; H, 7.34; N, 9.72%. Found: C, 79.13; H, 7.29; N, 9.72%.  
 
6.7.3 Stoichiometric reactions 
 
Synthesis of [{H2B(Im
t
Bu)2}Ca{NHCH2Ph}(THF)] (70) 
 
 
 
 
 
NMR scale reaction in C6D6: benzylamine (8.19 µL, 75 µmol) and 62 (40 mg, 75 µmol). 
The solution instantly turned crimson. 1H NMR data showed complete conversion 
within the first point of analysis. By comparison with the known structure of β-
diketiminato analogue the compound is expected to be dimeric. Due to slow protonation 
of the ligand by the amine, however, the compound could not be isolated. 1H{11B} 
NMR ppm (C6D6): 7.20 (s, 2H, H-5), 6.87-7.03 (m, 5H, Ph-H), 6.57 (s, 2H, H-4), 4.45 
(broad s, 2H, BH2), 3.55 (broad, 2H, NHCH2Ph), 3.48 (m, 4H, THF), 1.24 (m, 4H, 
THF), 1.20 (s, 18H, C(CH3)3), 0.11 (s, 18H, HN(Si(CH3)3)2), -1.25 (broad s, NH). 
13C{1H} NMR ppm (C6D6): 198.0 (C-2), 144.3 (i-Ph-C), 129.5 (m-Ph-C), 127.3 (o-Ph-
C), 127.2 (p-Ph-C), 126.1 (C-5), 115.0 (C-4), 68.4 (THF), 55.6 (C(CH3)3), 45.8 
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(NHCH2Ph), 31.7 (C(CH3)3), 26.1 (THF), 3.0 (HN(Si(CH3)3)2). 
11B{1H} NMR ppm 
(C6D6): -5.68 (BH2). 
 
Synthesis of [{H2B(Im
t
Bu)2}Ca{NH(CH2)2OMe}] (71) 
 
 
 
 
 
NMR scale reaction in C6D6: 2-methoxyethylamine (12.6 µL, 144 µmol) and 62 (80 mg, 
144 µmol): the solution instantly turned orange. 1H NMR data showed complete 
conversion within the first point of analysis. By comparison with the known structure of 
β-diketiminato analogue the compound is expected to be dimeric. Due to slow 
protonation of the ligand by the amine, however, the compound could not be isolated. 
1H{11B} NMR ppm (C6D6): 7.30 (s, 2H, H-5), 7.57 (s, 2H, H-4), 3.57 (m, 4H, free THF), 
4.40 (broad, 2H, BH2), 3.01 (broad m, 5H, CH3OCH2) 1.41 (m, 4H, free THF), 1.32 (s, 
18H, C(CH3)3), 0.85 (s, 2H, NHCH2), -0.89 (broad s, 1H, NH). 
13C{1H} NMR ppm 
(C6D6): 199.3 (C-2), 126.1 (C-5), 114.8 (C-4), 55.8 (OCH2), 54.7 (THF), 31.6 (OCH3), 
30.3 (C(CH3)3), 26.1 (C(CH3)3). 
11B{1H} NMR ppm (C6D6): -5.71 (BH2). 
 
 
6.8 Synthesis and characterisation of tris(carbene)borate compounds 
 
 
6.8.1 Synthesis of tris(imidazolin-2-ylidene-1-yl)borate alkaline earth amides 
and iodides: General Procedure 
 
In a glovebox, the appropriate tris(imidazole)boronium salt, calcium-, strontium- or 
barium iodide and potassium (bis(trimethylsilyl))amide were weighed out at a 1:1:3 or 4 
ratio into a dry Schlenk flask. 15 mL of dry THF were added under argon at -78 °C. The 
solution was stirred at room temperature overnight. The solvent was removed in vacuo 
and the crude product extracted with toluene. The mixture was stirred for another hour 
prior to canula filtration away from insoluble KI and concentration of the filtrate to 
incipient crystallisation. Crystals were obtained after 3-7 days at -20 ºC. All X-ray 
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structures were obtained from crystals selected under a cryogenic flow of nitrogen due 
to their extreme temperature-sensitivity. 
 
Synthesis of [{HB(Im
t
Bu)3}Ca{N(SiMe3)2}] (73) 
 
 
 
 
[HB(ImtBu)3]Br2 (72 0.5 g, 0.92 mmol), calcium iodide (0.27 g, 0.92 mmol), 
[KN(SiMe3)2] (0.73 g, 3.67 mmol): off-white powder (0.52 g, 0.89 mmol, 97 %). 
1H{11B} NMR ppm (d8-tol): 7.33 (s, 3H, H-5), 6.65 (s, 3H, H-4), 4.97 (broad, 1H, BH), 
1.37 (s, 27H, C(CH3)3), 0.27 (broad, 18H, Si(CH3)3). 
13C{1H} NMR ppm (d8-tol): 198.5 
(C-2), 127.3 (C-5), 113.9 (C-4), 55.8 (C(CH3)3), 31.2 (C(CH3)3), 2.6 (Si(CH3)3). 
11B{1H} 
NMR ppm (d8-tol): 2.53 (BH). Anal. Calc. for C27H52BCaN7Si2 (581.8): C, 55.74; H, 
9.01; N, 16.85%. Found: C, 55.69; H, 8.96; N, 16.91%. 
 
Synthesis of [Ca{N(SiMe3)2}{N-(Im
t
Bu)2}] (80) 
 
 
 
10% by-product of the synthesis of 73, isolated in the first crystallisation fraction. 1H 
NMR ppm (d8-tol): 8.02 (broad s, 1H, H-2), 6.98 (broad s, 1H, H-5), 6.42 (broad s, 1H, 
H-4), 1.03 (s, 9H, C(CH3)3), 0.44 (s, 18H, Si(CH3)3). 
13C{1H} NMR ppm (d8-tol): 135.7 
(C-2), 124.9 (C-5), 114.8 (C-4), 53.5 (C(CH3)3), 28.7 (C(CH3)3), 4.8 (Si(CH3)3). 
 
Synthesis of [{HB(Im
t
Bu)3}Sr{N(SiMe3)2}{N-(Im
t
Bu)}] (74) 
 
 
 
 
 
 
72 (1.00 g, 1.84 mmol), strontium iodide (0.62 g, 1.84 mmol), [KN(SiMe3)2] (1.46 g, 
7.34 mmol): colourless crystals (0.55 g, 0.73 mmol, 53% based on [HB(ImtBu)3]Br2). 
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X-ray crystallography and NMR showed presence of toluene in the lattice. 1H{11B} 
NMR ppm (d8-tol, 298 K): 7.47 (broad s, 1H, H-7), 7.33 (d, 3H, H-5, 
3
J = 1.5 Hz), 7.19 
(broad s, 1H, H-10), 6.65 (d, 3H, H-4, 3J = 1.5 Hz), 6.55 (broad s, 1H, H-9), 5.00 (broad, 
1H, BH), 1.39 (s, 27H, ligand C(CH3)3), 0.99 (s, 9H, co-ligand C(CH3)3), 0.27 (s, 18H, 
Si(CH3)3). 
13C{1H} NMR ppm (d8-tol, 298 K): 201.5 (C-2), 137.1 (C-7), 129.3 (C-10), 
127.6 (C-5), 113.6 (C-4/9), 55.7 (ligand + co-ligand C(CH3)3), 31.2 (ligand C(CH3)3), 
30.0 (co-ligand C(CH3)3), 2.59 (Si(CH3)3). 
11B{1H} NMR ppm (d8-tol, 298 K): 3.35 
(BH). Anal. Calc. for C34H64BN9Si2Sr (753.5): C, 54.19; H, 8.56; N, 16.73%. Found: C, 
54.29; H, 8.56; N, 16.79%. 
 
Synthesis of [{HB(Im
t
Bu)3}Sr{N(SiMe3)2}(THF)] (74’) 
 
 
 
 
 
72 (1.33 g, 2.45 mmol), strontium iodide (0.31 g, 0.92 mmol), [KN(SiMe3)2] (0.73 g, 
3.67 mmol), filtration through filter canula only, all glassware prewashed with a basic 2-
propanol solution of potassium hydroxide before drying 1 day at 150 oC: colourless 
crystals after 1 day at -20 oC (0.26 g, 0.37 mmol, 40% based on SrI2). A second 
crystallisation fraction yielded 0.15 g of 74. 1H{11B} NMR ppm (d8-tol): 7.20 (d, 3H, H-
5, 3J = 1.2 Hz), 6.48 (d, 3H, H-4, 3J=1.2 Hz), 4.86 (broad, 1H, BH), 3.55 (m, 4H, THF), 
1.39 (m, 4H, THF), 1.37 (s, 27H, C(CH3)3), 0.40 (s, 18H, Si(CH3)3). 
13C{1H} NMR 
ppm (d8-tol): 198.7 (C-2), 126.8 (C-5), 113.8 (C-4), 68.3 (THF), 55.3 (C(CH3)3), 31.3 
(C(CH3)3), 25.5 (THF), 6.7 (Si(CH3)3). 
11B{1H} NMR ppm (d8-tol): 2.40 (BH). Anal. 
Calc. for C31H60BN7OSi2Sr (701.5): C, 53.08; H, 8.62; N, 13.98%. Found: C, 52.99; H, 
8.55; N, 13.88%. 
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Synthesis of [{HB(Im
t
Bu)3}Ba{N(SiMe3)2}{N-(Im
t
Bu)}1.5] (75) 
 
 
 
 
 
 
72 (1.00 g, 1.84 mmol), barium iodide (0.72 g, 1.84 mmol), [KN(SiMe3)2] (1.46 g, 7.34 
mmol): colourless crystals in an oily mass of free 1-tert-butylimidazole (0.77 g, 0.89 
mmol, 48% based on BaI2). In solution each barium centre is solvated by two 1-tert-
butylimidazole fragments due to the presence of free imidazole around the crystals. 
1H{11B} NMR ppm (d8-tol): 7.34 (broad s, 2H, H-7), 7.30 (s, 3H, H-5), 6.98 (s, 2H, H-
10), 6.54 (s, 3H, H-4), 6.42 (s, 2H, H-9), 4.98 (broad, 1H, BH), 2.12 (m, tol), 1.30 (s, 
27H, ligand C(CH3)3), 0.97 (s, 18H, co-ligand C(CH3)3), 0.51 (Si(CH3)3). 
13C{1H} 
NMR ppm (d8-tol): 205.9 (C-2), 147.5 (C-7), 135.5 (C-10), 126.5 (C-5), 115.5 (C-9), 
113.1 (C-4), 55.0 (ligand C(CH3)3), 53.9 (co-ligand C(CH3)3), 31.2 (ligand C(CH3)3), 
29.7 (co-ligand C(CH3)3), 6.5 (Si(CH3)3). Multiple attempts to obtain elemental analysis 
data of 75 failed due to the extreme air-, moisture- and temperature-sensitivity of the 
crystals. 
 
Synthesis of [{HB(Im
t
Bu)3}CaI{N-(Im
t
Bu)}] (76) 
 
 
 
 
 
 
72 (0.5 g, 0.92 mmol), calcium iodide (0.27 g, 0.92 mmol), [KN(SiMe3)2] (0.55 g, 2.76 
mmol): off-white powder after 2 days at -20 ºC (0.42 g, 0.62 mmol, 68%). 1H{11B} 
NMR ppm (d8-tol): 7.91 (broad s, 1H, H-7), 7.19 (d, 3H, H-5, 
3
J = 1.5 Hz), 6.55 (broad 
s, 1H, H-10), 6.44 (d, 3H, H-4, 3J = 1.5 Hz), 6.10 (broad s, 1H, H-9), 4.88 (broad, 1H, 
BH), 1.31 (s, 27H, ligand C(CH3)3), 0.84 (s, 9H, co-ligand ligand C(CH3)3). 
13C{1H} 
NMR ppm (d8-tol): 195.5 (C-2), 129.0 (C-7), 125.4 (C-10), 125.0 (C-5), 115.3 (C-9), 
113.4 (C-4), 54.3 (ligand +co-ligand C(CH3)3), 29.9 (ligand C(CH3)3), 28.8 (co-ligand 
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C(CH3)3). 
11B{1H} NMR ppm (d8-tol): 1.7 (BH). Anal. Calc. for C28H46BCaNI8 (672.5): 
C, 50.01; H, 6.89; N, 16.66%. Found: C, 49.93; H, 6.87; N, 16.58%. 
 
Synthesis of [{HB(Im
t
Bu)3}CaI(THF)] (76’) 
 
 
 
 
 
5-10% by-product of the synthesis of 76 detected in the 1H NMR spectrum of the crude. 
Although colourless single crystals were isolated for X-ray crystallography, sufficient 
pure material was not available for NMR or elemental analysis.  
 
6.8.2 Synthesis of tris(imidazolyl-2-ylidenyl)borate alkaline earth compounds 
77 and 78: General Procedure:  
 
In a glove-box, 72 and 36b or 36c were weighed at a 1:1.5 ratio into a dry Schlenk flask. 
Dry THF was added at -78 °C and the mixture was left to stir at room temperature 
overnight. The solvent was removed in vacuo and the crude product extracted with 
toluene. The mixture was stirred for another hour prior to canula filtration away from 
insoluble KI and concentration of the solution to incipient crystallisation. After 3-5 days 
at -20 ºC, the mother liquor was filtered into a second Schlenk flask and the transparent 
crystals completely dried on vacuum line.  
 
Synthesis of [{HB(Im
t
Bu)3}CaBr]2  (77) 
 
 
 
 
 
 
72 (0.5 g, 0.92 mmol) and 36b (0.70 g, 1.38 mmol): colourless crystals after 2 days at -
20 ºC (0.32 g, 0.64 mmol, 69%). 1H{11B} NMR ppm (d8-tol): 7.24 (d, 3H, H-5, 
3
J = 1.2 
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Hz), 6.53 (d, 3H, H-4, 3J = 1.2 Hz), 4.94 (broad, 1H, BH), 1.54 (s, 27H, C(CH3)3). 
13C{1H} NMR ppm (d8-tol): 199.4 (C-2), 125.9 (C-5), 114.0 (C-4), 55.9 (C(CH3)3), 32.2 
(C(CH3)3). 
11B{1H} NMR ppm (d8-tol): 1.91 (BH). Anal. Calc. for C21H34BBrCaN6 
(501.3): C, 50.31; H, 6.84; N, 16.76%. Found: C, 50.28; H, 6.76; N, 16.67%. 
 
Synthesis of [{HB(Im
t
Bu)3}2Sr] (78) 
 
 
 
 
 
 
Redistribution product from the attempted synthesis of [{HB(ImtBu)3}SrBr]2: 72 (0.5 g, 
0.92 mmol) and 36c (0.76 g, 1.38 mmol): colourless crystals after 4 days at -20 ºC (0.21 
g, 0.25 mmol, 54% based on ligand). 1H{11B} NMR ppm (d8-tol): 7.25 (d, 3H, H-5, 
3
J = 
1.5 Hz), 6.57 (d, 3H, H-4, 3J = 1.5 Hz), 4.92 (s, 1H, BH), 1.31 (s, 27H, C(CH3)3). 
13C{1H} NMR ppm (d8-tol): 201.6 (C-2), 128.1 (C-5), 113.8 (C-4), 55.7 (C(CH3)3), 31.3 
(C(CH3)3). 
11B{1H} NMR ppm (d8-tol): 3.84 (BH). Anal. Calc. for C42H68B2N12Sr 
(850.3): C, 59.33; H, 8.06; N, 19.77%. Found: C, 59.27; H, 8.14; N, 19.69%. 
  
6.9 Dearomatisation and deprotonation of a bis(imino)pyridine 
ligand by group 2 dialkyls 
 
 
Synthesis of [{2,6-(Dipp-NCCH2)2(C5H3N)}Mg(THF)2] (86a) 
 
 
 
 
50 mg of 37a (102.6 µmol) and 49 mg of ligand precursor 82 (102.6 µmol) were 
dissolved in C6D6. First slightly pink then slowly turning dark green, the reaction was 
followed by NMR at 60 oC temperature and reached completion after 1.5 days (NMR 
yield: 98%, colour: orange). Yellow crystals suitable for X-ray crystallography were 
isolated by recrystallisation from hexane at -30 oC (52 mg, 78%), m.p. 110 oC. 1H NMR 
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ppm (C6D6): 7.56 (d, 2H, m-pyr-H, 
3
J = 8.4 Hz), 7.25 (d, 4H, m-Ar-H, 3J = 7.2 Hz), 
7.27-7.18 (m, 2H, p-Ar-H), 7.09 (d, 1H, p-pyr-H, 3J = 8.4 Hz), 4.66 (s, 2H, C=CH2), 
3.67 (s, 2H, C=CH2), 3.56 (sept, 4H, 
iPr-CHMe2, 
3
J = 6.7 Hz), 3.19 (m, 4H, THF), 1.46 
(d, 12H, iPr-CH3, 
3
J = 6.7 Hz), 1.17 (d, 12H, iPr-CH3, 
3
J = 6.7 Hz), 1.06 (m, 4H, THF). 
13C{1H} NMR ppm (C6D6): 155.9 (N-C=CH2), 155.7 (N-C=CH2) 152.7 (i-Ar-C), 145.7 
(o-Ar-C), 137.5 (p-pyr-C), 124.0 (m-Ar-C), 123.4 (p-Ar-C), 117.5 (m-pyr-C), 79.3 
(C=CH2), 70.0 (THF), 28.4 (
iPr-CHMe2), 26.8 + 25.4 (
iPr-CH3), 25.2 (THF). IR (KBr): 
3042, 2955, 2865, 1644, 1580, 1565, 1472, 1431, 1379, 1359, 1312, 1251, 1201, 1161, 
1103, 1082, 1030, 995, 928, 885, 870, 815, 800, 771, 742, 693, 670,646. Anal. Calc. for 
C41H57MgN3O2 (648.2): C, 75.97; H, 8.86: N, 6.48%. Found: C, 75.87; H, 8.81: N, 
6.51%. 
 
Monodeprotonated intermediate 85a observed by NMR 
 
 
 
 
 
1H NMR ppm (C6D6): 7.66 (dd, 1H, pyr-H-5, 
3
J = 6.5 Hz, 4J = 2.7 Hz), 6.88-6.94 (m, 
2H, pyr-H-3 + pyr-H-4), 4.60 (s, 1H, C=CH2), 3.99 (s, 1H, C=CH2), 3.54, 2.80 (2 
septuplets, 2H:2H, iPr-CHMe2, 
3
J = 6.5 Hz), 1.72 (s, 3H, N=CCH3), 1.47, 1.43, 1.32, 
0.94 (4 doublets, 6H:6H:6H:6H, iPr-CH3, 
3
J = 6.5 Hz) 0.04 (s, 18H, CH(SiMe3)2), -1.57 
(1H, s, CH(SiMe3)2).  
 
 Synthesis of [{2,6-(Dipp-NCCH2)2(C5H3N)}Ca(THF)2]( 86b) 
 
 
 
 
50 mg of 37b (99.4 µmol) and 48 mg of ligand precursor 82 (99.4 µmol) were dissolved 
in C6D6. First dark green, the reaction mixture slowly turned yellow-green. The reaction 
was followed by NMR at room temperature and reached completion after 1.5 days 
(NMR yield: 98%). Orange crystals suitable for X-ray crystallography were isolated by 
recrystallisation from hexane at room temperature (55 mg, 83%), m.p. 112-114 oC. 1H 
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NMR ppm (C6D6): 7.72 (d, 2H, m-pyr-H, 
3
J = 8.0 Hz), 7.26 (d, 4H, m-Ar-H, 3J = 7.2 
Hz), 7.10-7.17 (m, 3H, p-pyr-H + p-Ar-H), 4.59 (s, 2H, C=CH2), 3.65 (s, 2H, C=CH2), 
3.59 (sept, 4H, iPr-CHMe2, 
3
J = 6.8 Hz), 3.12 (m, 4H, THF), 1.48 (d, 12H, iPr-CH3, 
3
J = 
6.8 Hz), 1.15 (d, 12H, iPr-CH3, 
3
J = 6.8 Hz), 1.12 (m, 4H, THF). 13C{1H} NMR ppm 
(C6D6): 159.3 + 158.1 (N-C=CH2) 151.3 (i-Ar-C), 144.7 (o-Ar-C), 136.5 (p-pyr-C), 
123.5 (m-Ar-C), 122.2 (p-Ar-C), 118.4 (m-pyr-C), 76.5 (C=CH2, identified by HMQC), 
68.6 (THF), 28.2 (iPr-CHMe2), 25.9 + 25.5 (
iPr-CH3), 25.2 (THF). IR (KBr): 3049, 
2955, 2863, 1638, 1585, 1559, 1461, 1429, 1385, 1363, 1315, 1252, 1211, 1163, 1109, 
1059, 1030, 992, 932, 884, 859, 818, 793, 770, 755, 748, 725, 672, 637. Anal. Calc. for 
C41H57CaN3O2: (664.0): C, 74.16; H, 8.65: N, 6.33%. Found: C, 74.06; H, 8.63; N, 6.36. 
 
Symmetric dearomatised intermediate 83b observed by NMR  
 
 
 
 
 
1H NMR ppm (C6D6, 298 K): 5.00 (d, 2H, m-pyr-H, 
3
J = 3.2 Hz), 4.69 (broad, 1H, p-
pyr-H), 1.84 (s, 6H, N=CCH3), 0.32 (pyr-CH(SiMe3)2), identified by COSY), –1.84 (s, 
1H, CaCH(SiMe3)2). 
 
Asymmetric dearomatised intermediate 84b observed by NMR  
 
 
 
 
1H NMR ppm (C6D6): 6.44 (d, 1H, pyr-H-3, 
3
J = 10.1 Hz), 5.32 (dd, 1H, pyr-H-4, 3J = 
10.1 Hz, 4.9 Hz), 4.57 (broad, 1H, pyr-H-5), 1.80 and 1.77 (2 singlets, 3H each, 
N=CCH3), 0.30 (pyr-CH(SiMe3)2, identified by COSY), -1.82 (1H, s, CaCH(SiMe3)2). 
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Monodeprotonated intermediate 85b observed by NMR 
 
 
 
 
1H NMR ppm (C6D6): 7.88 (d, 1H, pyr-H-3, 
3
J = 8.1 Hz), 7.18 (m, 1H, pyr-H-4), 6.88 
(d, 1H, pyr-H-5, 3J = 7.5 Hz), 3.94 and 3.64 (two s, 1H each, C=CH2), 1.68 (s, 3H, 
N=CCH3), –1.82 (s, 1H, CaCH(SiMe3)2). 
 
 Synthesis of [{2,6-(Dipp-NCCH2)2(C5H3N)}Sr(THF)]6 (86c) 
 
 
 
 
50 mg of 37c (90.8 µmol) and 44 mg of ligand precursor 82 (90.8 µmol) were dissolved 
in C6D6. First dark blue, the reaction mixture quickly turned bright green. The reaction 
was followed by NMR at room temperature and reached completion after 4 hours 
(NMR yield: 95%). Bright red crystals suitable for X-ray crystallography were isolated 
by recrystallisation from hexane at room temperature (41 mg, 71%), m.p. 116 oC. 1H 
NMR (C6D6): 7.76 (d, 2H, m-pyr-H, 
3
J = 8.0 Hz), 7.26 (d, 4H, m-Ar-H, 3J = 7.2 Hz), 
7.04-7.18 (m, 3H, p-pyr-H + p-Ar-H), 4.53 (s, 2H, C=CH2), 3.59 (s, 2H, C=CH2), 3.57 
(sept, 4H, iPr-CHMe2, 
3
J = 6.8 Hz), 3.15 (m, 4H, THF), 1.47 (d, 12H, iPr-CH3, 
3
J = 6.8 
Hz), 1.16 (m, 4H, THF), 1.15 (d, 12H, iPr-CH3, 
3
J = 6.8 Hz). 13C{1H} NMR ppm (C6D6): 
160.1 (N-C=CH2), 158.6 (N-C=CH2) 151.4 (i-Ar-C), 144.4 (o-Ar-C), 136.2 (p-pyr-C), 
123.6 (m-Ar-C), 121.8 (p-Ar-C), 118.8 (m-pyr-C), 75.8 (C=CH2), 68.2 (THF), 28.2 (
iPr-
CHMe2), 25.9 + 25.7 (
iPr-CH3), 25.4 (THF). IR (KBr): 3047, 2958, 2859, 1644, 1587, 
1561, 1527, 1460, 1425, 1378, 1356, 1311, 1248, 1207, 1166, 1099, 1052, 1023, 998, 
941, 855, 824, 795, 776, 760, 744, 732, 694, 665. Anal. Calc. for C37H49N3OSr: (639.4): 
C, 69.50; H, 7.72; N, 6.57%. Found: C, 69.28; H, 7.83; N, 6.17%. 
 
N
N N
SrDipp Dipp
THF
N
NN Ca
DippDipp
CH(SiMe3)2
2
3
4
5
6
207 
 
Symmetric dearomatised intermediate 83c observed by NMR  
 
 
 
 
 
1H NMR ppm (C6D6, 298 K): 5.00 (d, 2H, m-pyr, 
3
J = 3.2 Hz), 4.72 (m, 1H, p-pyr), 
1.86 (s, 6H, N=CCH3), 0.30 (pyr-CH(SiMe3)2, identified by COSY), -1.83 (s, 1H, 
SrCH(SiMe3)2). 
 
Asymmetric dearomatised intermediate 84c observed by NMR  
 
 
 
 
1H NMR ppm (C6D6, 298 K): 6.22 (d, 1H, pyr-H-3, 
3
J = 9.6 Hz), 5.34 (dd, 1H, pyr-H-4, 
3
J = 9.6 Hz, 5.8 Hz), 4.34 (md, 1H, pyr-H-5, 3J = 5.8 Hz), 1.80 and 1.72 (2 singlets, 3H 
each, N=CCH3), 0.28 (pyr-CH(SiMe3)2, identified by COSY), –1.98 (1H, s, 
SrCH(SiMe3)2). 
 
Monodeprotonated intermediate 85c observed by NMR 
 
 
 
 
1H NMR ppm (C6D6): 7.93 (d, 1H, pyr-H-5, 
3
J = 8.3 Hz), 7.35 (m, 1H, pyr-H-4), 6.85 
(d, 1H, pyr-H-5, 3J = 7.6 Hz), 4.48 (s, 1H, C=CH2), 3.86 (s, 1H, C=CH2), 1.66 (s, 3H, 
N=CCH3), -1.88 (s, 1H, SrCH(SiMe3)2). 
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 Synthesis of [{2,6-(Dipp-NCCH2)2(C5H3N)}Ba(THF)]6 (86d) 
 
 
 
 
50 mg of 37d (83.3 µmol) and 40 mg of ligand precursor 82 (83.3 µmol) were dissolved 
in C6D6. Instantly dark blue, the reaction mixture slowly turned brown-green, then dark 
brown. The reaction was followed by NMR at room temperature. All ligand was 
instantly consumed to form a dark blue intermediate which was then slowly transformed 
within 8 hours into the desired dark red product (NMR yield: 98%). Dark red crystals 
suitable for X-ray crystallography were isolated by recrystallisation from hexane at 
room temperature (42 mg, 73%), m.p. 132 oC. 1H NMR ppm (C6D6): 7.74 (d, 2H, m-
pyr-H, 3J = 8.0 Hz), 7.28 (d, 4H, m-Ar-H, 3J = 7.2 Hz), 7.06-7.22 (m, 3H, p-pyr-H + p-
Ar-H), 4.43 (s, 2H, C=CH2), 3.45 (s, 2H, C=CH2), 3.45 (sept, 4H, 
iPr-CHMe2, 
3
J = 6.8 
Hz), 3.26 (m, 4H, THF), 1.46 (d, 12H, iPr-CH3, 
3
J = 6.8 Hz), 1.26 (m, 4H, THF), 1.15 
(d, 12H, iPr-CH3, 
3
J = 6.8 Hz). 13C{1H} NMR ppm (C6D6): 160.8 (N-C=CH2), 158.8 (N-
C=CH2) 149.7 (i-Ar-C), 144.6 (o-Ar-C), 136.0 (p-pyr-C), 123.7 (m-Ar-C), 121.8 (p-Ar-
C), 119.0 (m-pyr-C), 74.9 (C=CH2), 67.9 (THF), 28.2 (
iPr-CHMe2), 26.0 + 25.8 (
iPr-
CH3), 25.6 (THF). IR (KBr): 3047, 2955, 2860, 1638, 1581, 1559, 1530, 1461, 1432, 
1382, 1356, 1321, 1249, 1201, 1169, 1100, 1055, 1027, 1005, 935, 878, 853, 824, 799, 
774, 758, 742, 723, 698, 663. Anal. Calc. for C37H49BaN3O (689.3): C, 64.49; H, 7.17; 
N, 6.10%. Found: 64.38; H, 7.14; N, 6.04%. 
 
Symmetric dearomatised intermediate 83d observed by NMR  
 
 
 
 
 
1H NMR ppm (C6D6): 5.99 (d, 2H, m-pyr-H, 
3
J = 3.6 Hz), 4.65 (dd, 1H, p-pyr-H, 3J = 
3.6 Hz, 7.0 Hz), 1.89 (s, 6H, N=CCH3), 0.31 (pyr-CH(SiMe3)2), identified by COSY), -
1.74 (s, 1H, BaCH(SiMe3)2). 
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Asymmetric dearomatised intermediate 84d observed by NMR  
 
 
 
 
1H NMR ppm (C6D6): 6.25 (d, 1H, pyr-H-3, 
3
J = 9.6 Hz), 5.35 (dd, 1H, pyr-H-4, 3J = 
9.6 Hz, 5.9 Hz), 4.36 (dd, 1H, pyr-H-5, 3J = 5.9 Hz, 2.9 Hz), 3.21, 3.12, 3.01 (3 
septuplets, 1H:1H:2H, iPr-CHMe2, 
3
J = 6.5 Hz), 1.82, 1.75 (2 singlets, 3H each, 
N=CCH3), 0.29 (pyr-CH(SiMe3)2, identified by COSY), -1.87 (1H, s, BaCH(SiMe3)2). 
 
Synthesis of [2,6-(Dipp-N=CEt)2(C5H3N)] (87) 
 
 
 
 
Methyl iodide (260 µL, 4.16 mmol) was added to a toluene solution of calcium complex 
86b (690 mg, 1.04 mmol). The orange mixture was heated at 60 oC for two days. The 
resultant colourless suspension was extracted with CH2Cl2 and the organic phase dried 
over MgSO4 before removal of the solvent in vacuo, yielding a crude pale yellow solid 
which was recrystallised from cold CH2Cl2 (0.47 g, 0.92 mmol, 89%).
 1H NMR ppm 
(CDCl3): 8.41 (d, 2H, m-pyr-H, 
3
J = 7.5 Hz), 7.29 (t, 1H, p-pyr-H, 3J = 7.5 Hz), 6.99-
7.13 (m, 6H, Ar-H), 2.87 (sept, 4H, iPr-CHMe2, 
3
J = 7.0 Hz), 2.76 (q, 4H, Et-CH2,
 3
J = 
7.7 Hz), 1.14 + 1.16 (two overlapping d, 24H, 3J = 7.0 Hz), 0.97 (t, 6H, Et-CH3,
 3
J = 7.7 
Hz). 13C{1H} NMR ppm (CDCl3): 170.5 (N=C), 154.9 (o-pyr-C), 146.6 (i-Ar-C), 137.3 
(p-pyr-C), 135.6 (o-Ar-C), 124.1 (m-pyr-C), 123.3 (m-Ar-C), 123.2 (p-Ar-C), 28.7 (iPr-
CHMe2), 23.7 (
iPr-CH3), 22.2 (Et-CH2), 11.1 (Et-CH3). Anal. Calc. for C35H47N3 
(509.8): C, 82.46; H, 9.29; N, 8.24%. Found: C, 81.20; H, 9.15: N, 8.10%.  
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Synthesis of [{2,6-(Dipp-NC=CHMe)2(C5H3N)}Sr(THF)2] (91) 
 
 
 
 
33 mg of 37c (58.9 µmol) and 30 mg of ligand precursor 87 (58.9 µmol) were dissolved 
in C6D6. The solution instantly turned dark blue and 
1H NMR data showed complete 
conversion of the starting materials to a 1:2 mixture of the dearomatised complexes 88 
and 89 respectively. The deep blue colour slowly faded into dark green and then dark 
red over a period of 3 days at room temperature, ultimately yielding compound 91 as a 
dark red compound (NMR yield 95%). 1H NMR ppm (C6D6): 7.55 (d, 2H, m-pyr-H, 
3
J 
= 7.9 Hz), 7.25 (d, 4H, m-Ar-H, 3J = 7.3 Hz), 7.23 (t, 1H, p-pyr-H, 3J = 7.9 Hz), 7.01 (t, 
2H, p-Ar-H, 3J = 7.3 Hz), 3.95 (q, 2H, C=CHCH3, 
3
J = 7.7 Hz), 3.60 (sept, 2H, iPr-
CHMe2, 
3
J = 7.0 Hz), 3.14-3.30 (m, 10H, iPr-CHMe2 + THF), 2.16 (d, 6H, C=CHCH3, 
3
J = 7.7 Hz), 1.43 (d, 12H, iPr-CH3, 
3
J = 7.0 Hz), 1.19-1.21 (m, 20H, iPr-CH3 + THF).  
 
Symmetric dearomatised intermediate 88 observed by NMR  
 
 
 
 
 
1H NMR ppm (C6D6): 6.99-7.15 (m, 6H, Ar-H), 5.03 (d, 2H, m-pyr-H, 
3
J = 3.4 Hz), 
4.78 (dd, 1H, p-pyr-H, 3J = 5.3, 3.4 Hz), 3.60 + 3.65 (two overlapping sept, 2H, iPr-
CHMe2, 
3
J = 7.3 Hz), 2.95 + 2.99 (two overlapping sept, 2H, iPr-CHMe2, 
3
J = 7.3 Hz), 
2.14 (q, 4H, Et-CH2,
 3
J = 7.7 Hz), 1.16-1.26 + 1.42-1.46 (two m, 24H, iPr-CH3), 1.10 (t, 
6H, Et-CH3,
 3
J = 7.7 Hz), 0.39 (broad d, 1H, C-CH(SiMe3)2), 0.33 + 0.27 (two s, 18H 
each, SiMe3), -1.89 (s, 1H, Sr-CH(SiMe3)2). 
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Asymmetric dearomatised intermediate 88 observed by NMR  
 
 
 
 
1H NMR ppm (C6D6): 6.99-7.15 (m, 6H, Ar-H), 6.18 (d, 1H, H-3, 
3
J = 10.2 Hz), 5.31 
(dd, 1H, H-4, 3J = 10.2, 5.7 Hz), 4.31 (dd, 1H, H-5, 3J = 5.7, 1.8 Hz), 3.21 + 3.26 (two 
overlapping sept, 2H, iPr-CHMe2, 
3
J = 6.6 Hz), 3.09 (sept, 1H, iPr-CHMe2, 
3
J = 6.6 Hz), 
2.81 (sept, 1H, iPr-CHMe2, 
3
J = 7.2 Hz), 2.21 + 2.26 (two overlapping q, 4H, Et-CH2,
 3
J 
= 7.5 Hz), 1.16-1.26 + 1.42-1.46 (two m, 24H, iPr-CH3), 0.85 + 0.92 (two t, 3H each, 
Et-CH3,
 3
J = 7.5 Hz), 0.50 (broad s, 1H, C-CH(SiMe3)2), 0.17 + 0.27 (two s, 18H each, 
SiMe3), -2.19 (s, 1H, Sr-CH(SiMe3)2). 
 
Monodeprotonated intermediate 89 observed by NMR 
 
 
 
 
1H NMR ppm (C6D6): 7.76 (d, 1H, H-3, 
3
J = 7.9 Hz), 7.20 (t, 1H, H-4, 3J = 7.9 Hz), 
6.53 (d, 1H, H-5, 3J = 7.9 Hz), 2.89-3.83 (m, iPr-CHMe2 + C=CHMe), 2.42 (q, 2H, Et-
CH2, 
3
J = 8.8 Hz), 2.21 (d, 3H, C=CHCH3, 
3
J = 7.7 Hz), 1.08-1.28 (m, iPr-CH3), 0.98 (t, 
3H, Et-CH3,
 3
J = 8.8 Hz), -2.18 (s, 1H, Sr-CH(SiMe3)2). 
 
 
6.10 Dearomatisation of dipp-BIAN by group 1 and 2 alkyls 
 
Numbering scheme for all compounds:  
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Synthesis of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}K]2 (93) 
 
 
 
 
25 mg of [KCH(SiMe3)2] (99.8 µmol) and 50 mg of dipp-BIAN (99.8 µmol) were 
dissolved in C6D6. The reaction mixture turned instantly dark green (NMR yield >99%). 
Green crystals suitable for X-ray crystallography could be isolated upon crystallisation 
from toluene at room temperature. The reaction was later scaled up in toluene with 
[KCH(SiMe3)2] (396 mg, 2.00 mmol) and dipp-BIAN (1.00 g, 2.00 mmol), 95% 
isolated yield (1.32 g, 1.90 mmol). 1H NMR ppm (C6D6): 7.00-7.21 (m, 6H, Ar-H), 6.51 
(d, 1H, H-3’, 3J = 7.5 Hz), 6.03 (t, 1H, H-4’, 3J = 7.5 Hz), 5.65 (d, 1H, H-5’, 3J = 7.5 
Hz), 5.60 (d, 1H, H-3, 3Jcis = 9.8 Hz), 4.65 (dd, 1H, H-4, 
3
Jcis = 9.8 Hz,
 3
J = 4.1 Hz) , 
4.41 (broad, 1H, H-5), 3.59-3.60 (m, 2H, iPr-CHMe2), 3.06 + 2.98 (two sept, 1H each, 
iPr-CHMe2, 
3
J = 6.7 Hz), 1.51 + 1.44 (two d, 3H each, iPr-CH3, 
3
J = 6.7 Hz), 1.23 + 
1.17 + 1.13 (three d, 9H: 3H: 6H, iPr-CH3, 
3
J = 6.7 Hz), 0.55 (s, 1H, C-CH(SiMe3)2), 
0.18 + 0.04 (two s, 9H each, C-CH(SiMe3)2). 
13C{1H} NMR ppm (C6D6): 175.7 (C-1’), 
153.9, 152.5, 148.7, 148.5, 141.8, 141.6, 136.6, 136.4, 129.9, 128.2, 127.9, 125.4, 124.4, 
124.2, 123.7 (C-5’ + C-3), 123.1, 123.0, 122.9, 121.2 (C-4’), 120.4, 116.8 (C-4), 102.7, 
38.5 (C-5), 29.1 + 28.9 + 28.6 + 28.5 (iPr-CHMe2), 25.2 (C-CH(SiMe3)2), 24.9 + 24.7 + 
24.6 + 24.4 + 23.9 + 23.8 (iPr-CH3), 2.3 + 2.1 (C-CH(SiMe3)2). Anal. Calc. for 
C43H59KN2Si2 (699.2): C, 73.86; H, 8.51; N, 4.01%. Found: C, 73.79; H, 8.59; N, 3.96%. 
 
Synthesis of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}Mg{CH(SiMe3)2}(THF)] (94) 
 
 
 
 
 
 
50 mg of 37a (103.9 µmol) and 52 mg of dipp-BIAN (103.9 µmol) in C6D6. The 
reaction mixture was heated at 60 oC over night and slowly turned dark green. 1H NMR 
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data showed the clean formation of complex 94 as the sole product of the reaction 
(NMR yield 100%). The reaction was scaled up (37a 271 mg, 0.599 mmol; dipp-BIAN 
300 mg, 0.599 mmol), heated for 24 hours at 60 oC in toluene before the solvent was 
removed in vacuo. Due to failure to recrystallise the crude solid from minimal amount 
of pentane, even after months of storage at -30 oC, complex 94 was used as a crude 
green solid, whose purity was confirmed by NMR and elemental analysis data. 1H NMR 
ppm (C6D6): 7.15-7.25 (m, 6H, Ar-H), 6.45 (d, 1H, H-3’, 
3
J = 7.7 Hz), 6.05 (t, 1H, H-4’, 
3
J = 7.7 Hz), 5.47 (dd, 1H, H-3, 3Jcis = 10.2 Hz, 
4
J = 2.3 Hz), 5.44-5.47 (m, 1H, H-5’), 
5.05 (dd, 1H, H-4, 3Jcis = 10.2, 
3
J = 4.4Hz), 4.07 (m, 1H, H-5), 3.78 (broad m, THF), 
3.55 + 3.11 (two sept, 2H each, iPr-CHMe2, 
3
J = 6.8 Hz), 1.41-1.44 (m, 14H, iPr-CH3 + 
THF), 1.39 + 1.36 + 1.31 + 1.29 + 1.16 + 1.13 (six d, 3H each, iPr-CH3, 
3
J = 6.8 Hz)), 
0.46 (d, 1H, C-CH(SiMe3)2, 
3
J = 1.6 Hz), 0.00 (s, 18H, Mg-CH(SiMe3)2), 0.01 + -0.03 
(two s, 9H each, C-CH(SiMe3)2), -1.59 (s, 1H, Mg-CH(SiMe3)2). 
13C{1H} NMR ppm 
(C6D6): 181.9 (C-1’), 149.5, 148.8, 148.2, 146.5, 144.5, 139.5, 139.4, 133.1, 133.0 (C-
3’), 131.8, 127.2, 126.0, 125.8 (C-4), 125.2, 124.9, 124.8 (C-5’), 124.6, 124.5, 124.0, 
123.4 (C-4’), 122.6 (C-3), 122.1, 111.8 (C-2), 68.9 (THF, very broad), 38.4 (C-5), 29.1 
+ 28.9 + 28.6 + 28.6 (iPr-CHMe2), 25.9 + 25.33 + 25.29 + 25.27 + 25.1 + 24.9 + 24.8 + 
24.7 (iPr-CH3), 23.9 (THF), 22.7 (C-CH(SiMe3)2), 5.6 (Mg-CH(SiMe3)2), 2.1 + 1.0 (C-
CH(SiMe3)2), -3.1 (Mg-CH(SiMe3)2). Anal. Calc. for C54H86MgN2OSi4 (915.9): C, 
70.81; H, 9.46; N, 3.06%. Found: C, 70.79; H, 9.36; N, 2.95%. 
 
Synthesis of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}Ca{CH(SiMe3)2}(THF)2] (95) 
 
 
 
 
 
 
50 mg of 37b (99.8 µmol) and 50 mg of dipp-BIAN (99.8 µmol) were dissolved in C6D6. 
The reaction mixture turns instantly dark green. 1H NMR data showed the clean 
formation of complex 95 as the sole product of the reaction (NMR yield 100%). The 
reaction was scaled up (37b 1.00 g, 2 mmol; dipp-BIAN 1.00 g, 2 mmol), stirred for 10 
minutes at room temperature in toluene before the solvent was removed in vacuo. Due 
to failure to recrystallise the crude solid from minimal amount of pentane, even after 
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months of storage at -30 oC, complex 95 was used as a crude dark green solid, whose 
purity was confirmed by NMR and elemental analysis data. 1H NMR ppm (C6D6): 7.15-
7.26 (m, 6H, Ar-H), 6.46 (d, 1H, H-3’, 3J = 7.7 Hz), 6.06 (t, 1H, H-4’, 3J = 7.7 Hz), 
5.43-5.47 (m, 2H, H-5’ + H-3), 4.96 (dd, 1H, 3Jcis = 10.2, 
3
J = 4.4 Hz), 4.12 (m, 1H, H-
5), 3.62 (sept, 2H, iPr-CHMe2, 
3
J = 6.8 Hz), 3.51 (broad m, THF), 3.24 (sept, 2H, iPr-
CHMe2, 
3
J = 6.7 Hz), 1.49 (d, 6H each, iPr-CH3, 
3
J = 6.7 Hz), 1.41 + 1.34 (two d, 3H 
each, iPr-CH3, 
3
J = 6.8 Hz), 1.18-1.31 (m, 20H, THF + iPr-CH3), 0.48 (d, 1H, C-
CH(SiMe3)2, 
3
J = 1.6 Hz), 0.21 (s, 18H, Ca-CH(SiMe3)2), 0.04 + 0.00 (two s, 9H each, 
C-CH(SiMe3)2), -1.72 (s, 1H, Ca-CH(SiMe3)2). 
13C{1H} NMR ppm (C6D6): 181.7 (C-
1’), 150.1, 149.7, 148.2, 146.1, 143.3, 142.7, 138.8, 137.0, 132.5 (C-3’), 131.2, 126.4, 
126.2, 124.5, 124.5 (C-3), 124.4, 124.0, 123.8, 123.5 (C-4), 123.1, 122.7 (C-5’), 122.6 
(C-4’), 110.7 (C-2), 69.6 (THF, very broad), 38.3 (C-5), 29.3 + 29.2 + 28.9 + 28.5 (iPr-
CHMe2), 26.0 + 25.6 + 25.3 + 25.2 + 25.2 + 24.7 + 24.4 + 24.3 (
iPr-CH3), 25.3 (THF), 
23.4 (C-CH(SiMe3)2), 14.3 (Ca-CH(SiMe3)2), 6.1 (Ca-CH(SiMe3)2), 2.1 + 1.0 (C-
CH(SiMe3)2). Anal. Calc. for C58H94CaN2O2Si4 (1003.8): C, 69.40; H, 9.44; N, 2.79%. 
Found: C, 69.34; H, 9.34; N, 2.73%. 
 
Synthesis of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}Sr{CH(SiMe3)2}(THF)2] (96) 
 
 
 
 
 
 
50 mg of 37c (90.8 µmol) and 45 mg of dipp-BIAN (90.8 µmol) were dissolved in C6D6. 
The reaction mixture turns instantly dark green. 1H NMR data showed the clean 
formation of complex 96 as the sole product of the reaction (NMR yield 100%). The 
reaction was scaled up (37b 551 mg, 1 mmol; dipp-BIAN 0.50 g, 1 mmol), stirred for 
10 minutes at room temperature in toluene before the solvent was removed in vacuo. 
Due to failure to recrystallise the crude solid from minimal amount of pentane, even 
after months of storage at -30 oC, complex 96 was used as a crude dark green solid, 
whose purity was confirmed by NMR and elemental analysis data. 1H NMR ppm 
(C6D6): 6.97-7.16 (m, 6H, Ar-H), 6.45 (d, 1H, H-3’, 
3
J = 7.7 Hz), 6.06 (t, 1H, H-4’, 3J = 
7.7 Hz), 5.41 (dd, 1H, H-3, 3Jcis = 10.2 Hz, 
4
J = 2.1 Hz), 5.40-5.42 (m, 1H, H-5’), 4.89 
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(dd, 1H, H-4, 3Jcis = 10.2, 
3
J =4.6 Hz), 4.15 (m, 1H, H-2), 3.68 (sept, 2H, iPr-CHMe2, 
3
J 
= 6.8 Hz), 3.37 (broad m, THF), 3.27 (sept, 2H, iPr-CHMe2, 
3
J = 6.7 Hz), 1.53 + 1.52 
(two d, 3H each, iPr-CH3, 
3
J = 6.7 Hz), 1.38 + 1.36 (two d, 3H each, iPr-CH3, 
3
J = 6.8 
Hz), 1.25-1.31 (m, 20H, iPr-CH3 + THF), 0.49 (d, 1H, C-CH(SiMe3)2, 
3
J = 1.6 Hz), 0.30 
(s, 18H, Sr-CH(SiMe3)2), 0.06 + -0.01 (two s, 9H each, C-CH(SiMe3)2), -1.86 (s, 1H, Sr-
CH(SiMe3)2). 
13C{1H} NMR ppm (C6D6): 181.1 (C-1’), 151.1, 150.2, 149.0, 146.9, 
143.3, 142.6, 138.6, 138.4, 132.4 (C-3’), 131.0, 126.3, 125.9, 124.5 (C-5’), 124.2, 124.3, 
123.7, 123.1, 123.0, 122.9 (C-3), 122.5 (C-4), 122.2 (C-4’), 109.5 (C-2), 69.4 (THF, 
very broad), 38.4 (C-5), 29.5 + 29.3 + 29.0 + 28.6 (iPr-CHMe2), 26.0 + 25.7 + 25.4 + 
25.3 + 25.2 + 24.9 + 24.4 + 24.3 (iPr-CH3), 25.3 (THF), 23.6 (C-CH(SiMe3)2), 19.1 (Sr-
CH(SiMe3)2), 6.4 (Sr-CH(SiMe3)2), 2.2 + 1.1 (C-CH(SiMe3)2). Anal. Calc. for 
C58H94N2O2Si4Sr (1051.3): C, 66.26; H, 9.01; N, 2.66%. Found: C, 66.33; H, 8.97; N, 
2.70%. 
 
Synthesis of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}Ba{CH(SiMe3)2}(THF)2] (97) 
 
 
 
 
 
 
50 mg of 37d (83.3 µmol) and 42 mg of dipp-BIAN (83.3 µmol) were dissolved in C6D6. 
The reaction mixture turns instantly dark green. 1H NMR shows presence of three 
components among which the heteroleptic barium alkyl complex 97 (70%) and the 
homoleptic barium complex 98 (20%). Upon recrystallisation of the crude mixture from 
toluene at -30 oC for a week, orange crystals of compound 99 suitable for X-ray 
diffraction analysis were isolated from the reaction mixture. The amount of 99 which 
was isolated was, however, insufficient for the acquisition of both NMR and elemental 
analysis data. Although attempts to separate 97 and 98 by recrystallisation failed 
preventing the acquisition of elemental analysis data, compound 98 could be 
synthesised in high purity by independent methods (vide infra). 1H NMR ppm (C6D6) 
for 97: 7.08-7.23 (m, 6H, Ar-H), 6.48 (d, 1H, H-3’, 3J = 7.7 Hz), 6.08 (t, 1H, H-4’, 3J = 
7.7 Hz), 5.47-5.51 (m, 2H, H-5’ + H-4), 4.88 (dd, 1H, H-4, 3Jcis = 10.2, 
3
J = 4.4Hz), 
4.21 (m, 1H, H-5), 3.69 (sept, 2H, iPr-CHMe2, 
3
J = 6.8 Hz), 3.32 (broad m, 8H, THF), 
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3.27 (sept, 2H, iPr-CHMe2, 
3
J = 6.7 Hz), 1.53 + 1.49 (two d, 3H each, iPr-CH3, 
3
J = 6.7 
Hz), 1.37 + 1.34 (two d, 3H each, iPr-CH3, 
3
J = 6.8 Hz), 1.22-1.32 (m, 20H, THF + iPr-
CH3), 0.50 (d, 1H, C-CH(SiMe3)2, 
3
J = 1.6 Hz), 0.29 (s, 18H, Ba-CH(SiMe3)2), 0.09 + 
0.04 (two s, 9H each, C-CH(SiMe3)2), -1.73 (broad s, 1H, Ba-CH(SiMe3)2). 
13C{1H} 
NMR ppm (C6D6): 179.9 (C-1’), 150.8, 149.8, 148.8, 147.0, 143.2, 142.7, 138.0, 135.7, 
132.2 (C-3’), 131.1, 126.1, 125.6, 124.4 (C-5’), 124.2, 124.0, 123.9, 123.8, 123.6, 123.2, 
122.9 (C-3), 122.6 (C-4), 122.0 (C-4’), 107.5 (C-2), 68.3 (THF, very broad), 38.4 (C-5), 
33.8 (Ba-CH(SiMe3)2), 29.6 + 29.5 + 29.0 + 28.8 (
iPr-CHMe2), 25.6 + 25.5 + 25.2 + 
25.1 + 25.0 + 24.9 + 24.5 + 24.3 (iPr-CH3), 25.4 (THF), 23.8 (C-CH(SiMe3)2), 6.1 (Ba-
CH(SiMe3)2), 2.2 + 1.4 (C-CH(SiMe3)2).  
 
Independent syntheses of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}2Ba (THF)2] (98) 
 
 
 
 
 
a) 15 mg of 37d (25.0 µmol) and 25 mg of dipp-BIAN (50 µmol) were dissolved in d8-
toluene at room temperature. After 10 minutes the solution had turned a homogeneous 
dark green. 1H NMR data showed the clean formation of 98 as the sole product of the 
reaction. b) [KCH(SiMe3)2] (300 mg, 1.50 mmol) and 37d (455 mg, 0.75 mmol) were 
stirred in THF at room temperature for 24 hours prior to removal of the solvent in vacuo 
and extraction into toluene. Removal of the solvent yielded complex 98 as a crude dark 
green solid whose 1H NMR spectrum was reminiscent of that obtained from the reaction 
described in a). 1H NMR ppm (d8-tol): 6.84-7.32 (m, 12H, Ar-H), 6.46 (d, 2H, H-3’, 
3
J 
= 7.7 Hz), 6.00 (t, 2H, H-4’, 3J = 7.7 Hz), 5.34 (dd, 2H, H-5’, 3J = 7.7 Hz, 4J = 4.2 Hz), 
5.17 (dd, 2H, H-3, 3Jcis = 10.2 Hz, 
4
J =1.5 Hz), 4.77 (dd, 2H, H-4, 3Jcis = 10.2, 
3
J = 4.3 
Hz), 4.16 (broad s, 2H, H-5), 3.46-3.62 (m, 12H, THF + iPr-CHMe2), 3.09 (sept, 4H, 
iPr-CHMe2, 
3
J = 6.6 Hz), 1.45 (m, 8H, THF), 1.38 + 1.35 (two d, 6H each, iPr-CH3, 
3
J = 
6.7 Hz), 1.24 (d, 6H, iPr-CH3, 
3
J = 6.8 Hz), 1.03-1.14 (m, 30H, iPr-CH3), 0.49 (broad s, 
2H, CH(SiMe3)2, 
3
J = 1.6 Hz), 0.02 + -0.04 (two s, 9H each, SiMe3). 
13C{1H} NMR 
ppm (d8-tol): 180.3 (C-1’), 151.0, 150.70, 150.69, 149.9, 147.69, 147.64, 143.7, 143.25, 
143.22, 138.73, 138.70, 138.61, 138.56, 138.15, 138.23, 137.47, 137.57, 132.5, 131.1, 
126.7, 126.0, 124.9, 124.65, 124.71, 124.6, 123.77, 123.73, 123.5, 122.3, 122.1, 109.22, 
N
N
Dipp
Dipp
(Me3Si)2HC *
Ba (THF)2
2
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109.19, 68.0 (THF, broad), 38.8 (C-5), 29.9 + 29.7 + 29.5 + 29.1 +28.8 (iPr-CHMe2), 
26.24 + 26.18 + 26.11 + 25.9 + 25.5 + 24.4 + 23. 8 (iPr-CH3), 25.1 (THF), 23.4 + 23.2 
(CH(SiMe3)2), 2.8 + 1.3 (SiMe3).  
 
Independent syntheses of [{(C
5
-CH(SiMe3)2)(dipp-BIAN)}2Ca (THF)] (100) 
 
 
 
 
[KCH(SiMe3)2] (300 mg, 1.50 mmol) and 37b (379 mg, 0.75 mmol) were stirred in 
THF at room temperature for 24 hours prior to removal of the solvent in vacuo and 
extraction into hexane. Removal of the solvent yielded complex 100 as a crude dark 
green solid which was recrystallised from a 10:1 toluene/THF mixture at -30 oC over 
several days, yielding complex 100 as dark green solid (265 mg, 25%) in a first fraction 
and green crystals in a second one. Due to apparent fluxional behaviour in solution 1H 
NMR peaks were extremely broad and 13C{1H} NMR signals too weak for analysis. 1H 
NMR (C6D6): 6.99-7.25 (m, 12H, Ar-H), 6.45 (broad d, 2H, H-3’, 
3
J = 7.7 Hz), 6.05 
(broad t, 2H, H-3’, 3J = 7.7 Hz), 5.23-5.38 (broad m, 4H, H-3/4), 4.99 (broad d, 2H, H-
5’, 3J = 7.7 Hz), 4.18 (s, 2H, H-5), 3.60 (broad m, 4H, THF), 2.99-3.44 (broad m, 8H, 
iPr-CHMe2), 0.68-1.34 (broad m, 52H each, 
iPr-CH3 + THF), 0.51 (broad s, 1H, C-
CH(SiMe3)2), 0.05 + -0.04 (two broad s, 9H each, C-CH(SiMe3)2). Anal. Calc. for 
C90H126CaN4OSi4 (1432.4): %C, 75.46; H, 8.87; N, 3.91%. Found: C, 75.29; H, 8.74; N, 
3.84%. 
 
Synthesis of [{(C
5
-CH(SiMe3)(2-NMe2-Ph))(dipp-BIAN)}K]6 (101) 
 
 
 
 
 
 
[K{CH(SiMe3)(2-NMe2-Ph)}] (25 mg, 83.5 µmol) and dipp-BIAN (42 mg, 83.5 µmol) 
were dissolved in d8-toluene. The solution instantly turned dark green. Crystallisation 
after one day at room temperature afforded dark green crystals of the (R,S) + (S,R) 
N
N
Dipp
Dipp
(Me3Si)2HC *
Ca THF
2
N
N
Dipp
Dipp
K
*
Me3Si
NMe2
*
6
(R,S) + (S,R) 88%
(S,S) + (R,R) 12%
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diastereomer of complex 101 (51 mg, 68.3 µmol 82%). 1H NMR ppm (d8-tol) of the 
major (R,S) + (S,R) diastereomer (88%): 6.88-7.20 (m, 10H, Ar-H), 6.04 (d, 1H, H-3’, 
3
J = 7.7 Hz), 5.60 (t, 1H, H-4’, 3J = 7.7 Hz), 5.44-5.50 (m, 2H, H-3/5’), 4.63-4.67 (m, 
1H, H-4), 3.81 (broad s, 1H, H-5), 3.49 (sept, 2H, iPr-CHMe2, 
3
J = 6.7 Hz), 3.35 (s, 1H, 
CH(SiMe3)), 2.95 (sept, 1H, 
iPr-CHMe2, 
3
J = 6.6 Hz), 2.85 (broad m, 1H, iPr-CHMe2), 
2.33 (s, 6H, NMe2), 1.52 (d, 3H, 
iPr-CH3, 
3
J = 6.6 Hz), 1.30-1.44 (m, 6H, iPr-CH3), 
0.98-0.19 (m, 12H, iPr-CH3), 0.81 (d, 3H, 
iPr-CH3, 
3
J = 6.7 Hz), -0.03 (s, 9H, SiMe3); 
minor (R,R) + (S,S) diastereomer (12%): 6.66 (d, 1H, H-3’, 3J = 7.7 Hz), 5.85-5.88 (m, 
1H, H-4’), 3.46-3.49 (m, 1H, H-3/5’), 4.78 (broad d, 1H, H-4, 3Jcis = 10.1 Hz), 3.81 
(broad s, 1H, H-5), 3.53 (m, 2H, iPr-CHMe2 + CH(SiMe3), identified by COSY), 2.95 + 
2.85 (two broad sept, 1H each, iPr-CHMe2), 2.45 (s, 6H, NMe2), 0.99-1.57 (m, 24H, 
iPr-
CH3), 0.00 (s, 9H, SiMe3). 
13C{1H} NMR ppm (d8-tol), mixture of both diastereomers: 
174.1 (C-1), 153.2, 152.6, 148.0, 141.1, 140.8, 140.1, 137.8, 137.7, 137.6, 137.2, 137.1, 
136.1, 135.1, 132.1 (C-3’), 128.1, 125.3, 123.8, 123.7, 123.5, 123.0 (C-3/5’), 122.5 
(C3/5’), 120.7, 119.3 (C-4’), 111.8 (C-4), 45.1 (NMe2), 42.1 (C-5), 40.1 (CH(SiMe3)), 
29.2 +29.1 + 28.8 + 28.4 (iPr-CHMe2), 25.7 + 25.2 + 25.1 + 24.5 + 24.4 + 24.2 + 23.5 + 
23.4 + 23.2 (iPr-CH3), -0.04 (SiMe3). Anal. Calc. for C288H360K6N18Si6 (4477.14): %C, 
77.26; H, 8.10; N, 5.63. Found: %C, 77.22; H, 8.19; N, 5.58. 
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6.11 1H NMR spectra of compounds lacking elemental analysis data 
and/or crystal structures 
 
 
Figure 76. 
1H NMR spectrum of complex 64. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 77. 
1H NMR spectrum of complex 65. 
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Figure 78. 
1H NMR spectrum of complex 66. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 79. 
1H NMR spectrum of complex 75. 
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Figure 80. 
1H NMR spectrum of complex 94. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 81. 
1H NMR spectrum of complex 96. 
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6.12 X-ray crystallography data 
 
 
 37a 41 43 44 
Molecular formula C22H54MgO2Si4 C41H71N4OSi2Sr C144.30H126.30Cl6.90N4 C86H86MgN2O 
Formula weight 
(g mol-1) 
487.32 779.82 2161.00 1187.88 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic 
Space group C 2/c P 21/n P 21 P 21 
a (Å) 18.1694(4) 11.7396(2) 14.8918(2) 13.9290(5) 
b (Å) 9.5586(2) 18.1629(3) 22.3244(4) 15.8762(7) 
c (Å) 18.6690(5) 22.0002(3) 18.9375(3) 15.5792(7) 
α (deg) 90 90 90 90 
β (deg) 109.4520(10) 105.0920(10) 109.1590(10) 96.364(2) 
γ (deg) 90 90 90 90 
V (Å3) 3057.25(12) 4529.20(12) 5947.07(16) 3423.9(2 
Z 4 4 2 2 
µ (mm-1) 0.230 1.276 0.218 0.075 
ρ (g cm-3) 1.059 1.144 1.207 1.152 
θ range (o) 5.20 to 27.50 4.93 to 27.48 3.46 to 25.04 4.07 to 25.08 
Measured/indepen- 
dent reflections/ Rint 
21287 / 3470 / 
0.0651 
63038 / 10311 / 
0.0577 
87101 / 20791 / 
0.0719 
35511 / 11921 / 
0.1168 
R1,
a wR2 [I > 2σ(I)]
b 0.0397, 0.1038 0.0337, 0.0752 0.0682, 0.1738 0.0658, 0.1330 
R1,
a wR2 (all data)
b 0.0503, 0.1107 0.0529, 0.0831 0.0906, 0.1912 0.1202, 0.1581 
 
 
41.  The asymmetric unit contains one molecule of benzene solvent. 
 
43.  The asymmetric unit contains two independent molecules of the ligand and three independent 
molecules of solvent CHCl3. The N-H hydrogens have been located in the difference Fourier map 
and were freely refined with idealised bond length. Due to solvent loss all CHCl3 molecules have an 
occupation factor of 70-80%. One of the solvent molecules presents a disorder in one Cl atom in a 
1:1 ratio. Bond lengths in this disorder have been restrained.  
 
44.  Each asymmetric unit contains one Mg complex and one molecule of toluene which is disordered 
over two sites in the ratio 56:44. Bond lengths of the two CH3 groups had to be restrained. In the 
adducted THF molecule, atom C(79) presents a disorder over two sites in a 75:25 ratio. The bond 
length C(78)-C(79A) had to be restrained. 
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 58 60 63 64 
Molecular formula C14H26BIN4 C24H30BIN4 C29.50H61.50BN5O2Si2Sr C32H56B2CaN8O 
Formula weight 
(g mol-1) 
388.10 512.23 672.95 630.55 
Crystal system Monoclinic Monoclinic Tetragonal Orthorhombic 
Space group P 21/c P21/m P 42/n P b c a 
a (Å) 11.9656(2) 8.2566(1) 20.54500(10) 16.0309(3) 
b (Å) 10.06550(10) 19.2495(3) 20.54500(10) 19.9759(4) 
c (Å) 15.1879(2) 8.8410(1) 18.9151(2) 23.0604(5) 
α (deg) 90 90 90 90 
β (deg) 96.4050(10) 115.216(1) 90 90 
γ (deg) 90 90 90 90 
V (Å3) 1817.81(4) 1271.25(3) 7984.01(10) 7384.7(3) 
Z 4 2 8 8 
µ (mm-1) 1.759 1.276 1.440 0.205 
ρ (g cm-3) 1.418 1.338 1.120 1.134 
θ range (o) 3.03 to 30.00 3.53 to 30.01 3.67 to 27.49 3.81 to 24.21 
Measured/indepen- 
dent reflections/ Rint 
34042 / 5294 / 
0.0409 
25876 / 3804 / 
0.0413 
132210 / 9125 /  
0.0736 
92909 / 5875 / 
0.2578 
R1,
a wR2 [I > 2σ(I)]
b 0.0682, 0.1256 0.0269, 0.0597 0.0566, 0.1267 0.0609, 0.1191 
R1,
a wR2 (all data)
b 0.0921, 0.1397 0.0351, 0.0632 0.0928, 0.1493 0.1067, 0.1410 
 
 
63. The complex contains one disordered (80:20) THF co-ligand. Each molecule of the complex co-
crystallises with 1/4 of solvent which could be modelled either as hexane or THF, disordered about a 
centre of inversion. NMR spectroscopy indicated that hexane was present.  
  
64.  The sample consisted of low melting crystals which were selected using a modified cryogenic 
device, similar to that described by Veith and Baerninghausen.[288] Weak diffraction resulted in a 
high Rint. The compound contains one THF co-ligand showing a 1:1 disorder in C(32).  
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 67 74 75 76' 
Molecular formula C63H80B2Ca2I2N8O2 C48H80BN9Si2Sr C89H156B2Ba2N20Si4 C25H42BCaIN6O 
Formula weight 
(g mol-1) 
1336.93 937.82 1915.00 758.64 
Crystal system Triclinic Orthorhombic Monoclinic Monoclinic 
Space group P 1 P c a b P 21/n P 21/c 
a (Å) 12.7284(4) 19.16240(10) 22.00420(10) 18.4848(16) 
b (Å) 15.4087(6) 20.46130(10) 13.95240(10) 10.5873(9) 
c (Å) 18.6707(8) 27.5283(2) 34.0515(2) 20.6304(15) 
α (deg) 88.9100(10) 90 90 90 
β (deg) 84.7710(10) 90 91.5650(10) 93.155(5) 
γ (deg) 65.664(2) 90 90 90 
V (Å3) 3321.9(2) 10793.50(11) 10450.30(11) 4031.3(6) 
Z 2 8 4 4 
µ (mm-1) 1.147 1.082 0.845 0.95 
ρ (g cm-3) 1.337 1.154 1.217 1.25 
θ range (º) 3.67 to 24.94 3.12 to 27.49 3.52 to 27.47 3.47 to 26.02 
Measured/indepen- 
dent reflexions/ Rint 
30202 / 11375 / 
0.1265 
176037 / 12336 / 
0.1222 
135871 / 23755 / 
0.0801 
24028 / 7870 / 
0.060 
R1,
a wR2 [I > 2σ(I)]
b 0.1107, 0.2617 0.0467, 0.0909 0.0399, 0.0797 0.059, 0.123 
R1, wR2 (all data)
b 0.1665, 0.2925 0.0848, 0.1051 0.0724, 0.0900 0.090, 0.138 
 
 
67. The asymmetric unit consists of two molecules of the calcium iodide dimer and one solvent 
molecule of toluene. Both THF groups binding to Ca show potential disorder which could not be 
resolved due to the very weak dataset. The B-H hydrogens were located in the difference Fourier 
map but could not be refined freely because of the poor dataset.  
 
74.  The complex co-crystallises with two molecules of toluene, of which the second presents a potential 
disorder (C(42)-C(48)). Resolving the disorder, however, did not lead to a better result. 
 
75. The complex co-crystallises with two molecules of toluene solvent. One of the tert-butylimidazole 
co-ligands presents a disorder (35:65) in two of the CH3 groups of the tert-butyl substituent. 
 
76'. The complex co-crystallises with two molecules of toluene solvent, one of which is disordered about 
a centre of inversion, the other one over two sites in a 36:64 ratio. The THF co-ligand presents a 
disorder (49:51) in C(23) and C(24). 
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 77 78 79 80 81 
Molecular 
formula 
C70H100B2Br2Ca2N12 C70H100B2N12Sr C100H112B2N12O4Sr2 C26H60CaN6Si4 C52H58B2N4 
Formula weight 
(g mol-1) 
1371.22 1218.86 1742.88 609.24 760.64 
Crystal system Triclinic Monoclinic Triclinic Monoclinic Monoclinic 
Space group P1 C 2/c P1 P21/a C 2/c 
a (Å) 10.81420(10) 25.2604(6) 13.0315(3) 16.6547(3) 17.5721(5) 
b (Å) 12.53040(10) 11.2390(2) 14.9297(4) 10.5277(2) 11.7891(3) 
c (Å) 14.9414(2) 25.2461(6) 15.1218(4) 22.7316(4) 21.3849(4) 
α (deg) 69.7990(10) 90 98.9760(10) 90 90 
β (deg) 88.4830(10) 105.2890(10) 114.247(2) 106.132(1) 103.475(2) 
γ (deg) 77.9470(10) 90 111.9350(10) 90 90 
V (Å3) 1855.92(3) 6913.7(3) 2315.81(10) 3828.72(12) 4308.13(18) 
Z 1 4 1 4 4 
µ (mm-1) 1.277 0.828 1.209 0.312 0.067 
ρ (g cm-3) 1.227 1.171 1.250 1.057 1.173 
θ range (o) 3.01 to 30.01 3.34 to 27.45 4.02 to 24.99 3.90 to 26.50 3.97 to 27.47 
Measured / 
independent 
reflections / Rint 
51329 /  
10759 /  
0.0578 
26486 /  
7654 /  
0.1566 
27544 /  
8086 /  
0.1060 
29884 /  
7866 /  
0.0625 
27498 /  
4879 /  
0.0964 
R1,
a wR2  
[I > 2σ(I)]b 
0.0452,  
0.1062 
0.0600,  
0.1435 
0.0600,  
0.1244 
0.0490,  
0.1172 
0.0487, 
0.1187 
R1,
a wR2  
(all data)b 
0.0710,  
0.1189 
0.0992,  
0.1699 
0.1087,  
0.1474 
0.0717,   
0.1317 
0.0718, 
0.1352 
 
77. The complex co-crystallises with two molecules of toluene solvent. 
 
78. The crystals lost solvent during data collection, hence the bad Rint. It was not possible to use all 
collected data for integration which led to a lower completeness of data (97%). Each asymmetric 
unit consists of 1/2 molecule of the homoleptic Sr complex and two molecules of toluene in three 
positions. One toluene molecule is located on a two-fold axis. Another is disordered about a centre 
of inversion with 50% occupation factor. For the third one, heavily disordered over four positions in 
a 50:15:15:20 ratio, carbon atoms were fitted to a regular hexagon and refined isotropically.  
 
79. The dimer co-crystallises with two molecules of toluene. The two bridging oxygen atoms are 
disordered over three positions in a 2:3:3 ratio. 
 
81. The compound co-crystallises with one molecule toluene solvent disordered in a 1:3 ratio. 
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 86a 86b 86c 86d 
Molecular formula C41H57MgN3O2 C41H57CaN3O2 C258H330N18O6Sr6 C258H330Ba6N18O6 
Formula weight  
(g mol-1) 
648.21 663.98 4305.12 4603.44 
Crystal system Monoclinic Monoclinic Cubic Cubic 
Space group P 21/n P 21/n P a3 P a3 
a (Å) 11.3851(2) 11.5654(3) 28.6787(3) 28.7452(3) 
b (Å) 17.0663(4) 17.1777(5) 28.6787(3) 28.7452(3) 
c (Å) 19.7459(5) 19.9552(6) 28.6787(3) 28.7452(3) 
α (deg) 90 90 90 90 
β (deg) 101.9072 102.483(2) 90 90 
γ (deg) 90 90 90 90 
V (Å3) 3754.10(15) 3870.72(19) 23587.3(4) 23751.8 
Z 4 4 4 4 
µ (mm-1) 0.085 0.199 1.406 1.038 
ρ (g cm-3) 1.147 1.139 1.212 1.287 
θ range (o) 4.67 to 27.50 5.40 to 27.49 3.01 to 25.02 3.61 to 25.03 
Measured/indepen- 
dent reflections/ 
Rint 
45139 / 8530 / 
0.0967 
45280 / 8750 / 
0.1412 
74769 / 6706 / 
0.1521 
202576 / 6961 / 
0.1544 
R1,
a wR2 [I > 
2σ(I)]b 
0.0615, 0.1477 0.0565, 0.1251 0.0472, 0.0827 0.0692, 0.1701 
R1,
a wR2 (all data)
b 0.0997, 0.1730 0.1119, 0.1522 0.0892, 0.0962 0.1115, 0.1947 
 
 
86c. The asymmetric unit contains one molecule of the Sr complex and one benzene solvent molecule. 
C(14)-Sr interactions lead to a hexameric structure. One of the iso-propyl substituents presents a 1:1 
disorder in C(32). 
 
86d. The asymmetric unit contains one molecule of the Ba complex and one benzene solvent molecule. 
C(14)-Ba interactions lead to a hexameric structure. The THF co-ligand presents a potential disorder 
in C(42) but solving the disorder gave no improvement. 
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  93 99 100 101 
Molecular formula C100H134K2N4Si4 C86H118N4Si4 C100H140CaN4O2Si4 C288H360K6N18Si6 
Formula weight 
(g mol-1) 
1582.67 1320.20 1582.60 4477.08 
Crystal system Triclinic Trigonal Triclinic Cubic  
Space group P 1¯ P 31 2 1 P 1¯ I a3 
a (Å) 12.8884(5) 13.7376(4) 17.3947(6) 39.6750(7) 
b (Å) 13.4573(5) 13.7376(4) 18.2532(9) 39.6750(7) 
c (Å) 15.4273(6) 37.1695(13) 19.0363(9) 39.6750(7) 
α (deg) 110.607(2) 90 116.153(2) 90 
β (deg) 96.794(3) 90 108.911(2) 90 
γ (deg) 97.900(2) 120 91.946(2) 90 
V (Å3) 2440.37(16) 6074.9(3) 5020.1(4) 62452.6(19) 
Z 1 3 2 8 
µ (mm-1) 0.191 0.118 0.156 0.154 
ρ (g cm-3) 1.077 1.083 1.047 0.952 
θ range (º) 6.40 to 25.00 2.97 to 25.05 4.81 to 25.05 2.99 to 25.02 
Measured/indepen- 
dent reflexions/ Rint 
27778 / 8336 /  
0.0641 
28082 / 7053 / 
0.0931 
79347 / 17520 / 
0.1864 
55758 / 9182 /  
0.1026 
R1,
a wR2 [I > 2σ(I)]
b 0.0704, 0.1528 0.0684, 0.1120 0.0975, 0.2301 0.1001, 0.2422 
R1,
a wR2 (all data)
b 0.0990, 0.1706 0.1416, 0.1325 0.2083, 0.2979 0.1786, 0.2848 
 
93. The dimer co-crystallises with one molecule of toluene solvent. 
100. The crystal was very small and weakly diffracting, hence the high Rint. The asymmetric unit contains 
the complex and three solvent molecules. Two half-occupied THF (bond lengths in the THF 
containing O(3) had to be restrained) and one benzene molecule disordered over two sites in a 63:37 
ratio. Atoms of the benzene unit have been refined isotropically. All methyl groups of the 
CH(SiMe3)2 substituent containing Si(1) and Si(2) present a rotational disorder in a 42:58 ratio.  
101. The asymmetric unit contains 1/6 of a hexameric arranged K complex. It further contains one 
toluene solvent molecule with 50% occupation factor which is disordered over a two-fold axis. 
Another toluene molecule is disordered about a three-fold axis with an occupation factor of 33%. A 
trace of a further solvent molecule was located over a three-fold axis but could not properly be 
solved. The very large crystal diffracted well at low angles but presented a decline in intensity above 
2θ = 35o. Therefore the solvent disorders could not be solved satisfactory. The PLATON programme 
SQUEEZE was employed to take care of the solvent-containing voids. Checkcif detected a potential 
disorder in one of the iso-propyl groups (C(39)-C(41)). Due to the lack of high angle intensity data 
this could not be solved properly.  
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6.13 Kinetic data for hydroamination catalysis 
 
 
NB: The temperatures quoted here are those displayed by the internal probe of the 
NMR spectrometer. For real temperatures derived from displayed temperatures, 
refer to the equations in section 6.5.1. 
 
 
 
 
 
 
 
 
 
288-293 K: cooling power 5% 
298-302 K: no cooling 
 
 
 
 
 
 
 
 
 
308-323 K: no cooling 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 35b (2 mol%) 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 35c (2 mol%) 
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293-308 K: cooling power 5% 
 
 
 
 
 
 
 
 
308-321 K: no cooling 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 36b (2 mol%) 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 36c (2 mol%) 
230 
 
 
 
 
 
 
 
 
268-288 K: cooling power 5%  
 
 
 
 
 
 
 
 
 
273-288 K: cooling power 5% 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 2 (2 mol%) 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 33 (2 mol%) 
231 
 
 
 
 
 
 
 
 
298-313 K: cooling power 5% 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.80 M, 0.5 mL) with 34 (2 mol%) 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.56 M, 0.5 mL C6D6)  
with variable concentration of 35b (298 K) 
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Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.56 M, 0.5 mL C6D6)  
with variable concentration of 35c (313 K) 
Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.56 M, 0.5 mL C6D6)  
with variable concentration of 36b (293 K) 
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Kinetic analyses for the cyclisation of (1-allylcyclohexyl) 
methylamine (0.56 M, 0.5 mL C6D6)  
with variable concentration of 36c (293 K) 
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